CTID,Title,Conditions,Results First Posted,Ticker
NCT00707057,Ibuprofen Extended-Release Dental Pain Study,Pain|Post-Operative Pain|Third Molar Extraction,3/23/2011,
NCT00491530,"A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia",Mixed Dyslipidemia,12/7/2009,ABT
NCT00427921,Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderate to Severe Crohn's Disease (ACCESS),Crohn's Disease,10/23/2009,ABT
NCT00358917,Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Administration When Coadministered With Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Antiretroviral-Experienced Human Immunodeficiency Virus Type 1 Infected Subjects,Human Immunodeficiency Virus Infections,2/1/2010,ABT
NCT00300482,Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood,Dyslipidemia|Coronary Heart Disease|Mixed Dyslipidemia,3/25/2009,ABT
NCT00300469,Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood,Mixed Dyslipidemia|Coronary Heart Disease|Dyslipidemia,3/25/2009,ABT
NCT00300456,Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood,Dyslipidemia|Coronary Heart Disease|Mixed Dyslipidemia,3/25/2009,ABT
NCT00300430,"Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.",Dyslipidemia|Coronary Heart Disease|Mixed Dyslipidemia,7/23/2009,ABT
NCT00234832,A Long Term Study of Sibutramine and the Role of Obesity Management in Relation to Cardiovascular Disease in Overweight and Obese Patients,Obesity,4/15/2010,ABT
NCT01295814,Efficacy Study of Adalimumab to Treat Interstitial Cystitis,Interstitial Cystitis,7/16/2015,ABT
NCT01138475,Trial Of Paricalcitol and Cholecalciferol(Vitamin D3) in the Treatment Of Secondary Hyperparathyroidism in Patients After ROUX-EN-Y Gastric Bypass Surgery,Gastric Bypass|Parathyroid Hormone,3/22/2017,ABT
NCT00413244,The Cardiac Benefit of Testosterone Replacement in Men With Low Testosterone Levels With Coronary Artery Disease After Successful Intervention of the Blockage or Narrowed Heart Artery,Coronary Artery Disease,1/5/2017,ABT
NCT00194116,"Double-blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar II Depression",Bipolar Disorder,7/17/2019,ABT
NCT00194129,Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Disorder and Substance Abuse Disorder,Bipolar Disorder,12/23/2013,ABT
NCT00711009,Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL),Human Immunodeficiency Virus Infection,2/2/2011,ABT
NCT01070303,"Remission in Subjects With Crohn's Disease, Open Label Extension",Crohn's Disease,5/7/2010,ABT
NCT00647270,"Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week Dosing",Rheumatoid Arthritis,5/10/2010,ABT
NCT00660010,Study of Lupron Depot In The Treatment of Central Precocious Puberty,"Puberty, Precocious",7/20/2010,ABT
NCT00639158,Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood,Dyslipidemias|Coronary Heart Disease|Combined (Atherogenic) Dyslipidemia|Mixed Dyslipidemia,11/5/2009,ABT
NCT00635817,A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty,"Puberty, Precocious",2/9/2011,ABT
NCT00630877,Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin,Dyslipidemia,10/9/2009,ABT
NCT00626431,A Study of Leuprolide to Treat Prostate Cancer,Prostate Cancer,11/1/2010,ABT
NCT00626392,Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With Dyslipidemia,Dyslipidemia,8/25/2009,ABT
NCT00566722,Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy,Psoriasis,5/28/2010,ABT
NCT00465088,An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME),Hyperlipidemia|Mixed Dyslipidemia,5/13/2009,ABT
NCT00409682,Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease,Crohn's Disease,8/4/2011,ABT
NCT00408629,Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Active Ulcerative Colitis,Ulcerative Colitis,3/31/2011,ABT
NCT00385736,Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis,Ulcerative Colitis,5/27/2010,ABT
NCT00348283,Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Involving the Colon,Crohn's Disease,2/11/2010,ABT
NCT00262522,"Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, When Coadministered With Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Naive Human Immunodeficiency Virus Type 1 Infected Subjects",Human Immunodeficiency Virus Infections,8/20/2009,ABT
NCT00195715,Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease,Crohn's Disease,1/7/2010,ABT
NCT00195702,Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate.,Rheumatoid Arthritis,3/1/2010,ABT
NCT00195676,Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis,Psoriasis,11/19/2010,ABT
NCT00195650,Long Term Open Label Continuation Study,Rheumatoid Arthritis,7/31/2012,ABT
NCT00085644,Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis,Ankylosing Spondylitis,3/11/2010,ABT
NCT00055497,"Remission in Subjects With Crohn's Disease, 1 Year Phase",Crohn's Disease,5/18/2010,ABT
NCT00048542,Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA),"Arthritis, Juvenile Idiopathic",1/11/2010,ABT
NCT00573313,Effects of SAMe in Patients With Alcoholic Liver Disease,"Liver Disease, Alcoholic",6/10/2013,ABT
NCT00799617,The Testosterone Trials in Older Men,Andropause,8/28/2017,ABT
NCT01608100,Evaluation of a New Cardiac Biomarker Assay,Acute Coronary Syndrome|Acute Myocardial Infarction,3/17/2015,ABT
NCT00933933,Evaluation of Diagnostic HIV Ag/Ab Combo Assay,Human Immunodeficiency Viruses,8/19/2010,ABT
NCT00686205,Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay,Healthy Donors|HIV Positive,7/5/2010,ABT
NCT01396525,Trial to Evaluate the Safety & Efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery,Peripheral Vascular Disease,10/1/2012,ABT
NCT00844532,Trial to Evaluate the Safety & Efficacy of the Absolute Pro™ Peripheral Self-Expanding Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery.,Peripheral Vascular Disease,9/7/2012,ABT
NCT01786993,MultiPoint Pacing IDE Study,Heart Failure,9/30/2016,ABT
NCT01401361,Atrial Flutter Ablation With Contact Therapy Cool Path Ablation System Along With EnSite Velocity Contact System,Typical Atrial Flutter,12/23/2013,ABT
NCT00984204,Clinical Evaluation of Therapy™ Cool Path™ Duo Cardiac Ablation System for the Treatment of Typical Atrial Flutter (AFL),Typical Atrial Flutter,12/20/2013,ABT
NCT00916370,SPIRIT PRIME Clinical Trial,Myocardial Ischemia|Coronary Artery Stenosis|Coronary Disease|Coronary Artery Disease|Coronary Restenosis,6/1/2012,ABT
NCT00307047,SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System,Coronary Artery Disease,10/21/2010,ABT
NCT00180479,SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS),Stents|Coronary Artery Disease|Total Coronary Occlusion|Coronary Artery Restenosis|Stent Thrombosis|Vascular Disease|Myocardial Ischemia|Coronary Artery Stenosis,12/15/2008,ABT
NCT01663363,Safety and Effectiveness of Wavefront-Guided LASIK Corrections of Myopic Refractive Errors,Myopia,6/26/2015,ABT
NCT01098812,Clinical Evaluation of a 1-Piece Intraocular Lens,Cataract,7/2/2013,ABT
NCT00961051,Evaluation of an Investigational Multi-Purpose Solution (MPS),Study Focus is Healthy Contact Lens Wearers,1/7/2014,ABT
NCT00747227,Safety and Efficacy of a Violet Visible Light Blocking Intraocular Lens (IOL),Cataract,11/11/2011,ABT
NCT01064401,Efficacy and Safety of BIIB019 (Daclizumab High Yield Process) Versus Interferon β 1a in Participants With Relapsing-Remitting Multiple Sclerosis,Relapsing-Remitting Multiple Sclerosis,7/11/2016,ABBV
NCT00660387,"Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects",Advanced Parkinson's Disease,1/16/2015,ABBV
NCT00360568,Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects,Dyskinesias|Parkinson's Disease|Severe Motor Fluctuations,1/16/2015,ABBV
NCT00335153,Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease,Advanced Parkinson's Disease,1/16/2015,ABBV
NCT00357994,"Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects",Advanced Parkinson's Disease,1/16/2015,ABBV
NCT03069365,A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal Impairment,Hepatitis C Virus (HCV),3/4/2019,ABBV
NCT02966795,A Study of of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection,Hepatitis C Virus (HCV),7/10/2019,ABBV
NCT01185301,Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA),Early Rheumatoid Arthritis,11/15/2013,ABBV
NCT00939003,Study of Adalimumab in Patients With Axial Spondyloarthritis,Axial Spondyloarthritis,3/6/2012,ABBV
NCT00763321,Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP),Chronic Low Back Pain,12/23/2013,ABBV
NCT00761150,Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP),Chronic Low Back Pain,12/23/2013,ABBV
NCT00667446,Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty,Precocious|Leuprolide Acetate|Luteinizing Hormone (LH)|Gonadotrophin-releasing Hormone Agonist (GnRHa)|Tanner Staging|Depot Formulation|Suppression of LH|Central Precocious Puberty (CPP)|Gonadotrophin-releasing Hormone (GnRH)|Lupron|GnRH Analog|Pediatrics Central Precocious Puberty,12/10/2013,ABBV
NCT00616772,"Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood",Coronary Artery Disease|Coronary Heart Disease|Dyslipidemia,1/20/2014,ABBV
NCT00497146,The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4,Chronic Kidney Disease|Left Ventricular Hypertrophy,12/23/2011,ABBV
NCT00195663,Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis,Early Rheumatoid Arthritis,2/25/2010,ABBV
NCT02553317,Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura,Acquired Thrombotic Thrombocytopenic Purpura,5/22/2019,
NCT01991860,US Phase III Study of APD421 in PONV,PONV,9/6/2018,
NCT02449291,Study of APD421 as PONV Treatment (no Prior Prophylaxis),Postoperative Nausea and Vomiting,12/18/2018,
NCT02337062,Phase IIIb Study of APD421 in Combination as PONV Prophylaxis,PONV,8/4/2017,
NCT02646566,Study of APD421 as PONV Treatment (Prior Prophylaxis),Postoperative Nausea and Vomiting,12/18/2018,
NCT01174004,A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis,Parkinson's Disease Psychosis,3/26/2014,ACHC
NCT00658567,A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis,Parkinson's Disease Psychosis,9/9/2014,ACHC
NCT00550238,A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis,Parkinson's Disease Psychosis,6/24/2019,ACHC
NCT00477672,A Study of the Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis,Parkinson's Disease Psychosis,3/26/2014,ACHC
NCT00198822,Impact of Maternal Vitamin A or Beta-Carotene Supplementation on Maternal and Infant Mortality in Bangladesh,Vitamin A Deficiency|Maternal Mortality|Infant Mortality,10/12/2011,
NCT00791934,Clinical Study of Safety and Efficacy for the Relieva Stratus With Elution of Triamcinolone Acetonide,Sinusitis,7/14/2014,
NCT01202578,Evaluation of the Tympanostomy Tube Delivery System,Otitis Media With Effusion|Acute Otitis Media,7/11/2014,
NCT01660763,Efficacy and Safety Trial to Evaluate the Sufentanil NanoTab® PCA System/15 mcg (Zalviso™) for Post-Operative Pain in Patients After Knee or Hip Replacement Surgery,Post Operative Pain,2/3/2014,ACRX
NCT02662556,"A Multicenter, Open-Label Trial to Evaluate the Safety and Efficacy of the Sufentanil Sublingual Tablet 30 mcg in Patients With Post-Operative Pain",Acute Moderate-to-severe Pain,3/15/2017,ACRX
NCT02447848,Open-Label Safety and Efficacy of the Sufentanil Sublingual Tablet 30 mcg for Acute Pain,Moderate-to-severe Acute Pain,10/19/2017,ACRX
NCT02356588,A Trial Evaluating the Efficacy and Safety of the Sublingual Sufentanil Tablet 30 mcg for Post-Operative Pain After Abdominal Surgery,Post-Operative Pain,2/13/2017,ACRX
NCT02662764,Study to Evaluate the Overall Performance of the Zalviso System™ (Sufentanil Sublingual Tablet System) 15 mcg,Moderate-to-severe Acute Pain,8/8/2018,ACRX
NCT01539538,"A Multicenter, Randomized, Open-Label, Parallel-Group Trial to Compare the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalviso™)to Intravenous Patient-Controlled Analgesia With Morphine for the Treatment of Acute Post-Operative Pain",Post-Operative Pain,3/27/2014,ACRX
NCT01539642,"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalviso™) for the Treatment of Post-Operative Pain in Patients After Open Abdominal Surgery",Post-Operative Pain,2/3/2014,ACRX
NCT01446042,Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism,Male Hypogonadism,6/13/2018,
NCT02132169,A Multi-Center Study Evaluating the Safety of AC-170 0.24%,Atopic Disease (Including Allergic Conjunctivitis),7/26/2017,
NCT01881113,"A Multi-Center, Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle",Allergic Conjunctivitis,11/9/2017,
NCT01685242,"A Single-Center,Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle",Allergic Conjunctivitis,10/10/2017,
NCT01551056,A Multi-Center Study Evaluating the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle in the Conjunctival Allergen Challenge (CAC),Allergic Conjunctivitis,10/3/2017,
NCT01332188,Efficacy of AC-170 for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (CAC) Model,Allergic Conjunctivitis,8/30/2017,
NCT02667288,An Open-Label Safety Study of A-101 Solution,Seborrheic Keratosis,11/17/2017,ACRS
NCT02667275,"A Randomized, Double-Blind, Vehicle-Controlled Study in Subjects With Seborrheic Keratosis",Seborrheic Keratosis,11/13/2017,ACRS
NCT02667236,A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis.,Seborrheic Keratosis,11/13/2017,ACRS
NCT03824912,Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis,Tinea Pedis,6/13/2019,
NCT02352363,Randomized Safety Study of CVT-301 Compared to an Observational Control Group,Idiopathic Parkinson's Disease,7/10/2018,ACOR
NCT02271217,A Study to Evaluate the Efficacy and Safety of Two Dose Strengths of Dalfampridine Extended Release Tablets.,Post-Ischemic Stroke,12/4/2017,ACOR
NCT02240030,Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes,Idiopathic Parkinson's Disease,4/17/2018,ACOR
NCT01683838,Safety and Efficacy of Oral Fampridine-Sustained Release (SR) for the Treatment of Spasticity Resulting From Spinal Cord Injury,Spinal Cord Injury|Muscle Spasticity,2/5/2014,ACOR
NCT01328379,Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis,Multiple Sclerosis,8/13/2013,ACOR
NCT00654927,"Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis",Multiple Sclerosis,2/29/2012,ACOR
NCT00649792,"Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial",Multiple Sclerosis,2/27/2012,ACOR
NCT00648908,"Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial",Multiple Sclerosis,2/27/2012,ACOR
NCT00483652,Study of Fampridine-SR Tablets in Multiple Sclerosis Patients,Multiple Sclerosis,4/14/2011,ACOR
NCT00127530,Study of Oral Fampridine-SR in Multiple Sclerosis,Multiple Sclerosis,5/6/2011,ACOR
NCT00041717,Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting From Spinal Cord Injury,Spinal Cord Injury|Muscle Spasticity,5/31/2013,ACOR
NCT01966003,Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer,Non-small Cell Lung Cancer Metastatic,10/19/2017,
NCT03287791,A Study to Evaluate Safety and Equivalence of Generic Azelaic Acid Foam and Finacea® Foam in Participants With Rosacea,Rosacea,7/17/2019,
NCT02616601,"Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis",Actinic Keratosis,7/17/2019,
NCT02471183,Study to Assess the Tolerability and the Safety of the Transition From Inhaled Treprostinil to Oral Selexipag in Patients With Pulmonary Arterial Hypertension,Pulmonary Arterial Hypertension,12/28/2017,
NCT01987895,Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile - Associated Diarrhea,Clostridium Difficile Infection,5/4/2018,
NCT01983683,Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea,Clostridium Difficile Infection,4/13/2018,
NCT01841762,Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument,Pulmonary Arterial Hypertension,10/31/2018,
NCT01743001,Clinical Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger Syndrome,Pulmonary Arterial Hypertension,1/30/2018,
NCT01474109,Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients,Systemic Sclerosis|Ulcers,1/6/2015,
NCT01106014,Selexipag (ACT-293987) in Pulmonary Arterial Hypertension,Pulmonary Arterial Hypertension,3/1/2016,
NCT03187678,Safety Study of the Switch From Oral Selexipag to Intravenous Selexipag in Subjects With Stable Pulmonary Arterial Hypertension,Pulmonary Arterial Hypertension,5/21/2019,
NCT00709956,Iloprost Power 15 in Pulmonary Arterial Hypertension,Pulmonary Arterial Hypertension,10/26/2012,
NCT00709098,Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension,Pulmonary Arterial Hypertension,10/29/2012,
NCT00660179,Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension,Pulmonary Arterial Hypertension,5/5/2014,
NCT01338415,FUTURE 3 Study Extension,Pulmonary Arterial Hypertension,12/11/2017,
NCT00631475,Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443,Idiopathic Pulmonary Fibrosis,8/3/2012,
NCT01223352,Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension,Pulmonary Arterial Hypertension,6/29/2017,
NCT00391443,BUILD 3: Bosentan Use in Interstitial Lung Disease,Idiopathic Pulmonary Fibrosis,5/25/2012,
NCT00319696,Bosentan in Digital Ulcers,Digital Ulcers,8/8/2012,
NCT00319046,"Clinical Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Miglustat in Patients With Stable Type 1 Gaucher Disease",Gaucher Disease Type 1,5/23/2012,
NCT00319111,Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH),Pulmonary Hypertension,12/31/2012,
NCT00319020,Bosentan in Children With Pulmonary Arterial Hypertension Extension Study,Pulmonary Arterial Hypertension,3/29/2017,
NCT02274766,Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia,Dyskinesia|Levodopa-Induced Dyskinesia (LID)|Parkinson's Disease (PD),1/10/2018,ADMS
NCT02136914,ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study),Dyskinesia|Levodopa Induced Dyskinesia (LID)|Parkinson's Disease,2/6/2018,ADMS
NCT01397422,Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study),Dyskinesia|Levodopa Induced Dyskinesia|Parkinson's Disease,11/6/2017,ADMS
NCT01814800,"Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)",Primary Immune Deficiency Disorder,10/5/2016,ADMA
NCT02266810,Safety and Efficacy of the Propel Mini and Propel Nova Steroid-Eluting Sinus Implant in Frontal Sinus,Chronic Sinusitis,10/6/2017,
NCT00336505,Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia (CAP),Pneumonia,2/26/2010,
NCT00336544,Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia,Pneumonia,2/26/2010,
NCT00316121,Safety and Efficacy Study of Healos as a Bone Replacement to Treat Degenerative Disc Disease,Degenerative Disc Disease,3/3/2011,
NCT00943306,"Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia",Familial Hypercholesterolemia,5/10/2018,
NCT00730236,A Safety and Efficacy Study of AEGR-733 to Treat Homozygous Familial Hypercholesterolemia (FH),Homozygous Familial Hypercholesterolemia,2/22/2013,
NCT02674854,Double-masked Study of PG324 Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension,Open-angle Glaucoma|Ocular Hypertension,5/1/2019,AERI
NCT02558400,Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension,Open-angle Glaucoma|Ocular Hypertension,6/4/2019,AERI
NCT02558374,Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension,Open-angle Glaucoma|Ocular Hypertension,4/6/2018,AERI
NCT02246764,Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension,Ocular Hypertension|Glaucoma,4/6/2018,AERI
NCT02207621,Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma and Ocular Hypertension,Ocular Hypertension|Open-angle Glaucoma,4/6/2018,AERI
NCT02207491,Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension,Ocular Hypertension|Open-angle Glaucoma,4/13/2018,AERI
NCT01767155,Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer,Endometrial Cancer,7/31/2018,AEZS
NCT02558829,Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency,Growth Hormone Deficiency With Pituitary Anomalies,2/9/2018,AEZS
NCT00670306,Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH),Benign Prostatic Hypertrophy,1/19/2011,AEZS
NCT00448747,"Investigation of a New, Oral Growth Hormone Secretagogue, AEZS-130 as a Growth Hormone Stimulation Test.",Diagnosis of Adult Growth Hormone Deficiency (AGDH),7/23/2019,AEZS
NCT02777931,Efficacy and Safety of NFC-1 in Adolescents With Genetic Disorders Impacting mGluR and ADHD,Attention Deficit Disorder With Hyperactivity,3/29/2018,GNMX
NCT01478971,Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis,Chronic Kidney Disease|Anemia,5/26/2014,
NCT00598442,Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis,Chronic Renal Failure|Chronic Kidney Disease|Anemia,7/30/2012,
NCT00598273,Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis,Chronic Renal Failure|Chronic Kidney Disease|Anemia,7/30/2012,
NCT00597753,Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis,Chronic Renal Failure|Chronic Kidney Disease|Anemia,7/30/2012,
NCT00597584,Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis,Chronic Renal Failure|Chronic Kidney Disease|Anemia,7/30/2012,
NCT01420653,Maxigesic 325 Acute Dental Pain Study,Dental Pain,12/6/2018,
NCT01236768,"Transdermal Contraceptive Delivery System (TCDS), Also Known as AG200-15 Patch Arm",Contraception,9/15/2017,AGRX
NCT01181479,Study to Evaluate the Contraceptive Efficacy/Safety of a Low Dose EE/LNG Transdermal Contraceptive Delivery System,Contraception,7/3/2018,AGRX
NCT00811954,Comparative Study of Three NNRTI-Sparing HAART Regimens,HIV Infection,9/5/2014,
NCT01164722,Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia,Anal Cancer|Neoplasm of Uncertain Malignant Potential|Nonneoplastic Condition|Precancerous Condition,10/31/2016,
NCT02059642,A 6 Week Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD ( Attention Deficit/Hyperactivity ),"ADHD|Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive Type",3/28/2017,
NCT01201798,Safety and Efficacy of Difluprednate 0.05% for the Treatment of Anterior Uveitis,Endogenous Anterior Uveitis,11/15/2012,ALC
NCT01124045,Difluprednate Pediatric Study for the Treatment of Inflammation Post-Cataract Surgery,Cataracts|Inflammation,6/19/2013,ALC
NCT01109173,Confirmatory Study Nepafenac 0.3%,Cataract,11/30/2012,ALC
NCT00732225,DisCoVisc Comparative Evaluation,Cataracts,7/30/2010,ALC
NCT00578929,Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients,Seasonal Allergic Rhinitis,2/9/2010,ALC
NCT00578331,Safety Study of Olopatadine Nasal Spray,Perennial Allergic Rhinitis,2/3/2010,ALC
NCT00576251,TOBRADEX Ophthalmic Suspension Versus Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension,Ocular Inflammation Associated With Blepharaconjunctivitis,1/14/2010,ALC
NCT00051168,A Long-term Safety Study of Once-daily Travatan,"Glaucoma, Open-angle|Ocular Hypertension",4/12/2010,ALC
NCT00853905,Will the Use of Triesence During Glaucoma Surgery Provide Lower Eye Pressure and Improve the Results of the Surgery?,Glaucoma,3/21/2016,ALC
NCT01028378,Safety and Efficacy Study of Topography-Guided LASIK to Treat Myopia and Hyperopia,Myopia|Hyperopia,4/11/2016,ALC
NCT01997229,Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study),Refractory Generalized Myasthenia Gravis,2/7/2018,ALXN
NCT00122317,Extension Study of Eculizumab in Patients With Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH),"Paroxysmal Hemoglobinuria, Nocturnal",6/5/2017,ALXN
NCT02145182,Prevention of Delayed Graft Function Using Eculizumab Therapy (PROTECT Study),Delayed Graft Function,12/17/2018,ALXN
NCT01176266,Open-Label Study of Asfotase Alfa in Infants and Children ≤ 5 Years of Age With Hypophosphatasia (HPP),Hypophosphatasia,2/26/2018,ALXN
NCT01371825,"Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Sebelipase Alfa in Children With Growth Failure Due to Lysosomal Acid Lipase Deficiency",Lysosomal Acid Lipase Deficiency|Wolman Disease,4/18/2016,ALXN
NCT00628589,Staccato Loxapine in Agitated Patients With Schizophrenia,Patients With Schizophrenia and Acute Agitation,6/29/2017,
NCT00721955,Staccato Loxapine in Agitated Patients With Bipolar Disorder,Bipolar I Disorder,6/29/2017,
NCT01304706,Fluocinolone Acetonide in Diabetic Macular Edema (FAME) Extension Study,Diabetic Macular Edema,5/4/2015,ALIM
NCT00490815,Pharmacokinetic and Efficacy Study of Fluocinolone Acetonide Inserts in Patients With Diabetic Macular Edema,Diabetic Macular Edema,2/13/2014,ALIM
NCT00344968,Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema,Diabetic Macular Edema,5/7/2014,ALIM
NCT01180647,Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail,Opiate Dependence,4/7/2016,
NCT02696434,Evaluating Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Transitioning From Buprenorphine Maintenance Prior to First Dose of VIVITROL,Opioid Use Disorder,2/12/2019,
NCT02669758,A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia,Schizophrenia,7/9/2019,
NCT02634346,A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study),Schizophrenia,6/27/2018,
NCT02537574,Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension),Opioid Use Disorder,1/9/2019,
NCT02218008,A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - FORWARD-5 Study,Major Depressive Disorder,3/27/2019,
NCT02158546,A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 Study,Major Depressive Disorder,6/25/2019,
NCT02158533,A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study,Major Depressive Disorder,3/27/2019,
NCT02141399,A Long-Term Safety Study of ALKS 5461,Major Depressive Disorder,12/14/2018,
NCT02085135,A Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD),Major Depressive Disorder,3/27/2019,
NCT01895452,An Extension of a Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070),Schizophrenia,8/25/2017,
NCT01626456,A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070),Schizophrenia,10/27/2016,
NCT01469039,"A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia",Schizophrenia,1/22/2016,
NCT00834080,ALK21-021: A Safety Study of Medisorb® Naltrexone (VIVITROL®) Administered to Health Care Professionals,Opiate Dependence,7/29/2013,
NCT00640614,Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy,Contact Dermatitis,12/22/2015,
NCT00623636,Phase 3 Study of MAP0004 in Adult Migraineurs,Migraine Disorders,10/29/2013,AGN
NCT00105027,The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study,"Macular Edema, Cystoid|Retinal Vein Occlusion",1/19/2011,AGN
NCT02455050,A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief,Dry Eye Syndromes,1/4/2017,AGN
NCT02132117,Safety and Efficacy of Oxymetazoline HCl Cream 1.0% in Patients With Persistent Erythema Associated With Rosacea,Erythema|Rosacea,8/2/2016,AGN
NCT02131636,Efficacy and Safety of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea,Erythema|Rosacea,3/10/2016,AGN
NCT02095158,A Long-Term Safety and Efficacy Study AGN-19920 in Patients With Persistent Erythema Associated With Rosacea,Erythema|Rosacea,9/21/2016,AGN
NCT01844388,A Study to Compare a New Eye Drop Formulation With Refresh Contacts®,Contact Lens Lubrication,9/29/2014,AGN
NCT01459588,"Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease",Dry Eye Syndromes,3/14/2013,AGN
NCT01099774,Safety and Efficacy of Different Formulations of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension,Glaucoma|Ocular Hypertension,4/27/2012,AGN
NCT00524264,A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery,Cataract Extraction|Pain|Inflammation,10/1/2009,AGN
NCT00521456,A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery,Cataract Extraction,10/1/2009,AGN
NCT00509873,A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis,Bacterial Conjunctivitis,11/30/2011,AGN
NCT01830140,A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension,Glaucoma|Ocular Hypertension,5/6/2015,AGN
NCT01974141,A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris,Acne Vulgaris,2/6/2017,AGN
NCT02165111,Efficacy of Botulinum Toxin In Scleroderma-Associated Raynaud's Syndrome,Scleroderma|Raynaud's Syndrome,12/22/2016,AGN
NCT01449682,Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injections.,Retinal Vein Occlusion|Macular Edema,5/31/2017,AGN
NCT01422161,Study of Botulinum Toxin and Recovery of Hand Function After Stroke,Stroke With Hemiparesis,5/31/2019,AGN
NCT01974323,Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris,Acne Vulgaris,2/6/2017,AGN
NCT01765764,Bimatoprost for the Treatment of Eyebrow Hypotrichosis,Eyebrow Hypotrichosis,1/26/2015,AGN
NCT00910845,Study of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence,Overactive Bladder,3/5/2013,AGN
NCT00907426,Safety and Efficacy Study of Bimatoprost to Treat Hypotrichosis of the Eyelashes After Application to the Eyelid Margin,Hypotrichosis,9/19/2012,AGN
NCT00693420,Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence,Eyelashes,5/12/2009,AGN
NCT00518089,A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis,Bacterial Conjunctivitis,11/30/2011,AGN
NCT00156910,A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent Headaches,Migraine Disorders,12/7/2010,AGN
NCT00691197,Safety and Acceptability of Using a Rewetting Drop With Contact Lens Wear,Ametropia,12/10/2009,AGN
NCT01790685,Ozurdex for Retinal Vein Occlusion Study (ORVO Study),Retinal Vein Occlusion,4/3/2015,AGN
NCT01698554,Bimatoprost in the Treatment of Eyelash Hypotrichosis,Idiopathic Eyelash Hypotrichosis,2/10/2015,AGN
NCT01224015,Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines,Facial Rhytides|Crow's Feet Lines|Glabellar Lines,2/25/2014,AGN
NCT01189760,Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines,Facial Rhytides|Crow's Feet Lines|Glabellar Lines,12/3/2013,AGN
NCT01189747,Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines,Lateral Canthus Rhytides|Crow's Feet Lines,12/3/2013,AGN
NCT02413346,A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris,Acne Vulgaris,5/4/2018,AGN
NCT02322866,"Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne",Acne Vulgaris,5/7/2018,AGN
NCT02320149,Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne,Acne Vulgaris,5/17/2018,AGN
NCT02867709,"Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine","Migraine, With or Without Aura",1/29/2019,AGN
NCT02828020,"Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine","Migraine, With or Without Aura",1/3/2019,AGN
NCT02553772,A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease.,Dry Eye Syndromes,11/17/2017,AGN
NCT02280473,A Safety and Efficacy Study of Refresh Optive® Gel Drops in Patients With Dry Eye Disease,Dry Eye Syndromes,6/7/2017,AGN
NCT02261493,A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides,Facial Rhytides|Glabellar Rhytides,7/25/2017,AGN
NCT02261467,A Safety and Efficacy Study of OnabotulinumtoxinA in Forehead and Glabellar Facial Rhytides,Forehead Rhytides|Glabellar Rhytides,6/23/2017,AGN
NCT02147197,A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas,Leiomyoma|Uterine Hemorrhage,4/5/2019,AGN
NCT02147158,A Study of the Efficacy and Safety of Ulipristal Acetate Intermittent Treatment for Abnormal Uterine Bleeding Associated With Leiomyomas,Leiomyoma|Uterine Hemorrhage,6/4/2019,AGN
NCT01662492,A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine,Migraine Disorders,9/5/2017,AGN
NCT01603628,BOTOX® Treatment in Pediatric Lower Limb Spasticity,Pediatrics|Muscle Spasticity|Cerebral Palsy,8/14/2018,AGN
NCT01603602,BOTOX® Treatment in Pediatric Upper Limb Spasticity,Pediatrics|Muscle Spasticity|Cerebral Palsy|Stroke,8/14/2018,AGN
NCT01575054,BOTOX® Treatment in Adult Patients With Post-Stroke Lower Limb Spasticity,Muscle Spasticity,2/1/2016,AGN
NCT02848326,"Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention","Migraine, With or Without Aura",12/6/2018,AGN
NCT00168428,A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent Headaches,Migraine Disorders,12/7/2010,AGN
NCT00367133,Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema,Diabetic Macular Edema,7/9/2010,AGN
NCT01767519,A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence,Overactive Bladder|Urinary Incontinence,1/12/2016,AGN
NCT01600716,Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS),Urinary Incontinence|Multiple Sclerosis|Neurogenic Bladder,3/22/2016,AGN
NCT00445003,Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy,Proliferative Diabetic Retinopathy|Diabetic Macular Edema,7/13/2011,AGN
NCT00444600,Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema,Diabetic Retinopathy|Diabetic Macular Edema,7/12/2011,AGN
NCT01177098,Safety and Efficacy of a New Formulation of Bimatoprost/Timolol Ophthalmic Solution Compared With Bimatoprost/Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension,Glaucoma|Ocular Hypertension,3/12/2013,AGN
NCT00915525,Long Term Follow-up Study of Safety and Efficacy of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence,Overactive Bladder|Urinary Incontinence,12/18/2015,AGN
NCT00910520,Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence,Overactive Bladder,3/5/2013,AGN
NCT00884585,Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis,Atopic Conjunctivitis,11/5/2012,AGN
NCT00876447,A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis,Overactive Bladder,7/14/2014,AGN
NCT00461292,Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder,Overactive Bladder,10/17/2011,AGN
NCT00311376,Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder,Overactive Bladder,10/17/2011,AGN
NCT00168389,A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema,Diabetic Macular Edema,8/4/2014,AGN
NCT00168337,A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema,Diabetic Macular Edema,8/4/2014,AGN
NCT00168324,A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion,Macular Edema|Retinal Vein Occlusion,8/26/2009,AGN
NCT00168298,A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion,Macular Edema|Retinal Vein Occlusion,8/26/2009,AGN
NCT00333814,A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis,Intermediate Uveitis|Posterior Uveitis,4/14/2011,AGN
NCT01818336,Evaluation of Skin Testing Reagents for Penicillin Allergy,History of IgE Dependent Reaction to a Penicillin Product,1/4/2017,
NCT00376675,Methylphenidate in Treating Patients With Fatigue Caused by Cancer,"Fatigue|Unspecified Adult Solid Tumor, Protocol Specific",10/10/2014,
NCT00079001,Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases,Metastatic Cancer|Prostate Cancer,10/30/2014,
NCT02319005,ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC),"Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)|Amyloidosis, Hereditary|Amyloid Neuropathies, Familial|Amyloid Neuropathies|Amyloidosis, Hereditary, Transthyretin-Related|Familial Transthyretin Cardiac Amyloidosis",7/18/2018,ALNY
NCT01960348,"APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis","TTR-mediated Amyloidosis|Amyloidosis, Hereditary|Amyloid Neuropathies, Familial|Familial Amyloid Polyneuropathies|Amyloid Neuropathies|Amyloidosis, Hereditary, Transthyretin-Related",9/6/2018,ALNY
NCT00035815,Insulin-like Growth Factor-1 in Amyotrophic Lateral Sclerosis (ALS) Trial,Amyotrophic Lateral Sclerosis,2/15/2013,
NCT00818662,A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease,Alzheimer´s Disease,10/28/2014,
NCT00440050,"DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease",Alzheimer's Disease,8/30/2010,
NCT02694978,A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA),Iron Deficiency Anemia,6/11/2018,AMAG
NCT01114217,A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia,Iron Deficiency Anemia,6/11/2018,AMAG
NCT01114139,A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia,Iron Deficiency Anemia,6/11/2018,AMAG
NCT01353976,Safety and Efficacy of Econazole Nitrate Foam 1% in Subjects With Tinea Pedis,Tinea Pedis|Athlete's Foot,1/9/2013,
NCT03585504,Immediate Versus Delayed Insertion of Implanon in Postpartum Adolescents,Contraceptive Usage,10/4/2018,
NCT02680041,18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer Treatment,Prostate Cancer,1/28/2019,
NCT01401647,"Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia",Cardiac Arrest,1/30/2017,
NCT00982007,Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA),Iron Deficiency Anemia,10/18/2013,
NCT00981045,Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and Impaired Renal Function,Iron Deficiency Anemia|Impaired Renal Function,10/18/2013,
NCT00704353,Safety and Tolerability of a Single Dose of FCM vs. Standard of Care in Treating Iron Deficiency Anemia,Anemia,11/25/2013,
NCT00704028,Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Iron Dextran in Treating Iron Deficiency Anemia,Anemia,11/25/2013,
NCT00703937,Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Standard of Care in Treating Iron Deficiency Anemia,Anemia,11/25/2013,
NCT00548860,Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients,Anemia,5/29/2015,
NCT00548691,Safety and Tolerability of FCM vs Standard of Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease Patients,Anemia,5/13/2015,
NCT00396292,Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in Subjects Who Display Postpartum Anemia,Anemia,12/10/2013,
NCT00395993,Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding,Anemia,11/18/2013,
NCT00354484,Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients,Postpartum Anemia,12/5/2013,
NCT00317239,VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease,Anemia,11/25/2013,
NCT00317226,Long Term Safety Study of (VIT45) Extension Study: Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease,Anemia,6/10/2015,
NCT00236977,Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia,Anemia,3/9/2010,
NCT00994318,Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD),Iron Deficiency Anaemia|Chronic Kidney Disease,5/7/2014,
NCT00658736,Efficacy of EUS-guided Celiac Plexus Blockade in Chronic Pancreatitis,Chronic Pancreatitis,6/14/2017,
NCT01345019,Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma,Cancer|Hematologic Malignancies|Multiple Myeloma|Oncology|Bone Metastases|Multiple Myeloma Bone Lesions,3/7/2018,AMGN
NCT00984282,Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer,Thyroid Neoplasms,12/10/2013,AMGN
NCT00769704,Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma,Melanoma,12/17/2015,AMGN
NCT00111007,A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma,Melanoma,2/23/2011,AMGN
NCT00073307,Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer,"Carcinoma, Renal Cell",12/14/2011,AMGN
NCT02986139,Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis,"Arthritis, Rheumatoid; Arthritis, Psoriatic",10/31/2018,AMGN
NCT02739984,Evaluation of Evolocumab (AMG 145) Efficacy in Diabetic Adults With Hypercholesterolemia/Mixed Dyslipidemia,Hypercholesterolemia|Mixed Dyslipidemia|Type 2 Diabetes,8/31/2018,AMGN
NCT02662569,Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia,"Diabetes, Hyperlipidemia, Mixed Dyslipidemia",1/11/2019,AMGN
NCT02483585,Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) Compared to Placebo in Migraine Prevention,Migraine,6/25/2018,AMGN
NCT02456740,Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention,Migraine,7/10/2018,AMGN
NCT02412878,Once-weekly Versus Twice-weekly Carfilzomib in Combination With Dexamethasone in Adults With Relapsed and Refractory Multiple Myeloma,Multiple Myeloma,12/13/2018,AMGN
NCT02376790,Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis,Psoriatic Arthritis,2/22/2019,AMGN
NCT02341417,Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on Dialysis,"Secondary Hyperparathyroidism, Chronic Kidney Disease",5/18/2018,AMGN
NCT02304484,Open-label Extension (OLE) Study to Assess Safety and Efficacy of Evolocumab,Hypercholesterolemia,3/19/2019,AMGN
NCT02207634,Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects,Dyslipidemia,1/16/2018,AMGN
NCT02157948,A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis,Postmenopausal Osteoporosis,8/16/2017,AMGN
NCT02114931,Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis,"Arthritis, Rheumatoid",4/24/2017,AMGN
NCT02102204,Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis,"Hyperparathyroidism, Secondary",11/17/2017,AMGN
NCT01984424,Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-3,Hyperlipidemia,3/13/2018,AMGN
NCT01932970,Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to Etelcalcetide,"Hyperparathyroidism, Secondary",4/4/2017,AMGN
NCT01901185,Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject Etanercept,Rheumatoid Arthritis|Psoriatic Arthritis,11/21/2014,AMGN
NCT01896232,Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet,Secondary Hyperparathyroidism|Chronic Kidney Disease,3/27/2017,AMGN
NCT01879319,Study to Assess in Home Use of Evolocumab (AMG 145) Administration Using Either an Automated Mini-doser or a Prefilled Autoinjector/Pen,Primary Hypercholesterolemia|Mixed Dyslipidemia,12/23/2015,AMGN
NCT01854918,Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia,Hyperlipidemia and Mixed Dyslipidemia,6/11/2019,AMGN
NCT01849497,Study to Assess In-home Use of Evolocumab (AMG 145) Using a Prefilled Syringe or a Prefilled Autoinjector/Pen,Primary Hypercholesterolemia|Mixed Dyslipidemia,10/9/2015,AMGN
NCT01818752,"Phase 3 Study of Carfilzomib, Melphalan, Prednisone vs Bortezomib, Melphalan, Prednisone in Newly Diagnosed Multiple Myeloma",Multiple Myeloma,8/1/2017,AMGN
NCT01813422,GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound,Hypercholesterolemia,1/4/2018,AMGN
NCT02729025,Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a)),"Subjects With Hyperlipidemia, Dyslipidemia",4/23/2019,AMGN
NCT01788046,Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis,"Hyperparathyroidism, Secondary",3/27/2017,AMGN
NCT01785875,Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis,"Hyperparathyroidism, Secondary",3/27/2017,AMGN
NCT01785849,Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis,"Hyperparathyroidism, Secondary",3/27/2017,AMGN
NCT01764633,Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk,Dyslipidemia,2/15/2018,AMGN
NCT01763905,Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects -2,Hyperlipidemia,12/22/2015,AMGN
NCT01763866,LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2,Hyperlipidemia,12/22/2015,AMGN
NCT01763827,Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2,Hyperlipidemia,12/30/2015,AMGN
NCT01652872,Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease,Anemia in Chronic Kidney Disease Patients Not on Dialysis,11/8/2018,AMGN
NCT01631214,Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis,Postmenopausal Women With Osteoporosis,12/12/2018,AMGN
NCT01575873,Efficacy and Safety of Denosumab Compared With Risedronate in Individuals Taking Glucocorticoids,"Steroid-induced Osteopor, Glucocorticoid-induced Ostepor",7/27/2018,AMGN
NCT01575834,Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis,Postmenopausal Osteoporosis,11/8/2018,AMGN
NCT01568866,Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients,Multiple Myeloma,12/11/2015,AMGN
NCT01516879,Durable Effect of PCSK9 Antibody CompARed wiTh placEbo Study,Hypercholesterolemia,9/29/2015,AMGN
NCT01444417,Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients,Idiopathic Thrombocytopenic Purpura|Thrombocytopenia|Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)|Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)|Thrombocytopenic Purpura|Immune Thrombocytopenia,1/19/2017,AMGN
NCT01970475,Efficacy and Safety Study of ABP 501 Compared to Adalimumab in Subjects With Moderate to Severe Rheumatoid Arthritis,"Arthritis, Rheumatoid",12/13/2016,AMGN
NCT01080391,"Phase 3 Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma",Relapsed Multiple Myeloma,7/8/2015,AMGN
NCT01071954,A Study Evaluating the Safety and Efficacy of Long-term Dosing of Romiplostim in Thrombocytopenic Pediatric Patients With Immune (Idiopathic) Thrombocytopenia Purpura,Thrombocytopenia in Pediatric Subjects With Immune Idiopathic Thrombocytopenic Purpura ITP,1/29/2019,AMGN
NCT01796301,An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Women,Postmenopausal Osteoporosis,11/8/2018,AMGN
NCT00975221,Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy,"Hyperparathyroidism, Primary|Hypercalcemia",1/25/2016,AMGN
NCT00975000,Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients,Chronic Allograft Nephropathy|Chronic Kidney Disease|Chronic Renal Failure|Disordered Mineral Metabolism|End Stage Renal Disease|Hyperparathyroidism|Hypophosphatemia|Kidney Disease|Kidney Transplantation|Post Renal Transplantation,1/29/2016,AMGN
NCT00925600,Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss,Cancer|Cataract|Low Bone Mineral Density|Osteopenia|Osteoporosis|Prostate Cancer,5/30/2017,AMGN
NCT00911170,PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study,Cancer|Colon Cancer|Colorectal Cancer|Fever|Locally Advanced|Metastatic Colorectal Cancer|Neutropenia|Rectal Cancer,1/7/2014,AMGN
NCT00838201,Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer,Cancer|Carcinoma|Castrate-Resistant Prostate Cancer|Prostate Cancer|Tumors,9/24/2013,AMGN
NCT02585895,Evolocumab Compared to LDL-C Apheresis in Patients Receiving LDL-C Apheresis Prior to Study Enrollment,Hypercholesterolemia,9/19/2017,AMGN
NCT01001377,ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer,Metastatic Colorectal Cancer,3/24/2014,AMGN
NCT00358215,RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial,Heart Failure|Anemia|Cardiovascular Disease|Ventricular Dysfunction|Congestive Heart Failure,12/13/2013,AMGN
NCT02186171,A Study to Compare the Safety and Efficacy of Romosozumab (AMG 785) Versus Placebo in Men With Osteoporosis,Osteoporosis in Men,5/27/2019,AMGN
NCT02016716,A Randomized Phase 3 Study to Evaluate Two Formulations of Romosozumab in Postmenopausal Women With Osteoporosis,Postmenopausal Osteoporosis,11/8/2018,AMGN
NCT01763918,Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2,Hyperlipidemia,12/22/2015,AMGN
NCT01624142,Trial Assessing Long Term USe of PCSK9 Inhibition in Subjects With Genetic LDL Disorders,Severe Familial Hypercholesterolemia,1/28/2019,AMGN
NCT01588496,Trial Evaluating PCSK9 Antibody in Subjects With LDL Receptor Abnormalities,Homozygous Familial Hypercholesterolemia,10/2/2015,AMGN
NCT02384460,ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis Bullosa,Epidermolysis Bullosa,10/16/2018,FOLD
NCT01218659,Study to Compare the Efficacy and Safety of Oral AT1001 and Enzyme Replacement Therapy in Patients With Fabry Disease,Fabry Disease,11/1/2018,FOLD
NCT00925301,Study of the Effects of Oral AT1001 (Migalastat Hydrochloride) in Patients With Fabry Disease,Fabry Disease,10/30/2018,FOLD
NCT01103284,Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults,Type 1 Diabetes Mellitus,5/26/2016,
NCT00562302,Bio-Seal Biopsy Track Plug for Reducing Pneumothorax Rates Post Lung Biopsy Procedure,Pneumothorax,3/27/2013,
NCT00772031,NINDS CRC Chronic Migraine Treatment Trial,Chronic Migraine,1/19/2012,
NCT02504541,Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism,Hypogonadism,3/30/2018,ATRS
NCT02159469,Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism,Hypogonadism,1/9/2018,ATRS
NCT00909181,Study of Topically Administered Oxybutynin Gel in Patients With Urge Incontinence,Urge Urinary Incontinence|Urinary Frequency,1/19/2011,ATRS
NCT02734810,SIMPLICITY: Studying Impacts on Malabsorption With Liprotamase in Cystic Fibrosis,Exocrine Pancreatic Insufficiency|Cystic Fibrosis,5/11/2018,
NCT02279498,SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis,Exocrine Pancreatic Insufficiency|Cystic Fibrosis,8/14/2018,
NCT02174848,Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration,Pantothenate Kinase-Associated Neurodegeneration,7/17/2019,
NCT01741532,Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN),Pantothenate Kinase-Associated Neurodegeneration,5/23/2019,
NCT00768287,"Study of Recombinant Factor IX Product, IB1001, in Subjects With Hemophilia B",Hemophilia B,9/10/2018,APVO
NCT01229449,Ibuprofen/Acetaminophen Versus Nurofen Plus® and Panadeine® Extra Dental Pain Study,Post-operative Pain,9/17/2018,
NCT01808144,Lesinurad and Febuxostat Combination Extension Study in Gout,Gout,1/30/2018,
NCT01650246,Open-Label Lesinurad Monotherapy Extension Study in Gout,Gout,5/26/2016,
NCT01510769,Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat,Tophaceous Gout,5/26/2016,
NCT01510158,Combining Lesinurad With Allopurinol in Inadequate Responders,Gout,8/18/2016,
NCT01508702,Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors,Gout,2/12/2016,
NCT01493531,Combining Lesinurad With Allopurinol in Inadequate Responders,Gout,5/26/2016,
NCT00603902,BLOSSOM: Behavioral Modification and Lorcaserin Second Study for Obesity Management,Obesity,2/7/2013,ARNA
NCT00603291,BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus,Obesity,2/7/2013,ARNA
NCT00395135,BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management,Obesity,2/7/2013,ARNA
NCT01351480,Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) Patients,Rheumatoid Arthritis,3/13/2017,
NCT01511939,Trial to See if Topical Pennsaid for Knee Pain Affects Coagulation Values in Patients Who Are Also Taking Anticoagulants,Osteoarthritis of the Knee|Coagulopathy,6/26/2014,
NCT00729690,Effect of Oral Pregabalin on Spinal Neurotransmitters in Patients Undergoing Knee Replacement,PAIN,12/19/2012,
NCT00791102,Topical ASP-1001 (Contrast Media Formulation) and the Acute Response to Nasal Allergen Challenge (NAC),Allergic Rhinitis,7/10/2013,
NCT00377637,A Study of Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus Nephritis.,Lupus Nephritis,12/6/2011,
NCT00683930,A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV),Pemphigus Vulgaris (PV),6/22/2011,
NCT00157014,Canadian Cardiology de Novo Study: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens,Heart Diseases|Heart Transplantation,2/21/2011,
NCT02218372,A Study to Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Oral Liquid or Capsules) in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD),Clostridium Difficile-associated Diarrhea (CDAD),12/7/2018,
NCT02045862,"A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder",Urinary Bladder Overactive|Overactive Bladder|Urgency Incontinence|Urinary Bladder Diseases\Urologic Diseases,6/6/2018,
NCT01972841,"This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder",Urinary Bladder Overactive|Urinary Bladder Diseases\Urologic Diseases|Overactive Bladder|Urgency Incontinence,6/12/2018,
NCT01565707,A Study to Investigate How Effective and Safe Solifenacin Succinate Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug,"Urinary Bladder, Overactive",1/30/2017,
NCT01565694,"A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Participants 5 to 18 Years of Age With Neurogenic Detrusor Overactivity",Neurogenic Detrusor Overactivity,5/6/2019,
NCT01981954,"A Clinical Study to Investigate How Solifenacin Fluid is Taken up, How Long it Stays in the Body and How Effective and Safe it is in Treating Children Aged From 6 Months to Less Than 5 Years With Symptoms of Neurogenic Detrusor Overactivity (NDO)",Neurogenic Detrusor Overactivity|Pediatric,6/21/2018,
NCT01655069,A Study to Investigate How Safe and Effective Solifenacin Solution is in Treating Children/Adolescents With Symptoms of Overactive Bladder (OAB) Who Completed Study 905-CL-076,"Urinary Bladder, Overactive",12/11/2017,
NCT01908829,A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin),Urinary Bladder Diseases|Urinary Bladder Overactive|Urologic Diseases,10/9/2017,
NCT02118896,Study to Ascertain if Prolonged Release Tacrolimus (FK506E - MR4) is Safe and Effective When Used in the Long Term and in Combination With Other Immunosuppressive Drugs in Patients Who Have Received a Transplant,Heart Transplantation|Liver Transplantation|Kidney Transplantation,3/15/2016,
NCT01618669,A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT),Coronary Artery Disease (CAD),2/8/2016,
NCT00634049,Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi,Aspergillosis|Invasive Fungal Infections,1/11/2016,
NCT00413218,Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections,"Candidiasis, Invasive|Candidemia|Mycoses",8/1/2017,
NCT00412893,Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis,Aspergillosis|Invasive Fungal Infection,3/31/2015,
NCT01212991,A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer,Prostate Cancer,10/16/2014,
NCT00974311,Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy,Castration-Resistant Prostate Cancer,10/30/2012,
NCT01533428,A Study to Evaluate Efficacy and Safety of a Single Application of Capsaicin 8%Transdermal Delivery System Compared to Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN),Diabetic Peripheral Neuropathy|Pain,3/13/2015,
NCT00912964,A Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder,"Urinary Bladder, Overactive",10/17/2012,
NCT00826280,Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI),Coronary Artery Disease (CAD),10/21/2011,
NCT00688688,Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder,"Urinary Bladder, Overactive",10/19/2012,
NCT00662909,A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder,"Urinary Bladder, Overactive",10/17/2012,
NCT00373425,A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors,Non-small Cell Lung Cancer,6/3/2014,
NCT00064701,Comparative Study of Modified Release (MR) Tacrolimus/Mycophenolate Mofetil (MMF) in de Novo Kidney Transplant Recipients,Kidney Transplantation,9/26/2013,
NCT01234870,Comprehensive Evaluation of Ischemic Heart Disease Using MRI,"Heart Disease, Ischemic|Atherosclerosis, Coronary",9/26/2014,
NCT00254163,"Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia Patients",B-Cell Chronic Lymphocytic Leukemia,11/3/2016,
NCT00683878,Add-on to Thiazolidinedione (TZD) Failures,Type 2 Diabetes,2/23/2017,AZN
NCT00643851,An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets,Type 2 Diabetes,2/23/2017,AZN
NCT02338193,"Dapagliflozin and Metformin,Alone and in Combination, in Overweight/Obese Prior GDM Women",Diabetes Prevention in Women After GDM Who Are at High-risk,4/30/2019,AZN
NCT02022007,Saxagliptin + Metformin Compared to Saxagliptin or Metformin Monotherapy in PCOS Women With Impaired Glucose Homeostasis,Polycystic Ovary Syndrome|Disorder of Glucose Regulation,6/28/2017,AZN
NCT00374907,A Study Assessing Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise,Type 2 Diabetes,1/21/2011,AZN
NCT00728481,The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis,Eosinophilic Esophagitis|Gastroesophageal Reflux Disease|EE|GERD,12/6/2012,AZN
NCT00671853,Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD),Bipolar Disorder|Anxiety|Anxiety Disorders|Substance Use Disorders,10/11/2013,AZN
NCT00667992,Study Comparing Budesonide Hydrofluoroalkane (HFA) vs Chlorofluorocarbon (CFC) Pressurized Metered Dose Inhalers (pMDI) in Patients With Mild to Moderate Asthma,Asthma,11/7/2012,AZN
NCT01052428,Molecular Mechanisms of Volume Overload-Aim 1(SCCOR in Cardiac Dysfunction and Disease),Mitral Regurgitation,4/16/2012,AZN
NCT01052272,Impact of Diabetes on Left Ventricular Remodeling,Diabetes,12/17/2012,AZN
NCT00880919,Seroquel Extended Release (XR) for the Management of Borderline Personality Disorder (BPD),Borderline Personality Disorder,12/28/2016,AZN
NCT00588406,Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.,Asthma,1/21/2016,AZN
NCT02460978,Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes,Type 1 Diabetes Mellitus,11/6/2018,AZN
NCT02268214,Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes,Type 1 Diabetes Mellitus,3/29/2018,AZN
NCT02155660,Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History,Moderate to Very Severe Chronic Obstructive Pulmonary Disease,6/26/2019,AZN
NCT02138916,Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History,Moderate to Very Severe Chronic Obstructive Pulmonary Disease,6/13/2019,AZN
NCT01880424,"A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)",Irritable Bowel Syndrome With Constipation (IBS-C),9/27/2016,AZN
NCT01434186,"A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination With Metformin IR or Metformin XR in Pediatric Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone","Diabetes Mellitus, Type 2",4/18/2017,AZN
NCT01195662,A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication,Type 2 Diabetes,5/23/2014,AZN
NCT01157078,A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD),Major Depressive Disorder|Depression,11/20/2012,AZN
NCT01153347,A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder,Major Depressive Disorder|Depression,11/20/2012,AZN
NCT01152554,A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder,Major Depressive Disorder|MDD|Depression,10/29/2012,AZN
NCT01137474,A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker,Type 2 Diabetes,5/1/2014,AZN
NCT01042977,Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease,Type 2 Diabetes Mellitus|Cardiovascular Disease|Inadequate Glycaemic Control,8/23/2013,AZN
NCT01031680,"Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and Hypertension",Type 2 Diabetes Mellitus|Cardiovascular Disease|Hypertension|Inadequate Glycaemic Control,8/23/2013,AZN
NCT00984867,Dapagliflozin DPPIV Inhibitor add-on Study,Type 2 Diabetes,10/14/2013,AZN
NCT00960076,An 18 Week Efficacy and Safety Study of Saxagliptin and Metformin XR Combination in Subjects With Type 2 Diabetes,Type 2 Diabetes,9/27/2011,AZN
NCT00877890,"A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5)",Type 2 Diabetes Mellitus,6/19/2012,AZN
NCT00859898,Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes,Type 2 Diabetes Mellitus,3/20/2014,AZN
NCT00765817,Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus,Type 2 Diabetes,1/26/2011,AZN
NCT00753896,Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin,Type 2 Diabetes,3/20/2012,AZN
NCT00736879,Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes,Type 2 Diabetes Mellitus,5/2/2014,AZN
NCT00676338,"Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)",Type 2 Diabetes Mellitus,11/26/2012,AZN
NCT00673231,"Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin",Type 2 Diabetes,8/23/2013,AZN
NCT00641056,Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3),Type 2 Diabetes Mellitus,7/4/2012,AZN
NCT00637273,"A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)",Type 2 Diabetes Mellitus,6/19/2012,AZN
NCT00614939,Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment,Type 2 Diabetes,7/7/2010,AZN
NCT00528879,A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone,Type 2 Diabetes,5/2/2014,AZN
NCT00528372,A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise,Type 2 Diabetes,5/14/2014,AZN
NCT00603239,Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin,Type 2 Diabetes Mellitus,9/2/2010,AZN
NCT00375492,Effect on Weight Loss of Exenatide Versus Placebo,Type 2 Diabetes Mellitus,9/4/2009,AZN
NCT01408303,[E]PANOVA Combined With a [S]TATIN in [P]ATIENTS With HYPERT[R]IGLYCER[I]DEMIA to Reduce Non-HDL CHOLES[T]EROL,Hypertriglyceridemia|Cardiovascular Disease,12/5/2014,AZN
NCT00135330,An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus,"Diabetes Mellitus, Type 2",8/28/2009,AZN
NCT00082381,Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin,"Diabetes Mellitus, Type 2",7/31/2013,AZN
NCT03162055,Efficacy and Safety of Glycopyrronium/Formoterol Fumarate Fixed-dose Combination Relative to Umeclidinium/Vilanterol Fixed-dose Combination Over 24 Weeks in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease,Chronic Obstructive Pulmonary Disease COPD,5/22/2019,AZN
NCT02918071,"Study to Assess Functionality, Reliability, and Performance of a Single-Use Auto-Injector With Benralizumab Administered at Home",Asthma,11/2/2018,AZN
NCT02814643,Study to Evaluate the Potential Effect of Benralizumab on the Humoral Immune Response to the Seasonal Influenza Vaccination in Adolescent and Young Adult Patients With Severe Asthma,Asthma,3/1/2018,AZN
NCT02796677,AMPLIFY - D6571C00001 Duaklir USA Phase III Study,Chronic Obstructive Pulmonary Disease,11/9/2018,AZN
NCT02681094,"A Multi-Center, Randomized, Double-Blind, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin Co-administered With Dapagliflozin Compared to Saxagliptin or Dapagliflozin All Given as add-on Therapy to Metformin in Subject With Type 2 Diabetes",Type 2 Diabetes Mellitus|Inadequate Glycaemic Control,10/10/2018,AZN
NCT02551874,"A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin",Type 2 Diabetes Mellitus,9/18/2018,AZN
NCT02417961,"Study to Assess Functionality, Reliability, and Performance of a Pre-filled Syringe With Benralizumab Administered at Home",Asthma,6/12/2017,AZN
NCT02413398,A Study to Evaluate the Effect of Dapagliflozin on Blood Glucose Level and Renal Safety in Patients With Type 2 Diabetes,Type 2 Diabetes Mellitus,10/31/2018,AZN
NCT02322775,Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma,Asthma,2/14/2017,AZN
NCT02284893,Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone,Type 2 Diabetes,6/1/2018,AZN
NCT02281357,Phase 3 Study to Evaluate the Efficacy & Safety of Tralokinumab in Adults & Adolescents With OCS Dependent Asthma,Asthma,5/16/2018,AZN
NCT02258542,A Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus LABA,Asthma,2/6/2019,AZN
NCT02229396,Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo,Diabetes Mellitus,9/8/2017,AZN
NCT02229383,Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus,Diabetes Mellitus,9/18/2017,AZN
NCT02194699,A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma,Uncontrolled Asthma,3/21/2018,AZN
NCT02161757,A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma,Uncontrolled Asthma,4/17/2018,AZN
NCT02157935,Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary Disease,COPD Patients,6/12/2017,AZN
NCT02091986,"A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg",Asthma,4/10/2017,AZN
NCT02075255,Efficacy and Safety Study of Benralizumab to Reduce OCS Use in Patients With Uncontrolled Asthma on High Dose Inhaled Corticosteroid Plus LABA and Chronic OCS Therapy,Asthma,10/17/2017,AZN
NCT02009865,Epanova® for Lowering Very High Triglycerides II (EVOLVE II),Hypertriglyceridemia,1/15/2016,AZN
NCT01994720,[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES],Acute Ischaemic Stroke|Transient Ischaemic Attack,6/12/2017,AZN
NCT01928771,Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma,Asthma,5/3/2017,AZN
NCT01914757,Efficacy and Safety Study of Benralizumab in Adults and Adolescents Inadequately Controlled on Inhaled Corticosteroid Plus Long-acting β2 Agonist,Asthma,1/25/2017,AZN
NCT01974752,Selumetinib (AZD6244: ARRY-142886) (Hyd-Sulfate) in Metastatic Uveal Melanoma (SUMIT),Metastatic|Uveal Melanoma,9/28/2016,AZN
NCT01843062,Comparing Complete Remission After Treatment With Selumetinib/Placebo in Patient With Differentiated Thyroid Cancer,Differentiated Thyroid Cancer,4/22/2019,AZN
NCT01732822,A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease,Peripheral Artery Disease,10/30/2017,AZN
NCT01652729,"Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus",Diabetes Type 2,4/23/2015,AZN
NCT01652716,Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes,"Diabetes Mellitus, Type 2",9/16/2015,AZN
NCT01646320,Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes,Type 2 Diabetes,4/11/2016,AZN
NCT01619059,Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 Diabetes,Type 2 Diabetes,3/17/2016,AZN
NCT01606007,Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes,Type 2 Diabetes,10/20/2015,AZN
NCT01572792,"Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)",Chronic Obstructive Pulmonary Disease,4/21/2017,AZN
NCT01444430,A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents,Asthma,12/15/2016,AZN
NCT01437540,Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease,Chronic Obstructive Pulmonary Disease,5/11/2017,AZN
NCT01437397,"Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",Chronic Obstructive Pulmonary Disease,3/23/2017,AZN
NCT01395524,A 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patients With Non-cancer-related Pain and Opioid-induced Constipation,Opioid-Induced Constipation (OIC),6/17/2015,AZN
NCT01370538,Efficacy of Esomeprazole in Patients With Frequent Heartburn,Heartburn,4/11/2013,AZN
NCT01370525,Efficacy of Esomeprazole in Patients With Frequent Heartburn,Heartburn,3/14/2013,AZN
NCT01360021,New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day,Asthma,3/11/2014,AZN
NCT01336205,Assessment of Long-term Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation,Opioid-Induced Constipation (OIC),10/20/2014,AZN
NCT01323790,Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation,Opioid-Induced Constipation (OIC),6/2/2015,AZN
NCT01309841,Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation,Opioid-Induced Constipation (OIC),6/1/2015,AZN
NCT01225562,"Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin",Myocardial Infarction|Cardiovascular Death|Atherothrombosis|Stroke,12/9/2015,AZN
NCT01197755,Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate and Have Had Inadequate Response to Single TNF-alpha Antagonist,Rheumatoid Arthritis,4/7/2014,AZN
NCT01197534,Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Disease Modifying Anti-rheumatic Drug (DMARD) But Not Responding.,Rheumatoid Arthritis,4/17/2014,AZN
NCT01197521,Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Not Responding.,Rheumatoid Arthritis,4/7/2014,AZN
NCT01204775,"Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes",Type 2 Diabetes,4/18/2017,AZN
NCT01144338,Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus,8/8/2018,AZN
NCT01045161,"Efficacy, Safety, and Tolerability of Aclidinium Bromide in the Treatment of Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-38)",Chronic Obstructive Pulmonary Disease,12/9/2015,AZN
NCT01044459,"Long-term Safety, Tolerability and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-35)",Chronic Obstructive Pulmonary Disease,9/13/2012,AZN
NCT00970268,"Long-term Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-36)",Chronic Obstructive Pulmonary Disease,9/14/2012,AZN
NCT00918138,Study To Evaluate 24 Hour Blood Sugar Control (24-hour Mean Weighted Glucose) In Subjects That Are Taking Saxagliptin 5 mg Added Onto Metformin XR 1500 XR mg Compared To Subjects Taking Metformin XR 1500 mg Up-titrated To Metformin XR 2000 mg,Type 2 Diabetes,10/6/2011,AZN
NCT00891462,Efficacy and Safety of Aclidinium Bromide for Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-33),Chronic Obstructive Pulmonary Disease,9/13/2012,AZN
NCT00885378,Efficacy and Safety Study of Saxagliptin + Metformin Immediate Release (IR) Versus Metformin IR Alone in Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus,12/16/2011,AZN
NCT00812955,"Safety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol (""Bad Cholesterol"") and Triglycerides","Dyslipidemia, Hypercholesterolemia, Hypertriglyceridemia",8/1/2012,AZN
NCT00811473,Pediatric Bipolar Depression,Bipolar Depression,12/1/2011,AZN
NCT00777153,Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma,Recurrent Glioblastoma,12/21/2012,AZN
NCT00757588,Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin,Type 2 Diabetes,12/13/2011,AZN
NCT00683657,Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone,Type 2 Diabetes,3/10/2010,AZN
NCT00680017,30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease,Dyslipidemia|Kidney Disease,7/16/2012,AZN
NCT00620542,CRESTOR Athero Imaging Head to Head IVUS Study,Coronary Atherosclerosis,6/25/2012,AZN
NCT00617669,A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer,Prostate Cancer,5/31/2012,AZN
NCT00554229,A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone Metastases,Prostate Cancer,5/31/2012,AZN
NCT00534599,Generalized Anxiety Disorder Adjunct Study,Anxiety|Anxiety Disorders|Anxiety Neuroses|Anxiety States,4/5/2011,AZN
NCT00500318,A Study of Exercise Endurance and Lung Hyperinflation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD),"Pulmonary Disease, Chronic Obstructive",12/17/2012,AZN
NCT00468559,Phase 3/Safety & Efficacy of Esomeprazole in Infants,Gastroesophageal Reflux Disease (GERD),6/2/2014,AZN
NCT00463606,A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia,Hypercholesterolemia|Dyslipidemia,8/1/2012,AZN
NCT00441727,Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA),Gastric Ulcer|Duodenal Ulcer,2/13/2012,AZN
NCT00419952,A Comparison of SYMBICORT® pMDI With Budesonide HFA pMDI in African American Subjects With Asthma.,Asthma,10/30/2012,AZN
NCT00419757,"An Efficacy Study Comparing SYMBICORT® Pressurised Metered Dose Inhaler (pMDI) With Budesonide Hydrofluoroalkanes (HFA) pMDI, in Hispanic Subjects With ICS Dependent Asthma",Asthma,8/27/2012,AZN
NCT00419744,A Comparison of SYMBICORT® pMDI With Formoterol Turbuhaler® in Subjects With COPD,Chronic Obstructive Pulmonary Disease,9/16/2010,AZN
NCT00391872,A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome,Acute Coronary Syndrome,3/13/2012,AZN
NCT00389064,Efficacy and Safety Study of Seroquel SR in the Treatment of Generalised Anxiety Disorder,Anxiety Disorders,6/23/2009,AZN
NCT00388973,Efficacy and Safety Study of Seroquel SR in the Treatment of Major Depressive Disorder,Major Depressive Disorder,4/1/2010,AZN
NCT00358436,Efficacy and Safety of LAS 34273 in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease(COPD),Chronic Obstructive Pulmonary Disease (COPD),11/1/2012,AZN
NCT00327015,A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise,Diabetes,9/25/2009,AZN
NCT00316082,Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise,Diabetes,9/25/2009,AZN
NCT00313313,A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas,Diabetes,9/25/2009,AZN
NCT00308139,Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1),Type 2 Diabetes Mellitus,8/17/2012,AZN
NCT00297115,Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The HERMES Study (BY217/M2-125),Chronic Obstructive Pulmonary Disease (COPD),5/19/2011,AZN
NCT00297102,Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The AURA Study (BY217/M2-124),Chronic Obstructive Pulmonary Disease (COPD),5/19/2011,AZN
NCT00295633,A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone,"Diabetes Mellitus, Type 2",9/25/2009,AZN
NCT00244621,Atacand Dose Ranging in Hypertensive Pediatric Subjects 1 Year to Less Than 6 Years of Age,Hypertension,9/15/2009,AZN
NCT00227305,Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder,Schizophrenia|Bipolar I Disorder,10/5/2012,AZN
NCT00121667,Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone,"Diabetes Mellitus, Type 2",4/8/2011,AZN
NCT00121641,Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise,"Diabetes Mellitus, Type 2",5/11/2011,AZN
NCT00355615,PLUTO: Pediatric Lipid-redUction Trial of rOsuvastatin,Familial Hypercholesterolemia,7/20/2009,AZN
NCT00663260,Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment,"Diabetes Mellitus, Type 2",2/10/2017,AZN
NCT00357370,A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes,Type 2 Diabetes,5/11/2017,AZN
NCT01248416,"Aromatase Inhibitors, Alone And In Combination With Growth Hormone In Adolescent Boys With Idiopathic Short Stature",Idiopathic Short Stature,6/7/2018,AZN
NCT02547935,"A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKD","Type 2 Diabetes Mellitus, CKD and Albuminuria",6/4/2019,AZN
NCT01242527,Epanova® for Lowering Very High Triglycerides,Severe Hypertriglyceridemia,9/6/2013,AZN
NCT00952588,"Study to Investigate the Efficacy, Safety and Tolerability of AZD1152 Alone and in Combination With Low Dose Cytosine Arabinoside (LDAC)in Acute Myeloid Leukaemia (AML) Patients",Acute Myeloid Leukemia,3/31/2014,AZN
NCT00384176,First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX,Colorectal Cancer,11/28/2012,AZN
NCT00392288,Efficacy and Safety of Ciclesonide (CIC) Administered Twice Daily in Pediatric Patients With Asthma.,Asthma,12/30/2009,AZN
NCT00193596,Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site,"Neoplasms, Unknown Primary",5/3/2013,AZN
NCT01078675,An Study to Evaluate Rosuvastatin in Children and Adolescents With Familial Hypercholesterolaemia,Familial Hypercholesterolaemia,2/2/2015,AZN
NCT00525824,"12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe",Hypercholesterolemia|Coronary Heart Disease|Atherosclerosis,10/7/2009,AZN
NCT00560885,AtriCure Bipolar Radiofrequency Ablation of Permanent Atrial Fibrillation,Atrial Fibrillation,3/14/2013,ATRC
NCT01934010,AM-101 in the Treatment of Post-Acute Tinnitus 1,Tinnitus,3/9/2018,EARS
NCT01803646,AM-101 in the Treatment of Acute Tinnitus 2,Tinnitus,5/28/2018,EARS
NCT02291861,Addressing Involuntary Movements in Tardive Dyskinesia,Tardive Dyskinesia,4/11/2018,
NCT01897896,Alternatives for Reducing Chorea in Huntington Disease,Chorea Associated With Huntington Disease,4/16/2019,
NCT02195700,Aim to Reduce Movements in Tardive Dyskinesia,Tardive Dyskinesia,3/20/2018,
NCT01667679,Efficacy and Safety of 20 mg Sumatriptan Powder Delivered Intranasally With the Bi-directional Device Compared With 100 mg Sumatriptan Tablets in Adults With Acute Migraine With or Without Aura,Migraine|Headaches,3/14/2017,
NCT00573443,Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS,Pseudobulbar Affect (PBA),7/10/2013,
NCT00674661,Corneal Collagen Cross-Linking for Ectasia (CXL),Ectasia,1/27/2017,AVDR
NCT00647699,Corneal Collagen Cross-linking for Progressive Keratoconus,Progressive Keratoconus,7/7/2016,AVDR
NCT00279916,Short Term Relief of Eustachian Tube Dysfunction and Serous Otitis Media Using Intranasal Steroid Sprays,"Otitis Media, Serous|Negative Middle Ear Pressure|Rhinitis|Otitis Media With Effusion|Otitis Media, Secretory",8/15/2011,
NCT01447719,Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07,Alzheimer's Disease,5/7/2012,CDMO
NCT01400425,Potential of Florbetapir F 18 PET to Inform Clinical Diagnosis and Management of Patients With Progressive Cognitive Decline,Progressive Cognitive Decline,3/22/2013,CDMO
NCT00857415,Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain,Alzheimer's Disease,5/7/2012,CDMO
NCT00734747,Safety and Efficacy the Medigus SRS Endoscopic Stapling System in Gastroesophageal Reflux Disease (GERD),Gastroesophageal Reflux Disease (GERD),8/14/2015,
NCT02585934,Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study,Alzheimer's Disease,12/5/2018,AXGT
NCT02263326,Dolutegravir Antiretroviral Strategy to Promote Improvement and Reduce Drug Exposure,HIV Infection,11/12/2018,
NCT00329433,Study Comparing Desirudin With Heparin to Prevent Vein Clots After Heart and Lung Surgery,Deep Venous Thrombosis,6/13/2011,
NCT00817063,Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema,Eczema,11/9/2017,
NCT01895972,Long-Term Safety of Latanoprostene Bunod Ophthalmic Solution 0.024% in Japanese Subjects With OAG or OHT,Glaucoma|Ocular Hypertension,6/5/2018,BHC
NCT01749930,Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension,Open-Angle Glaucoma|Ocular Hypertension,11/21/2018,BHC
NCT01749904,Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular Hypertension,Open-Angle Glaucoma|Ocular Hypertension,11/7/2018,BHC
NCT01475643,Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.,Cataract,6/11/2019,BHC
NCT01367249,Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery,Pain|Inflammation|Cataract,5/6/2014,BHC
NCT01230060,One-Piece Hydrophobic Acrylic Intraocular Lens in Subjects Undergoing Cataract Extraction,Aphakia|Cataract,8/22/2013,BHC
NCT01175590,Safety of Besivance™ (Besifloxacin Ophthalmic Suspension) 0.6% Compared to Vehicle,Bacterial Conjunctivitis,5/1/2013,BHC
NCT01060072,Evaluation of Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery,Inflammation|Pain,1/13/2012,BHC
NCT01010633,Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery,Inflammation|Pain,1/9/2012,BHC
NCT00853970,Efficacy Study of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery,Pain|Inflammation,1/26/2011,BHC
NCT00704418,Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery,Cataract,1/26/2011,BHC
NCT00703781,Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery,Cataract,12/9/2011,BHC
NCT00699153,Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery,Ocular Inflammation,9/23/2010,BHC
NCT00645671,Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery,Ocular Inflammation,9/23/2010,BHC
NCT00586664,Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis,Allergic Conjunctivitis,3/26/2012,BHC
NCT00972777,Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis,Bacterial Conjunctivitis,3/29/2012,BHC
NCT00424398,Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis,"Conjunctivitis, Allergic",3/26/2012,BHC
NCT01701024,Clinical Study to Test the Efficacy and Safety of ACYC to Treat Moderate to Severe Acne,Acne,1/10/2017,BHC
NCT00529087,Study Evaluating Subcutaneous MOA-728 for the Treatment of Opioid-Induced Constipation (OIC) in Subjects With Chronic Non-Malignant Pain,Constipation,5/11/2010,BHC
NCT00232596,Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy,Seizures,10/25/2011,BHC
NCT02493452,Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C),Irritable Bowel Syndrome Characterized by Constipation,6/14/2019,BHC
NCT00235755,Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy,Seizures,11/7/2011,BHC
NCT02387359,The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C),Irritable Bowel Syndrome Characterized by Constipation,6/14/2019,BHC
NCT02122471,12-Week Study of Plecanatide for CIC (The National CIC3 Study),Chronic Idiopathic Constipation,3/14/2019,BHC
NCT01919697,Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC),Chronic Idiopathic Constipation,7/2/2019,BHC
NCT01543178,Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study,Irritable Bowel Syndrome With Diarrhea,7/8/2015,BHC
NCT00731679,Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS),Non-Constipation Irritable Bowel Syndrome,7/28/2014,BHC
NCT00724126,Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS),Non-Constipation Irritable Bowel Syndrome,7/28/2014,BHC
NCT00679432,(CB-01-02/01) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis,Ulcerative Colitis,8/1/2014,BHC
NCT00486031,"Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study",Inflammatory Bowel Disease|Ulcerative Colitis,1/19/2018,BHC
NCT01429987,The Plecanatide Chronic Idiopathic Constipation (CIC) Study,Chronic Idiopathic Constipation,11/29/2017,BHC
NCT01144637,"A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects",Smallpox,1/3/2019,
NCT01945593,BAX 855 Continuation,Hemophilia A,5/1/2019,SHPGF
NCT02283268,Recombinant Von Willebrand Factor in Subjects With Severe Von Willebrand Disease Undergoing Surgery,Von Willebrand Disease,8/31/2017,SHPGF
NCT02210091,BAX 855 Pediatric Study,Hemophilia A,1/27/2017,SHPGF
NCT01913405,Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical Procedures,Hemophilia A,5/14/2018,SHPGF
NCT01410227,"Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)",Von Willebrand Disease,4/21/2016,SHPGF
NCT01175213,Tolerability and Safety of Immune Globulin Subcutaneous Solution (IGSC) and rHuPH20 in PID,Primary Immunodeficiency Diseases (PID),5/26/2016,SHPGF
NCT00814320,Gammagard Liquid and rHuPH20 in PID,Primary Immunodeficiency Diseases (PID),12/3/2015,SHPGF
NCT00666263,Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor Neuropathy,Multifocal Motor Neuropathy,3/13/2013,SHPGF
NCT00157157,Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients,Hemophilia A,7/15/2011,SHPGF
NCT00851721,Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor,Hemophilia A or B With Inhibitors|Hemophilia A|Hemophilia B,3/14/2014,SHPGF
NCT01736475,Study Investigating a PEGylated Recombinant Factor VIII (BAX 855) for Hemophilia A (PROLONG-ATE Study),Hemophilia A,9/7/2016,SHPGF
NCT01485796,"Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD",Primary Immunodeficiency Diseases (PID),4/24/2017,SHPGF
NCT01218438,"Phase 2/3 Study of IGSC, 20% in PIDD",Primary Immunodeficiency Diseases (PID),2/15/2017,SHPGF
NCT01178294,Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia A,Acquired Hemophilia A,12/21/2015,SHPGF
NCT00546871,"Comparison of Intravenous and Subcutaneous Administration of IGIV, 10% in Primary Immunodeficiency (PID) Subjects",Primary Immunodeficiency Diseases (PID),8/23/2012,SHPGF
NCT01757405,Recombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand Regimen,Hemophilia A|Hemophilia B,10/25/2016,SHPGF
NCT01219881,Comparing Desflurane to Sevoflurane for the Effect on Recovery Time in Patients Undergoing Urological Cystoscope Surgery,Cystoscopes|Baxter Anaesthesia Brand of Desflurane|Sevoflurane,11/29/2012,BAX
NCT02185729,Comparing Soybean Oil-Based (Intralipid) With an Olive Oil-Based (ClinOleic) Lipid Emulsion on Healthy Volunteers,"Diseases, Metabolic|Insulin Sensitivity",12/31/2014,BAX
NCT00672854,Study Comparing a Soybean Oil-Based With an Olive Oil-Based Lipid Emulsion in ICU Patients Requiring TPN,Parenteral Nutrition,8/1/2014,BAX
NCT01500135,Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment of Needle Hole Bleeding in Vascular Surgery,Bleeding,2/8/2017,BAX
NCT00999141,Efficacy and Safety of FS VH S/D 4 S-apr for Flap Adherence in Rhytidectomy,Face-lift|Facial Rhytidectomy,8/27/2012,BAX
NCT00892957,FS VH S/D 500 S-apr in Vascular Surgery,Hemostasis in Participants Receiving Peripheral Vascular Expanded Polytetrafluoroethylene (ePTFE) Graft Prostheses,11/27/2012,BAX
NCT01389284,Evaluate Efficacy and Safety of Extended Release (ER) Naproxen Sodium,"Pain, Postoperative",5/7/2013,
NCT01495858,Evaluate Analgesic / Sedative Efficacy of Naproxen Sodium and Diphenhydramine in Patients With Postsurgical Dental Pain,"Pain, Postoperative",6/17/2014,
NCT01280591,Evaluate Analgesic/Sedative Efficacy of Naproxen Sodium and Diphenhydramine in Patients With Postsurgical Dental Pain,"Pain, Postoperative",6/17/2014,
NCT00722761,Safety and Efficacy Of Drospirenone and Ethinyl Estradiol vs Placebo in the Treatment of Truncal Acne,Acne Vulgaris,3/5/2013,
NCT00720057,Assessing the Analgesic Efficacy of Naproxen Sodium in Postsurgical Dental Pain.,Toothache,1/25/2011,
NCT01094886,Switching Drug Therapy for the Prevention of Blood Clot Formation From Enoxaparin to Rivaroxaban After Orthopedic Surgery for Either Total Hip or Total Knee Replacement,"Arthritis|Osteoarthritis, Knee|Osteoarthritis, Hip|Thromboembolism",2/27/2012,
NCT02106832,Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE),Bronchiectasis,9/1/2017,
NCT02064439,Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism),Pulmonary Embolism|Thromboembolism|Thrombosis|Venous Thrombosis|Venous Thromboembolism,12/19/2017,
NCT01877915,"A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure",Heart Failure|Coronary Artery Disease,5/10/2019,
NCT01830543,A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention,Atrial Fibrillation|Percutaneous Coronary Intervention,7/31/2017,
NCT01799993,Inhaled Amikacin Solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia,"Pneumonia, Bacterial",6/26/2018,
NCT01764841,Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE),Bronchiectasis,5/24/2017,
NCT01729871,A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy,Atrial Fibrillation,11/10/2015,
NCT01674647,Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion,Atrial Fibrillation,2/3/2015,
NCT01521559,Study to Assess the Clinical Efficacy and Safety of Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) in Patients With Branch Retinal Vein Occlusion (BRVO),Branch Retinal Vein Occlusion,11/13/2014,
NCT01363440,Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Patients With Diabetic Macular Edema,Diabetic Macular Edema,4/20/2015,
NCT02066402,Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI),Bacterial Infections,6/7/2017,
NCT01234337,Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breast Cancer,Breast Cancer,9/3/2015,
NCT00964795,"Open-label Extension Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Neovascular (""Wet"") Age-related Macular Degeneration (AMD)",Neovascular Age-related Macular Degeneration,3/23/2015,
NCT00943072,Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO),Macular Edema Secondary to Central Retinal Vein Occlusion,5/27/2013,
NCT00930553,An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab,"Multiple Sclerosis, Relapsing-Remitting",5/15/2017,
NCT00809965,An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome,Acute Coronary Syndrome|Myocardial Infarction|Myocardial Ischemia|Unstable Angina,6/2/2014,
NCT00751400,Naproxen Sodium Extended-Release Actual Use Study,Pain,5/17/2011,
NCT00571649,Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients,Venous Thromboembolism,6/27/2012,
NCT00548405,"Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two","Multiple Sclerosis, Relapsing-Remitting",1/8/2015,
NCT00530348,"Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One","Multiple Sclerosis, Relapsing-Remitting",11/24/2014,
NCT00509795,Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD),Macular Degeneration,4/16/2012,
NCT00440193,Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep Vein Thrombosis - The EINSTEIN DVT Study,Venous Thrombosis,1/24/2013,
NCT00439777,Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Pulmonary Embolism - The EINSTEIN PE Study,Pulmonary Embolism,1/24/2013,
NCT00439725,Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study,Venous Thromboembolism,4/12/2012,
NCT00403767,An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation,Atrial Fibrillation|Stroke|Embolism,7/17/2012,
NCT00655629,"Vardenafil Orodispersible Tablet (ODT) Versus Placebo in Males With Erectile Dysfunction, 50% of Whom Are to be 65 Years or Older.",Erectile Dysfunction,1/21/2011,
NCT01890434,Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD),Coronary Artery Disease,5/16/2018,
NCT01788358,Open-Label Long-Term Safety and Efficacy Study of Fixed Dose Combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Subjects With Moderate to Severe Essential Hypertension,Hypertension,8/17/2015,
NCT01555463,"Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea",Papulopustular Rosacea,1/27/2015,
NCT01427803,Actual Use Trial of Naproxen Sodium,Pain,5/20/2013,
NCT01383486,Self Selection Trial of Naproxen Sodium,Pain,11/29/2012,
NCT01365052,Safety Trial of Naproxen Sodium/ Diphenhydramine,Pain,6/16/2014,
NCT01344460,Gadobutrol Enhanced MRA of the Renal Arteries,Renal Artery Obstruction,8/26/2015,
NCT01344447,Gadobutrol Enhanced MRA of the Supra-aortic Vessels,Carotid Stenosis,8/26/2015,
NCT01271712,Study of Regorafenib as a 3rd-line or Beyond Treatment for Gastrointestinal Stromal Tumors (GIST),Gastrointestinal Stromal Tumors,10/25/2013,
NCT01254292,LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study,Contraception,4/7/2014,
NCT01103323,Patients With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy,Metastatic Colorectal Cancer,11/19/2012,
NCT01104584,Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast Magnetic Resonance Imaging (MRI),Breast Cancer,11/11/2014,
NCT01067976,Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI,Breast Cancer|Diagnostic Imaging,11/11/2014,
NCT01029340,Trial to Evaluate the Efficacy and Safety of a New Full Length Recombinant Human FVIII for Hemophilia A,Blood Coagulation Disorders|Hemophilia A,11/18/2013,
NCT00937391,Contrast-enhanced MRI in Children 2 Months to <2 Years,Magnetic Resonance Imaging,10/13/2011,
NCT00909857,Effect on Primary Dysmenorrhea,Primary Dysmenorrhea,2/27/2012,
NCT00901901,Nexavar-Tarceva Combination Therapy for First Line Treatment of Patients Diagnosed With Hepatocellular Carcinoma,"Carcinoma, Hepatocellular",9/30/2013,
NCT00855465,A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH.,Pulmonary Hypertension,3/11/2014,
NCT00810693,A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH),Pulmonary Hypertension,2/26/2014,
NCT00761462,BAY 0 9867 Cipro Pediatric Use Study (QUIP),Infectious Diseases,4/14/2009,
NCT00754065,To Compare SH T00658ID Over Ortho Tri-Cyclen Lo (US/Canada),Contraception,8/28/2012,
NCT00709852,Safety and Efficacy of Gadobutrol 1.0 Molar (Gadavist) in Patients for Central Nervous System (CNS) Imaging,Diagnostic Imaging|Central Nervous System Diseases,3/6/2012,
NCT00692770,Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM),"Carcinoma, Hepatocellular",12/1/2014,
NCT00623480,Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects Compared to That of Episodic Treatment,Hemophilia A,8/7/2013,
NCT00623467,Safety and Efficacy of Gadobutrol 1.0 Molar ( Gadavist ) in Patients for Central Nervous System (CNS) Imaging,Central Nervous System Diseases,10/6/2011,
NCT00699751,A Phase III Study of Radium-223 Dichloride in Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal Metastases,Hormone Refractory Prostate Cancer|Bone Metastases,5/7/2014,
NCT00567164,Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ,"Contraception|Ovulation Inhibition|Contraceptives, Oral",3/12/2014,
NCT00528112,Levonorgestrel Contraceptive Intrauterine Systems (LCS) Pearl Index Study,Contraception,9/24/2012,
NCT00522873,Endometrial Safety Study,Postmenopause,6/28/2012,
NCT00501059,A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease,Moderate Risk of CVD,1/8/2018,
NCT00492024,BAY12-8039: 5 Days for Sinusitis vs Placebo,Sinusitis,12/2/2009,
NCT00459667,BEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New Dose,"Multiple Sclerosis, Relapsing-Remitting",8/17/2009,
NCT00468481,Efficacy and Safety Study for an Oral Contraceptive Containing Folate,Neural Tube Defects|Contraception|Oral Contraceptives (OC),1/25/2011,
NCT00446199,Low-dose Hormone Therapy for Relief of Vasomotor Symptoms,Vasomotor Symptoms|Hot Flashes,4/18/2012,
NCT00362232,Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thromboembolism (DVT) and Pulmonary Embolism (PE). A Study of BAY59-7939 in the Prevention of Venous Thrombo Embolism (VTE) in Subjects Undergoing Elective Total Knee Replacement.,Venous Thromboembolism,6/13/2012,
NCT00360490,Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS),Menorrhagia,11/19/2009,
NCT00293059,Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding,Metrorrhagia,6/6/2011,
NCT00244140,Ultravist: Safety and Efficacy in Computed Tomography of Head and Body,Computed Tomography|Diagnostic Imaging,7/20/2009,
NCT00105443,A Phase III Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma,"Carcinoma, Hepatocellular",9/27/2010,
NCT00863746,A 3rd/4th Line Placebo-controlled Trial of Sorafenib in Patients With Predominantly Non Squamous Non-Small Cell Lung Cancer (NSCLC).,Carcinoma|Non-Small-Cell Lung,7/30/2013,
NCT01233258,A Trial to Compare Prophylaxis Therapy to On-demand Therapy With a New Full Length Recombinant FVIII in Patients With Severe Hemophilia A,Hemophilia A,2/11/2014,
NCT01069900,Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection,Intraabdominal Infections,12/8/2015,
NCT01890421,Gadobutrol/Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD),Coronary Artery Disease,5/16/2018,
NCT01191788,"Building Recovery By Improving Goals, Habits, and Thoughts",Depression|Substance Use,6/25/2012,
NCT01123512,The Kiva® System as a Vertebral Augmentation Treatment,"Spinal Fractures|Fractures, Compression|Back Injuries",8/21/2014,
NCT00734474,A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin,"Diabetes Mellitus, Type 2",1/28/2015,
NCT00809809,Zinc for the Treatment of Herpes Simplex Labialis (HSL),Herpes Simplex Labialis,1/8/2014,
NCT00860470,Antenatal Micronutrient Supplementation and Infant Survival,Infant Mortality|Preterm Birth|Low Birth Weight|Neonatal Mortality|Perinatal Mortality,5/27/2015,
NCT00957996,Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza,Seasonal Influenza|Cough|Sore Throat|Nasal Congestion|Myalgia|Headache|Fatigue,2/12/2015,BCRX
NCT00293020,Study of the Safety of BEMA™ Fentanyl Use for Breakthrough Pain in Cancer Subjects on Chronic Opioid Therapy,Pain|Cancer,10/5/2012,BDSI
NCT01755546,Long-term Open-Label Safety Study to Evaluate EN3409,Low Back Pain|Osteoarthritis|Neuropathic Pain,9/12/2018,BDSI
NCT01675167,Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Experienced Subjects,Low Back Pain,2/3/2016,BDSI
NCT01633944,Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Naive Subjects,Low Back Pain,2/3/2016,BDSI
NCT01298765,Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain,Pain|Low Back Pain|Osteoarthritis|Neuropathic Pain,8/7/2018,BDSI
NCT01256450,Efficacy and Safety Study of Buprenorphine HCl Buccal Film in Subjects With Low Back Pain,Pain|Low Back Pain,12/8/2015,BDSI
NCT01568112,Effect of Aspirin Pretreatment or Slow Dose Titration on Flushing and Gastrointestinal Events in Healthy Volunteers Receiving Delayed-release Dimethyl Fumarate,Healthy,6/13/2016,BIIB
NCT00774202,"Higher Dose of Rituxan Versus Standard Doses of Rituxan With Cyclophosphamide, Vincristine, and Prednisone in Subjects With Chronic ITP",Immune Thrombocytopenic Purpura,11/14/2018,BIIB
NCT02097745,A Study of the Efficacy and Safety of Re-treatments With Rituximab in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-tnfa Therapies,Rheumatoid Arthritis,11/7/2014,BIIB
NCT00468546,A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Combination With Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Who Failed on Anti-Tumor Necrosis Factor Alpha Therapy,Rheumatoid Arthritis,10/25/2016,BIIB
NCT00306592,Natalizumab Re-Initiation of Dosing,"Multiple Sclerosis, Relapsing-Remitting",1/26/2010,BIIB
NCT00090051,FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients,Chronic Lymphocytic Leukemia,1/23/2012,BIIB
NCT02525874,Effect of BG00012 on Lymphocyte Subsets and Immunoglobulins in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS).,"Multiple Sclerosis, Relapsing-Remitting|Multiple Sclerosis",6/27/2019,BIIB
NCT02292537,A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA),Spinal Muscular Atrophy,2/21/2018,BIIB
NCT02219932,Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis,Multiple Sclerosis,3/27/2017,BIIB
NCT01939002,Characterize Flu-like Symptoms in Relapsing Multiple Sclerosis Patients Transitioning From Non-Pegylated Interferon Beta (IFN-β) Therapies to Peginterferon Beta-1a (BIIB017),Relapsing Multiple Sclerosis,1/25/2017,BIIB
NCT01462318,An Open-Label Immunogenicity and Pharmacokinetics Study of Daclizumab High Yield Process Prefilled Syringe in Relapsing Remitting Multiple Sclerosis,Relapsing-Remitting Multiple Sclerosis,3/14/2017,BIIB
NCT01332019,Long-Term Safety and Efficacy Study of Peginterferon Beta-1a,Relapsing Multiple Sclerosis,1/13/2017,BIIB
NCT00906399,Efficacy and Safety Study of Peginterferon Beta-1a in Participants With Relapsing Multiple Sclerosis,Relapsing Multiple Sclerosis,9/19/2014,BIIB
NCT00828204,Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects,Multiple Sclerosis,8/9/2011,BIIB
NCT00451451,Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis,Relapsing-Remitting Multiple Sclerosis,6/2/2014,BIIB
NCT00420212,Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis,Relapsing-Remitting Multiple Sclerosis,6/2/2014,BIIB
NCT01887678,Study of Intra-articular Injections vs Placebo in Patients With Pain From Osteoarthritis of the Knee,"Osteoarthritis, Knee",3/20/2015,
NCT00104234,Study of rhASB in Patients With Mucopolysaccharidosis VI,Mucopolysaccharidosis VI,3/6/2009,BMRN
NCT00067470,Study of Recombinant Human N-acetylgalactosamine 4-sulfatase (rhASB) in Patients With MPS VI,Mucopolysaccharidosis VI,8/17/2009,BMRN
NCT00943579,Open-Label Extension Study of Kuvan for Autism,Autistic Disorder,7/4/2013,BMRN
NCT01889862,Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU,Phenylketonuria (PKU),7/12/2019,BMRN
NCT01819727,An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165,Phenylketonuria,9/10/2018,BMRN
NCT01415427,Long-Term Efficacy and Safety Extension Study of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome),Mucopolysaccharidosis IV A|Morquio A Syndrome|MPS IVA,5/19/2017,BMRN
NCT01114737,Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients,Phenylketonuria,2/1/2016,BMRN
NCT01275066,A Double-Blind Study to Evaluate the Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome),MPS IV A,4/15/2014,BMRN
NCT00332189,Study of Phenoptin in Subjects With Phenylketonuria Who Participated in Protocols PKU-004 or PKU-006,Phenylketonuria,11/16/2012,BMRN
NCT00272792,Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet,Phenylketonurias,7/9/2009,BMRN
NCT00104247,Study to Evaluate the Safety and Efficacy of Phenoptin™ in Subjects With Phenylketonuria Who Have Elevated Phenylalanine Levels,Phenylketonurias,4/16/2009,BMRN
NCT00912925,Clinical Study of Aldurazyme in Patients With Mucopolysaccharidosis (MPS) I,Mucopolysaccharidosis I|Hurlers Syndrome|Hurler-Scheie Syndrome,8/19/2009,
NCT00146770,Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Mucopolysaccharidosis I (MPS I) Patients,Mucopolysaccharidosis I|Hurler's Syndrome|Hurler-Scheie Syndrome|Scheie Syndrome,6/16/2009,
NCT02839330,"A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age",Avian Influenza,4/4/2019,
NCT02474589,"A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat",Smallpox,11/28/2017,
NCT02359890,SMART-SF Radiofrequency Ablation Safety Study,Atrial Fibrillation,10/17/2017,
NCT01639495,THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation CONTINUED ACCESS,Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation,5/15/2018,
NCT01385202,THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation,Heart Diseases|Arrhythmia|Atrial Fibrillation,1/26/2015,
NCT00116428,NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation,Heart Diseases|Arrhythmia|Atrial Fibrillation,3/14/2013,
NCT00260429,Collagenase in the Treatment of Dupuytrens Disease,Dupuytren's Disease,12/9/2010,BSTC
NCT02130063,"IDA-01 A Randomised, Open-Label, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) and Iron Sucrose",Iron Deficiency Anaemia,5/22/2018,
NCT00646399,Safety and Efficacy of Pagibaximab Injection in Very Low Birth Weight Neonates for Prevention of Staphylococcal Sepsis,Staphylococcal Sepsis,10/24/2011,
NCT01689779,High Dose Preoperative Cholecalciferol Supplementation and Perioperative Vitamin D Status,Hypovitaminosis D,9/28/2017,
NCT00538915,"Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD)",Primary Immune Deficiency Disorders (PIDD),3/26/2012,
NCT01612767,BIOHELIX-I Bare Metal Stent Study,Coronary Arteries Disease,5/30/2017,
NCT02110238,Non-Inferiority Study Comparing 3 Weekly Injections of SUPARTZ® vs 3 Weekly Injections of Euflexxa® for Knee OA,Osteoarthritis,6/23/2016,
NCT02502149,"Pharmacokinetics and Safety of rFVIIIFc Manufactured at 15,000 L (15K) Scale",Severe Hemophilia A,4/6/2018,
NCT01458106,"Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Recombinant Coagulation Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Pediatric Subjects With Hemophilia A",Hemophilia A,12/12/2014,
NCT01440946,"Study of Recombinant Coagulation Factor IX Fc Fusion Protein, BIIB029, in Previously Treated Pediatric Participants With Hemophilia B",Hemophilia B,6/18/2015,
NCT01181128,"Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Subjects With Severe Hemophilia A",Severe Hemophilia A,8/29/2014,
NCT01027364,Study of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Participants With Hemophilia B,Severe Hemophilia B,9/4/2014,
NCT01454739,Long-Term Safety and Efficacy of rFVIIIFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia A,Hemophilia A,11/22/2018,
NCT01425723,Long-Term Safety and Efficacy of rFIXFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia B,Severe Hemophilia B,11/22/2018,
NCT01368276,An Extended Use Study of Safety and Efficacy of Talimogene Laherparepvec in Melanoma,Melanoma,12/18/2015,
NCT01528709,Aggressive Cholesterol Therapy to Inhibit Vein Graft Events After CABG (ACTIVE Trial),Saphenous Vein Graft Disease,8/9/2018,
NCT01929031,Efficacy and Safety of Ibuprofen and Caffeine in Dental Pain,"Pain, Postoperative|Tooth Diseases",11/16/2016,
NCT02580591,Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3),"Diabetes Mellitus, Type 1",11/2/2018,
NCT02414958,Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2),"Diabetes Mellitus, Type 1",11/20/2018,
NCT02302716,A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diabetes Mellitus,"Diabetes Mellitus, Type 2",10/24/2017,
NCT02182830,24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension,"Diabetes Mellitus, Type 2|Hypertension",7/31/2018,
NCT01792518,"MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin","Diabetes Mellitus, Type 2",3/6/2017,
NCT01778049,Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes,"Diabetes Mellitus, Type 2",4/4/2016,
NCT01734785,Safety and Efficacy of the Combination of Empagliflozin and Linagliptin Compared to Linagliptin Alone Over 24 Weeks in Patients With Type 2 Diabetes,"Diabetes Mellitus, Type 2",4/18/2016,
NCT01719003,Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 Diabetes,"Diabetes Mellitus, Type 2|Hyperglycemia",2/19/2016,
NCT01634152,Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma,Asthma,12/21/2015,
NCT01422876,Efficacy and Safety of Empagliflozin (BI 10773) / Linagliptin (BI 1356) Fixed Dose Combination in Treatment naïve and Metformin Treated Type 2 Diabetes Patients,"Diabetes Mellitus, Type 2",4/2/2015,
NCT01421459,A Study in Adults With Type 2 Diabetes,"Diabetes Mellitus, Type 2",10/9/2014,
NCT01421147,A Study in Adults With Type 1 Diabetes,"Diabetes Mellitus, Type 1",10/9/2014,
NCT01370005,12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus,"Diabetes Mellitus, Type 2|Hypertension",6/17/2014,
NCT01634139,Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma,Asthma,7/12/2016,
NCT01306214,Safety and Efficacy of BI 10773 as add-on to Insulin Regimen in Patients With Type 2 Diabetes Mellitus,"Diabetes Mellitus, Type 2|Obesity",6/17/2014,
NCT01289990,Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 Diabetes,"Diabetes Mellitus, Type 2",7/15/2014,
NCT01277523,Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma,Asthma,10/20/2014,
NCT01257230,Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma,Asthma,8/8/2014,
NCT01210001,Efficacy and Safety of Empagliflozin (BI 10773) in Type 2 Diabetes Patients on a Background of Pioglitazone Alone or With Metformin,"Diabetes Mellitus, Type 2",6/17/2014,
NCT01194830,Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-study,"Diabetes Mellitus, Type 2",10/26/2012,
NCT01183013,"30 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+30 and 5+45 mg) qd Versus Respective Monotherapies, Followed by a Comparison of 5mg+30mg and 5mg+45mg Versus Respective Monotherapies in Type 2 Diabetes for up to 54 Weeks","Diabetes Mellitus, Type 2",4/21/2014,
NCT01177813,Efficacy and Safety of Empagliflozin (BI 10773) Versus Placebo and Sitagliptin Over 24 Weeks in Patients With Type 2 Diabetes,"Diabetes Mellitus, Type 2",6/16/2014,
NCT01172821,Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma II,Asthma,2/7/2014,
NCT01172808,Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma I,Asthma,2/7/2014,
NCT01167881,Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes,"Diabetes Mellitus, Type 2",8/8/2014,
NCT01164501,Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal Impairment,"Diabetes Mellitus, Type 2|Renal Insufficiency",6/16/2014,
NCT01159600,Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 Diabetes,"Diabetes Mellitus, Type 2",6/17/2014,
NCT01131676,BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).,"Diabetes Mellitus, Type 2",5/16/2016,
NCT01087502,Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Moderate to Severe Renal Impairment,"Diabetes Mellitus, Type 2",10/17/2013,
NCT00996658,Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone,"Diabetes Mellitus, Type 2",3/26/2013,
NCT00954447,Efficacy and Safety of Linagliptin in Combination With Insulin in Patients With Type 2 Diabetes,"Diabetes Mellitus, Type 2",9/27/2012,
NCT00776984,Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study II),Asthma,9/27/2012,
NCT00772538,Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study I),Asthma,9/27/2012,
NCT00105989,Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive Disorder,"Depressive Disorder, Major",7/17/2009,
NCT02850965,"Efficacy, Safety and Immunogenicity of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque Psoriasis",Psoriasis,2/8/2019,
NCT02802345,Efficacy and Safety of Nintedanib Co-administered With Sildenafil in Idiopathic Pulmonary Fibrosis Patients With Advanced Lung Function Impairment,Idiopathic Pulmonary Fibrosis,1/11/2019,
NCT02640612,Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis,"Arthritis, Rheumatoid",12/5/2018,
NCT02296138,Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.,"Pulmonary Disease, Chronic Obstructive",6/4/2018,
NCT02164864,Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI),Atrial Fibrillation|Percutaneous Coronary Intervention,7/31/2018,
NCT02149108,Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1),Colorectal Neoplasms,7/21/2017,
NCT02137226,BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis,"Arthritis, Rheumatoid",12/8/2017,
NCT02104947,Reversal of Dabigatran Anticoagulant Effect With Idarucizumab,Hemorrhage,8/18/2017,
NCT02006732,Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2),"Pulmonary Disease, Chronic Obstructive",1/20/2016,
NCT01979952,Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF),Idiopathic Pulmonary Fibrosis,4/17/2018,
NCT01964352,Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1),"Pulmonary Disease, Chronic Obstructive",11/25/2015,
NCT01814553,ADAM-Afatinib Diarrhea Assessment and Management,"Carcinoma, Non-Small-Cell Lung",10/31/2016,
NCT01732796,IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1,"Hepatitis C, Chronic",4/18/2016,
NCT01728324,"Phase 3 Study of BI 207127 in Combination With Faldaprevir and Ribavirin for Treatment of Patients With Hepatitis C Infection, Including Patients Who Are Not Eligible to Receive Peginterferon: HCVerso2","Hepatitis C, Chronic",2/12/2016,
NCT01696058,Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®,"Pulmonary Disease, Chronic Obstructive",11/10/2014,
NCT01694771,Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®,"Pulmonary Disease, Chronic Obstructive",9/4/2014,
NCT01533935,Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients.,"Pulmonary Disease, Chronic Obstructive",9/15/2015,
NCT01525615,A Study to Determine the Effect of Tiotropium + Olodaterol Fixed Dose Combination on Exercise Endurance Time During Constant Work Rate Cycle Ergometry Test in COPD,"Pulmonary Disease, Chronic Obstructive",9/15/2015,
NCT01523587,LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy,"Carcinoma, Non-Small-Cell Lung",11/21/2014,
NCT01533922,Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients,"Pulmonary Disease, Chronic Obstructive",9/15/2015,
NCT01431287,Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD),"Pulmonary Disease, Chronic Obstructive",7/16/2015,
NCT01431274,Tiotropium+Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD),"Pulmonary Disease, Chronic Obstructive",7/16/2015,
NCT01399619,Phase III Trial of BI 201335 (Faldaprevir) in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)-Human Immunodeficiency Virus (HIV) Coinfected Patients (STARTverso 4),"Hepatitis C, Chronic",9/4/2015,
NCT01358864,Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3),"Hepatitis C, Chronic",10/28/2015,
NCT01335477,Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients II,Pulmonary Fibrosis,2/13/2015,
NCT01335464,Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients,Pulmonary Fibrosis,2/13/2015,
NCT01330316,A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients,Hepatitis C,7/31/2015,
NCT01345682,LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy,"Head and Neck Neoplasms|Carcinoma, Squamous Cell",4/14/2015,
NCT01297270,Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-naïve Genotype 1 Hepatitis C Infected Patients (STARTverso 2),Hepatitis C,9/18/2015,
NCT01179347,Tiotropium Bromide in Cystic Fibrosis,Cystic Fibrosis,3/26/2013,
NCT01126437,Comparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease,"Pulmonary Disease, Chronic Obstructive",6/20/2014,
NCT01125566,LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment,Breast Neoplasms,8/21/2014,
NCT01019694,Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease,"Pulmonary Disease, Chronic Obstructive",5/1/2012,
NCT01015118,LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer,Ovarian Neoplasms|Peritoneal Neoplasms,1/15/2015,
NCT00932646,Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease,"Pulmonary Disease, Chronic Obstructive",6/27/2014,
NCT00931385,Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease,"Pulmonary Disease, Chronic Obstructive",7/1/2014,
NCT00877929,Telmisartan Fixed Dose Combination vs Amlodipine in Hypertensive Patients With Type 2 Diabetes Mellitus,Hypertension,6/7/2011,
NCT00860262,Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension,Hypertension,1/4/2011,
NCT00949650,BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation,"Carcinoma, Non-Small-Cell Lung|Adenocarcinoma",11/19/2013,
NCT00819091,"Randomized, Double-blind (db), Placebo-controlled 18 Week Study of Linagliptin (BI 1356) in Type 2 Diabetic Patients With Insufficient Glycaemic Control on a Sulfonylurea Drug","Diabetes Mellitus, Type 2",8/1/2011,
NCT00928746,Actuation Indicator Trial in Patients With COPD,"Pulmonary Disease, Chronic Obstructive",9/28/2010,
NCT00819052,Switching Nevirapine Immediate Release( IR) Based Regimen to Nevirapine Extended Release (XR) Based Regimen in Human Immunodeficiency Virus One (HIV-1) Infected Patients,HIV Infections,2/24/2012,
NCT00808067,RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial,Atrial Fibrillation,4/8/2014,
NCT00806819,Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC,"Carcinoma, Non-Small-Cell Lung",11/20/2014,
NCT00800683,"Safety and Efficacy in Type 2 Diabetic Patients With Severe Chronic Renal Impairment, 5 mg BI 1356 (Linagliptin) vs. Placebo, Insulin Background Inclusive","Diabetes Mellitus, Type 2",2/1/2012,
NCT00782509,12 / 48 wk Pivotal PFT vs PBO in COPD II,"Pulmonary Disease, Chronic Obstructive",6/17/2014,
NCT00782210,12 / 48 Week Pivotal PFT vs PBO in COPD I,"Pulmonary Disease, Chronic Obstructive",4/30/2014,
NCT00740051,"A Randomised, db, Placebo-controlled Study of BI 1356 for 18 Weeks Followed by a 34 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients for Whom Treatment With Metformin is Inappropriate","Diabetes Mellitus, Type 2",10/26/2011,
NCT00736099,Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DM,"Diabetes Mellitus, Type 2",3/8/2012,
NCT00680186,Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE),Thromboembolism,6/14/2012,
NCT00656136,BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1),"Carcinoma, Non-Small-Cell Lung",11/27/2013,
NCT00657150,Dabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip Arthroplasty,Venous Thromboembolism,12/17/2010,
NCT00622284,Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 Diabetes,"Diabetes Mellitus, Type 2",2/20/2012,
NCT00601250,Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes,"Diabetes Mellitus, Type 2",6/7/2011,
NCT00601523,Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).,Parkinson Disease,8/25/2011,
NCT00561925,VERxVE Study on Efficacy and Safety of Nevirapine XR in Comparison to Nevirapine IR With Truvada in Naive HIV+ Patients,HIV Infections,1/19/2012,
NCT00558259,Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE,Venous Thromboembolism,3/2/2012,
NCT00479401,"Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Patients",Early Parkinson Disease (Early PD),4/15/2010,
NCT00400153,Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD),"Pulmonary Disease, Chronic Obstructive",6/1/2009,
NCT00387088,Tiotropium / Respimat One Year Study in COPD.,"Pulmonary Disease, Chronic Obstructive",1/22/2010,
NCT00329238,Secondary Prevention of Venous Thrombo Embolism (VTE).,Thromboembolism,9/14/2011,
NCT00291330,Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism,Thromboembolism,2/11/2011,
NCT00281580,Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension,Hypertension,4/28/2010,
NCT00262600,Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate,Atrial Fibrillation|Stroke,2/10/2011,
NCT00168844,Tiotropium / Respimat One-Year Study,"Pulmonary Disease, Chronic Obstructive",10/7/2009,
NCT00168831,Tiotropium / Respimat One-Year Study,"Pulmonary Disease, Chronic Obstructive",10/7/2009,
NCT00152971,Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacement,"Arthroplasty, Replacement, Knee|Thromboembolism",12/17/2010,
NCT00144339,Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients,"Pulmonary Disease, Chronic Obstructive",8/17/2009,
NCT01559116,Characterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary Disease,"Pulmonary Disease, Chronic Obstructive",7/16/2015,
NCT00054717,Randomized Evaluation of Strategic Intervention in Multidrug Resistant Patients With Tipranavir (RESIST),HIV Infections,11/19/2009,
NCT02085161,To Evaluate the Effect of Inhaled Medication Together With Exercise and Activity Training on Exercise Capacity and Daily Activities in Patients With Chronic Lung Disease With Obstruction of Airways,"Pulmonary Disease, Chronic Obstructive",1/6/2017,
NCT01040728,"A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease","Pulmonary Disease, Chronic Obstructive",6/30/2014,
NCT00796614,Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder,"Bladder, Neurogenic",9/12/2012,
NCT00146328,Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected Subjects,HIV Infections,7/16/2009,
NCT01885559,HALT Progression of Polycystic Kidney Disease (HALT PKD) Study B,"Kidney, Polycystic",3/10/2015,
NCT00283686,HALT Progression of Polycystic Kidney Disease (HALT PKD) Study A,"Kidney, Polycystic",2/27/2015,
NCT01635881,Evaluation of Coronary Luminal Diameter Enlargement With Emerge™ 1.20 mm PTCA Dilatation Catheter,Coronary Artery Disease,11/6/2013,BSX
NCT01936467,Comparison of Two Needle Aspiration Techniques for Endoscopic Ultrasound-guided Fine Needle Aspiration (EUS-FNA) in Solid Pancreatic Lesions,Pancreatic Solid Lesions|Pancreatic Mass,4/13/2017,BSX
NCT00433966,Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction,Myocardial Infarction,12/4/2017,BSX
NCT01510327,PLATINUM Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions-Pharmacokinetics (PLATINUM PK),Coronary Artery Disease,4/5/2012,BSX
NCT01665053,The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s),Coronary Artery Disease,1/7/2016,BSX
NCT01500434,The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL),Coronary Artery Disease,2/14/2012,BSX
NCT01182441,Evaluation of the WATCHMAN Left Atrial Appendage (LAA) Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy,Atrial Fibrillation|Stroke,7/26/2018,BSX
NCT00896337,EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries,Iliac Artery Stenosis,7/3/2012,BSX
NCT00823212,The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions,Coronary Artery Disease,1/27/2012,BSX
NCT00489541,TAXUS PERSEUS Small Vessel,Coronary Artery Disease,6/28/2011,BSX
NCT00484315,TAXUS PERSEUS Workhorse,Coronary Artery Disease,6/28/2011,BSX
NCT00433771,A Study of the WallFlex™ Biliary Fully-covered Stent for the Palliative Treatment of Malignant Bile Duct Obstruction,"Cholestasis, Extrahepatic",2/9/2010,BSX
NCT00286078,Treatment for Migraines With an Implantable Device,Migraine,8/9/2016,BSX
NCT00205855,An Implantable Spinal Cord Stimulation Pain Management System,"Chronic Pain|Pain, Intractable|Pain|Back Pain|Failed Back Surgery Syndrome",10/26/2012,BSX
NCT00131573,An Implantable Microstimulator for the Chronic Treatment of Urinary Urgency-Frequency Syndrome,Overactive Bladder,11/19/2013,BSX
NCT00080470,An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urge Incontinence,Urinary Incontinence,10/10/2013,BSX
NCT00129545,WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial Fibrillation,Atrial Fibrillation|Stroke,5/15/2015,BSX
NCT00790335,Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis,Deep Vein Thrombosis|Venous Thrombosis|Postphlebitic Syndrome|Venous Thromboembolism|Post Thrombotic Syndrome,3/29/2018,BSX
NCT00829413,SonoVue®-Enhanced Ultrasound (US) Versus Unenhanced US for Focal Liver Lesion Characterization,Liver Neoplasms,8/3/2018,
NCT00788697,SonoVue®-Enhanced Ultrasound Versus Unenhanced US for Focal Liver Lesion Characterization,Liver Neoplasms,6/14/2017,
NCT00856843,BLI800-303: An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects,Colonoscopy,11/10/2010,
NCT00756977,BLI850 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy,Colon Cancer,8/9/2013,
NCT00756548,BLI850-302: BLI850 vs an Approved Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy,Colon Cancer,12/27/2013,
NCT00373334,Safety and Efficacy Study of Axid Use in Infants Suffering From Gastroesophageal Reflux Disease (GERD),Gastroesophageal Reflux Disease|GERD|Heartburn,11/17/2009,
NCT00729430,Effect of High Dose Fish Oil Supplementation After Recent Heart Attack Using Magnetic Resonance Imaging,"Myocardial Infarction|Death, Sudden, Cardiac",6/1/2017,
NCT01931150,Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT,Cetuximab-induced Papulopustular (Acneiform) Rash Who Have|Metastatic Colorectal Cancer or Head and Neck Squamous Cell Carcinoma,1/13/2017,BMY
NCT00683852,"A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy",Major Depressive Disorder,7/19/2017,BMY
NCT00556140,The Combination of Aripiprazole and Antidepressants in Psychotic Major Depression,Psychotic Depression,8/20/2012,BMY
NCT00194077,Study of Aripiprazole (Abilify) in Children With Symptoms of Mania,Bipolar Disorder,12/5/2013,BMY
NCT00194012,Study of Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolar Disorder,Bipolar Disorder,5/5/2014,BMY
NCT00870727,Study of Aripiprazole in the Treatment of Pervasive Developmental Disorders,Pervasive Developmental Disorder,11/28/2018,BMY
NCT02032875,"Phase III Daclatasvir, Sofosbuvir, and Ribavirin in Cirrhotic Participants and Participants Post-liver Transplant",Hepatitis C,10/20/2015,BMY
NCT00643201,Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism,Venous Thrombosis,4/10/2014,BMY
NCT00633893,Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism,Venous Thrombosis,10/25/2013,BMY
NCT00496769,A Phase III Study of Apixaban in Patients With Atrial Fibrillation,Atrial Fibrillation,11/14/2013,BMY
NCT00324155,Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma,Melanoma,3/10/2014,BMY
NCT00095238,Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve),Congestive Heart Failure,6/8/2010,BMY
NCT00252564,"Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer",Metastatic Colorectal Cancer,3/14/2011,BMY
NCT02673489,A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection,Hepatitis C,3/29/2018,BMY
NCT02032901,Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV,Hepatitis C,9/14/2015,BMY
NCT02032888,A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.,Hepatitis C,10/27/2015,BMY
NCT01714817,Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis,Lupus Nephritis,12/21/2017,BMY
NCT01598090,Phase 3 Efficacy and Safety Study of Peginterferon Lambda-1a and Ribavirin With Telaprevir,Hepatitis C Virus,5/21/2019,BMY
NCT01515189,Phase 3 Trial in Subjects With Metastatic Melanoma Comparing 3 mg/kg Ipilimumab Versus 10 mg/kg Ipilimumab,Melanoma,3/24/2017,BMY
NCT01492426,Study Comparing Daclatasvir (BMS-790052) With Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Virus Infection,Hepatitis C,6/3/2016,BMY
NCT01471574,Safety and Efficacy Study of Daclatasvir (BMS-790052) Plus Pegylated Interferon-Alfa 2a and Ribavirin in Patients Coinfected With Untreated Hepatitis C Virus and HIV Virus,"Hepatitis C, Genotype 1",12/17/2015,BMY
NCT01450761,Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone,Small Cell Lung Carcinoma,7/18/2016,BMY
NCT01389323,"BMS-790052 (Daclatasvir) Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C",Hepatitis C,9/16/2015,BMY
NCT01285609,Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin,Lung Cancer - Non Small Cell Squamous,6/23/2016,BMY
NCT01142726,Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis,Rheumatoid Arthritis,10/17/2014,BMY
NCT01079806,A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus Infection,"Chronic Hepatitis B Virus, Pediatric",4/21/2014,BMY
NCT01057810,Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer,Prostate Cancer,8/18/2016,BMY
NCT01741545,Safety and Efficacy Study in Subjects With Chronic HCV and Underlying Hemophilia,Hepatitis C Virus,6/24/2019,BMY
NCT01003990,Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access,HIV,5/11/2017,BMY
NCT00929864,Abatacept Versus Adalimumab Head-to-Head,Rheumatoid Arthritis,1/3/2014,BMY
NCT00861614,Study of Immunotherapy to Treat Advanced Prostate Cancer,Prostate Cancer,3/16/2016,BMY
NCT00744497,Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer,Prostatic Neoplasms,2/6/2014,BMY
NCT00663702,Phase IIIB Switching From Intravenous to Subcutaneous Study,"Arthritis, Rheumatoid",3/26/2012,BMY
NCT00559585,Methotrexate-Inadequate Response Study,Rheumatoid Arthritis (RA),7/6/2011,BMY
NCT00547521,Phase IIIB Subcutaneous Abatacept Monotherapy Study,Rheumatoid Arthritis (RA),1/24/2011,BMY
NCT00533897,Phase IIIB Subcutaneous Missed Dose Study,Rheumatoid Arthritis,6/3/2011,BMY
NCT00457002,Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness,Venous Thrombosis|Pulmonary Embolism,5/20/2014,BMY
NCT00423319,Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3),Deep Vein Thrombosis|Pulmonary Embolism,5/14/2014,BMY
NCT00412984,Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation,Atrial Fibrillation|Atrial Flutter,4/29/2013,BMY
NCT00410410,A Study of Abatacept in Patients With Active Ulcerative Colitis,Ulcerative Colitis,12/2/2010,BMY
NCT00410072,Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B,"Hepatitis B, Chronic",2/3/2012,BMY
NCT00395018,Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection,"Hepatitis B, Chronic",5/31/2012,BMY
NCT00371683,Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery,Deep Vein Thrombosis|Pulmonary Embolism,12/30/2015,BMY
NCT00256750,Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT),Kidney Transplantation|Chronic Kidney Failure,8/19/2016,BMY
NCT00272779,BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada,HIV Infections,5/9/2011,BMY
NCT00124982,Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy,Rheumatoid Arthritis,6/2/2011,BMY
NCT00123487,Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML,"Myeloid Leukemia, Chronic, Accelerated Phase|Leukemia, Lymphoblastic, Acute, Philadelphia-Positive",10/22/2014,BMY
NCT00123474,Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML,"Myeloid Leukemia, Chronic, Chronic-Phase",8/26/2015,BMY
NCT00122382,Remission and Joint Damage Progression in Early Rheumatoid Arthritis,Rheumatoid Arthritis,7/13/2010,BMY
NCT00114777,Study of Belatacept in Subjects Who Are Undergoing a Renal Transplant,Renal Transplantation,7/7/2017,BMY
NCT00096785,Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection,Hepatitis B|Chronic Disease,1/6/2010,BMY
NCT00095147,Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis,Rheumatoid Arthritis,1/21/2011,BMY
NCT00094653,"MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma",Melanoma|Metastases,6/23/2011,BMY
NCT00095173,BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis,Juvenile Rheumatoid Arthritis,1/18/2017,BMY
NCT01448044,Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C,Hepatitis C,9/7/2015,BMY
NCT00065507,Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation,Hepatitis B,7/2/2010,BMY
NCT00048932,A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis,Rheumatoid Arthritis,5/3/2011,BMY
NCT00048581,Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past.,Rheumatoid Arthritis,6/23/2011,BMY
NCT00048568,A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate,Rheumatoid Arthritis,12/5/2011,BMY
NCT00035932,"Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV",HIV Infections,12/24/2010,BMY
NCT00789581,A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer,Breast Cancer,4/12/2017,BMY
NCT00225017,Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study,HIV Infection|Hyperlipidemia,8/2/2012,BMY
NCT01335698,Phase IIIB Study Evaluating the Effects of Atazanavir Powder With Ritonavir in HIV-infected Pediatric Patients,HIV,2/8/2016,BMY
NCT00833703,Long Term Safety of Clopidogrel in Neonates/Infants With Systemic to Pulmonary Artery Shunt Palliation,"Heart Defects, Congenital",8/16/2011,BMY
NCT00396877,Efficacy And Safety Of Clopidogrel In Neonates /Infants With Systemic To Pulmonary Artery Shunt Palliation,"Heart Defects, Congenital",3/11/2011,BMY
NCT00335452,Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS,Acute Coronary Disease|Angina Unstable,10/7/2010,BMY
NCT00249873,Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A),Atrial Fibrillation|Vascular Risk,3/26/2010,BMY
NCT00249795,Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I),Atrial Fibrillation|Cardiovascular Disease,10/15/2010,BMY
NCT00481247,A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia,"Myeloid Leukemia, Chronic",3/15/2011,BMY
NCT00410202,Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus,"Hepatitis B, Chronic",7/4/2012,BMY
NCT01172145,Treatment of Apathy in Alzheimer's Disease With Modafinil,Apathy|Alzheimer's Disease,3/4/2011,
NCT00457730,A Study to Test the Use of Duloxetine for Pain in MS,Multiple Sclerosis,4/6/2015,
NCT01508910,Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina,Chronic Myocardial Ischemia|Refractory Angina Pectoris|Advanced Coronary Heart Disease,2/15/2017,CLBS
NCT00143598,The SOX Trial: Compression Stockings to Prevent the Post-Thrombotic Syndrome,Deep Venous Thrombosis,8/18/2014,
NCT00688740,Docetaxel in Node Positive Adjuvant Breast Cancer,Breast Cancer,2/14/2011,
NCT00312208,Docetaxel in Breast Cancer,Breast Cancer,2/17/2010,
NCT00021255,Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer,Breast Neoplasms,11/15/2016,
NCT01265667,Trial of CF101 to Treat Patients With Psoriasis,Plaque Psoriasis,9/20/2017,CANF
NCT01158157,VA-006 Vaccinia Vaccine (ACAM2000) for the Production of VIGIV,Smallpox Vaccine Adverse Reaction,3/26/2019,
NCT01456000,HeartLight Ablation in Patients With Paroxysmal Atrial Fibrillation (PAF),Paroxysmal Atrial Fibrillation,9/8/2016,
NCT00591591,Brain Oxygenation and Hemodynamics During Sleep in Obstructive Sleep Apnea Sufferers,Obstructive Sleep Apnea Syndrome,3/11/2011,
NCT02970162,Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS),Lambert-Eaton Myasthenic Syndrome,12/24/2018,CBIO
NCT01377922,A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS),Lambert Eaton Myasthenic Syndrome,1/4/2018,CBIO
NCT01281202,Vigabatrin for the Treatment of Cocaine Dependency,Cocaine Addiction|Cocaine Dependence,2/23/2016,CBIO
NCT00179647,Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma,Multiple Myeloma,3/3/2010,CELGZ
NCT01925768,Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis,Psoriatic Arthritis,6/13/2016,CELGZ
NCT01690299,Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis,Psoriasis|Psoriatic Arthritis,8/4/2015,CELGZ
NCT01583374,Study of Apremilast to Treat Subjects With Active Ankylosing Spondylitis,Ankylosing Spondyloarthritis,3/17/2015,CELGZ
NCT01307423,Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA),Psoriatic Arthritis,8/15/2014,CELGZ
NCT01232283,Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis.,Plaque Psoriasis,11/5/2014,CELGZ
NCT01212770,PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis,Psoriatic Arthritis,5/20/2014,CELGZ
NCT01212757,PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis,Psoriatic Arthritis,5/19/2014,CELGZ
NCT01178281,Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence,Primary Myelofibrosis|MPN-associated Myelofibrosis,3/14/2014,CELGZ
NCT01172938,Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis,Psoriatic Arthritis,5/20/2014,CELGZ
NCT00988208,Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer,Prostate Cancer,9/5/2013,CELGZ
NCT01029262,A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Lower Risk Myelodysplastic Syndrome (MDS) Without Del 5q,Anemia,6/18/2015,CELGZ
NCT00910910,Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial),B-Cell Chronic Lymphocytic Leukemia,12/21/2016,CELGZ
NCT00864253,A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma,Malignant Melanoma,6/5/2014,CELGZ
NCT00844649,Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas,Metastatic Pancreatic Cancer,12/11/2013,CELGZ
NCT00689936,"Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma",Multiple Myeloma,8/11/2017,CELGZ
NCT00540514,Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,8/19/2013,CELGZ
NCT00071799,A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care,Myelodysplastic Syndromes,7/5/2010,CELGZ
NCT00056160,CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma,Multiple Myeloma,3/3/2010,CELGZ
NCT01074047,Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML),Acute Myeloid Leukemia,2/26/2015,CELGZ
NCT01881230,Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer),Breast Tumor|Breast Cancer|Cancer of the Breast|Estrogen Receptor- Negative Breast Cancer|HER2- Negative Breast Cancer|Progesterone Receptor- Negative Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer|Triple-negative Breast Cancer|Triple-negative Metastatic Breast Cancer|Metastatic Breast Cancer,3/8/2018,CELGZ
NCT01197560,Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL),Diffuse Large B-cell Lymphoma,8/20/2014,CELGZ
NCT01311687,"A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide in Combination With Low-Dose Dexamethasone Versus High-Dose Dexamethasone in Subjects With Refractory Multiple Myeloma or Relapsed and Refractory Multiple Myeloma and Companion Study",Multiple Myeloma,4/30/2014,CELGZ
NCT00083551,UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy,Multiple Myeloma,9/22/2015,CELGZ
NCT02096861,Demonstrate Noninferiority in Efficacy and to Assess Safety of CT-P13 in Patients With Active Crohn's Disease,Crohn's Disease,4/11/2018,
NCT00617981,Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC),Hepatocellular Carcinoma,3/24/2017,CLSN
NCT00226655,"An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies",Brain Edema|Brain Tumor,8/31/2012,
NCT00088166,XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors,Brain Edema|Brain Tumor,8/13/2014,
NCT00094458,Trial Comparing Infliximab and Infliximab and Azathioprine in the Treatment of Patients With Crohn's Disease na�ve to Both Immunomodulators and Biologic Therapy (Study of Biologic and Immunomodulator Naive Patients in Chrohn's Disease: SONIC,Crohn Disease,6/23/2009,
NCT00307437,A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Psoriasis,Psoriasis,11/2/2012,
NCT00267969,A Study of Safety and Effectiveness of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Plaque-type Psoriasis,Psoriasis,8/24/2012,
NCT00656448,A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDS,Acute Myelogenous Leukemia|Myelodysplastic Syndrome|Leukemia,12/23/2013,
NCT00973479,An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate Therapy,"Arthritis, Rheumatoid",10/14/2013,
NCT00361335,A Study of Safety and Effectiveness of Golimumab in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy,Rheumatoid Arthritis,8/24/2012,
NCT00299546,A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s),"Arthritis, Rheumatoid",9/28/2011,
NCT00265096,A Study of the Safety and Efficacy of Golimumab in Patients With Active Psoriatic Arthritis,"Arthritis, Psoriatic",4/16/2012,
NCT00264537,A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naive,Rheumatoid Arthritis,7/13/2009,
NCT00264550,An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy,Rheumatoid Arthritis,3/21/2014,
NCT00265083,A Study of the Safety and Efficacy of Golimumab in Subjects With Active Ankylosing Spondylitis,"Spondylitis, Ankylosing",7/13/2009,
NCT00046228,A Study of Abciximab and Reteplase When Administered Prior to Catherization After a Myocardial Infarction (Finesse),Myocardial Infarction,5/15/2009,
NCT00336492,A Study of the Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Patients With Moderately to SeverelyActive Ulcerative Colitis,Ulcerative Colitis,8/10/2011,
NCT01160380,A Study of the Effectiveness of Armodafinil to Treat Cancer-Related Fatigue in Patients With Multiple Myeloma,Fatigue|Multiple Myeloma,11/6/2014,
NCT00758498,Study of the Effect of Armodafinil Treatment in Healthy Subjects With Excessive Sleepiness Associated With Jet Lag Disorder,Excessive Sleepiness,7/8/2010,
NCT00635089,Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis,Eosinophilic Esophagitis,3/23/2017,
NCT01305408,Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder,Depression,1/26/2015,
NCT01073163,Study to Assess the Effect of Treatment With Bendamustine in Combination With Rituximab on QT Interval in Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL),Non-Hodgkin's Lymphoma|Mantle Cell Lymphoma,4/4/2014,
NCT01072929,A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder,Depression,1/26/2015,
NCT01072630,Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder,Depression,1/26/2015,
NCT00813488,Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for Breakthrough Pain in Patients With Chronic Pain,Chronic Pain,12/31/2010,
NCT00463047,Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through Pain,Chronic Pain,12/14/2010,
NCT00236080,Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL,Chronic Shift Work Sleep Disorder,2/3/2010,
NCT00228566,Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome,Excessive Daytime Sleepiness|Narcolepsy|Obstructive Sleep Apnea/Hypopnea Syndrome (OSAHS),6/25/2010,
NCT00228553,Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness,Excessive Daytime Sleepiness|Narcolepsy|Obstructive Sleep Apnea/Hypopnea Syndrome|Chronic Shift Work Sleep Disorder,3/31/2010,
NCT00078312,"Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder","Narcolepsy|Sleep Apnea, Obstructive|Sleep Apnea Syndromes|Shift-Work Sleep Disorder",2/22/2010,
NCT00538434,Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years,Eosinophilic Esophagitis,9/2/2016,
NCT01748292,Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab,Macular Degeneration,10/20/2017,
NCT00782340,A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa,Symptomatic Neurogenic Orthostatic Hypotension (NOH)|Non-diabetic Neuropathy|Primary Autonomic Failure|Dopamine Beta Hydroxylase Deficiency,5/16/2014,
NCT00633880,Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH),Symptomatic Neurogenic Orthostatic Hypotension (NOH)|Non-diabetic Neuropathy|Primary Autonomic Failure|Dopamine Beta Hydroxylase Deficiency,5/20/2014,
NCT01176240,A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease,Orthostatic Hypotension|Parkinson's Disease,5/20/2014,
NCT00738062,Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH),Neurogenic Orthostatic Hypotension|Non-Diabetic Autonomic Neuropathy|Multiple System Atrophy|Dopamine Beta Hydroxylase Deficiency,5/16/2014,
NCT02269241,"Safety, Efficacy, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles",Contraception,7/23/2019,
NCT00893113,An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract Symptoms,Erectile Dysfunction|Lower Urinary Tract Symptoms,8/1/2016,
NCT00608491,Effectiveness of Ultrafiltration in Treating People With Acute Decompensated Heart Failure and Cardiorenal Syndrome (The CARRESS Study),Heart Failure,6/24/2013,CHFS
NCT01412424,Efficacy and Safety of Octreotide (MYCAPSSA™ [Formerly Octreolin™]) for Acromegaly,Acromegaly,12/1/2015,CHMA
NCT00240487,Nitric Oxide Administration for Acute Respiratory Distress Syndrome,Acute Respiratory Distress Syndrome,4/24/2015,
NCT00757237,Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas Aeruginosa,Cystic Fibrosis,7/4/2011,
NCT01087801,A Study of Synthetic Human Secretin (ChiRhoStim®) Administered Intravenously to Stimulate Exocrine Pancreas Fluid Secretion for Collection Via Endoscope and Laboratory Analysis of DNA Markers,Pancreatic Disease,12/2/2011,
NCT00004978,An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy,HIV Infections,4/25/2011,
NCT00604383,Protein Kinase C (PKC) Inhibitor-Diabetic Retinopathy Phase 3 Study,Diabetic Retinopathy,1/28/2016,
NCT00266695,Treatment for Completers of the Study B7A-MC-MBCM,Diabetic Retinopathy,1/28/2016,
NCT00133952,Effect of Ruboxistaurin on Clinically Significant Macular Edema,Diabetic Macular Edema,1/28/2016,
NCT00090519,Reduction in the Occurrence of Center-Involved Diabetic Macular Edema,Diabetic Retinopathy,5/16/2016,
NCT00548548,A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer,Adenocarcinoma,1/19/2012,
NCT00975143,Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne,Severe Nodular Acne,7/4/2014,
NCT01620762,Phase III Cat-PAD Study,Rhinoconjunctivitis,5/14/2018,
NCT02722278,A Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men,Hypogonadism,2/23/2018,
NCT01403116,Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men,Male Hypogonadism,8/14/2018,
NCT01765179,Safety and Efficacy Trial of Testosterone Undecanoate,Male Hypogonadism,9/21/2017,
NCT01699178,"Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men",Male Hypogonadism,10/30/2018,
NCT00809523,A Trial of Negative Ion Generation Versus Light-Emitting Diode Phototherapy for Seasonal Affective Disorder (SAD),Seasonal Affective Disorder,3/6/2013,
NCT00133978,Trial of Glutamine and Antioxidant Supplementation in Critically Ill Patients,Critical Illness|Sepsis|Multiple Organ Failure,9/9/2014,
NCT00196196,A Precision and Accuracy Study of the Codman Valve Position Verification (VPV) System.,Hydrocephalus|Normal Pressure Hydrocephalus,12/5/2008,
NCT02134210,Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO),Plaque Psoriasis,5/13/2019,CHRS
NCT02115750,Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA),Rheumatoid Arthritis,6/26/2019,CHRS
NCT01072188,Clinical Efficacy of 10% Arginine Bicarbonate Prophylaxis Paste,Hypersensitivity,2/19/2010,
NCT01024738,Study to Determine the Anti-plaque Efficacy of Commerical Toothpastes and an Oral Rinse,Dental Plaque,12/3/2009,
NCT01021007,Clinical Research Study Efficacy of a Prototype Oral Rinse,Dental Plaque,11/26/2009,
NCT00966953,Development of Clinical Method to Determination Triclosan Retention in Plaque Following Brushing.,Gingival Diseases,8/27/2009,
NCT00926029,Compare the Clinical Efficacy of Prototype Toothpastes,Dental Plaque,6/23/2009,
NCT00763269,The Efficacy of a Toothpaste to Reduce Sensitivity,Dentin Hypersensitivity,9/17/2010,
NCT00763048,Collection of Gingival Crevicular Fluid From Periodontitis Patients,Gingival Diseases,3/1/2011,
NCT00762515,Clinical Study to Evaluate the Treatment of Gingivitis of Two Toothpastes,Dental Plaque,12/14/2010,
NCT00762177,Investigate Oral Bacteria in Adult Population,Oral Bacteria,2/14/2011,
NCT00761930,Compare the Clinical Efficacy of Prototype Toothpastes.,Gingival Diseases,10/20/2010,
NCT00759187,Evaluate Clinical Research From Commerical Oral Care Products,Gingival Diseases,11/18/2008,
NCT00759031,Investigation of Dental Plaque and Gingival Index,Dental Plaque,11/25/2008,
NCT00758563,Train New Examiners Via Modified Gingival Margin Plaque,Dental Plaque,11/20/2008,
NCT00758394,Clinical Study to Compare Dental Plaque Control,Dental Plaque,11/19/2008,
NCT00758290,Clinical Study to Evaluate Dental Plaque,Gingival Diseases,11/25/2008,
NCT00762619,Clinical Study to Examine Brushing on Dental Implants,Gingival Diseases,1/25/2011,
NCT00130208,Effect of Sulodexide in Early Diabetic Nephropathy,Diabetic Nephropathy,3/23/2018,
NCT01074125,A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease,Hyperphosphatemia|End-Stage Renal Disease,12/4/2014,
NCT01685684,Oxycodone DETERx™ Versus Placebo in Chronic Low Back Pain (CLBP),Chronic Low Back Pain,2/23/2017,COLL
NCT02605174,"Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of Migraine",Migraine With or Without Aura,7/30/2018,
NCT00297830,Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation,Heart Transplantation|Liver Transplantation|Bone Resorption,9/15/2016,
NCT00697463,Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women,Menopause|Fracture|Osteoporosis,7/26/2018,
NCT02485717,Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies,Scabies,1/16/2019,
NCT02485704,Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies,Scabies,1/16/2019,
NCT00578877,Contraceptive Effectiveness and Safety of the SILCS Diaphragm,Contraception,8/24/2017,
NCT01371565,Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome,Cushing's Disease|Cushing's Syndrome,11/20/2013,CORT
NCT00936741,An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome,Cushing's Syndrome,4/2/2014,CORT
NCT00569582,A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome,Cushing's Syndrome,5/28/2012,CORT
NCT00232739,Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions,Coronary Artery Disease,2/8/2010,
NCT00231283,NEXUS Study for the Treatment of de Novo Native Coronary Artery Lesions,Coronary Artery Disease,3/23/2010,
NCT00345631,Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device,"Angioplasty, Transluminal, Percutaneous Coronary|Coronary Arteriosclerosis|Peripheral Arteriosclerosis",3/19/2012,
NCT01694966,The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy,Colorectal Cancer,11/6/2017,
NCT00638690,Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy,Prostatic Neoplasms,5/16/2013,
NCT01165554,Positron Emission Tomography (PET) Imaging of Brain Amyloid Compared to Post-Mortem Levels,Brain Fibrillarab Levels,12/4/2013,
NCT00731549,Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia,Schizophrenia,11/11/2014,
NCT01060592,LapBand Adjustment to Improve Early Weight Loss,Obesity,4/4/2013,
NCT00719680,Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID),Primary Immune Deficiency,1/25/2013,
NCT01545076,Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20),Chronic Inflammatory Demyelinating Polyneuropathy|Polyradiculoneuropathy,7/4/2018,
NCT02316353,A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema,Hereditary Angioedema Types I and II,11/14/2018,
NCT02027701,Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP),"Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)|Polyradiculoneuropathy, Chronic Inflammatory Demyelinating",10/2/2018,
NCT00945906,An Open Enrollment Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency,Factor XIII Deficiency,10/12/2012,
NCT00885742,A Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency,Factor XIII Deficiency,7/4/2012,
NCT00803101,"An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N (Kcentra) Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical Procedure",Reversal of Coagulopathy,2/25/2014,
NCT00708435,Efficacy and Safety Study of BERIPLEX® P/N (Kcentra) Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant Therapy,Blood Coagulation Disorders|Acute Major Bleeding,8/13/2013,
NCT00419341,Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement Therapy,Primary Immune Deficiency,1/25/2013,
NCT00322556,Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID),Agammaglobulinemia|IgG Deficiency|Common Variable Immunodeficiency,10/26/2012,
NCT00292981,C1 Esterase Inhibitor in Hereditary Angioedema (HAE)(Extension Study),Hereditary Angioedema,6/23/2011,
NCT02093897,"Pharmacokinetic, Efficacy, and Safety Study of Recombinant Factor VIII Single Chain (rVIII-SingleChain) in Children With Severe Hemophilia A",Congenital Hemophilia A,1/27/2017,
NCT01486927,"An Open-label Safety, Efficacy and Pharmacokinetic Study of a Recombinant FVIII Compared to Recombinant Human Antihemophilic FVIII in Patients With Severe Hemophilia A",Hemophilia A,8/9/2016,
NCT00168103,Human C1 Esterase Inhibitor (C1-INH) in Subjects With Acute Abdominal or Facial Hereditary Angioedema (HAE) Attacks,Hereditary Angioedema,8/24/2010,
NCT01496274,A Safety and Efficacy Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B,Hemophilia B,5/9/2016,
NCT00088530,"BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)","Lymphoma, Non-Hodgkin",6/1/2017,CTIC
NCT00323037,A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure,Congestive Heart Failure,3/13/2009,CTIC
NCT01704651,Accelerating Gastrointestinal Recovery,Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Cancer,10/24/2016,
NCT00701636,Pharmacokinetics of Daptomycin During Cardiopulmonary Bypass Surgery,Late Effects of Surgery|Staphylococcus Aureus|Surgical Site Infection,8/29/2016,
NCT01345929,"Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis",Complicated Urinary Tract Infection|Pyelonephritis,1/15/2015,
NCT01445678,Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Meropenem in Complicated Intraabdominal Infections,Complicated Intra-abdominal Infection,1/15/2015,
NCT00107978,Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus,Staphylococcal Skin Infection,2/1/2010,CPIX
NCT00107952,Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus,Bacterial Pneumonia,12/8/2009,CPIX
NCT00091819,Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus,Staphylococcal Skin Infection,12/8/2009,CPIX
NCT00606489,Efficacy and Safety Study of Caldolor (Intravenous Ibuprofen) in Hospitalized Adult and Pediatric Burn Patients,Burns,8/11/2011,CPIX
NCT01332253,Safety and Efficacy of Intravenous Ibuprofen for Treatment of Pain in Pediatric Patients Undergoing Tonsillectomy,Tonsillectomy,11/3/2016,CPIX
NCT01002573,"Safety, Efficacy, and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients",Fever,11/7/2016,CPIX
NCT00478192,Study of Efficacy & Safety for 3 Infusion Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia,Hyponatremia,4/21/2010,CPIX
NCT00470600,Efficacy and Safety Study of Caldolor (IV Ibuprofen) in Hospitalized Adult Orthopedic Patients,Pain,12/8/2011,CPIX
NCT00225732,Trial of Caldolor for Treatment of Pain in Post-Operative Adult Patients,Pain,9/15/2011,CPIX
NCT00618956,A Study Of Milnacipran In Patients With Fibromyalgia: Effects On 24 Hour Ambulatory Blood Pressure Monitoring,Fibromyalgia,9/3/2009,
NCT00314249,Study of Milnacipran for the Treatment of Fibromyalgia,Fibromyalgia,11/2/2009,
NCT01946412,Roll-Over Study of Ivacaftor in Cystic Fibrosis Pediatric Subjects With a CF Transmembrane Conductance Regulator Gene (CFTR) Gating Mutation,Cystic Fibrosis,2/1/2017,
NCT01707290,Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation,Cystic Fibrosis,5/12/2017,
NCT01705145,Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation,Cystic Fibrosis,4/24/2015,
NCT01614457,Study of Ivacaftor in Subjects With Cystic Fibrosis (CF) Who Have the R117H-CF Transmembrane Conductance Regulator (CFTR) Mutation (KONDUCT),Cystic Fibrosis,2/12/2015,
NCT01614470,Study of Ivacaftor in Subjects With Cystic Fibrosis (CF) Who Have a Non-G551D CF Transmembrane Conductance Regulator (CFTR) Gating Mutation,Cystic Fibrosis,10/29/2014,
NCT01117012,Rollover Study of VX-770 in Cystic Fibrosis Subjects,Cystic Fibrosis,7/7/2015,
NCT00909727,Study of Ivacaftor in Cystic Fibrosis Subjects Aged 6 to 11 Years With the G551D Mutation,Cystic Fibrosis,8/21/2012,
NCT00909532,Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older With the G551D Mutation,Cystic Fibrosis,8/21/2012,
NCT00699998,A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects,Acute Coronary Syndrome,5/7/2013,
NCT00097591,A Comparison of Prasugrel (CS-747) and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention,Coronary Arteriosclerosis|Acute Coronary Syndromes,9/16/2010,
NCT00993824,Glycemic Effect of Colesevelam HCl (Welchol) in Patients With Type 2 Diabetes,Type 2 Diabetes,6/17/2014,
NCT02072434,Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Nonvalvular Atrial Fibrillation (NVAF),Atrial Fibrillation,3/13/2019,
NCT00986154,Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).,Venous Thromboembolism|Deep Vein Thrombosis (DVT)|Pulmonary Embolism (PE)|Thromboembolism|Venous Thrombosis,2/25/2015,
NCT00789750,Colesevelam as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus,6/26/2017,
NCT00789737,Welchol as Monotherapy for Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus,1/22/2014,
NCT00781391,Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation,Stroke|Atrial Fibrillation|Embolism,3/25/2015,
NCT00649389,Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension,Hypertension,9/1/2010,
NCT00570739,"Effects of Metformin Hydrochloride (HCl) in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus and the Effects of Colesevelam HCl on Lipids and Glucose on Pre-diabetic Patients.",Type 2 Diabetes Mellitus|Hypercholesterolemia|Pre-diabetes,7/13/2010,
NCT00527514,Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension,Hypertension,9/23/2009,
NCT00484419,"Effects of Colesevelam HCl, Rosiglitazone, Sitagliptin on Control of Blood Glucose and Lipids in Type 2 Diabetes Patients Whose Blood Glucose Isn't Completely Controlled With Metformin",Type 2 Diabetes|Hyperlipidemia,6/17/2009,
NCT02073682,Cancer Venous Thromboembolism (VTE),Venous Thromboembolism (VTE)|Deep Vein Thrombosis (DVT)|Pulmonary Embolism (PE)|Cancer,10/24/2018,
NCT00151775,Assessment of Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescent Patients With High Blood Pressure,Hypertension,4/2/2010,
NCT02753699,Long Term Follow-up Study to Assess Durability of Sustained Virologic Response in Alisporivir-treated Hepatitis C Patients,Hepatitis C,8/26/2016,
NCT01467882,"Efficacy, Safety, and Pharmacokinetics (PK) of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty",Central Precocious Puberty,9/4/2015,
NCT01318694,Efficacy and Safety of Alisporivir Triple Therapy in Chronic Hepatitis C Genotype 1 Treatment-naïve Participants,Hepatitis C,9/30/2016,
NCT01545232,"Pragmatic, Randomized Optimal Platelet and Plasma Ratios",Trauma,6/3/2015,
NCT00779402,PROvenge Treatment and Early Cancer Treatment,Prostate Cancer,1/29/2018,
NCT00005947,Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy,Prostate Cancer,11/1/2010,
NCT00065442,Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy,Prostate Cancer,9/6/2010,
NCT01491607,Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy Adults,Anthrax,11/28/2013,
NCT02290509,Safety and Immunogenicity of Flublok Quadrivalent vs IIV4 in Adults 18-49 Years of Age,Influenza,9/22/2016,
NCT02168946,"Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults",Urinary Tract Infection Complicated|Acute Pyelonephritis|Hospital Acquired Bacterial Pneumonia|Ventilator-associated Bacterial Pneumonia|Bacteremia|Abdominal Infection,12/11/2018,
NCT02166476,Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP,Urinary Tract Infection Complicated|Acute Pyelonephritis,10/26/2017,
NCT01080300,Breeze3:Study of Gabapentin Extended Release in the Treatment of Vasomotor Symptoms(Hot Flashes)in Postmenopausal Women,Hot Flashes,3/26/2014,
NCT00777023,Study of Gabapentin Extended Release (G-ER)in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women.,Hot Flashes,2/17/2012,
NCT00755417,Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women,Hot Flashes,3/7/2012,
NCT00636636,Safety and Efficacy of Gabapentin in Postherpetic Neuralgia,"Neuralgia,Postherpetic",1/13/2012,
NCT00436969,ORTHOVISC Shoulder Osteoarthritis Study,Glenohumeral Osteoarthritis,4/11/2014,
NCT01242085,Preoperative Alignment of Total Knee Replacement,Knee Arthritis,5/8/2013,
NCT03127956,A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris,Acne Vulgaris,2/5/2019,DERM
NCT03073486,A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris,Acne Vulgaris,2/5/2019,DERM
NCT03028363,A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris,Acne Vulgaris,2/5/2019,DERM
NCT02553798,Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis,Hyperhidrosis,9/25/2018,DERM
NCT02530294,Study of Glycopyrronium in Subjects With Axillary Hyperhidrosis,Hyperhidrosis,8/14/2018,DERM
NCT02530281,Study of Glycopyrronium in Axillary Hyperhydrosis,Hyperhidrosis,8/14/2018,DERM
NCT01594762,Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers,Diabetic Foot Infection,6/14/2017,
NCT01590758,Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers,Diabetic Foot Infection,6/14/2017,
NCT03383783,Evaluation of the Fluoride Dose Response of a Modified In Situ Caries Model,Caries,5/20/2019,
NCT00403546,High-Dose Oral Ziprasidone Versus Conventional Dosing in Participants With Residual Schizophrenia Symptoms,Schizophrenia,6/6/2017,
NCT02569853,DFN-11 Injection in Episodic Migraine With or Without Aura,Episodic Migraine,7/25/2018,RDY
NCT02279082,DFN-02 Open Label Safety Study in Patients With Acute Migraine,Acute Migraine,8/28/2017,RDY
NCT03116698,"A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period",Actinic Keratosis (AK),4/24/2019,RDY
NCT00235716,"A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease",Alzheimer's Disease,1/29/2014,
NCT00614445,The Efficacy Of Diclectin® For Nausea And Vomiting Of Pregnancy,Nausea and Vomiting of Pregnancy,9/5/2011,
NCT01829243,"Milnacipran and Neurocognition, Pain and Fatigue in Fibromyalgia : A 13-week Randomized, Placebo Controlled Cross Over Trial",Fibromyalgia|Neurocognition,8/29/2014,
NCT01169467,Cerebral Perfusion Pressure Using Precedex and Other Sedatives,Endotracheal Intubation|Continuous IV Sedation|ICP Monitoring,11/2/2015,
NCT00894166,Evaluation of a Tailored Smoking Cessation Treatment Algorithm Based on Initial Treatment Response and Genotype,Smoking Cessation,12/26/2012,
NCT00887679,Treatment Effects of Escitalopram (Lexapro®) on Generalized Anxiety Disorder in Patients With HIV and AIDS,Anxiety Disorders|HIV Infections,3/10/2014,
NCT00829179,Role of RhuMab-E25 in Reducing Exhaled Nitric Oxide (NO) in Allergic Asthma,Allergic Asthma,10/21/2009,
NCT00302068,Exercise to Treat Depression in Individuals With Coronary Heart Disease,Depression|Heart Diseases,1/24/2013,
NCT00227370,Comparison of Oral Valganciclovir and Placebo for the Prevention of Cytomegalovirus (CMV) After Lung Transplantation,Cytomegalovirus Infections,4/29/2013,
NCT02720198,Levomilnacipran ER vs. Adjunctive Quetiapine for Adults With Inadequate Relief With SSRIs in MDD,Major Depressive Disorder,7/2/2019,
NCT01303861,Concurrent Bupropion / Varenicline for Smoking Cessation,Nicotine Dependence,8/1/2014,
NCT00340379,Ziprasidone vs. Sertraline/Haloperidol in Psychotic Depression,Affective Disorders,6/4/2013,
NCT01994993,Antibiotic Safety (SCAMP),Complicated Intra Abdominal Infections,2/27/2018,
NCT00763867,Evaluating the Effectiveness of Sildenafil at Improving Health Outcomes and Exercise Ability in People With Diastolic Heart Failure (The RELAX Study),Heart Failure,7/3/2013,
NCT00517933,Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis,"Pulmonary Fibrosis|Hypertension, Pulmonary",8/23/2013,
NCT01463293,B. Lactis HN019 for Functional Constipation,Constipation,7/24/2014,
NCT00382408,"A Clinical Trial to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001",Respiratory Tract Diseases,5/25/2012,
NCT00777556,Emergency Contraception Actual Use Study,Emergency Contraception,10/18/2012,
NCT00361569,"A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041(Synthetic Conjugated Estrogens, A) for Treatment of Vulvovaginal Atrophy",Menopause,4/14/2009,
NCT00196326,"Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral Contraceptive",Contraception,4/15/2009,
NCT02127970,Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections,Abscess|Wound Infection|Surgical Site Infection|Cellulitis,8/14/2018,
NCT01431339,Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections,Abscess|Wound Infection|Surgical Site Infection|Cellulitis,2/12/2014,
NCT01339091,Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections,Abscess|Wound Infection|Surgical Site Infection|Cellulitis,12/25/2013,
NCT02137785,Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities,Actinic Keratosis,9/16/2015,
NCT02586805,Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE,Hereditary Angioedema (HAE),4/24/2018,
NCT00711867,Comparison of Intraoperative Warming Devices,Total Knee Arthroplasty,12/2/2009,
NCT02117934,"Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine",Healthy,1/10/2018,DVAX
NCT01005407,"Safety and Immunogenicity Study of the Hepatitis B Virus (HBV) Vaccine, HEPLISAV Compared to Engerix-B Vaccine",Healthy,1/11/2018,DVAX
NCT00046930,Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia,Leukemia|Myelodysplastic Syndromes,9/6/2010,
NCT01465997,Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older,Epilepsy|Monotherapy,8/2/2017,
NCT01243177,Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older,Epilepsy|Monotherapy,2/23/2016,
NCT02305797,EDG004 Treatment of Adult Patients With Generalized Anxiety Disorder (GAD),Generalized Anxiety Disorder (GAD),9/26/2018,
NCT00566501,Open-Label Extension Study of 23 mg Donepezil SR in Patients With Moderate to Severe Alzheimer's Disease,Alzheimer's Disease,6/19/2012,
NCT00478205,Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease,Alzheimer's Disease,2/5/2013,
NCT00236197,E3810-A001-312: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers,Heartburn,11/5/2009,
NCT00236184,E3810-A001-313: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers,Heartburn,10/1/2009,
NCT00505284,An Evaluation of the Efficacy and Safety of E2007 in Patients With Painful Diabetic Neuropathy,Diabetic Neuropathy,2/8/2013,
NCT00592904,Evaluating E2007 (Perampanel) in Patients With Painful Diabetic Neuropathy (PDN) or Post-Herpetic Neuralgia (PHN),Neuralgia,2/8/2013,
NCT00398983,Randomized Study of Decitabine in Maintenance Therapy of Acute Myeloid Leukemia (AML),Acute Myelogenous Leukemia,3/4/2013,
NCT00839306,Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD),Gastroesophageal Reflux Disease (GERD),11/16/2015,
NCT00838526,Rabeprazole Extended-Release 50 mg vs. Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD),Gastroesophageal Reflux Disease (GERD),6/23/2015,
NCT00992589,Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD),Gastroesophageal Reflux,5/22/2013,
NCT00388726,E7389 Versus Treatment of Physician's Choice in Patients With Locally Recurrent or Metastatic Breast Cancer,Breast Cancer,1/30/2012,
NCT01976104,Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure,Thrombocytopenia Associated With Liver Disease,2/27/2018,
NCT01972529,Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective Procedure,Thrombocytopenia Associated With Liver Disease,2/27/2018,
NCT01454934,"A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Treatment of Physician's Choice in Subjects With Advanced Non-Small Cell Lung Cancer",Non-Small Cell Lung Cancer (NSCLC),3/1/2017,
NCT01327885,Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Dacarbazine in Subjects With Soft Tissue Sarcoma,Soft Tissue Sarcoma,2/28/2017,
NCT01321554,"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer (DTC)",Thyroid Cancer,12/12/2016,
NCT00911534,"Comparing the Efficacy, Safety, and Tolerability of Rabeprazole ER 50 mg With Placebo in Subjects With Symptomatic Gastroesophageal Reflux Disease (sGERD)",Symptomatic Gastroesophageal Reflux Disease (sGERD),2/2/2016,
NCT00735397,Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures,Epilepsy,1/26/2016,
NCT00699972,Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures,Refractory Partial Seizures,2/5/2013,
NCT00699582,To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures,Refractory Partial Seizures,11/22/2012,
NCT00658632,Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD),Gastroesophageal Reflux Disease (GERD),6/23/2015,
NCT00448539,Open-Label Extension Study of Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial Seizures,Refractory Partial Onset Seizures,12/10/2012,
NCT00368108,"Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations",Parkinson's Disease,2/5/2013,
NCT00337103,E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes,Metastatic Breast Cancer,9/30/2013,
NCT00334958,Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial Seizures,Epilepsy,2/5/2013,
NCT00260832,Trial of Decitabine in Patients With Acute Myeloid Leukemia,Acute Myeloid Leukemia,9/21/2011,
NCT00050960,"Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer",Non-small Cell Lung Cancer,8/24/2010,
NCT00327392,A Safety Study of AQUAVAN® (Fospropofol Disodium) Injection for Sedation During Minor Surgical Procedures.,Procedural Sedation,6/20/2012,
NCT00658775,"Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)",Gastroesophageal Reflux Disease (GERD),6/23/2015,
NCT00658528,Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD),Gastroesophageal Reflux Disease (GERD),6/23/2015,
NCT01513759,Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy,Pulmonary Embolism|Acute Pulmonary Embolism|Sub-massive Pulmonary Embolism|Massive Pulmonary Embolism|Pulmonary Thromboembolism,7/3/2019,
NCT02387801,A Study of the Early Activity of Ixekizumab (LY2439821) in Moderate-to-Severe Psoriasis,Psoriasis,10/21/2016,LLY
NCT00384930,Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia,Benign Prostatic Hyperplasia,8/19/2009,LLY
NCT02402933,Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents,Hypoglycemia|Diabetes Mellitus,6/26/2017,LLY
NCT00989157,Effects of Gastric Bypass on Blood Levels of Duloxetine,Bariatric Surgery,8/11/2014,LLY
NCT00375973,Double Blind Trial of Duloxetine in Chronic Fatigue Syndrome,"Fatigue Syndrome, Chronic",7/27/2015,LLY
NCT00408876,Duloxetine Versus Placebo in Chronic Low Back Pain,Back Pain Without Radiation,12/29/2009,LLY
NCT02132637,A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 Diabetes,Type 2 Diabetes Mellitus,4/20/2018,LLY
NCT01324999,Tadalafil for Sarcoidosis Associated Pulmonary Hypertension,Pulmonary Hypertension,7/24/2017,LLY
NCT01152190,A Study in Benign Prostatic Hyperplasia,Benign Prostatic Hyperplasia,5/20/2013,LLY
NCT01183780,A Study in Second Line Metastatic Colorectal Cancer,Colorectal Cancer,7/15/2015,LLY
NCT01168973,A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy,Non-Small Cell Lung Cancer,12/29/2014,LLY
NCT00422734,Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintaining an Erection and Sexual Quality of Life,Impotence,6/2/2009,LLY
NCT00112294,Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer,Non-Small-Cell Lung Carcinoma,10/5/2010,LLY
NCT00095199,Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer,Non Small Cell Lung Cancer,10/15/2012,LLY
NCT01994746,Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in Adults,"Diabetes Mellitus, Type 1",10/10/2016,LLY
NCT02718898,A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital Psoriasis,Genital Psoriasis|Psoriasis,3/23/2018,LLY
NCT02614196,Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study,Migraine,1/7/2019,LLY
NCT02614183,Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study,Migraine,11/29/2018,LLY
NCT02614287,"A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura",Migraine,1/7/2019,LLY
NCT02597049,A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus,4/27/2018,LLY
NCT02513550,A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis,Plaque Psoriasis,4/18/2018,LLY
NCT02397473,A Study Of Galcanezumab In Participants With Episodic Cluster Headache,Episodic Cluster Headache,3/13/2019,LLY
NCT02152371,A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes,"Diabetes Mellitus, Type 2",12/7/2016,LLY
NCT01816295,"A Study in Men With Low Testosterone to Measure the Effects of Testosterone Solution on Testosterone Levels, Sex Drive and Energy",Hypogonadism,10/2/2015,LLY
NCT01792284,A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus,Type 1 Diabetes Mellitus,4/20/2018,LLY
NCT01790438,A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 Diabetes,"Diabetes Mellitus, Type 2",5/3/2018,LLY
NCT01777191,Evaluation of Ixekizumab Using Auto-Injector or Prefilled Syringe in Participants With Moderate to Severe Plaque Psoriasis,Plaque Psoriasis,5/26/2016,LLY
NCT01721057,A Study in Moderate to Severe Rheumatoid Arthritis Participants,Rheumatoid Arthritis,6/12/2017,LLY
NCT01721044,A Moderate to Severe Rheumatoid Arthritis Study,Rheumatoid Arthritis,1/18/2018,LLY
NCT01711359,A Study in Participants With Moderate to Severe Rheumatoid Arthritis,Rheumatoid Arthritis,8/15/2017,LLY
NCT01710358,A Study in Moderate to Severe Rheumatoid Arthritis,Rheumatoid Arthritis,8/15/2017,LLY
NCT01695239,A Study of Ixekizumab in Participants With Active Psoriatic Arthritis,"Psoriasis, Arthritic",10/27/2016,LLY
NCT01624259,A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes,Type 2 Diabetes,10/9/2014,LLY
NCT01621178,A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD),Type 2 Diabetes|Chronic Kidney Disease,7/24/2017,LLY
NCT01582451,A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus,"Diabetes Mellitus, Type 2",4/20/2018,LLY
NCT01481779,A Study in Participants With Type 1 Diabetes Mellitus,"Diabetes Mellitus, Type 1",4/17/2018,LLY
NCT01474512,A Phase 3 Study in Participants With Moderate to Severe Psoriasis,Psoriasis,5/27/2016,LLY
NCT01473602,Second Study of the Effect of Teriparatide on Hip Fracture Healing,Femur Neck Fracture,11/17/2014,LLY
NCT01473589,Effect of Teriparatide on Hip Fracture Healing,Femur Neck Fracture,11/17/2014,LLY
NCT01474538,Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy,Type 2 Diabetes Mellitus,3/20/2014,LLY
NCT01468987,A Study in Participants With Type 2 Diabetes Mellitus,"Diabetes Mellitus, Type 2",4/17/2018,LLY
NCT01769378,Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8),Type 2 Diabetes Mellitus,10/14/2015,LLY
NCT01454284,A Study in Participants With Type I Diabetes Mellitus,"Diabetes Mellitus, Type 1",4/17/2018,LLY
NCT01435616,A Study in Patients With Type 2 Diabetes Mellitus,"Diabetes Mellitus, Type 2",4/13/2018,LLY
NCT01299272,A Study in Prevention of Re-emergence of Depression Symptoms,Major Depressive Disorder,4/17/2018,LLY
NCT01237587,A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome,Fibromyalgia,8/14/2018,LLY
NCT01226511,A Study in Pediatric Participants With Generalized Anxiety Disorder,"Anxiety Neuroses|Anxiety States, Neurotic|Neuroses, Anxiety",3/5/2014,LLY
NCT01205438,A Study of LY2127399 in Participants With Systemic Lupus Erythematosus,Systemic Lupus Erythematosus|Connective Tissue Disease|Autoimmune Disease,6/19/2018,LLY
NCT01202760,A Rheumatoid Arthritis Study in Participants,Rheumatoid Arthritis,4/25/2018,LLY
NCT01196091,A Study of LY2127399 in Participants With Systemic Lupus Erythematosus,Systemic Lupus Erythematosus|Connective Tissue Disease|Autoimmune Disease,6/12/2018,LLY
NCT01191268,A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4),"Diabetes Mellitus, Type 2",10/8/2014,LLY
NCT01187407,A Study of Flexible or Fixed Dose LY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment,Major Depressive Disorder (MDD),4/24/2018,LLY
NCT01185340,A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor,Major Depressive Disorder,4/27/2018,LLY
NCT01173601,A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder,Major Depressive Disorder,4/17/2018,LLY
NCT01170663,A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma,Gastric Cancer,7/31/2014,LLY
NCT01155661,A Safety Study in Participants With Major Depressive Disorder,"Depressive Disorder, Major",4/17/2018,LLY
NCT01140347,A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Participants With Hepatocellular Carcinoma After 1st-Line Therapy With Sorafenib,Hepatocellular Carcinoma,3/26/2015,LLY
NCT01139762,A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms,Benign Prostatic Hyperplasia|Enlarged Prostate,2/27/2013,LLY
NCT01126580,A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3),"Diabetes Mellitus, Type 2",1/16/2015,LLY
NCT01109316,Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use,"Diabetes Mellitus, Type 1",10/30/2012,LLY
NCT01064687,A Study in Participants With Type 2 Diabetes Mellitus,"Diabetes Mellitus, Type 2",1/26/2015,LLY
NCT01035138,A Study of Semagacestat for Alzheimer's Patients,Alzheimer's Disease,9/25/2014,LLY
NCT01018680,A Study Comparing Duloxetine Versus Placebo in Patients Taking a Nonsteroidal Anti-inflammatory Drug (NSAID) for Knee Pain Due to Osteoarthritis,Osteoarthritis Knee Pain,10/5/2012,LLY
NCT00958568,A Study in Relapse Prevention of Treatment-Resistant Depression,Treatment Resistant Depression,4/1/2014,LLY
NCT00945945,A Study of Duloxetine in Patients With Osteoarthritis Knee Pain,Osteoarthritis Knee Pain,3/8/2011,LLY
NCT00917384,Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma,Gastric Cancer|Adenocarcinoma,10/16/2014,LLY
NCT00855582,A Study in the Treatment of Erectile Dysfunction and Benign Prostate Hyperplasia,Erectile Dysfunction|Benign Prostatic Hyperplasia,6/30/2011,LLY
NCT00857454,A Trial to Evaluate the Ongoing Skin Safety of Testosterone MD-Lotion Formulations,Hypogonadism,1/5/2011,LLY
NCT00849901,A Study in the Treatment of Children and Adolescents With Major Depressive Disorder,Major Depressive Disorder,3/6/2012,LLY
NCT00849693,A Study in the Treatment of Children and Adolescents With Major Depressive Disorder,Major Depressive Disorder,4/19/2012,LLY
NCT00848081,A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha Blockers,Benign Prostatic Hyperplasia,9/14/2010,LLY
NCT00827242,Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) With Tadalafil Daily,Benign Prostatic Hyperplasia,11/17/2010,LLY
NCT00762411,"Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo",Alzheimer's Disease,9/25/2014,LLY
NCT00762034,"A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung Cancer",Non-small Cell Lung Cancer,11/28/2013,LLY
NCT00755807,Duloxetine for Multiple Sclerosis Pain,Multiple Sclerosis,12/9/2011,LLY
NCT00702650,A Titration Trial to Determine the Effectiveness of Testosterone MD-Lotion (Cutaneous Solution) Formulations,Hypogonadism,1/5/2011,LLY
NCT00686959,Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer,Non Small Cell Lung Cancer,11/26/2015,LLY
NCT00767806,A Study for Patient With Chronic Low Back Pain,Chronic Low Back Pain,10/18/2010,LLY
NCT00734604,A Study for Patients With Erectile Dysfunction to Test Whether Tadalafil Taken Once a Day Can Better Improve Psychological Outcomes.,Erectile Dysfunction,11/18/2010,LLY
NCT00604214,Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock,Sepsis,9/18/2012,LLY
NCT00594568,Effect of LY450139 on the Long Term Progression of Alzheimer's Disease,Alzheimer's Disease,9/25/2014,LLY
NCT00577863,Study of the Experience of Patients With Osteoporosis Using the Forteo B Pen to Self Administer Once Daily Teriparatide Therapy,Osteoporosis,6/24/2009,LLY
NCT00560417,Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide,"Diabetes Mellitus, Type 2",12/14/2010,LLY
NCT00510952,Comparison of Two Basal Insulins for Patients With Type 2 Diabetes on Anti-Hyperglycemic Medications (IOPE),"Diabetes Mellitus, Type 2",11/3/2009,LLY
NCT00494013,Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY),Diabetes Mellitus Type 2,11/4/2009,LLY
NCT00415194,A Study for Patients With Head and Neck Cancer,Head and Neck Neoplasms,4/6/2011,LLY
NCT00408421,Duloxetine Versus Placebo for Osteoarthritis Knee Pain,Osteoarthritis Knee Pain,8/19/2009,LLY
NCT00363415,Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer,Small Cell Lung Cancer,10/6/2009,LLY
NCT00343252,Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis,"Osteoporosis, Postmenopausal|Back Pain|Spinal Fracture",7/12/2010,LLY
NCT00332202,PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin,Non Hodgkin Lymphoma,9/10/2018,LLY
NCT00320489,Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia,Schizophrenia,10/22/2010,LLY
NCT00191646,"An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy","Genital Neoplasms, Female|Fallopian Tube Neoplasms|Ovarian Neoplasms|Pelvic Neoplasms|Peritoneal Neoplasms",9/9/2010,LLY
NCT00191152,A Phase III Trial For Patients With Metastatic Breast Cancer,Breast Cancer|Breast Neoplasms|Cancer of the Breast,12/8/2009,LLY
NCT00190684,"Long-Term, Open Label Atomoxetine Study",Attention Deficit Hyperactivity Disorder,1/17/2011,LLY
NCT00088465,Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder,Schizophrenic Disorders|Schizoaffective Disorder,1/11/2012,LLY
NCT00102804,Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer (NSCLC),Non-Small Cell Lung Cancer,12/29/2014,LLY
NCT00401973,Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine,Schizophrenia|Schizoaffective Disorders,9/30/2009,LLY
NCT00051558,Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced Osteoporosis,Osteoporosis,2/13/2009,LLY
NCT00487240,Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes,"Diabetes Mellitus, Type 1",9/25/2009,LLY
NCT00433290,Duloxetine vs. Placebo in the Treatment of Osteoarthritis Knee Pain,Osteoarthritis Knee Pain,8/24/2009,LLY
NCT01997411,Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes,"Diabetes Mellitus, Type 1",3/6/2017,LLY
NCT00922636,A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder,Attention Deficit Hyperactivity Disorder,8/18/2014,LLY
NCT00795821,A Study in Adult Patients With Major Depressive Disorder,"Depressive Disorder, Major",3/20/2018,LLY
NCT00549302,Study the Safety and Effectiveness of Tadalafil on High Blood Pressure in the Blood Vessel Going From the Heart to the Lungs,"Hypertension, Pulmonary",2/18/2013,LLY
NCT00428584,RNF and Betaseron® Tolerability Study,Relapsing Remitting Multiple Sclerosis (RRMS),3/4/2010,
NCT00110396,Rebif New Formulation (RNF) in Relapsing Forms of Multiple Sclerosis,Multiple Sclerosis,7/9/2010,
NCT01036165,"A Multicenter, Open-label, RebiSmart™ Autoinjector Ease of Use Study",Multiple Sclerosis,12/22/2010,
NCT00958009,"The Multicenter, Open-label, Single-use Autoinjector Convenience Study",Multiple Sclerosis,12/30/2010,
NCT00472797,Rebif New Formulation (RNF) Quality of Life (QOL) Study,Relapsing Multiple Sclerosis,9/2/2009,
NCT00689221,"Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status",Glioblastoma,11/4/2014,
NCT00409188,Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START),Non-small Cell Lung Cancer,11/20/2015,
NCT01077960,Safety and Efficacy Study of Serostim® Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome,Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome,6/23/2010,
NCT00725985,Oral Cladribine in Early Multiple Sclerosis (MS),Multiple Sclerosis,10/10/2013,
NCT00641537,CLARITY Extension Study,Relapsing-Remitting Multiple Sclerosis,12/2/2013,
NCT00109733,Cool.Click™ Adolescent Transition Study: Study of Saizen® in Subjects With Childhood-onset Growth Hormone Deficiency,Childhood-onset Growth Hormone Deficiency|Pituitary Dwarfism,6/22/2010,
NCT00105521,Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia,Parkinson's Disease|Dyskinesia,4/2/2018,
NCT00105508,Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia,Parkinson's Disease|Dyskinesia,7/25/2018,
NCT00082628,Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients,HIV Infections|Lipodystrophy,7/20/2018,
NCT00624338,Atacicept Phase 2/3 in Generalized Systemic Lupus Erythematosus (APRIL-SLE),"Lupus Erythematosus, Systemic",3/14/2016,
NCT00735007,12-week Study to Evaluate RebiSmart™ Suitability for Self Injection in Relapsing Multiple Sclerosis.,Multiple Sclerosis,8/11/2010,
NCT00784134,Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III,Intraventricular Hemorrhage,7/2/2017,
NCT01179217,A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia,Sickle Cell Anemia|Sickle ß0-Thalassemia,8/10/2017,EMMA
NCT00813319,Girls OnGuard: HPV Vaccination Uptake Among African American Adolescent Females,Vaccination,8/12/2014,
NCT02132195,Adrenocorticotropic Hormone (ACTH) for Frequently Relapsing and Steroid Dependent Nephrotic Syndrome,Nephrotic Syndrome,5/10/2019,
NCT00764504,Reverse Shoulder Prosthesis Study,Rotator Cuff Arthropathy|Failed Total Shoulder|Failed Hemi-arthroplasty,4/19/2011,
NCT00765362,Mobile - Bearing Knee Study,Inflammatory Tissue Disorder|Osteoarthritis|Avascular Necrosis|Post-traumatic Arthritis|Secondary Arthritis,4/19/2011,
NCT03178942,"Multiple-Site Study to Evaluate the Therapeutic Equivalence of Permethrin Cream, 5% in the Treatment of Scabies",Scabies,3/14/2019,
NCT00467870,Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men,Hypogonadism|Primary Hypogonadism|Secondary Hypogonadism,3/7/2017,ENDP
NCT01674634,Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's Contractures,Dupuytren's Contracture,2/20/2015,ENDP
NCT01243411,A Study of AA4500 in Men With Peyronie's Disease,Peyronie's Disease,4/15/2015,ENDP
NCT01221623,Study of AA4500 in the Treatment of Peyronie's Disease,Peyronie's Disease,4/7/2015,ENDP
NCT01221597,Study of AA4500 in the Treatment of Peyronie's Disease,Peyronie's Disease,4/7/2015,ENDP
NCT01228071,"Time to Eugonadal Range, Time to Steady State and Drying Time",Male Hypogonadism,7/22/2013,ENDP
NCT01210352,"Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects",Post Operative Pain,5/7/2019,ENDP
NCT00801398,Open-Label Safety and Tolerability Study of Oxymorphone for Acute Postoperative Pain in Pediatric Subjects.,Postoperative Pain,2/27/2019,ENDP
NCT00528606,"AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Dupuytren's Contracture",Dupuytren's Contracture,10/22/2010,ENDP
NCT00528424,"AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease",Advanced Dupuytren's Disease,10/22/2010,ENDP
NCT00528840,"Safety and Efficacy Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease",Advanced Dupuytren's Disease,10/22/2010,ENDP
NCT01407068,Administration of Two Injections for Multiple Dupuytren's Contractures,Dupuytren's Contracture,2/20/2015,ENDP
NCT02013544,Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause,Vaginal Atrophy,6/1/2017,
NCT01358760,Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy,Vaginal Atrophy,6/12/2017,
NCT01256684,DHEA Against Vaginal Atrophy - 3-Month Efficacy Study,Vaginal Atrophy,4/25/2017,
NCT01256671,DHEA Against Vaginal Atrophy - Safety Study of 12 Months,Vaginal Atrophy,10/18/2017,
NCT01846442,Topical DHEA Against Vaginal Atrophy,Vaginal Atrophy,4/28/2017,
NCT00750737,Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC),Invasive Fungal Infections|Hematologic Malignancies,1/6/2016,
NCT00578565,Rituximab in Rheumatoid Arthritis Lung Disease,Rheumatoid Arthritis|Interstitial Pneumonia,9/25/2012,
NCT01559922,Use of Artefill® for Moderate to Severe Atrophic Acne Scar Correction,Atrophic Acne Scar,2/14/2017,
NCT00452426,Safety and Effectiveness of a Computer-Assisted Personalized Sedation (CAPS) Device for Propofol Delivery During Endoscopy,"Colonoscopy|Endoscopy, Digestive System|Conscious Sedation",1/25/2011,
NCT00166205,Safety and Effectiveness Study of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity,"Obesity, Morbid",12/11/2008,
NCT02457546,The EVICEL® Neurosurgery Phase III Study,Cerebrospinal Fluid Leak,12/4/2018,
NCT02040428,The Fibrin Pad CV Phase III Study,Cardiovascular Disease,8/15/2017,
NCT01993888,The EVARREST® Fibrin Sealant Patch Liver Study,Hemorrhage,7/11/2016,
NCT00615550,PREGNANT Short Cervix Trial,Preterm Delivery|Short Cervix|Short Uterine Cervical Length,3/13/2012,
NCT02398188,Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat (AbCONTOUR2),Central Abdominal Bulging,1/7/2019,EVFM
NCT02334436,A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV-002,Glabellar Frown Lines,2/27/2019,EOLS
NCT02334423,A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV001,Glabellar Frown Lines,2/26/2019,EOLS
NCT01157845,Use of Methacetin Breath Test to Predict Liver Failure in Patients With Cirrhosis,Cirrhosis,3/4/2014,
NCT02905825,Urea Breath Test (UBT) With Breath Hp System /BreathID Hp Lab System Pediatrics,Helicobacter Pylori Infection,7/4/2018,
NCT02528721,Exalenz Lab Mode System Compared to Biopsy for H.Pylori Detection,Helicobacter Pylori Infection,3/3/2017,
NCT00736840,BreathID 13C-Methacetin Breath Test for Detecting Cirrhosis,Chronic Liver Disease,3/16/2012,
NCT01605227,Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100,Prostate Cancer|Castration Resistant Prostate Cancer|Pain|Prostatic Neoplasms,3/14/2018,EXEL
NCT00358501,Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients,Severe Hepatic Veno-Occlusive Disease,1/30/2017,
NCT01210716,Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device,Autoimmune Diseases|Renal Disorders|Hematologic Disorders|Oncologic Disorders,9/23/2013,
NCT01280981,A Study of Tranexamic Acid (XP12B) in Women With Heavy Menstrual Bleeding,Menorrhagia,7/26/2011,
NCT03017235,"A Study Comparing the Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution With PREPOPIK® for Colon Cleansing in Preparation for Colonoscopy",Bowel Preparation,11/14/2018,
NCT02149264,A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males,Adult Male Hypogonadism,7/28/2017,
NCT01895543,Safety and Tolerability Extension Trial for Patients With Chronic Idiopathic Constipation,Chronic Idiopathic Constipation,5/9/2016,
NCT01703741,A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel,Adult Male Hypogonadism,10/6/2017,
NCT01665599,A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel,Adult Male Hypogonadism,9/20/2017,
NCT01552343,Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary,Nocturia,5/5/2017,
NCT01262456,Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients,Nocturia,10/15/2015,
NCT01223937,Investigation of the Superiority Effect of Desmopressin to Placebo in Terms of Night Voids Reduction in Nocturia Adult Female Patients,Nocturia,10/15/2015,
NCT01127581,Efficacy & Safety Study Comparing Misoprostol Vaginal Insert (MVI) Versus Dinoprostone Vaginal Insert (DVI) for Reducing Time to Vaginal Delivery,Reducing Time to Vaginal Delivery|Cervical Ripening|Induction of Labor,3/7/2014,
NCT01073943,Investigation of PicoPrep Versus HalfLytely for Bowel Preparation for Colonoscopy - Day Before PicoPrep,Bowel Preparation,9/11/2012,
NCT01073930,Investigation of PicoPrep Versus HalfLytely for Bowel Preparation for Colonoscopy - Split Dose PicoPrep,Bowel Preparation,9/11/2012,
NCT00988091,Investigation of 1.2% Sodium Hyaluronate for Treatment of Painful Chronic Osteoarthritis of the Knee,Osteoarthritis of the Knee,6/4/2012,
NCT00946920,A Trial of Degarelix in Patients With Prostate Cancer,Prostate Cancer,6/2/2014,
NCT00928434,A Study of Degarelix in Patients With Prostate Cancer,Prostate Cancer,12/13/2016,
NCT00833248,Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer,Prostate Cancer,9/27/2012,
NCT00615836,"An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving (""Melt"") Formulation of Desmopressin for the Treatment of Nocturia in Adults",Nocturia,12/15/2015,
NCT00477490,Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia,Nocturia,11/2/2015,
NCT00451958,A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy,Prostate Cancer,3/21/2013,
NCT00401193,Efficacy and Safety of XP12B in Women With Menorrhagia,Menorrhagia|Heavy Menstrual Bleeding,2/24/2010,
NCT00386308,Efficacy and Safety Study of XP12B in Women With Menorrhagia,Menorrhagia|Heavy Menstrual Bleeding,2/22/2010,
NCT00308711,Safety/Efficacy Study Comparing the Misoprostol Vaginal Insert to Cervidil for Cervical Ripening and Induction of Labor,"Cervical Ripening|Labor, Induced",2/19/2010,
NCT00295750,The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer,Prostate Cancer,4/16/2009,
NCT00113568,Safety Study of XP12B in Women With Menorrhagia,Menorrhagia|Heavy Menstrual Bleeding,1/20/2010,
NCT00117286,Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer,Prostate Cancer,10/21/2010,
NCT01687712,Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF,Infertility,10/18/2017,
NCT00655356,Safety and Efficacy Study of Isolagen Therapy in the Treatment of Nasolabial Fold Wrinkles,Bilateral Nasolabial Fold Wrinkles,3/13/2012,FCSC
NCT00649428,Safety and Efficacy Study of Isolagen TherapyTM in the Treatment of Nasolabial Fold Wrinkles,Bilateral Nasolabial Fold Wrinkles,3/13/2012,FCSC
NCT00642642,Safety and Efficacy Study of Autologous Fibroblasts in the Treatment of Severe Facial Acne Scarring,Acne Scarring of the Face,8/21/2013,FCSC
NCT02357459,Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee,Osteoarthritis of the Knee,2/1/2018,FLXN
NCT02712320,Open-Label Safety Extension Study in Patients Who Have Previously Participated and Have Benefited From LMIS 50 mg,Prostatic Neoplasms,9/12/2018,
NCT02234115,"Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma",Prostatic Neoplasms,4/13/2018,
NCT00648895,A Study of the Effect of Nebivolol to Evaluate Its Vasodilatory Effects in Hypertensive Patients,Hypertension,9/20/2010,
NCT00297167,Study to Evaluate the Safety and Efficacy of EUR-1008 (APT-1008) Pancreatic Enzyme Product in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency,Cystic Fibrosis|Exocrine Pancreatic Insufficiency,4/4/2014,
NCT01499134,Comparison of 2 Beta Blocker Drugs on Peripheral Arterial Disease in Patients With High Blood Pressure,Peripheral Artery Disease|Hypertension,12/3/2014,
NCT01401595,Brain Imaging and Treatment Studies of the Night Eating Syndrome,Night Eating Syndrome,5/9/2017,
NCT01304589,Savella in Treatment for Provoked Vestibulodynia,Vestibulodynia|Vulvodynia,4/2/2014,
NCT00463346,Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism,Alcohol Dependence|Schizophrenia,1/15/2016,
NCT00513682,Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI),Cystic Fibrosis|Pancreatic Insufficiency,4/10/2014,
NCT00829296,Safety Study to Lower the Risk of Heart Failure is Also Effective in Reducing Stiffness of the Arteries,Hypertension|Diabetes,11/5/2014,
NCT00255086,The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease Patients,Alzheimer Disease,4/7/2017,
NCT00408317,Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI),Cystic Fibrosis|Exocrine Pancreatic Insufficiency,3/12/2014,
NCT02291679,Trial of Linaclotide in Patients With Chronic Idiopathic Constipation,Chronic Idiopathic Constipation,5/19/2017,
NCT01642914,Safety and Efficacy of Linaclotide in Patients With Chronic Constipation and Prominent Abdominal Bloating,Chronic Constipation|Constipation,4/26/2016,
NCT01499277,Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections,Complicated Skin and Soft Tissue Infection,11/9/2015,
NCT01412060,A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia,Schizophrenia,7/6/2018,
NCT01104792,Long-term Study of Cariprazine in Patients With Schizophrenia,Schizophrenia,7/26/2019,
NCT01104766,Safety and Efficacy of Cariprazine in Patients With Schizophrenia,Schizophrenia,10/29/2018,
NCT01104779,Safety and Efficacy of Cariprazine in Schizophrenia,Schizophrenia,11/14/2018,
NCT01059539,Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder,Bipolar I Disorder,6/13/2019,
NCT01058668,Safety and Efficacy of Cariprazine for Bipolar I Disorder,Mania|Bipolar I Disorder,4/12/2017,
NCT01058096,Safety and Efficacy of Cariprazine for Mania,Bipolar Disorder|Mania,4/17/2017,
NCT00948818,Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation,Irritable Bowel Syndrome Characterized by Constipation,1/30/2013,
NCT00938717,Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C),Irritable Bowel Syndrome With Constipation,1/30/2013,
NCT00765999,"An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation",Chronic Constipation|Irritable Bowel Syndrome With Constipation,2/15/2019,
NCT00765882,"Phase III, Randomized, Double-Blind, Placebo-Controlled, Trial of Linaclotide Administered to Patients With Chronic Constipation",Chronic Constipation,1/30/2013,
NCT00730171,"An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation",Irritable Bowel Syndrome With Constipation|Chronic Constipation,2/16/2018,
NCT00730015,Trial of Linaclotide in Patients With Chronic Constipation,Chronic Constipation,1/30/2013,
NCT01499290,Compare Ceftazidime-Avibactam + Metronidazole Versus Meropenem for Hospitalized Adults With Complicated Intra-Abdominal Infections,Complicated Intra-Abdominal Infection,3/1/2016,
NCT01599806,Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections),Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis,3/2/2016,
NCT01595438,Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections),Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis,3/9/2016,
NCT01644643,Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens,Complicated Urinary Tract Infection|Complicated Intra-abdominal Infection,12/14/2015,
NCT02670551,"Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression",Bipolar Disorder|Depression,1/30/2019,
NCT02670538,Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder,Bipolar Disorder|Depression,2/5/2019,
NCT01377194,Safety and Efficacy of Levomilnacipran ER (Levomilnacipran SR) in Major Depressive Disorder,Major Depressive Disorder,10/29/2013,
NCT01034462,Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder,Major Depressive Disorder,10/25/2013,
NCT00981214,Study of Pancreatic Enzyme Product in Pediatric Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency,Cystic Fibrosis|Exocrine Pancreatic Insufficiency,4/4/2014,
NCT00969709,Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder,Major Depressive Disorder,10/25/2013,
NCT00969150,Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder,Major Depressive Disorder,10/25/2013,
NCT00880100,Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF),Cystic Fibrosis|Pancreatic Insufficiency,2/19/2015,
NCT00797797,Study of Milnacipran Added to Pregabalin for Treatment of Fibromyalgia,Fibromyalgia,2/16/2011,
NCT00788593,"A Randomized, Double-Blind, Dose Response-Control, Crossover Study to Evaluate the Safety and Efficacy of Two Doses of EUR-1008 (APT-1008) in Chronic Pancreatitis (CP) Participants With Exocrine Pancreatic Insufficiency (EPI)",Chronic Pancreatitis|Exocrine Pancreatic Insufficiency,3/12/2014,
NCT00668525,Escitalopram in Adult Patients With Major Depressive Disorder,Major Depressive Disorder,5/6/2010,
NCT00683592,"Randomized, Double-Blind, Placebo Controlled Study of Vilazodone's Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD)",Major Depressive Disorder,10/27/2010,
NCT00644358,A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder (MDD),Major Depressive Disorder,9/25/2017,
NCT00621504,Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia,Bacterial Pneumonia,11/10/2010,
NCT00423657,Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections,Bacterial Infections,11/18/2010,
NCT00424190,Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections,Bacterial Infections,11/8/2010,
NCT00322153,A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease,Dementia of the Alzheimer's Type,9/16/2010,
NCT00107120,The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive Disorder,Major Depressive Disorder,11/4/2009,
NCT00559364,Safety and Efficacy Study of Viokase® 16 for the Correction of Steatorrhea,Exocrine Pancreatic Insufficiency|Chronic Pancreatitis|Pancreatectomy,3/12/2014,
NCT00509106,Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia,Bacterial Pneumonia,11/8/2010,
NCT01139450,Study of 0417 Ointment in the Treatment of Atopic Dermatitis,Atopic Dermatitis,9/30/2014,
NCT01053247,Study of 0416 Ointment in the Treatment of Atopic Dermatitis,Atopic Dermatitis,10/3/2014,
NCT02886715,A Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both to a Placebo Control in the Treatment of Acne Vulgaris,Acne Vulgaris,8/17/2018,
NCT02886702,A Study Comparing Tazarotene Cream 0.05% to TAZORAC® (Tazarotene) Cream 0.05% and Both to a Placebo Control in the Treatment of Plaque Psoriasis,Plaque Psoriasis,8/29/2018,
NCT02660580,MSB11022 in Moderate to Severe Chronic Plaque Psoriasis,Psoriasis|Plaque Type Psoriasis|Moderate to Severe Plaque Psoriasis,2/19/2019,
NCT01464190,"A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients",Chronic Kidney Disease Requiring Chronic Dialysis,2/17/2014,FMS
NCT01324128,"A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients",Chronic Kidney Disease Requiring Chronic Dialysis,4/1/2014,FMS
NCT02797080,Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia,Friedreich's Ataxia,5/1/2018,
NCT02593773,"Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia Study",Friedreich's Ataxia,5/18/2018,
NCT02415127,"Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia",Friedreich's Ataxia,12/8/2017,
NCT02405780,"A Study to Compare FKB327 Long-term Safety, Efficacy and Immunogenicity With Humira® in Rheumatoid Arthritis Patients","Arthritis, Rheumatoid",3/26/2019,
NCT02260791,A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients,"Arthritis, Rheumatoid",9/20/2017,
NCT01553747,"Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d)",Irritable Bowel Syndrome,7/30/2018,
NCT01553591,"Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d)",Irritable Bowel Syndrome,9/3/2018,
NCT02952898,"Study Comparing GDC 695 and Diclofenac Sodium Gel, 3% in Subjects With Actinic Keratoses",Actinic Keratosis,1/10/2019,
NCT01494467,Phase 3 Papulopustular Rosacea Study,Papulopustular Rosacea,1/16/2015,
NCT01493687,Phase 3 Papulopustular Rosacea Study,Papulopustular Rosacea (PPR),1/16/2015,
NCT01355471,Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea,Rosacea,11/21/2013,
NCT01355458,Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea,Rosacea,11/21/2013,
NCT01318733,Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea,Rosacea,1/8/2014,
NCT00688064,Adapalene-BPO Gel Associated With Doxycycline Hyclate 100 mg in the Treatment of Severe Acne Vulgaris,Severe Acne Vulgaris,3/31/2010,
NCT00687908,Adapalene-Benzoy Peroxide (BPO) Gel in the Treatment of Acne Vulgaris as a 6-month Maintenance,Acne,9/24/2010,
NCT00599521,"Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%",Acne Vulgaris,4/19/2011,
NCT00598832,"Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%",Acne Vulgaris,4/19/2011,
NCT00421993,A Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris,Acne Vulgaris,3/11/2009,
NCT00647556,Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage,Photoaging,2/24/2011,
NCT01659853,Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea,Erythema|Rosacea,7/10/2014,
NCT00658788,"Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis",Psoriasis,8/27/2014,
NCT01880320,"Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris",Acne Vulgaris,9/9/2016,
NCT01053312,PET Imaging of Brain Amyloid in Normal Pressure Hydrocephalus,Normal Pressure Hydrocephalus,6/5/2012,
NCT01265394,Positron Emission Tomography (PET) Amyloid Imaging of the Brain in Healthy Young Adult Subjects,Healthy,6/21/2013,
NCT01028053,Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease,Mild Cognitive Impairment|Alzheimer's Disease,9/11/2014,
NCT00126438,Meta-Iodobenzylguanidine (123I-mIBG) Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular Disease,"Heart Failure, Congestive",5/5/2017,
NCT00126425,Meta-Iodobenzylguanidine Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular Disease,"Heart Failure, Congestive",12/13/2016,
NCT01056640,Telemonitoring Versus Usual Care,Health Care Quality|Health Care Access,2/8/2013,
NCT00662038,Open-Label Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF),Idiopathic Pulmonary Fibrosis,3/29/2017,
NCT01366209,Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF),Idiopathic Pulmonary Fibrosis,3/12/2015,
NCT00287729,Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis,Idiopathic Pulmonary Fibrosis,6/13/2011,
NCT00287716,Three-Arm Study of the Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis,Idiopathic Pulmonary Fibrosis,6/13/2011,
NCT01007071,Effects of Growth Hormone on Cognition and Cerebral Metabolism in Adults With Growth Hormone Deficiency,Hypopituitarism,11/17/2017,
NCT00384449,Lucentis (Ranibizumab) for Eales' Disease,Eales' Disease,6/11/2019,
NCT00626782,Lucentis Versus Mitomycin C During Glaucoma Surgery,Glaucoma,3/13/2015,
NCT02698566,A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS),Macular Edema,7/26/2017,
NCT01120184,A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE),Breast Cancer,2/23/2017,
NCT01059630,"A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+Obinutuzumab (GA101) in Participants With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma (GADOLIN)",Non-Hodgkin's Lymphoma,11/17/2016,
NCT00567190,A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer,Metastatic Breast Cancer,9/13/2012,
NCT00022672,A Study to Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast Cancer,Breast Cancer,6/13/2013,
NCT00500539,Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation.,Asthma,4/27/2011,
NCT02053610,CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 2),"Lymphocytic Leukemia, Chronic",10/10/2014,
NCT01998880,CLL11: A Study of Rituximab With Chlorambucil or Chlorambucil Alone in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 1b),"Lymphocytic Leukemia, Chronic",1/28/2014,
NCT01010061,CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 1a),"Lymphocytic Leukemia, Chronic",4/1/2014,
NCT01662063,A Long-Term Extension Study of WA22762 and NA25220 of Subcutaneous (SC) Tocilizumab (TCZ) in Moderate to Severe Rheumatoid Arthritis (RA),Rheumatoid Arthritis,10/12/2016,
NCT01292473,"A Study to Evaluate the Efficacy, Response Duration and Safety of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine Treatment (H1)",Chronic Idiopathic Urticaria,9/2/2013,
NCT01287117,A Study of the Efficacy and Safety of Omalizumab (Xolair) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine (H1) Treatment,Chronic Idiopathic Urticaria,10/18/2013,
NCT01264939,"A Safety Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic Despite Treatment With H1 Antihistamines, H2 Blockers, and/or Leukotriene Receptor Antagonists",Chronic Idiopathic Urticaria,11/26/2013,
NCT00891735,A Study of Ranibizumab Administered Monthly or on an As-needed Basis in Patients With Subfoveal Neovascular Age-related Macular Degeneration (HARBOR),Age-related Macular Degeneration,1/18/2013,
NCT00257608,A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS),Non-Small Cell Lung Cancer,3/15/2016,
NCT01198327,Extended Follow-up of Patients With Macular Edema Due to Retinal Vein Occlusion,Retinal Vein Occlusion,1/13/2014,
NCT01489189,Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy,Proliferative Diabetic Retinopathy,6/1/2016,
NCT00104299,Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis,Vasculitis|Wegener's Granulomatosis|Microscopic Polyangiitis,8/25/2011,
NCT02872103,Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy,Breast Cancer|Neutropenia,3/26/2019,
NCT00973362,Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System,Human Papillomavirus Infection,1/6/2017,
NCT01191762,Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney Disease,Hyperparathyroidism|Chronic Kidney Disease,7/31/2014,
NCT00398866,A Study of Hyaluronan for the Treatment of Osteoarthritis in the Thumb,Osteoarthritis,7/7/2017,
NCT00444626,A Study to Compare the Safety and Effectiveness of a Non-FDA Approved Device Dermal Gel Extra (DGE) and an FDA Approved Device for the Correction of Nasolabial Folds (NLFs),Facial Wrinkles at the Nasolabial Folds,4/22/2015,
NCT01074944,A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease to Evaluate Once Daily Versus Twice Daily Dosing (EDGE),Gaucher Disease,12/2/2016,
NCT00943111,A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ENCORE),"Gaucher Disease, Type 1",9/4/2014,
NCT00891202,A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease (ENGAGE),"Gaucher Disease, Type 1",9/3/2014,
NCT00364351,Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy,Non Small Cell Lung Cancer,5/24/2011,
NCT00317642,A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I),Acute Myelogenous Leukemia,9/15/2011,
NCT00312377,ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer,Non-small Cell Lung Cancer|Lung Cancer,5/24/2011,
NCT00103662,Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients,Multiple Myeloma,9/29/2010,
NCT00103610,Mobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma Patients,"Lymphoma, Non-Hodgkin",9/29/2010,
NCT00158600,A Placebo-Controlled Study of Safety and Effectiveness of Myozyme (Alglucosidase Alfa) in Patients With Late-Onset Pompe Disease,Pompe Disease (Late-onset)|Glycogen Storage Disease Type II (GSD-II)|Acid Maltase Deficiency Disease|Glycogenosis 2,7/23/2010,
NCT00701415,"A Study of Two Fabrazyme (Agalsidase Beta) Dosing Regimens in Treatment-naïve, Male Pediatric Patients Without Severe Symptoms",Fabry Disease,6/29/2016,
NCT00404924,ZD6474 (ZACTIMA™) Phase III Study in EGFR Failures,Non-Small-Cell Lung Carcinoma,3/26/2012,
NCT00086580,"Fludarabine (Fludara®) Plus Alemtuzumab (CAMPATH®, MabCampath®) vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients",B-Cell Chronic Lymphocytic Leukemia,8/11/2011,
NCT00727597,A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT,Human Immunodeficiency Virus Infections,7/2/2013,
NCT00095121,Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis B,Chronic Hepatitis B,6/3/2011,GILD
NCT01174173,Ranolazine and Pulmonary Hypertension,Angina|Pulmonary Arterial Hypertension,4/23/2015,GILD
NCT00112047,Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects,HIV Infections,10/13/2010,GILD
NCT01440569,Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults,Acquired Immunodeficiency Syndrome|HIV Infections,10/28/2014,GILD
NCT01178073,A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH),"Hypertension, Pulmonary",4/28/2015,GILD
NCT03118843,Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study,Hepatitis C Virus Infection,4/3/2019,GILD
NCT02707601,"Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV Treatment",HIV-1 Infection|HCV Infection,10/9/2018,GILD
NCT02652624,"Safety and Efficacy of Switching to a FDC of B/F/TAF From E/C/F/TAF, E/C/F/TDF, or ATV+RTV+FTC/TDF in Virologically Suppressed HIV-1 Infected Women",HIV-1 Infection,11/2/2018,GILD
NCT02639338,Safety and Efficacy of SOF/VEL/VOX FDC for 8 Weeks and SOF/VEL for 12 Weeks in Adults Chronic Genotype 3 HCV Infection and Cirrhosis,Hepatitis C Virus Infection,11/14/2017,GILD
NCT02639247,Safety and Efficacy of SOF/VEL/VOX FDC for 12 Weeks and SOF/VEL for 12 Weeks in DAA-Experienced Adults With Chronic HCV Infection Who Have Not Received an NS5A Inhibitor,Hepatitis C Virus Infection,11/6/2017,GILD
NCT02607800,Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir and Sofosbuvir/Velpatasvir in Adults With Chronic HCV Infection Who Have Not Previously Received Treatment With Direct-Acting Antiviral Therapy,Hepatitis C,11/8/2017,GILD
NCT02607735,Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir in Adults With Chronic HCV Infection Who Have Previously Received Treatment With Direct-Acting Antiviral Therapy,Hepatitis C,12/13/2017,GILD
NCT02605954,Safety and Efficacy of Switching From Regimens of ABC/3TC + a 3rd Agent to E/C/F/TAF Fixed-Dose Combination (FDC) in Virologically-Suppressed HIV 1 Infected Adults,HIV-1 Infection,7/13/2018,GILD
NCT02480712,Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection,Hepatitis C Virus Infection,6/1/2017,GILD
NCT02469246,Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC,HIV-1 Infection,6/11/2018,GILD
NCT02346721,Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection,Hepatitis C Virus Infection,5/3/2017,GILD
NCT02345252,Switch Study to Evaluate the Safety and Efficacy of Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) in HIV-1 Positive Adults Who Are Virologically Suppressed on Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate (FTC/RPV/TDF),HIV-1 Infection,12/8/2017,GILD
NCT02345226,"Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIV-1 Infected Adults",HIV-1 Infection,10/19/2017,GILD
NCT02220998,Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 12 Weeks in Adults With Chronic Genotype 2 HCV Infection,Hepatitis C Virus Infection,11/15/2016,GILD
NCT02201953,Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 24 Weeks in Adults With Chronic Genotype 3 HCV Infection,Hepatitis C Virus Infection,10/26/2016,GILD
NCT02201940,Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic HCV Infection,Hepatitis C Virus Infection,9/16/2016,GILD
NCT02201901,Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B Cirrhosis,Hepatitis C Virus Infection,12/14/2016,GILD
NCT02121795,Switch Study to Evaluate F/TAF in HIV-1 Positive Participants Who Are Virologically Suppressed on Regimens Containing FTC/TDF,HIV-1 Infection,11/30/2016,GILD
NCT02073656,Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection,Hepatitis C Virus|HIV,10/21/2016,GILD
NCT02071082,Efficacy and Safety of E/C/F/TAF (Genvoya®) in HIV-1/Hepatitis B Co-infected Adults,HIV|HBV,4/4/2016,GILD
NCT01968551,Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults,HIV-1|HIV Infections|Acquired Immunodeficiency Syndrome,11/1/2016,GILD
NCT01962441,SOF (Sovaldi®) +RBV for 16 or 24 Weeks and SOF+RBV+Peg-IFN for 12 Weeks in Adults With Genotype 2 or 3 Chronic HCV Infection,Hepatitis C,2/5/2016,GILD
NCT01851330,Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3),Chronic Hepatitis C Virus,12/30/2014,GILD
NCT01818596,Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment,HIV|HIV Infections,2/18/2016,GILD
NCT01797445,"Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positive, Antiretroviral Treatment-Naive Adults",HIV|HIV Infections,1/8/2016,GILD
NCT01780506,"Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positive, Antiretroviral Treatment-Naive Adults",HIV|HIV Infections,1/8/2016,GILD
NCT01768286,Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection,Chronic Hepatitis C Virus,11/26/2014,GILD
NCT01705574,"Safety and Efficacy of E/C/F/TDF (Stribild®) Versus RTV-Boosted ATV Plus FTC/TDF (Truvada®) in HIV-1 Infected, Antiretroviral Treatment-Naive Women",Acquired Immunodeficiency Syndrome|HIV Infections,3/10/2016,GILD
NCT01701401,Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCV,Chronic Hepatitis C Virus,3/27/2015,GILD
NCT01667731,"Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults",Hepatitis C|Human Immunodeficiency Virus,11/21/2014,GILD
NCT01659021,Efficacy and Safety of Idelalisib (GS-1101; CAL-101) in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia,Chronic Lymphocytic Leukemia,3/31/2017,GILD
NCT01641822,Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF,Cystic Fibrosis,5/9/2016,GILD
NCT01641640,"Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection",Chronic Hepatitis C,5/8/2014,GILD
NCT01625338,Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies,Chronic Hepatitis C,11/9/2015,GILD
NCT01604850,Sofosbuvir + Ribavirin for 12 or 16 Weeks in Treatment Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection (FUSION),Chronic Hepatitis C,5/1/2014,GILD
NCT01569295,"A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)",Chronic Lymphocytic Leukemia,2/27/2018,GILD
NCT01555164,A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone,Type 2 Diabetes Mellitus,9/23/2014,GILD
NCT01542788,"Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon",Chronic Hepatitis C,2/17/2014,GILD
NCT01539512,"A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)",Chronic Lymphocytic Leukemia,10/16/2014,GILD
NCT01533259,"Open-Label Pilot Study to Evaluate Switching From a Regimen Consisting of Raltegravir Plus Emtricitabine/Tenofovir DF Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients",Acquired Immunodeficiency Syndrome|HIV Infections,1/26/2015,GILD
NCT01497366,Phase 3 Study of Sofosbuvir and Ribavirin,Hepatitis C,4/2/2014,GILD
NCT01495702,"Study to Evaluate Switching From Regimens Consisting of a Nonnucleoside Reverse Transcriptase Inhibitor Plus Emtricitabine and Tenofovir DF to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients",Acquired Immunodeficiency Syndrome|HIV Infections,1/26/2015,GILD
NCT01494987,Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus,9/1/2014,GILD
NCT01475838,"Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients",Acquired Immunodeficiency Syndrome|HIV Infections,1/26/2015,GILD
NCT01472185,Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus,10/15/2014,GILD
NCT01442038,Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI),Coronary Artery Disease|Angina Pectoris,7/15/2016,GILD
NCT01404234,Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways,Cystic Fibrosis|Pseudomonas Aeruginosa,5/1/2014,GILD
NCT01363011,Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment,Acquired Immunodeficiency Syndrome|HIV Infections,10/31/2014,GILD
NCT01314716,Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis,Bronchiectasis,4/16/2014,GILD
NCT01313624,Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis,Bronchiectasis,4/16/2014,GILD
NCT01309243,"Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults",HIV-1 Infection,11/27/2013,GILD
NCT01252940,Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF,HIV-1 Infection,4/19/2013,GILD
NCT01967940,"Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced Adults",HIV|HIV Infections|Acquired Immunodeficiency Syndrome,6/12/2017,GILD
NCT01108510,"Safety and Efficacy of COBI-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults",HIV|HIV Infections,10/28/2014,GILD
NCT01106586,"Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults",HIV|HIV Infections,10/22/2012,GILD
NCT01095796,"Study to Evaluate the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults",HIV|HIV Infections,10/22/2012,GILD
NCT01059565,Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis and Chronic Burkholderia Species Infection,Cystic Fibrosis|Burkholderia Infections,3/11/2014,GILD
NCT00712166,"Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis, Mild Lung Disease, and P. Aeruginosa",Cystic Fibrosis|Lung Infection|Pseudomonas Aeruginosa,12/20/2010,GILD
NCT00708162,"Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir",HIV Infection,11/6/2014,GILD
NCT00380068,Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension,Pulmonary Hypertension,11/19/2010,GILD
NCT00528957,Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children,HIV Infections,3/22/2012,GILD
NCT00128492,Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA),Cystic Fibrosis,3/11/2011,GILD
NCT00117676,A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Negative Chronic Hepatitis B,Chronic Hepatitis B,5/19/2010,GILD
NCT00116805,A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Positive Chronic Hepatitis B,Chronic Hepatitis B,5/19/2010,GILD
NCT00112359,International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa,Cystic Fibrosis,4/21/2011,GILD
NCT00104520,Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa,Cystic Fibrosis,3/11/2011,GILD
NCT00737568,Tenofovir Disoproxil Fumarate (Tenofovir DF) Versus Emtricitabine/Tenofovir DF in Subjects Resistant to Lamivudine,Hepatitis B,4/11/2013,GILD
NCT00734162,Evaluation of Tenofovir Disoproxil Fumarate in Adolescents With Chronic Hepatitis B Infection,Hepatitis B Virus (HBV),11/7/2012,GILD
NCT01721109,"Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents",Acquired Immunodeficiency Syndrome|HIV Infections,4/10/2017,GILD
NCT02276612,Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected Adolescents,HIV,2/22/2018,GILD
NCT01087528,Evaluation of PillCam™ Colon 2 in Visualization of the Colon,Colonic Diseases|Bowel Diseases,6/8/2012,
NCT00323284,A Study of the Trabecular Micro-bypass Stent in Combination With Cataract Surgery in Subjects With Open Angle Glaucoma,Open-Angle Glaucoma,10/4/2012,GKOS
NCT02832375,Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity,Dentin Sensitivity,2/27/2017,GSK
NCT01827670,Investigating the Efficacy of a Dentifrice in Providing Long Term Relief From Dentinal Hypersensitivity,Dentine Hypersensitivity,1/26/2015,GSK
NCT01817790,Assessment of Fluticasone Propionate on Ocular Allergy Symptoms,Allergic Rhinitis|Seasonal Allergic Rhinitis,4/3/2014,GSK
NCT01641237,Effect of Fluoride in a Dentifrice on Remineralization of Erosive Lesions,Enamel Erosion,7/31/2013,GSK
NCT01607411,A Clinical Study to Evaluate Experimental Children's Toothpastes in an In-Situ Caries Model,Dental Caries,8/26/2013,GSK
NCT01592864,The Efficacy of a Dentifrice in Providing Relief From the Pain of Dentinal Hypersensitivity,Dentine Hypersensitivity,3/10/2014,GSK
NCT01592851,Clinical Efficacy of a Toothpaste in Providing Relief From the Pain of Dentinal Hypersensitivity,Dentine Hypersensitivity,6/3/2014,GSK
NCT00708305,Evaluation of Plaque Fluid Fluoride Retention From Fluoride Toothpastes,Dental Caries,6/10/2013,GSK
NCT00708097,In Situ Caries Efficacy of Fluoride Toothpastes,Caries,6/24/2013,GSK
NCT00385008,TREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a Migraine,Migraine Disorders,2/12/2018,GSK
NCT01702532,Nicotine Mouth Film for Craving Relief.,Smoking Cessation,1/30/2014,GSK
NCT01499199,A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in the Central Nervous System in HIV-1 Infected ART-naive Subjects,"Infection, Human Immunodeficiency Virus",11/25/2013,GSK
NCT00459056,The Vascular Effects of Carvedilol Controlled Release (CR) in Abdominally Obese Hypertensive Patients,Abdominal Obesity|Hypertension,11/8/2013,GSK
NCT00275275,Pramipexole Conversion to Ropinirole Controlled Release (CR),Parkinson Disease,8/24/2012,GSK
NCT03296072,In Situ Erosion Study to Investigate the Effectiveness of an Experimental Toothpaste,Tooth Erosion,2/20/2019,GSK
NCT00831129,A Study for Pre-diabetic Patients With Cholesterol Lowering Drugs,Pre-diabetes,9/12/2013,GSK
NCT00531843,The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients,Venous Thromboembolism,12/24/2013,GSK
NCT00440115,Disease Management for Smoking Cessation,Smoking Cessation,6/7/2017,GSK
NCT00421343,Secondary Prevention of Osteoporosis,Osteoporosis,6/10/2011,GSK
NCT01751165,Safety and Immunogenicity of Different Dosing Schedules of GlaxoSmithkline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine in Adults 50 Years of Age or Older,Herpes Zoster,3/31/2017,GSK
NCT03014674,A Study to Compare the Pharmacokinetics of Mepolizumab as a Liquid Drug in a Safety Syringe or an Autoinjector Versus Lyophilised Drug,Asthma,8/14/2018,GSK
NCT00268983,Comparison Of Rituximab Versus Tositumomab and Iodine I 131 Tositumomab (BEXXAR® Therapeutic Regimen) For Patients With Relapsed Follicular Non-Hodgkins Lymphoma,"Lymphoma, Non-Hodgkin",8/2/2010,GSK
NCT00891982,A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash,Acne Vulgaris,7/25/2011,GSK
NCT01067339,Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Progenitor Cells and Coronary Atherosclerosis in Humans,Endothelial Dysfunction,3/15/2017,GSK
NCT01016678,Treximet Early Intervention Adolescent Migraine,Migraine,5/4/2016,GSK
NCT00765076,Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older,Influenza,4/5/2012,GSK
NCT00621842,Lamotrigine for Symptoms of Geriatric Bipolar Depression,"Bipolar Disorder|Depression, Bipolar",10/25/2011,GSK
NCT02229227,Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus,"Diabetes Mellitus, Type 2",6/29/2018,GSK
NCT02058563,"Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older",Rubella|Mumps|Measles,4/10/2017,GSK
NCT02019472,A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis,"Arthritis, Rheumatoid",9/14/2017,GSK
NCT01856309,Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003,"Arthritis, Rheumatoid",5/6/2019,GSK
NCT01663623,Belimumab in Remission of VASculitis,Vasculitis,4/17/2018,GSK
NCT01606761,"A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T)","Arthritis, Rheumatoid",2/5/2018,GSK
NCT01604343,"A Study of CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy (SIRROUND-D)","Arthritis, Rheumatoid",1/11/2018,GSK
NCT01484496,A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE),Systemic Lupus Erythematosus,7/25/2017,GSK
NCT01449929,"Dolutegravir Compared to Darunavir/Ritonavir , Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in ART-naive Subjects","Infection, Human Immunodeficiency Virus",3/27/2014,GSK
NCT01788228,Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure,Influenza,4/7/2015,GSK
NCT01148017,Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine,Meningococcal Meningitis,5/14/2014,GSK
NCT02478632,Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen,HIV Infections,10/20/2017,GSK
NCT01139580,The Purpose of This Study is to Demonstrate the Safety and Effectiveness of Calcipotriene Foam in Subjects With Scalp and Body Psoriasis,Psoriasis,9/23/2011,GSK
NCT01017146,"A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - W0260-301",Acne Vulgaris,7/6/2012,GSK
NCT01017120,"A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne",Acne Vulgaris,7/6/2012,GSK
NCT02355665,Study to Determine the Efficacy and Safety of a Novel Nicotine Replacement Therapy,Tobacco Dependence,1/8/2019,GSK
NCT02105987,"A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen","Infection, Human Immunodeficiency Virus",2/25/2016,GSK
NCT00866697,"Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer",Ovarian Cancer,12/19/2013,GSK
NCT00856297,Evaluation of Persistence of Anti-meningococcal Bactericidal Antibodies Among Adolescents Who Previously Received MenACWY Conjugate Vaccine,Meningococcal Meningitis,1/22/2014,GSK
NCT00852540,Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA,"Skin Infections, Bacterial",8/26/2011,GSK
NCT00724867,A Continuation Trial for Subjects With Lupus Who Completed Protocol HGS1006-C1056 in the United States,Systemic Lupus Erythematosus,3/28/2016,GSK
NCT00689117,A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel,Acne Vulgaris|Acne,12/2/2010,GSK
NCT00688519,Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies,Psoriasis,12/8/2010,GSK
NCT00689481,Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis Two of Two Phase 3 Studies,Psoriasis,12/8/2010,GSK
NCT01568892,Study Assessing Dolutegravir in HIV-1 Infected Subjects With Virus Resistant to Raltegravir and/or Elivitegravir,HIV Infections,2/19/2014,GSK
NCT00440947,Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection,"Infection, Human Immunodeficiency Virus I|HIV Infection",8/17/2011,GSK
NCT00410384,A Study of Belimumab in Subjects With Systemic Lupus Erythematosus,Systemic Lupus Erythematosus,5/5/2011,GSK
NCT00397839,The Effect Of Oral Ibandronate In Male Osteoporosis,Male Osteoporosis,12/21/2009,GSK
NCT00356915,Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail.,Onychomycosis,1/4/2012,GSK
NCT01328041,A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.,"Infection, Human Immunodeficiency Virus",7/21/2014,GSK
NCT00296504,A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected Subjects,"Infection, Human Immunodeficiency Virus",11/8/2011,GSK
NCT01263015,A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial),"Infection, Human Immunodeficiency Virus I",7/2/2014,GSK
NCT01227824,A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily,"Infection, Human Immunodeficiency Virus I",6/23/2014,GSK
NCT00776919,Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne,Acne Vulgaris,1/30/2012,GSK
NCT00915902,Fish Oil Study for High Triglyceride Levels in Children,Hypertriglyceridemia,5/7/2014,GSK
NCT03099096,Study of Mepolizumab Autoinjector in Asthmatics,Asthma,6/29/2018,GSK
NCT02986854,"Study to Assess the Safety and Immunogenicity of a Single Dose of GlaxoSmithKline's (GSK) Meningococcal MenACWY-CRM Vaccine (Menveo), Administered to Subjects 15 Through 55 Years of Age, Approximately 4-6 Years After Primary ACWY Vaccination","Infections, Meningococcal",8/3/2018,GSK
NCT02979639,"Study to Evaluate the Impact of Reactogenicity on Quality of Life (QoL), After Administration of GlaxoSmithKline (GSK) Biologicals' Candidate Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 50 Years of Age",Herpes Zoster,10/16/2018,GSK
NCT02683746,Safety and Efficacy Study of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus,"Diabetes Mellitus, Type 2",5/30/2018,GSK
NCT02581410,Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 65 Years of Age With and Without Zostavax® Vaccination at Least 5 Years Earlier,Herpes Zoster,9/26/2017,GSK
NCT02483975,Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma,Asthma,3/8/2017,GSK
NCT02311881,A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis,Pain,4/7/2017,GSK
NCT02301975,"An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma",Asthma,6/12/2017,GSK
NCT02281318,Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control,Asthma,5/4/2017,GSK
NCT02242643,Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age,Influenza,4/12/2016,GSK
NCT02184572,"Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age",Measles; Mumps; Rubella,7/3/2018,GSK
NCT02164513,"A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)","Pulmonary Disease, Chronic Obstructive",10/10/2018,GSK
NCT02152605,A Phase IIIb Study to Evaluate the Efficacy of Umeclidinium/Vilanterol (UMEC/VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD),"Pulmonary Disease, Chronic Obstructive",2/25/2016,GSK
NCT02145468,A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60),Acute Coronary Syndrome,6/2/2017,GSK
NCT02135692,"A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects",Asthma,5/2/2018,GSK
NCT02119286,"Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2","Pulmonary Disease, Chronic Obstructive",12/12/2014,GSK
NCT02105974,Study Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) Compared With Vilanterol Inhalation Powder (VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD),"Pulmonary Disease, Chronic Obstructive",4/13/2016,GSK
NCT02105961,Efficacy and Safety of Mepolizumab as an Add-on Treatment in Chronic Obstructive Pulmonary Disease (COPD),"Pulmonary Disease, Chronic Obstructive",4/6/2018,GSK
NCT02105948,Study to Evaluate Efficacy and Safety of Mepolizumab for Frequently Exacerbating Chronic Obstructive Pulmonary Disease (COPD) Patients,"Pulmonary Disease, Chronic Obstructive",4/6/2018,GSK
NCT02096263,"Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants",Poliomyelitis|Diphtheria|Haemophilus Influenzae Type b|Tetanus|Acellular Pertussis|Hepatitis B,8/1/2018,GSK
NCT02052596,"Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) When Co-administered With GSK Biologicals' Diphtheria, Tetanus and Pertussis Vaccine (Boostrix®) in Adults Aged 50 Years and Older",Herpes Zoster,4/24/2018,GSK
NCT01978093,"Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age",Neisseria Meningitidis|Haemophilus Influenzae Type b,6/25/2018,GSK
NCT02020889,A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis,Churg-Strauss Syndrome,1/26/2018,GSK
NCT01957163,"Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)","Pulmonary Disease, Chronic Obstructive",11/25/2014,GSK
NCT01879410,A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol With Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD),"Pulmonary Disease, Chronic Obstructive",8/15/2014,GSK
NCT01868009,DISKUS vs. ELLIPTA Device Preference Study in Chronic Obstructive Pulmonary Disease (COPD),"Pulmonary Disease, Chronic Obstructive",3/4/2014,GSK
NCT01842607,A Study to Determine Long-term Safety of Mepolizumab in Asthmatic Subjects,Asthma,3/3/2016,GSK
NCT01817764,A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol and Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD),"Pulmonary Disease, Chronic Obstructive",5/29/2014,GSK
NCT01777334,The Purpose of This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotriopium 18 mcg Once Daily Over a 24-week Treatment Period in Subjects With COPD,"Pulmonary Disease, Chronic Obstructive",6/5/2014,GSK
NCT01772147,Efficacy and Safety of the Addition of Fluticasone Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide Inhalation Powder (62.5 or 125mcg) Once-daily Over 12 Weeks.,"Pulmonary Disease, Chronic Obstructive",4/21/2014,GSK
NCT01772134,Efficacy and Safety of the Addition of Fluticanse Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide (62.5 or 125mcg) Once-daily Over 12 Weeks,"Pulmonary Disease, Chronic Obstructive",4/16/2014,GSK
NCT01738477,Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young Adults,Tetanus|Acellular Pertussis|Diphtheria,12/27/2017,GSK
NCT01767467,Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood Cancers,Herpes Zoster,5/25/2017,GSK
NCT01706328,A Study to Assess the Efficacy of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25 mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50 mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD),"Pulmonary Disease, Chronic Obstructive",3/5/2014,GSK
NCT01702428,"Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age",Rubella|Measles|Mumps,6/28/2018,GSK
NCT01691521,Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma,Asthma,1/26/2016,GSK
NCT01691859,MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects,Asthma,5/22/2018,GSK
NCT01686633,"An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (mcg) , FF/VI 100/25 mcg, and FF 100 mcg in Adults and Adolescents With Persistent Asthma.",Asthma,6/6/2014,GSK
NCT01682876,"Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age.","Meningococcal Disease|Infections, Meningococcal",10/6/2014,GSK
NCT01681992,Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life,Measles|Mumps|Rubella,8/17/2018,GSK
NCT01691508,Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma,Asthma,1/26/2016,GSK
NCT01641042,Comparison of GlaxoSmithKline (GSK)134612 in Subjects With Increased Risk for Meningococcal Disease Versus Healthy Subjects,"Infections, Meningococcal",10/18/2017,GSK
NCT01627327,Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Tiotropium Bromide Inhalation Powder 18mcg Once Daily in Subjects With COPD Who Have or Are At Risk for Co-morbid Cardiovascular Disease,"Pulmonary Disease, Chronic Obstructive",11/1/2013,GSK
NCT01621802,Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age,Rubella|Mumps|Measles,9/13/2017,GSK
NCT01610414,"Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A",Herpes Zoster,1/23/2018,GSK
NCT01436110,Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma,Asthma,9/3/2014,GSK
NCT01431950,Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents,Asthma,9/3/2014,GSK
NCT01436071,Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma,Asthma,9/3/2014,GSK
NCT01336608,A 24-week Arterial Stiffness Study With Fluticasone Furoate/Vilanterol in COPD,"Pulmonary Disease, Chronic Obstructive",7/10/2015,GSK
NCT01328444,An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444. Study A,"Pulmonary Disease, Chronic Obstructive",2/10/2014,GSK
NCT01323660,An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444.Study B,"Pulmonary Disease, Chronic Obstructive",4/11/2014,GSK
NCT01323621,Study Evaluating the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD),"Pulmonary Disease, Chronic Obstructive",2/6/2014,GSK
NCT01323634,Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease,"Pulmonary Disease, Chronic Obstructive",7/30/2013,GSK
NCT01316913,24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease,"Pulmonary Disease, Chronic Obstructive",2/24/2014,GSK
NCT01316900,24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease,"Pulmonary Disease, Chronic Obstructive",2/10/2014,GSK
NCT01316887,"A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 and GSK573719 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)","Pulmonary Disease, Chronic Obstructive",3/20/2014,GSK
NCT01313676,Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease,"Pulmonary Disease, Chronic Obstructive",8/9/2016,GSK
NCT01313650,A 24-week Evaluation of GSK573719/Vilanterol (62.5/25mcg) and Components in COPD,"Pulmonary Disease, Chronic Obstructive",3/4/2014,GSK
NCT01313637,A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD,"Pulmonary Disease, Chronic Obstructive",2/10/2014,GSK
NCT01310413,Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age,Influenza,3/31/2014,GSK
NCT01277666,A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease,Crohn's Disease,9/19/2017,GSK
NCT01245062,GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma,Melanoma,3/15/2013,GSK
NCT01231620,A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza,"Influenza, Human",11/20/2017,GSK
NCT01227889,A Study Comparing GSK2118436 to Dacarbazine (DTIC) in Previously Untreated Subjects With BRAF Mutation Positive Advanced (Stage III) or Metastatic (Stage IV) Melanoma,Cancer,5/16/2014,GSK
NCT01198756,A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Children,Influenza,3/12/2013,GSK
NCT01196988,Immunogenicity and Safety Study of GSK Biologicals' Influenza Vaccine When Administered in Children,Influenza,3/19/2013,GSK
NCT01204671,Safety and Immunogenicity Study of GSK Biologicals' Seasonal Influenza Candidate Vaccine (GSK2321138A),Influenza,6/17/2013,GSK
NCT01190189,Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study,"Infections, Papillomavirus",12/17/2018,GSK
NCT01181895,Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma,Asthma,8/26/2013,GSK
NCT01165229,"Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and Older",Herpes Zoster,11/20/2017,GSK
NCT01165177,"Study to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and Older",Herpes Zoster,5/1/2017,GSK
NCT01165138,Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics,Asthma,7/30/2013,GSK
NCT01159912,Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents,Asthma,8/8/2013,GSK
NCT01147848,HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and Adolescents,Asthma,9/5/2013,GSK
NCT01134042,Study HZA106829: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics,Asthma,8/8/2013,GSK
NCT01128894,A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.,"Diabetes Mellitus, Type 2",5/20/2014,GSK
NCT01098539,A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.,"Diabetes Mellitus, Type 2",5/16/2014,GSK
NCT01086384,Asthma Exacerbation Study,Asthma,9/11/2013,GSK
NCT01054885,Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD),"Pulmonary Disease, Chronic Obstructive",8/15/2013,GSK
NCT01053988,A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD),"Pulmonary Disease, Chronic Obstructive",8/15/2013,GSK
NCT01072149,"A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic (PD) Profiles of 3 Doses of Fluticasone Furoate (FF)/GW642444 Inhalation Powder at the End of a 28-day Treatment Period in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Compared to Placebo","Pulmonary Disease, Chronic Obstructive",12/25/2013,GSK
NCT01018186,Fluticasone Furoate/GW642444 Inhalation Powder Long-Term Safety Study,Asthma,10/29/2013,GSK
NCT01017952,A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD),"Pulmonary Disease, Chronic Obstructive",8/19/2013,GSK
NCT01014208,Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma,"Lymphoma, Large-Cell, Diffuse",10/16/2014,GSK
NCT01009463,A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD),"Pulmonary Disease, Chronic Obstructive",8/19/2013,GSK
NCT01000974,Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants,Haemophilus Influenzae Type b,8/19/2013,GSK
NCT01000727,The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial,Acute Coronary Syndrome,8/10/2017,GSK
NCT00980005,Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children,Influenza,2/15/2012,GSK
NCT00979602,"Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older",Influenza,9/21/2017,GSK
NCT00976391,A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine,"Diabetes Mellitus, Type 2",7/16/2014,GSK
NCT00937950,Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects,"Infections, Papillomavirus",1/15/2015,GSK
NCT01196975,A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults,Influenza,12/24/2012,GSK
NCT00903409,"Open-Label Extension of a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lovaza® and Simvastatin Therapy in Hypertriglyceridemic Subjects",Hypertriglyceridemia,8/4/2009,GSK
NCT03021304,Study of Mepolizumab Safety Syringe in Asthmatics,Asthma,1/31/2018,GSK
NCT00871117,Immunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 Years,Tetanus|Acellular Pertussis|Diphtheria,2/10/2011,GSK
NCT00849056,Safety and Efficacy of Albiglutide in Type 2 Diabetes,"Diabetes Mellitus, Type 2",7/1/2014,GSK
NCT00849017,Safety and Efficacy Study of Albiglutide in Type 2 Diabetes,"Diabetes Mellitus, Type 2",6/5/2014,GSK
NCT00843024,Migraine Study in Adolescent Patients,Migraine Disorders,5/9/2011,GSK
NCT00839527,A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes,"Diabetes Mellitus, Type 2",7/1/2014,GSK
NCT00838916,A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes,"Diabetes Mellitus, Type 2",6/4/2014,GSK
NCT00838903,Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes,"Diabetes Mellitus, Type 2",5/16/2014,GSK
NCT00835237,Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine.,Tetanus|Acellular Pertussis|Diphtheria,8/5/2010,GSK
NCT00799903,The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial,Atherosclerosis,8/10/2017,GSK
NCT00799825,Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US,"Infections, Papillomavirus",9/20/2013,GSK
NCT00764790,Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in Children,Influenza,7/27/2010,GSK
NCT00753272,Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older,Influenza,6/19/2012,GSK
NCT00772889,Evaluation of the Safety and Immunogenicity of the Influenza Vaccine GSK2186877A in the Elderly,Influenza,4/24/2012,GSK
NCT00753688,Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy,"Sarcoma, Soft Tissue",12/21/2011,GSK
NCT00996216,Clinical Trial for Non-responders Who Previously Participated in Eltrombopag Studies TPL 103922 or TPL 108390,Hepatitis C,12/6/2013,GSK
NCT00723450,Lamictal as Add-on Treatment for Bipolar I Disorder in Pediatric Patients,Bipolar Disorder,6/4/2014,GSK
NCT00684177,Retapamulin Versus Placebo in Secondarily-Infected Traumatic Lesions (SITL),"Skin Infections, Bacterial",8/4/2010,GSK
NCT00678886,Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1,"Diabetes Mellitus, Type 1",10/3/2017,GSK
NCT00650104,Long-term Extension Study Evaluating Extended Release Ropinirole XL (Formerly Referred to as Ropinirole CR) in Patients Who Already Completed Either Study 167 or 164,Parkinson Disease,4/21/2010,GSK
NCT00632736,An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease,Parkinson Disease|Parkinson's Disease,12/24/2010,GSK
NCT00624065,Research Study To Test Carvedilol CR + Lisinopril Versus Lisinopril + Placebo In Patients With High Blood Pressure,Hypertension,8/3/2009,GSK
NCT00616928,Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years,Influenza,2/7/2014,GSK
NCT00614614,"Immuno,Safety of GSK Vaccine 134612 Given at Age of 12-15 Months 15-18 Months Post-priming With GSK Vaccine 792014","Infections, Meningococcal",7/20/2012,GSK
NCT00601172,A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.,"Nausea and Vomiting, Chemotherapy-Induced",1/17/2018,GSK
NCT00579982,An Open-Label Trial Measuring Satisfaction And Convenience Of Two Formulations Of Lamotrigine In Subjects With A Mood Disorder,Mood Disorders,8/3/2009,GSK
NCT00573170,TREXIMET® Versus Butalbital-containing Combination Medications for the Acute Treatment of Migraine in Adults,"Migraine Disorders|Migraine, Acute",12/29/2010,GSK
NCT00529568,Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease,"Hepatitis C, Chronic",5/17/2012,GSK
NCT00529516,Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults,Influenza,5/30/2012,GSK
NCT00516321,Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease,"Hepatitis C, Chronic",7/30/2012,GSK
NCT00516139,Lamotrigine Extended-Release In Elderly Patients With Epilepsy,Epilepsy,1/13/2012,GSK
NCT00489970,"Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9",Acellular Pertussis|Tetanus|Diphtheria,8/11/2010,GSK
NCT00488514,Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents,Migraine Disorders,9/6/2010,GSK
NCT00441441,A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With Asthma,Asthma,9/23/2010,GSK
NCT00428090,Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease,Alzheimer's Disease,5/19/2017,GSK
NCT00423046,Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age,"Infections, Papillomavirus",8/25/2010,GSK
NCT00402363,"Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation","Fibrillation, Atrial",10/15/2010,GSK
NCT02207413,A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Candidate Vaccine (GSK2321138A) Manufactured Using a New Process in Adults and Children,Influenza,6/20/2016,GSK
NCT00398476,Fluticasone Nasal Spray Patient Preference Study,"Rhinitis, Allergic, Perennial",1/29/2018,GSK
NCT00390806,Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer,"Lung Cancer, Non-Small Cell",1/20/2014,GSK
NCT00387881,TREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1),"Migraine, Without Aura",7/10/2009,GSK
NCT00385255,"Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults",Acellular Pertussis|Diphtheria|Tetanus,9/17/2018,GSK
NCT00383162,A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2),Migraine Disorders,2/17/2010,GSK
NCT00383123,Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children,Influenza,12/4/2008,GSK
NCT00382993,A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2),Migraine Disorders,4/20/2010,GSK
NCT00374322,Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer,"Neoplasms, Breast",8/18/2014,GSK
NCT00370331,RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag,"Purpura, Thrombocytopaenic, Idiopathic",2/23/2010,GSK
NCT00369824,Evaluation of Safety and Immunogenicity of Co-administering HPV Vaccine With Other Vaccines in Healthy Female Subjects,"Infections, Papillomavirus",10/8/2009,GSK
NCT00363142,A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects,"HIV Infection|Infection, Human Immunodeficiency Virus",9/24/2009,GSK
NCT00359983,"Long-Term Antibody Persistence at 1, 3 and 5 Years After a Fourth Dose of GSK Biologicals' Hib-MenCY-TT Vaccine Compared to ActHIB",Neisseria Meningitidis|Haemophilus Influenzae Type b,7/20/2012,GSK
NCT00355082,Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy,"Epilepsy, Partial",11/25/2009,GSK
NCT00348140,Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease,Alzheimer's Disease,9/5/2017,GSK
NCT00347360,The COREG And Lisinopril Combination Therapy In Hypertensive Subjects (COSMOS) Trial,Hypertension,11/9/2009,GSK
NCT00346073,Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years,Acellular Pertussis|Diphtheria|Tetanus,8/7/2018,GSK
NCT00345683,"Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 12 to 15 Months of Age.",Haemophilus Influenzae Type b|Neisseria Meningitidis,7/20/2012,GSK
NCT00345579,"Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age",Haemophilus Influenzae Type b|Neisseria Meningitidis,7/20/2012,GSK
NCT00320385,Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer,"Neoplasms, Breast",11/30/2011,GSK
NCT00310375,Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial,Epilepsy,11/25/2016,GSK
NCT00294047,Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older,"Infections, Papillomavirus",3/27/2012,GSK
NCT00289783,Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine,Haemophilus Influenzae Type b|Neisseria Meningitidis,8/6/2012,GSK
NCT00273052,COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension,Hypertension,2/1/2010,GSK
NCT00346775,Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q),"Rhinitis, Allergic, Perennial",12/6/2017,GSK
NCT00289198,Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR),"Rhinitis, Allergic, Perennial",4/13/2018,GSK
NCT00256867,A Study In Patients With Type 2 Diabetes Mellitus,"Diabetes Mellitus, Type 2",3/23/2018,GSK
NCT00256854,Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome),Restless Legs Syndrome|Restless Legs Syndrome (RLS),3/15/2019,GSK
NCT00224484,Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old,Herpes Simplex,4/10/2017,GSK
NCT00197236,"Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months",Hepatitis A,7/24/2009,GSK
NCT00197015,Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children,Hepatitis A,4/1/2010,GSK
NCT00197002,Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age,Hepatitis A,2/20/2017,GSK
NCT00122681,Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18,"Infections, Papillomavirus",1/20/2010,GSK
NCT00118703,Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor Rhinitis,"Vasomotor Rhinitis|Rhinitis, Vasomotor",5/2/2017,GSK
NCT00117325,Study Of Adults And Adolescents With Vasomotor Rhinitis,"Rhinitis, Vasomotor",3/13/2018,GSK
NCT00116831,Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes,Atherosclerosis,3/31/2010,GSK
NCT00108082,The CLEVER Study - Coreg And Left Ventricular Mass Regression,"Hypertrophy, Left Ventricular",11/9/2009,GSK
NCT00104416,Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures,"Epilepsy, Tonic-Clonic",5/18/2010,GSK
NCT00090103,Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment,Prostatic Hyperplasia,3/16/2010,GSK
NCT01520909,"Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.",Idiopathic Thrombocytopenic Purpura,9/29/2014,GSK
NCT00075270,Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer,"Neoplasms, Breast",3/31/2014,GSK
NCT00424255,Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery,"Neoplasms, Head and Neck",2/11/2014,GSK
NCT01387230,Evaluate the Efficacy and Safety of GSK573719 Delivered Via a Novel Dry Powder Inhaler in Subjects With COPD,"Pulmonary Disease, Chronic Obstructive",2/11/2014,GSK
NCT00057330,HerpeVac Trial for Young Women,Herpes Simplex Infection,11/3/2011,GSK
NCT00056407,"""REDUCE"" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk","Neoplasms, Prostate",3/5/2010,GSK
NCT01086410,Safety Study of the Effects of Inhaled Fluticasone Furoate/GW642444 on the Hypothalamic-Pituitary-Adrenal (HPA) Axis,Asthma,8/8/2013,GSK
NCT02075515,"Consistency, Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults ≥ 50 Years of Age",Herpes Zoster,5/24/2017,GSK
NCT02045836,Study to Evaluate Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A When Co-administered With Pneumovax 23™ in Adults Aged 50 Years and Older,Herpes Zoster,7/5/2017,GSK
NCT01954251,Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older,Herpes Zoster,2/10/2016,GSK
NCT01899742,The Purpose of the This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotropium 18mcg Once Daily Over a a 12-week Treatment Period in Subjects With COPD Who Continue to Have Symptoms on Tiotropium,"Pulmonary Disease, Chronic Obstructive",2/25/2016,GSK
NCT01190176,Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects,"Infections, Papillomavirus",10/17/2018,GSK
NCT00464087,Switching From Fondaparinux to Bivalirudin or Unfractionated Heparin in ACS Patients Undergoing PCI,Acute Coronary Syndromes,8/1/2013,GSK
NCT02207829,A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium Compared With Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease,"Pulmonary Disease, Chronic Obstructive",2/9/2016,GSK
NCT02596451,"To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).",Osteoarthritis,6/28/2017,
NCT02465632,"To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris.",Acne Vulgaris,6/28/2017,
NCT02870205,Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR),Seasonal Allergic Rhinitis (SAR),4/6/2018,
NCT02709538,Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR),Perennial Allergic Rhinitis,9/13/2018,
NCT02631551,Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR),Seasonal Allergic Rhinitis,8/15/2018,
NCT00291226,Glycine vs Placebo for the Schizophrenia Prodrome,Schizophrenia Prodrome,12/29/2016,
NCT01415960,Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer,Prostate Cancer,1/18/2017,
NCT00609466,A Trial to Evaluate CG5503 Efficacy and Safety in Acute Pain After Bunionectomy,Bunionectomy|Pain|Postoperative Pain|Acute Pain,11/25/2009,
NCT01041859,"A Study to Evaluate the Efficacy, Safety, and Tolerability of Tapentadol ER Compared With Placebo in Patients With Chronic, Painful Diabetic Peripheral Neuropathy",Diabetic Peripheral Neuropathy,5/14/2012,
NCT00986180,NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back Pain,Pain|Back Pain|Low Back Pain|Back Pain With Radiation,2/29/2012,
NCT00771758,Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis,Back Pain,4/7/2011,
NCT00613938,A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain From Bunionectomy.,Arthralgia|Bunion|Hallux Valgus|Pain,4/23/2010,
NCT00487435,An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain,Pain|Osteoarthritis|Low Back Pain,7/23/2010,
NCT00361504,A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic Pain,"Osteoarthritis, Hip|Osteoarthritis, Knee|Lower Back Pain|Pain",9/4/2009,
NCT00894647,Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery,Actinic Keratosis,8/23/2010,
NCT00735462,Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts,Genital Warts,7/20/2011,
NCT00674739,Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts,Genital Warts,5/18/2011,
NCT00605176,Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs),Actinic Keratoses,6/22/2010,
NCT00603798,Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs),Actinic Keratosis,6/22/2010,
NCT01353079,Efficacy and Safety Study Of Short Ragweed Pollen Sublingual-Oral Immunotherapy,Allergy,2/5/2015,
NCT00599872,Efficacy Study of Sublingual Immunotherapy to Treat Ragweed Allergies,Allergic Rhinitis,1/14/2015,
NCT01731938,Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Soft Tissue Open Surgeries,Soft Tissue Surgical Bleeding,2/23/2017,
NCT00511147,IGIV Study for Chronic ITP Patients Ages 3-70,Idiopathic Thrombocytopenic Purpura,5/5/2017,
NCT01754480,Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Parenchymous Tissue Open Surgeries,Parenchymous Tissue Surgical Bleeding,2/8/2017,
NCT01662856,Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery,Vascular Surgical Bleeding,4/6/2017,
NCT00301366,The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency,Alpha 1-Antitrypsin Deficiency,8/19/2014,
NCT00295061,"Comparison of Pharmacokinetic, Safety, Tolerability of Alpha-1 MP and Prolastin In Alpha1-antitrypsin Deficient Adults",Alpha 1-Antitrypsin Deficiency,9/9/2014,
NCT00220740,Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP),"Polyradiculoneuropathy, Chronic Inflammatory Demyelinating",9/10/2015,
NCT02282527,A Study to Assess Safety and PK of Liquid Alpha₁-Proteinase Inhibitor (Human) in Treating Alpha₁-Antitrypsin Deficiency,Alpha₁-Antitrypsin Deficiency,3/13/2017,
NCT01355484,Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC),Muscle Wasting|Non Small Cell Lung Cancer,3/3/2016,
NCT01012674,Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF),Cerebral Arterial Diseases,8/25/2015,
NCT01010932,Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF),Cerebral Arterial Diseases,8/25/2015,
NCT01211873,Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions,Diagnostic Self Evaluation|Central Nervous System Diseases,5/29/2014,
NCT01361607,Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer,Pain|Advanced Cancer,4/23/2018,GWPH
NCT01337089,Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain,Pain|Advanced Cancer,4/23/2018,GWPH
NCT01262651,Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer,Pain|Advanced Cancer,4/23/2018,GWPH
NCT02224690,A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults,Epilepsy|Lennox-Gastaut Syndrome,7/27/2018,
NCT02224560,Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults,Epilepsy|Lennox Gastaut Syndrome,7/27/2018,
NCT02091375,Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1),Epilepsy|Dravet Syndrome,7/20/2018,
NCT00499109,Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC,Non-Small Cell Lung Cancer,3/26/2014,
NCT01959035,Aripiprazole Once-monthly in Patients With Schizophrenia,Schizophrenia,5/16/2016,
NCT01810380,Brexpiprazole in Patients With Acute Schizophrenia,Schizophrenia,3/29/2016,
NCT01795547,Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia,Schizophrenia,12/3/2015,
NCT02196506,Study of the Safety and Efficacy of Fixed-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder With and Without Anxious Distress,"Depressive Disorder|Depression|Depressive Disorder, Major|Mood Disorders|Mental Disorders",8/21/2018,
NCT02006654,Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor,Alzheimer's Disease,2/7/2018,
NCT02006641,Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil,Alzheimer's Disease,2/20/2018,
NCT01955161,Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil,Alzheimer's Disease,9/19/2017,
NCT01810783,Brexpiprazole in Patients With Schizophrenia,Schizophrenia,2/23/2017,
NCT01838681,Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment,Major Depressive Disorder,8/9/2017,
NCT01710709,Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder,Bipolar I,8/8/2018,
NCT01567527,"Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients",Bipolar I Disorder,8/24/2018,
NCT00734071,An Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder,Generalized Anxiety Disorder,12/18/2013,
NCT00731120,Study of Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder,Generalized Anxiety Disorder,12/18/2013,
NCT00730691,Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder,Generalized Anxiety Disorder,12/18/2013,
NCT00707980,Safety and Tolerability of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder,Major Depressive Disorder,12/13/2013,
NCT00672958,Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Adults With Major Depressive Disorder,Major Depressive Disorder,12/13/2013,
NCT00672620,Efficacy and Safety of Vortioxetine (Lu AA21004) in the Treatment of Patients With Major Depressive Disorder,Major Depressive Disorder,12/18/2013,
NCT01683058,"Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia",Schizophrenia,3/31/2015,
NCT01663532,"Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia",Schizophrenia,2/16/2015,
NCT02400346,Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment,Major Depression Disorder,6/26/2017,
NCT02079246,Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease,Alzheimer's Disease,8/10/2018,
NCT01942785,Study of Brexpiprazole as Adjunctive Treatment of Irritability in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Therapy,Major Depressive Disorder|Irritability,3/15/2016,
NCT01656889,Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers,Venous Leg Ulcers,3/14/2016,
NCT01737762,Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2,Venous Leg Ulcers,7/26/2017,
NCT01376297,A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting,Chemotherapy-Induced Nausea and Vomiting,11/17/2014,
NCT01363479,An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting,Chemotherapy-Induced Nausea and Vomiting,11/17/2014,
NCT01339260,An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting,Chemotherapy-Induced Nausea and Vomiting,11/26/2014,
NCT02517021,A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting,Chemotherapy-Induced Nausea and Vomiting,6/20/2018,
NCT01442376,Efficacy and Safety of Palonosetron Intravenous in Prevention of Chemotherapy Induced Nausea and Vomiting in Pediatric Patients,Chemotherapy-Induced Nausea and Vomiting,7/28/2014,
NCT01395901,Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric Patients,Postoperative Nausea and Vomiting,7/30/2014,
NCT01395914,Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3),Cachexia|Non-Small Cell Lung Cancer,7/11/2017,
NCT01387282,Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 2),Cachexia|Non-Small Cell Lung Cancer,7/11/2017,
NCT01387269,Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 1),Cachexia|Non-Small Cell Lung Cancer,7/11/2017,
NCT00707486,"A Randomized, Self Controlled Clinical Study of Hemostatic Efficacy of the HemCon Dental Dressing",Tooth Extractions,1/9/2013,
NCT02106494,"A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC",Chemotherapy-induced Nausea and Vomiting,12/28/2016,HRTX
NCT00343460,APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer,"Nausea and Vomiting|Unspecified Adult Solid Tumor, Protocol Specific",12/28/2016,HRTX
NCT02744755,Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis,Rheumatoid Arthritis,12/18/2018,
NCT02514772,"GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera®",Rheumatoid Arthritis,12/28/2017,
NCT02016105,Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira,Plaque Type Psoriasis,4/7/2017,
NCT00112918,Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer,Colorectal Cancer,9/6/2012,
NCT00089479,A Study of Xeloda (Capecitabine) in Women With High-Risk Breast Cancer,Breast Cancer,6/23/2011,
NCT01044498,A Study of Tocilizumab in Combination With an Oral Contraceptive in Patients With Rheumatoid Arthritis,Rheumatoid Arthritis,3/12/2013,
NCT02788279,A Study to Investigate Efficacy and Safety of Cobimetinib Plus Atezolizumab and Atezolizumab Monotherapy Versus Regorafenib in Participants With Metastatic Colorectal Adenocarcinoma (COTEZO IMblaze370),Colorectal Cancer,6/18/2019,
NCT02453256,A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc),Systemic Sclerosis,4/3/2019,
NCT02131064,A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer,Breast Neoplasms,6/8/2017,
NCT02008227,A Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing Therapy,Non-Squamous Non-Small Cell Lung Cancer,7/2/2017,
NCT02302807,A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211],Bladder Cancer,4/11/2018,
NCT01855789,A Study of the Impact of Methotrexate (MTX) Discontinuation on the Efficacy of Subcutaneous (SC) Tocilizumab (TCZ) With MTX,Rheumatoid Arthritis,12/26/2017,
NCT01853254,A Study of Pegasys (Peginterferon Alfa-2a) Administered Alone or in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C Who Have Participated in Previous Pegasys Trials,"Hepatitis C, Chronic",9/4/2013,
NCT01791153,An Efficacy and Safety Study of Tocilizumab (RoActemra/Actemra) in Participants With Giant Cell Arteritis (GCA),Giant Cell Arteritis,5/18/2017,
NCT01667419,A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma,Melanoma,10/17/2018,
NCT01663727,"Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer",Metastatic Breast Cancer,2/10/2016,
NCT01532869,A Study of RoActemra/Actemra (Tocilizumab) Versus Placebo in Patients With Systemic Sclerosis,"Sclerosis, Systemic",11/5/2015,
NCT01419197,A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed Therapy,Breast Cancer,5/5/2014,
NCT01351415,A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC),Non-Squamous Non-Small Cell Lung Cancer,9/18/2017,
NCT01328951,A Study of First-line Maintenance Erlotinib Versus Erlotinib at Disease Progression in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) Who Have Not Progressed Following Platinum-Based Chemotherapy,Non-Squamous Non-Small Cell Lung Cancer,2/29/2016,
NCT01232569,A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis,Rheumatoid Arthritis,10/23/2013,
NCT01194414,A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Participants With Moderate to Severe Active Rheumatoid Arthritis,Rheumatoid Arthritis,2/12/2013,
NCT01050257,A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza,Influenza,11/1/2013,
NCT01323153,A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE),Coronary Heart Disease,8/6/2018,
NCT01007435,A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis,Rheumatoid Arthritis,7/12/2013,
NCT01006980,A Study of Vemurafenib (RO5185426) in Comparison With Dacarbazine in Previously Untreated Patients With Metastatic Melanoma (BRIM 3),Malignant Melanoma,11/16/2011,
NCT00988221,A Study of Tocilizumab in Patients With Active Polyarticular Juvenile Idiopathic Arthritis,Juvenile Idiopathic Arthritis,11/1/2012,
NCT00943826,A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma,Glioblastoma,5/20/2013,
NCT00891020,A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs),Rheumatoid Arthritis,4/17/2012,
NCT00829166,A Study of Trastuzumab Emtansine Versus Capecitabine + Lapatinib in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer,Breast Cancer,4/23/2013,
NCT00810199,A Study of Tocilizumab and Methotrexate Treatment Strategies (Adding Tocilizumab to Methotrexate Versus Switching to Tocilizumab) in Patients With Active Rheumatoid Arthritis With Inadequate Response to Prior Methotrexate Treatment,Rheumatoid Arthritis,7/18/2014,
NCT00800735,A Study of PEGASYS (Pegylated-interferon Alfa-2a) With or Without Ribavirin in Patients With Chronic Hepatitis C Who Have Participated in Previous Roche or Roche Partner Protocols,"Hepatitis C, Chronic",9/13/2013,
NCT00720798,An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core Studies,Rheumatoid Arthritis,9/30/2014,
NCT00642460,A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA),Juvenile Idiopathic Arthritis,10/26/2011,
NCT00623428,A Study of Combination Therapy With PEGASYS (Pegylated Interferon Alfa-2a (40KD)) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 2 or 3 Who Do Not Achieve a Rapid Viral Response,"Hepatitis C, Chronic",6/24/2013,
NCT00545532,A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.,"Influenza, Human",7/12/2018,
NCT00535782,A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis,Rheumatoid Arthritis,11/14/2012,
NCT00531817,A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis,Rheumatoid Arthritis,8/4/2010,
NCT00528567,BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer,Breast Cancer,9/10/2013,
NCT00442702,"A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.",Anemia,10/3/2011,
NCT00294515,IMPACT Study: A Study of Valcyte (Valganciclovir) for Prevention of Cytomegalovirus Disease (CMV) in Kidney Allograft Recipients,Cytomegalovirus Infections,7/5/2010,
NCT00106535,A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis (RA),Rheumatoid Arthritis,6/7/2011,
NCT00105079,GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection,HIV Infections,11/2/2011,
NCT00090753,"A Study of Intravenous or Subcutaneous Methoxy Polyethylene Glycol-Epoetin Beta (RO0503821, Mircera) in Chronic Kidney Disease Patients With Renal Anemia",Anemia,1/5/2012,
NCT00009737,A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer,Colorectal Cancer,6/22/2016,
NCT00077623,A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.,Anemia,4/26/2016,
NCT00077610,A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients,Anemia,2/29/2016,
NCT00069121,A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer,Colorectal Cancer,7/29/2011,
NCT00069095,A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer,Colorectal Cancer,1/22/2016,
NCT00069108,A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer,Colorectal Cancer,2/24/2016,
NCT00048074,DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis,Post Menopausal Osteoporosis,2/3/2016,
NCT00048061,MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis,Post Menopausal Osteoporosis,5/30/2016,
NCT00090766,A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients,Cytomegalovirus Infections,10/31/2016,
NCT00483938,The Individualized Management With Pegylated-interferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Offering Viral Eradication: A Study of Pegylated-interferon Alfa-2a Plus Ribavirin in Participants With Chronic Hepatitis C (CHC) Non-genotype 2/3 (IMPROVE),"Hepatitis C, Chronic",1/23/2017,
NCT00006164,Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment,"Chronic Hepatitis c|Cirrhosis, Liver|Fibrosis, Liver|Hepatic Cirrhosis",9/4/2009,
NCT00572572,Aprepitant + a 5HT3 + Dexamethasone in Patients With Germ Cell Tumors,Germ Cell Tumors,4/6/2016,
NCT00216125,Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,2/8/2016,
NCT00613106,Double-Blind Follow-on Safety Study of HZT-501 (Ibuprofen 800 mg/Famotidine 26.6 mg) in Subjects Who Have Completed Participation in HZ-CA-301 (NCT00450658) or HZ-CA-303 (NCT00450216),Osteoarthritis|Rheumatoid Arthritis|Chronic Low Back Pain|Chronic Regional Pain Syndrome|Chronic Soft Tissue Pain,6/17/2011,
NCT00984815,Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment,Osteoarthritis|Rheumatoid Arthritis|Chronic Low Back Pain|Chronic Regional Pain Syndrome|Chronic Soft Tissue Pain,7/25/2013,
NCT01347073,"Study of the Safety, Pharmacokinetics and Efficacy of HPN-100, in Pediatric Subjects With Urea Cycle Disorders (UCDs)",Urea Cycle Disorders,5/28/2015,
NCT00992459,Efficacy and Safety of HPN-100 for the Treatment of Adults With Urea Cycle Disorders,Urea Cycle Disorders,8/12/2013,
NCT00947297,Study of the Safety of HPN (Hyperion)-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD),Urea Cycle Disorders,8/15/2013,
NCT00650078,Study to Assess the Safety and Efficacy of Modified-Release Prednisone (Lodotra®) Therapy in Patients With Active Rheumatoid Arthritis,Rheumatoid Arthritis,12/13/2012,
NCT01744782,Safety/Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cysteamine Treatment Naive Patients With Cystinosis,Cystinosis,1/16/2018,
NCT01733316,"Open-Label, Safety and Superior Effectiveness Study of Cysteamine Bitartrate Delayed-Release Capsules (RP103) in Cystinosis",Cystinosis,5/24/2017,
NCT01197378,Long-Term Safety Follow-up Study of Cysteamine Bitartrate Delayed-release Capsules (RP103),Cystinosis,7/24/2018,
NCT01000961,Phase 3 Study of Cysteamine Bitartrate Delayed-release (RP103) Compared to Cystagon® in Patients With Cystinosis,Cystinosis,11/19/2014,
NCT01528891,Dexmedetomidine as a Rapid Bolus in Children for Emergence Agitation,Tonsillectomy,11/25/2015,PFE
NCT01508455,"Open-Label, Safety, and Efficacy Study of Dexmedetomidine in Preterm Subjects Ages ≥28 Weeks to <36 Weeks Gestational Age",Anesthesia,12/11/2013,PFE
NCT02504294,A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis,Chronic Kidney Disease (CKD),6/13/2018,PFE
NCT01473420,A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin,Chronic Renal Failure|Chronic Kidney Disease,6/20/2018,PFE
NCT01473407,A Phase 3 Study Comparing the Effects of Intravenous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin,Chronic Kidney Disease|Chronic Renal Failure,7/13/2018,PFE
NCT00875550,Study Evaluating Safety and Efficacy of Dexmedetomidine (DEX) in Intubated and Mechanically Ventilated Pediatric Intensive Care Unit (PICU) Subjects,Sedation,10/30/2014,PFE
NCT01159262,"Safety, Efficacy and Pharmacokinetic Study of Dexmedetomidine in Pediatrics Ages ≥28 Weeks to ≤44 Weeks Gestational Age",Sedation,12/12/2014,PFE
NCT01158378,Safety and Effectiveness of the Adherus Dural Sealant System When Used as a Dural Sealant in Cranial Procedures,Elective Cranial Procedures With Dural Incision,4/8/2014,
NCT00828191,Subcutaneous Progesterone Versus Vaginal Progesterone Tablets for Luteal Phase Support in In Vitro Fertilization (IVF),In Vitro Fertilization,12/26/2012,
NCT01259856,Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET),High Risk Polycythemia Vera|High Risk Essential Thrombocythemia,7/24/2018,
NCT02006888,The Efficacy and Safety of IBI-10090 for the Treatment of Inflammation Associated With Cataract Surgery,Inflammation|Cataracts,4/23/2018,
NCT02547623,Study to Evaluate the Safety for the Treatment of Inflammation Associated With Cataract Surgery,Cataract,6/19/2018,
NCT01128959,Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy,Epilepsy,12/5/2016,
NCT02497976,Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial Cystitis,"Cystitis, Interstitial",3/22/2018,
NCT02504645,"A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus","Lupus Erythematosus, Systemic",4/11/2019,
NCT01411137,Carbidopa-Levodopa (CD-LD) ER Alone or in Combination With CD-LD IR to IPX066 Followed by IPX066 Extension Safety Study,Parkinson's Disease,4/18/2017,
NCT01130493,A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066,Parkinson's Disease,9/13/2017,
NCT01096186,An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease,Parkinson's Disease,3/3/2016,
NCT00974974,A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).,Parkinson's Disease,1/14/2016,
NCT00880620,A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease,Parkinson's Disease,2/22/2016,
NCT02395653,Safety and Clinical Utility Study of SSEC Fentanyl 40 mcg for Acute Post-op Pain Management in Pediatric Participants,"Pain, Postoperative",9/18/2017,
NCT01243944,Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: (The RESPONSE Trial),Polycythemia Vera,3/6/2015,INCY
NCT01632904,Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study,Polycythemia Vera,4/7/2015,INCY
NCT00952289,COntrolled MyeloFibrosis Study With ORal JAK Inhibitor Treatment: The COMFORT-I Trial,MPN (Myeloproliferative Neoplasms),1/24/2012,INCY
NCT00549562,Study of Paliperidone ER in Adolescents and Young Adults With Autism,Autism,5/16/2017,
NCT01760473,Reinforcing Effects of Intranasal (IN) Buprenorphine Versus Buprenorphine/Naloxone,Heroin Dependence,9/8/2017,
NCT02896296,Open-Label Treatment Extension Study,Opioid Use Disorder|Opioid-related Disorders,11/2/2018,
NCT02510014,Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder,Opioid Use Disorder|Opioid-related Disorders,3/29/2018,
NCT02357901,Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine,Opioid Dependence|Opioid Related Disorders,2/20/2018,
NCT02203838,Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia,Schizophrenia,9/28/2018,
NCT02109562,"Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients",Schizophrenia,10/26/2018,
NCT00330928,SPECTACL: SPECTroscopic Assessment of Coronary Lipid,"Angina Pectoris|Angina, Unstable|Myocardial Infarction",5/28/2009,
NCT00365989,MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication,Uterine Leiomyoma|Uterine Fibroids,2/5/2019,
NCT01161420,Stimulation Therapy for Apnea Reduction (Www.theSTARtrial.Com),Obstructive Sleep Apnea,12/15/2014,INSP
NCT00657540,Black Widow Spider Antivenin for Patients With Systemic Latrodectism,Latrodectism,9/18/2017,
NCT00956254,Fentanyl Sublingual Spray in Treating Opioid-tolerant Cancer Patients With or Without Oral Mucositis,"Mucositis|Pain|Unspecified Adult Solid Tumor, Protocol Specific",9/5/2013,
NCT00538850,Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain,Cancer,3/5/2014,
NCT02634788,Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain,Pain,8/14/2017,
NCT02318602,Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder,Seizures,7/25/2018,
NCT00538863,Long-term Safety and Efficacy Study of Fentanyl Sublingual Spray for the Treatment of Breakthrough Cancer Pain,Cancer|Pain,10/11/2013,
NCT03439072,G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes,Insulin Hypoglycemia|Type 1 Diabetes Mellitus|Severe Hypoglycemia,5/30/2019,
NCT01473524,Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis,Primary Biliary Cirrhosis,2/13/2017,ICPT
NCT00038467,Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer,Breast Neoplasms,4/10/2014,
NCT02291549,S8 Sinus Implant in Chronic Sinusitis Patients With Recurrent Nasal Polyps,Chronic Sinusitis|Nasal Polyposis,7/9/2018,XENT
NCT01253577,A Clinical Evaluation of a Steroid-Coated Sinus Stent When Used Following Functional Endoscopic Sinus Surgery in Patients With Chronic Sinusitis,Chronic Sinusitis,4/13/2015,XENT
NCT01732536,Steroid-Releasing S8 Sinus Implant for Recurrent Nasal Polyps,Chronic Sinusitis|Nasal Polyps,7/20/2018,XENT
NCT00794664,Safety and Efficacy of Mipomersen in Patients With Severe Hypercholesterolemia on a Maximally Tolerated Lipid-Lowering Regimen and Who Are Not on Apheresis,Hypercholesterolemia|Coronary Heart Disease,3/21/2013,IONS
NCT00770146,Safety and Efficacy of Mipomersen (ISIS 301012) As Add-on Therapy in High Risk Hypercholesterolemic Patients,Hypercholesterolemia|Coronary Heart Disease,3/20/2013,IONS
NCT00706849,Efficacy and Safety Study of ISIS 301012 (Mipomersen) as Add-on in Familial Hypercholesterolemic Patients With Coronary Artery Disease,Heterozygous Familial Hypercholesterolemia|Coronary Artery Disease,3/21/2013,IONS
NCT00694109,An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia,"Lipid Metabolism, Inborn Errors|Hypercholesterolemia, Autosomal Dominant|Hyperlipidemias|Metabolic Diseases|Hyperlipoproteinemia Type II|Metabolism, Inborn Errors|Genetic Diseases, Inborn|Infant, Newborn, Diseases|Metabolic Disorder|Congenital Abnormalities|Hypercholesterolemia|Hyperlipoproteinemias|Dyslipidemias|Lipid Metabolism Disorders",12/21/2015,IONS
NCT00607373,Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia,"Lipid Metabolism, Inborn Errors|Hypercholesterolemia, Autosomal Dominant|Hyperlipidemias|Metabolic Diseases|Hyperlipoproteinemia Type II|Metabolism, Inborn Errors|Genetic Diseases, Inborn|Infant, Newborn, Diseases|Metabolic Disorder|Congenital Abnormalities|Hypercholesterolemia|Hyperlipoproteinemias|Dyslipidemias|Lipid Metabolism Disorders",3/21/2013,IONS
NCT01737398,Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy,FAP|Familial Amyloid Polyneuropathy|TTR|Transthyretin|Amyloidosis,1/23/2019,IONS
NCT00125164,Prepubertal Children With Growth Failure Associated With Primary Insulin-Like Growth Factor-1 (IGF-1) Deficiency,Growth Disorders|Insulin-Like Growth Factor-1 Deficiency,4/30/2010,
NCT00125190,Recombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Short Stature Associated With IGF-1 Deficiency,Insulin-Like Growth Factor-1 Deficiency|Growth Disorders,4/15/2010,
NCT01753336,Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia,Cervical Dystonia,5/4/2017,
NCT01753310,Efficacy and Safety of DYSPORT® Using 2mL Dilution in Adults With Cervical Dystonia.,Cervical Dystonia,3/16/2017,
NCT01313299,Dysport® Adult Upper Limb Spasticity,Nervous System Disorders,10/23/2015,
NCT01313312,Dysport® Adult Upper Limb Spasticity Extension Study,Nervous System Disorders,6/7/2017,
NCT01251367,Dysport® Adult Lower Limb Spasticity Follow-on Study,Post-stroke Spasticity|Spasticity Post-Traumatic Brain Injury,11/9/2017,
NCT01249404,Dysport® Adult Lower Limb Spasticity Study,Leg Spasticity,10/17/2017,
NCT01251380,Dysport® Pediatric Lower Limb Spasticity Follow-on Study,Cerebral Palsy|Muscle Spasticity|Children,6/1/2017,
NCT01249417,Dysport® Pediatric Lower Limb Spasticity Study,Cerebral Palsy|Muscle Spasticity|Children,2/3/2017,
NCT00774930,An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome,Carcinoid Syndrome,2/9/2016,
NCT00447499,Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel,Acromegaly,12/20/2010,
NCT00353496,Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours,Endocrine Tumors,2/18/2015,
NCT00288509,Open-label Extension Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia,Cervical Dystonia,4/2/2010,
NCT00257660,"Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia",Cervical Dystonia,5/10/2010,
NCT00842348,Study of Lanreotide Autogel 120 mg in Patients With Non-functioning Entero- Pancreatic Endocrine Tumour,Non Functioning Entero-pancreatic Endocrine Tumour,2/17/2017,
NCT01626118,Study of Indomethacin Capsules to Treat Pain Following Bunionectomy,Other Acute Postoperative Pain,3/17/2014,
NCT01543685,Study of Indomethacin Capsules to Treat Pain Following Bunionectomy,Other Acute Postoperative Pain,12/19/2013,
NCT01462435,Study of Diclofenac Capsules to Treat Pain Following Bunionectomy,Other Acute Postoperative Pain,12/19/2013,
NCT01801735,Study of Meloxicam Capsules in Subjects With Osteoarthritis of the Knee or Hip,Osteoarthritis,5/12/2015,
NCT01787188,Study of Meloxicam Capsules to Treat Osteoarthritis Pain,Osteoarthritis,3/11/2015,
NCT01510912,Open-Label Study of Diclofenac Capsules to Treat Osteoarthritis Pain,Osteoarthritis,5/9/2014,
NCT01461369,Study of Diclofenac Capsules to Treat Osteoarthritis Pain,Osteoarthritis,5/26/2014,
NCT01004432,Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA),"Arthritis|Arthritis, Rheumatoid|Autoimmune Diseases",5/13/2014,JNJ
NCT01550744,"A Study of Ustekinumab to Evaluate a ""Subject-tailored"" Maintenance Dosing Approach in Subjects With Moderate-to-Severe Plaque Psoriasis",Psoriasis,11/7/2016,JNJ
NCT01241760,VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection,Genotype 1 Chronic Hepatitis C|Treatment Naive,6/4/2014,JNJ
NCT01054573,VX-950-TiDP24-C219: A Roll Over Trial for Patients in the Control Group of the C216 Study Who Received Telaprevir Placebo,"Hepatitis C, Chronic",4/19/2013,JNJ
NCT02114177,Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Chronic Hepatitis C Virus Infection Without Cirrhosis,Hepatitis C Virus Infection,4/12/2016,JNJ
NCT02114151,Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Genotype 1 Chronic Hepatitis C Virus Infection and Cirrhosis,Hepatitis C Virus Infection,4/4/2016,JNJ
NCT00177164,Risperdal Consta for Bipolar Disorder,Bipolar I Disorder,2/8/2016,JNJ
NCT01485991,"TMC435HPC3001 - An Efficacy, Safety and Tolerability Study for TMC435 vs Telaprevir in Combination With PegINFα-2a and Ribavirin in Chronic Hepatitis C Patients Who Were Null or Partial Responders to Prior PegINFα-2a and Ribavirin Therapy",Hepatitis C,4/10/2015,JNJ
NCT01479868,"A Study to Assess the Safety, Tolerability and Efficacy of TMC435 Along With Pegylated Interferon Alpha-2a (Pegasys) and Ribavirin (Copegus) Triple Therapy in Chronic Hepatitis C Genotype-1 Infected Patients Co-infected With Human Immunodeficiency Virus-Type 1",Hepatitis C Virus Genotype-1,10/29/2014,JNJ
NCT01349465,3-year Follow-up Study in Patients Previously Treated With TMC435-Containing Regimen for the Treatment of Hepatitis C Virus Infection,Hepatitis C,2/16/2017,JNJ
NCT01289782,"An Efficacy, Safety, and Tolerability Study of TMC435 in Treatment-naive, Genotype 1 Hepatitis C-infected Patients",Hepatitis C,6/4/2014,JNJ
NCT01290679,"An Efficacy, Safety, and Tolerability Study of TMC435 in Treatment-naive, Genotype 1 Hepatitis C-infected Participants",Hepatitis C,6/13/2014,JNJ
NCT01281839,"An Efficacy, Safety and Tolerability Study of TMC435 in Genotype 1 Hepatitis C-infected Patients Who Relapsed After Previous Therapy",Hepatitis C,4/23/2014,JNJ
NCT01846611,"A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer",Ovarian Neoplasms|Peritoneal Neoplasms|Fallopian Tube Neoplasms,2/6/2019,JNJ
NCT01722487,Open-label Phase 3 BTK Inhibitor Ibrutinib vs Chlorambucil Patients 65 Years or Older With Treatment-naive CLL or SLL,Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma,5/4/2016,JNJ
NCT01578707,A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia,Relapsed or Refractory Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma,10/12/2015,JNJ
NCT01343277,A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma,Advanced Liposarcoma or Leiomyosarcoma,1/28/2016,JNJ
NCT00488631,An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis,"Colitis, Ulcerative",11/11/2013,JNJ
NCT02905331,Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis,Psoriasis,9/6/2018,JNJ
NCT02497287,"A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression",Treatment-resistant Depression,4/29/2019,JNJ
NCT02493868,A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression,"Depressive Disorder, Treatment-Resistant",5/21/2019,JNJ
NCT02422186,"A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant Depression","Depressive Disorder, Treatment-Resistant",4/24/2019,JNJ
NCT02417064,"A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression",Treatment-resistant Depression,4/18/2019,JNJ
NCT02418585,"A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression",Treatment-resistant Depression,4/19/2019,JNJ
NCT02203032,A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab,Psoriasis,7/17/2017,JNJ
NCT02186873,A Study of Golimumab in Participants With Active Ankylosing Spondylitis,Ankylosing Spondylitis,11/13/2017,JNJ
NCT02181673,A Study of Golimumab in Participants With Active Psoriatic Arthritis,"Arthritis, Psoriatic",12/21/2017,JNJ
NCT01809327,"A Study to Evaluate the Effectiveness, Safety, and Tolerability of Canagliflozin in Combination With Metformin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control With Diet and Exercise","Diabetes Mellitus, Type 2",1/6/2016,JNJ
NCT01529515,A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia,Schizophrenia,6/18/2015,JNJ
NCT01515423,Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Patients With Schizophrenia,Schizophrenia,5/2/2016,JNJ
NCT01369342,A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2),Crohn's Disease|Inflammatory Bowel Disease|IBD|Colitis,1/6/2017,JNJ
NCT01369329,A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1),Crohn's Disease|IBD|Colitis|Inflammatory Bowel Disease,12/7/2016,JNJ
NCT01137812,The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial),"Diabetes Mellitus, Type 2",5/17/2013,JNJ
NCT01106690,The CANTATA-MP Trial (CANagliflozin Treatment and Trial Analysis - Metformin and Pioglitazone),"Diabetes Mellitus, Type 2",5/21/2013,JNJ
NCT01106677,The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial),"Diabetes Mellitus, Type 2",7/30/2013,JNJ
NCT01106651,A Safety and Efficacy Study of Canagliflozin in Older Patients (55 to 80 Years of Age) With Type 2 Diabetes Mellitus,"Diabetes Mellitus, Type 2",5/29/2013,JNJ
NCT01106625,The CANTATA-MSU Trial (CANagliflozin Treatment And Trial Analysis - Metformin and SUlphonylurea),"Diabetes Mellitus, Type 2",5/29/2013,JNJ
NCT01081834,The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial,"Diabetes Mellitus, Type 2",6/3/2013,JNJ
NCT01077362,A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents,"Arthritis, Psoriatic",2/27/2014,JNJ
NCT01064414,"An Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment","Diabetes Mellitus, Type 2|Renal Insufficiency",5/27/2013,JNJ
NCT01032629,CANVAS - CANagliflozin cardioVascular Assessment Study,"Diabetes Mellitus, Type 2|Cardiovascular Diseases|Risk Factors",12/7/2018,JNJ
NCT01009086,A Study of the Safety and Effectiveness of Ustekinumab in Patients With Psoriatic Arthritis,"Arthritis, Psoriatic",3/13/2014,JNJ
NCT00968812,CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride,"Diabetes Mellitus, Type 2",6/4/2013,JNJ
NCT00887198,Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer,Prostate Cancer,4/9/2015,JNJ
NCT01009047,An Efficacy and Safety Study of Extended-Release (ER) Paliperidone in Adolescent Participants With Schizophrenia,Schizophrenia,6/21/2013,JNJ
NCT00488319,Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.,Schizophrenia|Schizophrenic Disorders|Psychotic Disorders|Dementia Praecox,1/6/2014,JNJ
NCT00338286,A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy,Breast Cancer|Neoplasm Metastasis,3/24/2016,JNJ
NCT00103506,Study of DOXIL/CAELYX (Pegylated Liposomal Doxorubicin) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma,Multiple Myeloma,5/25/2015,JNJ
NCT00487539,An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis,"Colitis, Ulcerative",2/17/2014,JNJ
NCT02472145,An Efficacy and Safety Study of Decitabine (DACOGEN) Plus Talacotuzumab (JNJ-56022473; Anti CD123) Versus Decitabine (DACOGEN) Alone in Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy,"Leukemia, Myeloid, Acute",2/28/2019,JNJ
NCT01193153,A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder,Schizoaffective Disorder,1/5/2015,JNJ
NCT00855335,"A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant Women",HIV|HIV Infections|Pregnancy,9/15/2017,JNJ
NCT00584701,Pharmacogenomics in Autism Treatment,Autism,7/24/2012,JNJ
NCT00412373,Evaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in Patients With Schizoaffective Disorder.,Schizoaffective Disorder|Psychotic Disorder,12/9/2009,JNJ
NCT00257010,A 1-year Study in Adolescents to Assess the Long-term Safety of Almotriptan Malate When Treating Their Migraine Headaches,Migraine,12/6/2013,JNJ
NCT02348632,"""A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA""",Narcolepsy|Obstructive Sleep Apnea,6/25/2019,JAZZ
NCT02348606,"""Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA""",Obstructive Sleep Apnea,7/23/2019,JAZZ
NCT02348593,"""Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy""",Narcolepsy,7/23/2019,JAZZ
NCT02221869,A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy,Narcolepsy With Cataplexy,4/30/2019,JAZZ
NCT00803023,Safety and Tolerability Study Comparing Sodium Oxybate Given as an Oral Solution to a Single-blinded Combination of Oral Tablets Plus Oral Solution in Subjects With Fibromyalgia,Fibromyalgia,8/16/2011,JAZZ
NCT00628498,Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study,Hepatic Veno-Occlusive Disease,11/30/2017,JAZZ
NCT00423813,A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.,Fibromyalgia,1/10/2012,JAZZ
NCT00423605,Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia.,Fibromyalgia,10/20/2011,JAZZ
NCT00371137,A Safety and Efficacy Study of Xyrem® in Subjects With Fibromyalgia,Fibromyalgia,11/30/2011,JAZZ
NCT00097708,Experimental Medication For the Treatment of Generalized Anxiety Disorder,Anxiety Disorder,10/3/2014,JAZZ
NCT00066170,Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy,Narcolepsy,11/30/2011,JAZZ
NCT02579057,Sub-Q Versus IV Furosemide in Acute Heart Failure,Congestive Heart Failure,11/17/2017,
NCT00549393,Study of Bathing With Chlorhexidine Impregnated Cloths on Nosocomial Infections in the Pediatric Intensive Care Unit,Nosocomial Infections,10/2/2015,
NCT03198000,A Study to Evaluate the Efficacy of Investigational OTC Eye Drops,Ophthalmic Solutions,8/8/2018,JNJ
NCT01115673,To Evaluate the Safety and Efficacy of Acetaminophen 650 mg and 1000mg in Dental Pain After Surgery,Pain,5/28/2012,JNJ
NCT02120833,A Test to Determine the Usefulness and Safety of a Cream Used on Babies With Dry Itchy Skin,Eczema,9/7/2015,JNJ
NCT01226459,Clinical Trial in Females for Female Pattern Hair Loss,Androgenetic Alopecia,6/3/2014,JNJ
NCT01145625,Clinical Trial in Females With Female Pattern Hair Loss,Alopecia,4/25/2014,JNJ
NCT00722137,"Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma",Mantle Cell Lymphoma,11/17/2014,JNJ
NCT00796120,An Efficacy and Safety Study of Trabectedin Versus Doxorubicin-Based Chemotherapy in Participants With Translocation-Related Sarcomas (TRS),Sarcoma,9/16/2014,JNJ
NCT00402688,An Effectiveness and Safety Study for Levofloxacin in Chronic Prostatitis,Prostatitis,7/16/2009,JNJ
NCT00312845,Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma,Non-Hodgkin's Lymphoma,7/26/2011,JNJ
NCT00113607,An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer,Ovarian Cancer,8/23/2013,JNJ
NCT00097981,A Study of Thalidomide Plus Dexamethasone (Thal-Dex) Versus DOXIL plusThalidomide Plus Dexamethasone (DOXIL -Thal-Dex) in Patients With Newly Diagnosed Multiple Myeloma,Multiple Myeloma,11/27/2008,JNJ
NCT01063855,Concomitant Use of PriLigy in Men Treated for Erectile Dysfunction,Erectile Dysfunction|Sexual Dysfunction,11/5/2012,JNJ
NCT00662675,A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency,Exocrine Pancreatic Insufficiency|Steatorrhea|Malabsorption Syndromes|Cystic Fibrosis,3/17/2010,JNJ
NCT00590577,"Effectiveness and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Patients With Schizophrenia",Schizophrenia,10/5/2009,JNJ
NCT00589914,Comparison of Paliperidone Palmitate and RISPERDAL CONSTA in Patients With Schizophrenia,Schizophrenia,10/4/2011,JNJ
NCT00518323,"A Double-blind, Placebo-controlled Study of the Safety and Efficacy of Paliperidone Extended Release (ER) in the Treatment of Schizophrenia in Adolescent Patients",Schizophrenia,6/9/2010,JNJ
NCT00490971,A Study to Evaluate the Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Delaying the Recurrence of Symptoms in Bipolar I Disorder,Bipolar Disorder,3/5/2012,JNJ
NCT00440557,An Efficacy and Safety Study of Epoetin Alfa for Initiation and Maintenance Treatment of Patients With Anemia Associated With Chronic Kidney Disease,Anemia,2/8/2010,JNJ
NCT00440466,PROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD Patients,Anemia|Renal Diseases,4/14/2011,JNJ
NCT00132678,A Study of the Safety and Efficacy of Injectable Risperidone in the Prevention of Bipolar Mood Episodes,Bipolar Disorder,2/27/2009,JNJ
NCT00091442,A Study of Docetaxel Monotherapy or DOXIL and Docetaxel in Patients With Advanced Breast Cancer,Breast Cancer,10/2/2012,JNJ
NCT03475875,Contact Lenses With New UV-blocker Manufactured With Different Techniques,Correction of Refraction Error|Attenuation of Bright Light,6/4/2019,JNJ
NCT00529243,Evaluating the Effect of CHanging EnfuvirtidE to Raltegravir in HIV Infected Subjects,HIV Infections,6/8/2011,
NCT02793817,Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation and Pain,Post Surgical Ocular Inflammation and Pain,4/17/2019,KALA
NCT01722266,Liraglutide in the Treatment of Type 1 Diabetes Mellitus,Type 1 Diabetes,3/13/2015,
NCT02560584,A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting,Bladder Cancer,7/2/2018,
NCT01475825,A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol,Hypercholesterolemia|Heterozygous Familial,3/14/2019,
NCT02268994,KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD,Anemia of Chronic Kidney Disease,2/21/2018,
NCT01554982,A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis,End Stage Renal Disease|Kidney Failure|Renal Failure|Hyperphosphatemia|ESRD,7/13/2016,
NCT01191255,A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis,Hyperphosphatemia|Kidney Failure,12/10/2014,
NCT00266864,Testosterone Replacement Therapy in Chronic Spinal Cord Injury,Spinal Cord Injury|Hypogonadism,4/7/2014,
NCT01738984,A Home Exercise Program for Women With Infants & Young Children,MomZing Exercise Videos Online|Standard Exercise DVD,4/12/2016,
NCT00501046,A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2),Chronic Kidney Disease,3/2/2015,
NCT00500682,A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1),Chronic Kidney Disease,3/2/2015,
NCT02537431,Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH),X-linked Hypophosphatemia,9/25/2018,
NCT02007434,Patient Experience Study of Deoxycholic Acid Injection,Moderate or Severe Submental Fullness,7/3/2015,
NCT01546142,Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area,Moderate or Severe Submental Fullness,6/15/2015,
NCT01542034,Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area,Moderate or Severe Submental Fullness,6/15/2015,
NCT01426373,Open-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area,Moderate or Severe Submental Fullness,1/14/2016,
NCT02338843,A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension,Catecholamine-resistant Hypotension (CRH)|Distributive Shock|High Output Shock|Sepsis,1/17/2018,LJPC
NCT00775203,"A Randomized, Double-blind, Two-arm Study Comparing the Efficacy and Safety of Trazodone Contramid® OAD and Placebo in the Treatment of Unipolar Major Depressive Disorder.",Major Depressive Disorder,4/7/2010,
NCT02020369,Phase III Study of Coagulation FVIIa (Recombinant) in Congenital Hemophilia A or B Patients With Inhibitors,Hemophilia A With Inhibitors|Hemophilia B With Inhibitors,6/14/2017,
NCT03108482,Co-crystal E-58425 vs Tramadol and Celecoxib for Moderate to Severe Acute Pain After Bunionectomy. Phase III Clinical Trial.,Acute Post-surgical Pain,1/9/2019,
NCT02500836,"Topical Application of Cocaine HCl 4%, or 10%, or Placebo Solution in Local (Topical) Anesthesia",Any Ear Nose or Throat Conditions|With Identified Need for a Diagnostic Procedure or Surgery on or Through the Mucous Membranes of the Nasal Cavities,5/16/2017,LCI
NCT01347710,A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.,Coronary Artery Disease,4/5/2016,LNTH
NCT00162032,A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease,Kawasaki Disease,12/6/2013,LNTH
NCT02549339,Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest including12-month Follow-up,Actinic Keratosis,11/14/2018,
NCT02547363,Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up,Actinic Keratosis,12/25/2018,
NCT02547233,Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest Including 12-month Follow-up,Actinic Keratosis,12/25/2018,
NCT02361216,"Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Chest",Actinic Keratosis,10/3/2018,
NCT01866163,LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris,Psoriasis Vulgaris|Plaque Psoriasis,5/9/2016,
NCT01541553,A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp,Actinic Keratosis,3/28/2014,
NCT01188928,LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs),Psoriasis Vulgaris,4/9/2013,
NCT02063659,Telotristat Etiprate for Carcinoid Syndrome Therapy,Carcinoid Syndrome,9/25/2017,LXRX
NCT01677910,TELESTAR (Telotristat Etiprate for Somatostatin Analogue Not Adequately Controlled Carcinoid Syndrome),Carcinoid Syndrome,9/18/2017,LXRX
NCT01020838,Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to Histopathology,Alzheimer Disease,3/25/2015,
NCT01389102,Estradiol Transdermal Spray in the Treatment of Vasomotor Symptoms,Hot Flashes,6/11/2012,
NCT00518713,Clobazam in Patients With Lennox-Gastaut Syndrome,"Epilepsy|Epilepsy, Generalized|Seizures",2/9/2012,
NCT00904995,Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis,Leukemia|Fungal Infection,5/12/2011,
NCT00824993,Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients,Hematological Malignancies,5/11/2018,
NCT00352846,Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss,Non-Hodgkin's Lymphoma|Lymphoma,6/20/2013,
NCT00608959,Study of Antimicrobial Activity of Omiganan 1% Gel vs. Chlorhexidine 2% for Topical Skin Antisepsis in Healthy Adult Subjects,Infection,1/25/2010,MNK
NCT00564629,Study of the Efficacy and Safety of Intravenous vs Oral Acetaminophen for Treatment of Fever in Healthy Adult Males,Fever,9/21/2010,MNK
NCT00493311,Safety of Intravenous Acetaminophen Vs Placebo for the Treatment of Endotoxin-Induced Fever in Healthy Adult Males,Fever,9/21/2010,MNK
NCT02282930,Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of Progression,Progressive IgA Nephropathy|Proteinuria,6/26/2019,MNK
NCT00582010,Study to Evaluate if Inhaled Nitric Oxide Improves Liver Function After Transplantation,Reperfusion Injury|Liver Injury,11/6/2014,MNK
NCT01484652,Safety and Efficacy of COV795 in Moderate to Severe Post-Operative Bunionectomy Pain With an Open-label Extension,"Pain, Postoperative|Bunion",7/2/2014,MNK
NCT00931632,Inhaled Nitric Oxide (INO) for the Prevention of Bronchopulmonary Dysplasia (BPD) in Preterm Infants,Bronchopulmonary Dysplasia,8/11/2015,MNK
NCT00598702,Study of the Safety & Efficacy of Intravenous Acetaminophen in Pediatric Inpatients,Pain|Fever,1/6/2011,MNK
NCT00598559,Safety and Efficacy of Intravenous Acetaminophen (IV APAP) in Adult Inpatients,Acute Pain|Fever,12/10/2010,MNK
NCT00626028,Comparison of Inhaled Nitric Oxide and Oxygen in Patient Reactivity During Acute Pulmonary Vasodilator Testing,Idiopathic Pulmonary Arterial Hypertension|Congenital Heart Disease With Pulmonary Hypertension|Cardiomyopathy,9/16/2010,MNK
NCT00564486,Analgesic Efficacy & Safety of Intravenous (IV) Acetaminophen Versus Placebo for the Treatment of Postop Pain,Pain,11/30/2010,MNK
NCT00399568,Efficacy and Safety of Intravenous Acetaminophen Over 48 Hrs for the Treatment of Post-op Pain After Gynecologic Surgery,Postoperative Pain|Hysterectomy,12/10/2010,MNK
NCT00231153,Study of Omiganan 1% Gel in Preventing Catheter Infections/Colonization in Patients With Central Venous Catheters,Infection,8/13/2009,MNK
NCT00569530,Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide,Respiratory Distress Syndrome of Prematurity (Surfactant Dysfunction)|Bronchopulmonary Dysplasia,6/28/2016,MNK
NCT01451398,Comparison of Technosphere® Insulin Versus Technosphere Powder (Placebo) in Insulin-Naive Subjects With Type 2 Diabetes Mellitus,Type 2 Diabetes,10/17/2014,MNKD
NCT01445951,Clinical Trial Evaluating Technosphere® Insulin Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Over a 24-week Treatment Period,Type 1 Diabetes Mellitus,10/22/2014,MNKD
NCT00332488,Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes,"Diabetes Mellitus, Type 2",10/16/2014,MNKD
NCT00309244,Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up,Diabetes Type 2,10/16/2014,MNKD
NCT00308737,Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes,"Diabetes, Type 1|Diabetes, Type 2",10/16/2014,MNKD
NCT00308308,Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes,"Diabetes, Type I",10/16/2014,MNKD
NCT00694122,Comparison of Lantus and Neutral Protamine Hagedorn (NPH) Insulin in the Dawn Phenomenon,Type 1 Diabetes|Dawn Phenomenon,10/21/2014,
NCT00566735,The Use of Galantamine HBr (Reminyl) in Electroconvulsive Therapy: Impact on Mood and Cognitive Functioning,Major Depression|Bipolar Depression|Schizoaffective Disorder,12/3/2012,
NCT01853280,L-methylfolate Supplementation to OROS-Methylphenidate Pharmacotherapy in ADHD Adults,Attention Deficit Hyperactivity Disorder,11/14/2017,
NCT00823901,Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea,Rosacea,6/15/2012,
NCT02020031,Regional Prophylactic Vancomycin in Revision Total Knee Replacement,Arthropathy of Knee Joint,11/25/2016,
NCT00722124,S-Adenosyl-L-Methionine (SAMe) for Smoking Abstinence,Tobacco Dependence,9/9/2011,
NCT00426153,Octreotide in Severe Polycystic Liver Disease,"Polycystic Kidney, Autosomal Dominant|Polycystic Liver Disease|Hepatomegaly|Liver Diseases|Kidney, Polycystic|Abdominal Pain",11/21/2012,
NCT00120523,5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis,Atopic Dermatitis,1/16/2013,
NCT00783432,Study to Evaluate the Safety and Tolerability of a Nasal Spray in Patients With Chronic Allergic or Nonallergic Rhinitis,Chronic Allergic Rhinitis|Nonallergic Rhinitis,10/2/2009,
NCT01574612,Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old,Herpes Labialis,5/22/2014,
NCT00660829,A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies,Seasonal Allergic Rhinitis,1/28/2010,
NCT01915823,Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR),Seasonal Allergic Rhinitis,6/29/2015,
NCT01794741,3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis,Allergic Rhinitis,3/31/2015,
NCT01018862,A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis,Perennial Allergic Rhinitis,6/11/2012,
NCT00883168,A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies,Seasonal Allergic Rhinitis,9/7/2012,
NCT00740792,A Study Evaluating the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies,Seasonal Allergic Rhinitis,9/7/2012,
NCT00824473,A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies,Seasonal Allergic Rhinitis,1/28/2010,
NCT00720382,A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis,Perennial Allergic Rhinitis,1/15/2010,
NCT00720278,A Study to Evaluate the Safety and Efficacy of Two Nasal Sprays to Treat Seasonal Allergies,Seasonal Allergic Rhinitis,10/27/2009,
NCT00719862,A Study to Evaluate the Safety & Effectiveness of a Nasal Spray to Treat Seasonal Allergies,Seasonal Allergic Rhinitis,1/28/2010,
NCT00712920,A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergies,Perennial Allergic Rhinitis,1/15/2010,
NCT00671879,Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back,Lower Back Pain,11/21/2012,
NCT00671502,A Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back,Lower Back Pain,11/9/2011,
NCT00651118,A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies,Seasonal Allergic Rhinitis,9/26/2012,
NCT00660517,A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies,Seasonal Allergic Rhinitis,7/23/2012,
NCT01829711,Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia,"Leukemia, Hairy Cell",8/27/2018,
NCT01091246,A Study to Evaluate the Immunogenicity of Quadrivalent Live Attenuated Influenza Vaccine (LAIV) in Children,Healthy or Stable Chronic Illness,9/22/2011,
NCT00952705,A Study to Evaluate the Immunogenicity of Quadrivalent LAIV (MEDI8662) in Adults 18 to 49 Years of Age,Healthy or Stable Underlying Chronic Medical Condition,1/13/2012,
NCT00129766,Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children,Respiratory Syncytial Virus Infections,8/28/2013,
NCT00860067,A Study to Evaluate the Immunogenicity of Quadrivalent LAIV in Adults 18 to 49 Years of Age,Healthy or Stable Underlying Chronic Medical Condition,8/12/2011,
NCT00838110,A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease,Alzheimer's Disease,2/8/2013,
NCT02224625,Irritation and Sensitization of Chlorhexidine Gluconate (CHG) Cloth,Surgery,5/30/2016,
NCT01119963,"Progesterone (17P, Makena®) for Prolongation of Pregnancy in Women With Preterm Rupture of the Membranes (PROM)",Preterm Delivery,5/30/2018,
NCT00163020,17OHP for Reduction of Neonatal Morbidity Due to Preterm Birth (PTB) in Twin and Triplet Pregnancies,Preterm Birth,11/7/2012,
NCT00563368,A Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-agent Constituents for Treatment of Obesity in Adults,Obesity,9/3/2012,
NCT00554216,Study of VI-0521 Compared to Placebo in Treatment of Obesity in Adults,Obesity,9/6/2012,
NCT00553787,Study of VI-0521 Compared to Placebo in Treatment of Diabetes and Obesity in Adults With Obesity-Related Co-Morbid Conditions,Obesity|Type 2 Diabetes,9/6/2012,
NCT02753946,Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections,Urinary Tract Infection Symptomatic|Acute Pyelonephritis|Urinary Tract Infection Complicated,12/11/2018,
NCT00432835,Temporary Gastric Electrical Stimulation for Drug Refractory Gastroparesis,Gastroparesis,12/3/2012,MDT
NCT01217827,Implantable Cardioverter-Defibrillator Use in the VA System,Cardiomyopathies,12/7/2016,MDT
NCT00523978,A Clinical Study of the Arctic Front Cryoablation Balloon for the Treatment of Paroxysmal Atrial Fibrillation,Paroxysmal Atrial Fibrillation,8/28/2012,MDT
NCT01236365,Statins in Children With Type 1 Diabetes and Hypercholesterolemia,"Diabetes Mellitus, Insulin-Dependent|Hypercholesterolemia",5/21/2015,MDT
NCT01076452,Phase II Subthalamic Nucleus (STN) vs. Globus Pallidus (GPi) Trial,Parkinson's Disease,1/15/2014,MDT
NCT02247765,Controlled Acute Hypoxia Study Comparing Pulse Oximetry to Arterial Blood Samples During Motion,Healthy|Hypoxia,5/5/2017,MDT
NCT01664806,Laparoscopic Cholecystectomy And Capacitive Coupling - Coag Versus Blend Mode Causing Thermal Injury at Port Site Skin,Intraoperative Complications|Thermal Injury|Electrocoagulation,3/1/2013,MDT
NCT01426425,Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia,AtrioVentricular Nodal Reentrant Tachycardia|Supraventricular Tachycardia|Heart Disease,3/31/2017,MDT
NCT00514735,Tailored Treatment of Permanent Atrial Fibrillation,Atrial Fibrillation,5/9/2012,MDT
NCT00506493,Medtronic Concomitant Utilization of Radio Frequency for Atrial Fibrillation CURE-AF/Persistent,Atrial Fibrillation,10/16/2013,MDT
NCT00431834,Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF) Study,Atrial Fibrillation,10/16/2013,MDT
NCT00211536,Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration,Type 1 Diabetes,6/23/2011,MDT
NCT01497938,Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature,Type 1 Diabetes,3/17/2014,MDT
NCT00667459,Study of Safety & Effectiveness of PRESTIGE® LP Cervical Disc vs. Anterior Cervical Fusion in Cervical DDD,Cervical Degenerative Disc Disease,9/22/2014,MDT
NCT00434057,Evaluation of Pigmented Skin Lesions With MelaFind(R) System,Melanoma,11/11/2009,
NCT01984684,Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections,Skin and Subcutaneous Tissue Bacterial Infections|Skin Structures and Soft Tissue Infections,8/28/2017,MLNT
NCT01811732,Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections,Skin and Subcutaneous Tissue Bacterial Infections,8/24/2017,MLNT
NCT00994110,"Placebo Controlled Trial of SOM230 for the Reduction of Post-Pancreatectomy Fistula, Leak, and Abscess",Pancreatic Cancer,2/1/2016,
NCT02107196,12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D),Irritable Bowel Syndrome With Diarrhea,9/27/2016,
NCT01959880,CPG Styles Study: A Study of the Safety of the Contour Profile Gel Breast Implants (CPG Styles Study),Breast Augmentation|Breast Reconstruction|Breast Revision,11/11/2016,
NCT00812097,Mentor Siltex® Contour Profile Gel Mammary Prosthesis Clinical Trial,Breast Augmentation|Breast Reconstruction|Breast Revision,4/5/2016,
NCT00753922,Core Gel Study of the Safety and Effectiveness of Mentor Round Low Bleed Silicone Gel-filled Mammary Prostheses,Breast Reconstruction|Breast Augmentation|Breast Revision,8/23/2013,
NCT01465178,Improving the Understanding of the Response to Vitamin D Supplementation,Vitamin D Deficiency,11/25/2016,
NCT00681590,Safety of Vitamin D Supplementation in Older Persons,Vitamin D Deficiency,3/7/2016,
NCT01089647,Montelukast and Inhaled Nasal Steroid Tx in Adult Obstructive Sleep Apnea (OSA),Obstructive Sleep Apnea,12/3/2018,
NCT00887653,Changes in Lipids and Safety of Raltegravir in HIV+ Patients With Hyperlipidemia While on Current Standard Therapy,HIV|Hyperlipidemia|Hypertriglyceridemia|HIV Infections,10/10/2014,
NCT00142298,Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies,Chronic Hepatitis B,7/25/2011,
NCT00105534,Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003),Bacterial Conjunctivitis,10/27/2011,
NCT00105469,Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004),Bacterial Conjunctivitis,10/27/2011,
NCT01494506,"Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer",Metastatic Pancreatic Cancer,2/12/2016,MACK
NCT00876265,"Multicenter Study of the Safety and Effectiveness of Dermal Filler, Belotero®.",Facial Wrinkles,1/19/2012,
NCT01290341,Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis,Tinea Pedis,9/26/2013,
NCT01289015,Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis,Tinea Pedis,9/26/2013,
NCT00750139,Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Pedis,Tinea Pedis|Athlete's Foot,1/29/2013,
NCT00750152,Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Cruris,Tinea Cruris|Jock Itch,3/13/2012,
NCT00407030,IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Cervical Dystonia,Cervical Dystonia,12/31/2010,
NCT00406367,IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Blepharospasm,Blepharospasm,11/16/2010,
NCT01464307,Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Leg After a Stroke,Post-stroke Spasticity of the Lower Limb,11/7/2016,
NCT01392300,Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke,Post-stroke Spasticity of the Upper Limb,2/11/2016,
NCT01603459,Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm,Spasticity of the Upper and Lower Limb Due to Cerebral Causes,2/3/2017,
NCT00770211,IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines,Moderate to Severe Glabellar Frown Lines,9/13/2011,
NCT00770029,IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines No. 2,Moderate to Severe Glabellar Frown Lines,9/13/2011,
NCT01541254,Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device,Intracranial Aneurysms,9/15/2014,
NCT01578499,A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study),Primary Cutaneous Anaplastic Large Cell Lymphoma|Mycosis Fungoides|Cutaneous T-Cell Lymphoma,3/16/2018,
NCT01482962,Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma,Relapsed Peripheral T-Cell Lymphoma|Refractory Peripheral T-Cell Lymphoma,7/31/2018,
NCT01224171,Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease,Crohn's Disease,7/21/2014,
NCT01193257,Study Comparing Orteronel Plus Prednisone in Participants With Metastatic Castration-Resistant Prostate Cancer.,Prostate Cancer,12/18/2018,
NCT01193244,Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer,Prostate Cancer,5/17/2017,
NCT00783718,Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis,Ulcerative Colitis,7/18/2014,
NCT00783692,Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease,Crohn's Disease,7/21/2014,
NCT00507416,"Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone",Multiple Myeloma,5/1/2014,
NCT00712985,Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL),Breast Cancer,4/24/2014,
NCT01625182,Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.,Chronic Inflammatory Demyelinating Polyradiculoneuropathy,9/19/2017,
NCT00772382,Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia,Chronic Kidney Disease|Dialysis|Hyperphosphatemia,5/12/2014,
NCT00506441,"A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia",Chronic Kidney Disease|Dialysis|Hyperphosphatemia,7/25/2014,
NCT01214811,Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing,Inflammation|Burns|Ulcers,2/26/2013,
NCT02581345,Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis,Chronic Plaque Psoriasis|Psoriasis,9/12/2018,MNTA
NCT02722044,Usability of an AI for M923 in Subjects With Moderate to Severe RA,Rheumatoid Arthritis,5/1/2018,MNTA
NCT02607618,Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-2,Skin Structures and Soft Tissue Infections,7/11/2018,MTFB
NCT02600611,Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1,Skin Structures and Soft Tissue Infections,6/19/2018,MTFB
NCT02195986,A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis,Atrophic Vaginitis,9/6/2017,MYL
NCT01167140,Cryo-Touch II for the Treatment of Wrinkles,Facial Wrinkles,10/1/2012,
NCT00312195,Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Nonmalignant Pain,Chronic Non-malignant Pain,10/15/2010,
NCT00032487,Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT),Type 2 Diabetes Mellitus,2/12/2014,
NCT00844519,Effect of Maraviroc on Endothelial Function in HIV-Infected Patients,HIV Infection|Cardiovascular Disease|Inflammation|HIV Infections,6/19/2014,
NCT00100659,PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C,Chronic Hepatitis C,7/1/2013,
NCT00091949,Insulin Resistance Intervention After Stroke Trial,Stroke|Myocardial Infarction|Diabetes,10/28/2016,
NCT00539305,Hormone and Information Processing Study,Mild Cognitive Impairment|Alzheimer's Disease,7/14/2014,
NCT00253747,Smoking Cessation for Adults With Attention Deficit Hyperactivity Disorder (ADHD),ADHD|Smoking,9/17/2012,
NCT01106040,Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes,Breast Cancer|Melanoma,6/3/2013,NAVB
NCT00671918,Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma,Breast Cancer|Melanoma,6/3/2013,NAVB
NCT01291160,Transdermal Continuous Oxygen Therapy for Diabetic Foot Ulcers,Diabetic Foot Ulcers,5/13/2014,
NCT01835548,NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD),Attention Deficit Hyperactivity Disorder (ADHD),1/17/2018,NEOS
NCT01370733,Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder,Major Depressive Disorder,7/14/2015,
NCT01295710,Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD),GVHD|Adult Acute Myeloid Leukemia|Adult Acute Lymphoid Leukemia|Myelodysplastic Syndrome,3/20/2019,
NCT00105183,EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection,Chronic Obstructive Pulmonary|Idiopathic Pulmonary Fibrosis|Cystic Fibrosis|Bronchiectasis|Pulmonary Vascular Disease,6/8/2012,
NCT02059278,Safety and Efficacy of T-2345 Compared to Xalatan in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension,Primary Open Angle Glaucoma|Ocular Hypertension,8/22/2018,
NCT00449540,Efficacy and Safety of TMS for the Preemptive Treatment of Migraine With Aura,Migraine With Aura,8/10/2011,
NCT01906866,Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities,Sleep Disorders,10/30/2018,
NCT02736955,Rollover Study for Continuing Valbenazine (NBI-98854) Administration for the Treatment of Tardive Dyskinesia,Tardive Dyskinesia,12/19/2018,NBIX
NCT02405091,Safety and Tolerability Study of NBI-98854 for the Treatment of Tardive Dyskinesia,Tardive Dyskinesia,11/30/2018,NBIX
NCT02274558,A Phase 3 Study of NBI-98854 for the Treatment of Tardive Dyskinesia,Tardive Dyskinesia,7/11/2017,NBIX
NCT00264810,RNS® System Pivotal Study,Epilepsy,8/28/2013,
NCT00337285,An Open-label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD),Attention Deficit Hyperactivity Disorder|Attention Deficit Disorders With Hyperactivity|Attention Deficit Hyperactivity Disorders,7/17/2009,
NCT00710385,Abuse Liability of Suboxone Versus Subutex,Opioid-related Disorders,12/5/2016,
NCT00421954,Open-label Ziprasidone Study for Psychosis Treatment in Adolescents,"Schizophreniform Disorder|Schizoaffective Disorder|Psychosis|Depressive Disorder, Major|Bipolar Disorder",1/13/2017,
NCT02756624,"A Multi-Center, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of AC-170 Ophthalmic Solution",Healthy Subjects,7/26/2017,
NCT00525798,A Study to Evaluate Oral Salmon Calcitonin in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D,Osteoporosis,10/18/2012,
NCT02254486,"Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus Trisulfate Solution Using 2-Day Split-Dosing Regimen in Adults",Colon Cancer|Colorectal Carcinoma|Colon Cleansing,5/23/2017,
NCT00242580,A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib,Macular Degeneration|Choroidal Neovascularization,5/2/2011,NVS
NCT02476422,A Study to Assess the Efficacy and Tolerability of Diclofenac Potassium Soft Gelatin Capsules Compared With Ibuprofen Tablets in Patients With Moderate to Severe Postoperative Dental Pain,Post Operative Dental Pain,10/17/2016,NVS
NCT02271854,A Within-subject Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects Experiencing Delayed Onset Muscle Soreness,Muscle Soreness,4/5/2016,NVS
NCT00368277,"A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the Elderly",Hypertension,3/25/2011,NVS
NCT00251004,Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients,Kidney Transplantation|Graft Rejection,5/10/2011,NVS
NCT00132808,"Zoledronic Acid in the Prevention of Bone Loss in Postmenopausal Women With Osteopenia, 45 Years of Age and Older",Osteopenia,1/10/2011,NVS
NCT00393042,Sleep and Tolerability Study: Comparing the Effects of Adderall XR and Focalin XR,Attention Deficit Hyperactivity Disorder,4/19/2017,NVS
NCT02250443,"Study of Long-term Safety, Efficacy Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis",Sporadic Inclusion Body Myositis (sIBM),4/10/2018,NVS
NCT00386607,"A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.",Hypertension,5/10/2011,NVS
NCT00806195,Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants,Meningitis|Meningococcal Infection,7/9/2013,NVS
NCT00099268,Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy,Parkinson's Disease,3/8/2011,NVS
NCT02826603,Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis,Plaque Psoriasis,7/9/2019,NVS
NCT02748863,Study of Secukinumab With 2 mL Pre-filled Syringes,Psoriasis,6/26/2019,NVS
NCT02573467,"An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203",Sporadic Inclusion Body Myositis,3/13/2018,NVS
NCT02487498,Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.,Chronic Obstructive Pulmonary Disease,4/2/2018,NVS
NCT02487446,Efficacy and Safety Study of QVA149 in COPD Patients,Chronic Obstructive Pulmonary Disease,12/26/2017,NVS
NCT02404350,"Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic Arthritis",Psoriatic Arthritis,6/28/2019,NVS
NCT02375971,RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity,Retinopathy of Prematurity,7/31/2018,NVS
NCT02294227,"16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Psoriatic Arthritis","Arthritis, Psoriatic",7/2/2019,NVS
NCT02290821,Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects With Acute Blunt Trauma Injuries,Acute Blunt Soft Tissue Injuries/Contusions,4/19/2017,NVS
NCT02267135,Efficacy and Safety of Subcutaneous Secukinumab in Adults With Moderate to Severe Scalp Psoriasis,Chronic Scalp Psoriasis,2/28/2018,NVS
NCT02256488,Safety and Immunogenicity of Two Trivalent Subunit Influenza Vaccines in Healthy Adult Subjects,Prophylaxis: Influenza,8/7/2015,NVS
NCT02226120,Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction,Chronic Heart Failure With Reduced Ejection Fraction,2/20/2019,NVS
NCT02159053,"16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis","Spondylitis, Ankylosing",4/10/2019,NVS
NCT02074982,Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis,Chronic Plaque Type Psoriasis,7/21/2017,NVS
NCT02008916,"16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis Patients","Spondylitis, Ankylosing",12/12/2018,NVS
NCT01992107,Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old,Influenza,12/8/2015,NVS
NCT01992094,Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older,Influenza,12/10/2015,NVS
NCT01989468,24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis,Psoriatic Arthritis,4/16/2019,NVS
NCT01973205,Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine,Acute Migraine,6/11/2015,NVS
NCT01892436,Extension Study up to 3 Years for Secukinumab in Psoriatic Arthritis,Psoriatic Arthritis,6/12/2019,NVS
NCT01876368,Efficacy and Safety of LCZ696 Compared to Olmesartan in Essential Hypertensive Patients Not Responsive to Olmesartan,Hypertension,12/7/2015,NVS
NCT01870778,"Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF",Acute Heart Failure,3/30/2018,NVS
NCT01888432,Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplants,Liver Transplantation,11/12/2018,NVS
NCT01857206,Safety of Two Trivalent Influenza Vaccines Evaluated in Children and Adolescents 4 to 17 Years of Age,Influenza|Fever,11/3/2014,NVS
NCT01807520,"Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Nail Psoriasis",Moderate to Severe Nail Psoriasis,3/13/2018,NVS
NCT01806597,"Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Palmoplantar Psoriasis",Moderate to Severe Palmoplantar Psoriasis,2/21/2018,NVS
NCT01727141,"A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.",Chronic Obstructive Pulmonary Disease (COPD),6/9/2015,NVS
NCT01715298,NVA237 BID Versus Placebo Twelve-week Efficacy Study,Chronic Obstructive Pulmonary Disease,3/11/2015,NVS
NCT01713946,A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures,Tuberous Sclerosis Complex-associated Refractory Seizures,11/7/2018,NVS
NCT01712516,"A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation",Chronic Obstructive Pulmonary Disease (COPD),7/15/2015,NVS
NCT01709864,NVA237 Versus Placebo 12-week Efficacy Study,Chronic Obstructive Pulmonary Disease,2/12/2015,NVS
NCT01697696,Long Term Safety Study of NVA237 vs QAB149 in COPD Patients,Chronic Obstructive Pulmonary Disease (COPD),3/16/2016,NVS
NCT01682863,A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB149 in Patients With COPD Who Have Moderate to Severe Airflow Limitation,Chronic Obstructive Pulmonary Disease (COPD),3/30/2016,NVS
NCT01640951,4 Year Extension Study of Efficacy and Safety of Secukinumab in Patients With Moderate to Severe Chronic Plaque-type Psoriasis,Moderate to Severe Chronic Plaque-Type Psoriasis,5/25/2018,NVS
NCT01636687,Judging the Efficacy of Secukinumab in Patients With Psoriasis Using AutoiNjector: a Clinical Trial Evaluating Treatment Results (JUNCTURE),Plaque-type Psoriasis,9/27/2018,NVS
NCT01597908,Dabrafenib Plus Trametinib vs Vemurafenib Alone in Unresectable or Metastatic BRAF V600E/K Cutaneous Melanoma,Melanoma,12/4/2014,NVS
NCT01584648,A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma,Melanoma,8/15/2014,NVS
NCT01582061,"An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease.",Cushing's Disease,6/19/2018,NVS
NCT01598987,"Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients.",Renal Function|Liver Transplant,1/24/2017,NVS
NCT01555125,First Study of Secukinumab in Pre-filled Syringes in Subjects With Chronic Plaque-type Psoriasis: Response at 12 Weeks,Moderate to Severe Plaque-type Psoriasis,8/8/2018,NVS
NCT01544595,Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab,Moderate to Severe Plaque-type Psoriasis,12/20/2018,NVS
NCT01406938,Efficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose Regimens,Moderate to Severe Plaque-type Psoriasis,5/19/2015,NVS
NCT01392326,"Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA)",Psoriatic Arthritis,2/4/2016,NVS
NCT01377012,"Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Anti-TNFα Agents",Rheumatoid Arthritis,3/29/2017,NVS
NCT01374906,Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease,Cushing's Disease,4/11/2018,NVS
NCT01365455,Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year,Moderate to Severe Plaque-type Psoriasis,5/29/2015,NVS
NCT01358578,"Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis",Chronic Plaque Psoriasis,9/23/2015,NVS
NCT01356602,Safety and Efficacy of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients,Acute Gouty Arthritis,1/29/2014,NVS
NCT01358175,16 Week Efficacy and 2 Year Long Term Safety and Efficacy of Secukinumab in Patients With Active Ankylosing Spondylitis,Ankylosing Spondylitis,1/27/2017,NVS
NCT01350804,"Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis Factor α (Anti-TNFα) Agents (CAIN457F2309 and CAIN457F2309E1)",Rheumatoid Arthritis,5/23/2016,NVS
NCT01338818,Open-label Extension Evaluating Methylphenidate Hydrochloride Extended Release in Adults With Attention Deficit/Hyperactivity Disorder,Attention Deficit/Hyperactivity Disorder,5/26/2014,NVS
NCT01259492,Efficacy and Safety Study of Methylphenidate Hydrochloride Extended Release in Adults With Childhood-onset Attention Deficit/Hyperactivity Disorder (ADHD),Attention Deficit/Hyperactivity Disorder,4/29/2014,NVS
NCT01255423,Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied 4 Times Daily in Subjects With Acute Ankle Sprain,Ankle Sprain,10/4/2012,NVS
NCT01223027,Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma,Metastatic Renal Cell Carcinoma,11/6/2015,NVS
NCT01214837,Safety and Immunogenicity of 2 or 3 Doses of MenACWY Conjugate Vaccine in Healthy Infants and the Effects of a Booster Dose of MenACWY Administered in the Second Year of Life,Meningococcal Disease|Meningococcal Meningitis,10/2/2014,NVS
NCT01202188,"A Study to Assess the Efficacy, Safety and Tolerability of Once-daily (q.d.) QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",Chronic Obstructive Pulmonary Disease (COPD),5/3/2013,NVS
NCT01162122,Safety and Immunogenicity of MF59C.1 Adjuvanted Trivalent Subunit Influenza Vaccine in Elderly Subjects,Influenza,6/12/2014,NVS
NCT01151410,"An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age",Hypertension,3/7/2016,NVS
NCT01150357,Safety and Efficacy of Aliskiren in Pediatric Hypertensive Patients 6-17 Years of Age,Hypertension,10/15/2015,NVS
NCT01150097,Extension Study to Evaluate the Long-term Efficacy and Safety of Everolimus in Liver Transplant Recipients,Liver Transplant Recipient,5/30/2014,NVS
NCT01412944,Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis,Plaque-type Psoriasis,3/18/2015,NVS
NCT01120691,Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) Exacerbations,Chronic Obstructive Pulmonary Disease,9/30/2013,NVS
NCT01089127,Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD),Chronic Obstructive Pulmonary Disease,8/19/2011,NVS
NCT01080131,Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study.,Acute Gout,12/26/2011,NVS
NCT01079130,Efficacy and Safety of Different Doses of Indacaterol,Asthma,8/19/2011,NVS
NCT01072448,12-week Efficacy of Indacaterol,Chronic Obstructive Pulmonary Disease,8/19/2011,NVS
NCT01068600,Comparison of Efficacy of Indacaterol Versus Placebo Over 12 Weeks,Chronic Obstructive Pulmonary Disease,8/19/2011,NVS
NCT01035229,Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma.,Carcinoma,10/27/2014,NVS
NCT01034163,"A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma (HL)",Hodgkin's Lymphoma,7/7/2016,NVS
NCT01025817,Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in Kidney Transplant Recipients,Kidney Transplant,6/6/2014,NVS
NCT01023308,Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma,Multiple Myeloma,10/23/2015,NVS
NCT01007942,Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer,HER2/Neu Over-expressing Locally Advanced Breast Cancer|Metastatic Breast Cancer,4/5/2017,NVS
NCT01005901,"A Study to Assess the Safety, Tolerability and Efficacy of NVA237 Versus Placebo",Chronic Obstructive Pulmonary Disease,4/12/2012,NVS
NCT01000311,"A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 Months",Meningococcal Disease,3/26/2014,NVS
NCT00929110,"1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD)",Chronic Obstructive Pulmonary Disease,7/27/2012,NVS
NCT00902174,Imatinib (QTI571) in Pulmonary Arterial Hypertension,Pulmonary Arterial Hypertension,7/16/2013,NVS
NCT00900731,A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD),Chronic Obstructive Pulmonary Disease,8/19/2011,NVS
NCT00894387,"Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart Failure",Acute Decompensated Heart Failure|Congestive Heart Failure,10/10/2013,NVS
NCT00889863,Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA),Systemic Juvenile Idiopathic Arthritis With Active Flare,10/16/2012,NVS
NCT00877383,Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease,Chronic Obstructive Pulmonary Disease (COPD),8/19/2011,NVS
NCT00876395,Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer,Breast Cancer,12/19/2018,NVS
NCT00863655,Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole,Breast Cancer,8/31/2012,NVS
NCT00853827,Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients,Coronary Artery Disease (CAD)|Coronary Atherosclerosis,5/7/2014,NVS
NCT00853658,Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure,Chronic Heart Failure,11/25/2016,NVS
NCT00846586,Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease,Chronic Obstructive Pulmonary Disease (COPD),8/18/2011,NVS
NCT00879333,Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC),Advanced Gastric Cancer,4/6/2015,NVS
NCT00821093,Safety and Efficacy of Indacaterol Once Daily Versus Salmeterol Twice Daily in Chronic Obstructive Pulmonary Disease (COPD),Chronic Obstructive Pulmonary Disease (COPD),8/18/2011,NVS
NCT00820222,Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer,"Metastases, Brain",3/15/2013,NVS
NCT00790036,Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy,Diffuse Large B-cell Lymphoma,7/12/2017,NVS
NCT00789828,Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1),Tuberous Sclerosis|Subependymal Giant Cell Astrocytoma,5/1/2012,NVS
NCT00785785,A Study of Nilotinib Versus Imatinib in GIST Patients,Gastrointestinal Stromal Tumor (GIST),4/7/2016,NVS
NCT00718861,3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Acid for 6 Yrs,Post-menopausal Osteoporosis,12/30/2013,NVS
NCT00690430,Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease,Symptomatic Refractory Resistant Carcinoid Disease,7/30/2013,NVS
NCT00677807,"Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)",COPD,8/18/2011,NVS
NCT00630331,Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects,Influenza,1/16/2013,NVS
NCT00626327,Safety and Immune Response of Novartis MenACWY-CRM Conjugate Vaccine When Given to Healthy Toddlers,Meningococcal Infections,3/15/2013,NVS
NCT00624286,Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD),Chronic Obstructive Pulmonary Disease,8/18/2011,NVS
NCT00623103,Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD),Parkinson's Disease Dementia,11/28/2011,NVS
NCT00622869,Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients,Liver Transplantation,5/20/2013,NVS
NCT00891046,An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.,Systemic Juvenile Idiopathic Arthritis,3/10/2017,NVS
NCT00616421,Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children,Meningococcal Infections,6/9/2011,NVS
NCT00600886,Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly,Acromegaly,1/30/2015,NVS
NCT00824265,Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia,"Leukaemia, Lymphocytic, Chronic",7/25/2016,NVS
NCT00529529,Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma,Asthma,8/19/2011,NVS
NCT00790400,Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM),Tuberous Sclerosis Complex (TSC)|Lymphangioleiomyomatosis (LAM),8/28/2012,NVS
NCT00622635,A Crossover Study to Determine the 24 Hour Lung Function Profile of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD),Chronic Obstructive Pulmonary Disease,8/18/2011,NVS
NCT00510068,Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors,Advanced Neuroendocrine Tumors of Pancreatic Origin,12/15/2011,NVS
NCT00506415,"Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline",Alzheimer Disease,9/19/2012,NVS
NCT00474526,A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants,"Meningitis, Meningococcal",3/24/2014,NVS
NCT00471328,Efficacy and Safety of Nilotinib (AMN107) Compared With Current Treatment Options in Patients With GIST Who Have Failed Both Imatinib and Sunitinib,Gastrointestinal Stromal Tumors,5/17/2011,NVS
NCT00450437,A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults,Meningococcal Infections|Meningococcal Meningitis,9/24/2010,NVS
NCT00685373,"Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease",Cryopyrin-Associated Periodic Syndromes|Familial Cold Autoinflammatory Syndrome|Muckle Wells Syndrome|Neonatal Onset Multisystem Inflammatory Disease,5/27/2011,NVS
NCT00443898,"Efficacy, Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail",Onychomycosis,4/20/2011,NVS
NCT00443820,"Efficacy Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail",Onychomycosis,4/19/2011,NVS
NCT00439244,Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis,Osteoporosis,4/20/2011,NVS
NCT00436553,Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization,Macular Degeneration|Choroidal Neovascularization,4/19/2011,NVS
NCT00434148,"Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease",Cushing's Disease,2/6/2013,NVS
NCT00428389,Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease,Alzheimer's Disease,6/27/2011,NVS
NCT00412061,Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor,Carcinoid Tumor|Malignant Carcinoid Syndrome,3/12/2012,NVS
NCT00410124,RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib,Metastatic Renal Cell Carcinoma,1/15/2013,NVS
NCT00388505,Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis,Cystic Fibrosis,7/24/2012,NVS
NCT00355134,Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis,Multiple Sclerosis,6/26/2012,NVS
NCT00351468,EXTEND (Eltrombopag Extended Dosing Study),"Purpura, Thrombocytopaenic, Idiopathic",4/17/2017,NVS
NCT00340834,Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase,Multiple Sclerosis,5/16/2011,NVS
NCT00333840,Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia,Chronic Myelogenous Leukemia,10/14/2013,NVS
NCT00320710,Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer,Breast Cancer,8/4/2014,NVS
NCT00306787,Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes,Genital Herpes,6/17/2011,NVS
NCT00300274,Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection,Graft Rejection,8/16/2012,NVS
NCT00248170,Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer,Breast Cancer,10/9/2015,NVS
NCT00235391,Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload,Thalassemia|Sickle Cell Disease|Diamond Blackfan Anemia|Myelofibrosis,5/2/2011,NVS
NCT00145327,Double-blind Extension of HORIZON Pivotal Fracture Trial (Zoledronic Acid in the Treatment of Postmenopausal Osteoporosis),Osteoporosis,4/20/2011,NVS
NCT00669617,Study to Determine the Onset of Action of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD),Chronic Obstructive Pulmonary Disease,8/17/2011,NVS
NCT00103740,"Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period",Paget's Disease of Bone,5/2/2012,NVS
NCT00098059,Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection,Herpes Simplex,5/6/2009,NVS
NCT00171210,An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload,Transfusional Iron Overload in β-thalassemia,5/2/2011,NVS
NCT00079937,"Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma",Asthma,8/3/2011,NVS
NCT00073528,Study Comparing GW572016 And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer,"Neoplasms, Breast",5/17/2012,NVS
NCT00076336,Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis,"Hepatitis|Hepatitis B, Chronic|Cirrhosis",9/5/2011,NVS
NCT00051636,"Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period",Paget's Disease of Bone,5/7/2012,NVS
NCT00050011,Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy,Breast Neoplasms|Osteoporosis,1/28/2014,NVS
NCT01137682,Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly,Acromegaly,1/21/2015,NVS
NCT02059291,Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers,Hereditary Periodic Fevers,3/17/2017,NVS
NCT01544491,"Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients",Prevention of Acute Rejection in Paediatric Recipients of a Renal Transplant,5/31/2019,NVS
NCT00995709,Phase III Study in Refractory Behcet's Disease,Behcet Disease,8/31/2015,NVS
NCT00465985,"Efficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells Syndrome",Muckle Wells Syndrome,2/11/2011,NVS
NCT00996307,"Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months",Influenza,5/25/2011,NVS
NCT00973349,Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults,Influenza,5/25/2011,NVS
NCT00645411,Pediatric Safety and Immunogenicity Study of Cell-Culture Derived and Egg-based Subunit Influenza Vaccines in Healthy Children and Adolescents,Influenza,1/16/2013,NVS
NCT02296424,ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab,Systemic Juvenile Idiopathic Arthritis (SJIA),7/9/2019,NVS
NCT00620022,The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease,Chronic Obstructive Pulmonary Disease,8/17/2011,NVS
NCT03137784,Bronchodilator Effects and Safety of Glycopyrronium Bromide (25 ug and 50 ug o.d.) in Asthma,Asthma,1/16/2019,NVS
NCT01925209,"Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, Mobility in sIBM Patients",Sporadic Inclusion Body Myositis,5/12/2017,NVS
NCT01572727,"A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation",Breast Cancer,1/27/2017,NVS
NCT00972816,Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years),Influenza,1/27/2011,NVS
NCT00463567,"26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)","Pulmonary Disease, Chronic Obstructive|COPD|Lung Diseases, Obstructive",8/18/2011,NVS
NCT00477269,Safety and Efficacy of Imatinib Mesylate in Patients With Pulmonary Arterial Hypertension,Pulmonary Arterial Hypertension,3/23/2015,NVS
NCT02116803,An Open Label Multi-center Extension Study to Evaluate Long-term Safety/ Tolerability of Dovitinib in Patients With Solid Tumors Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored Single Agent Dovitinib Studies Which Fulfilled the Requirements for the Primary Objective,Solid Tumors,2/1/2018,NVS
NCT01514461,"A Randomized, Double-blind, Placebo Controlled Study to Assess Efficacy, Safety and Tolerability of LCQ908 in Subjects With Familial Chylomicronemia Syndrome",Familial Chylomicronemia Syndrome (FCS),6/3/2015,NVS
NCT01154127,Effect of NVA237 on Exercise Endurance in Patients With Chronic Obstructive Pulmonary Disease (COPD),Chronic Obstructive Pulmonary Disease,5/7/2012,NVS
NCT00765674,Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate-severe Hypertension,Hypertension,5/9/2011,NVS
NCT00739973,Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential Hypertension,Hypertension,5/3/2011,NVS
NCT00705575,Efficacy and Safety of the Combination Aliskiren (300 mg) and Hydrochlorothiazide (25mg) to Aliskiren (300mg) Monotherapy in Patients With Staged II Hypertension,Hypertension,1/21/2011,NVS
NCT00446511,"Extension Study to Assess Long Term Safety, Tolerability, and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension",Hypertension,6/6/2011,NVS
NCT00435162,Dose Response of Valsartan on Sitting Systolic Blood Pressure in Children 6 Months - 5 Years of Age With High Blood Pressure,Hypertension,5/9/2011,NVS
NCT00433836,Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children With High Blood Pressure,Hypertension,5/19/2011,NVS
NCT00414609,Safety and Efficacy of Aliskiren in Post Myocardial Infarction Patients (ASPIRE),Myocardial Infarction,7/13/2011,NVS
NCT00402103,An Assessment of Long Term Safety of the Combination of Aliskiren / Amlodipine in Patients With High Blood Pressure,Hypertension,1/11/2011,NVS
NCT00219141,Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension,Hypertension|Left Ventricular Hypertrophy|Overweight,5/10/2011,NVS
NCT00097786,Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications,"Diabetes Mellitus, Type 2",5/24/2011,NVS
NCT00599326,Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda,Porphyria Cutanea Tarda,2/10/2014,NVS
NCT01361308,Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS),Postmenopausal Symptoms,5/20/2014,
NCT01101841,24-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms,Hot Flashes,4/21/2014,
NCT00501293,Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD,ADHD,1/15/2010,
NCT00499863,Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD,ADHD,6/11/2009,
NCT01569841,A Trial Comparing the Efficacy of Insulin Degludec With Insulin Glargine on Glycaemic Control Using Continuous Glucose Monitoring in Patients With Type 1 Diabetes,"Diabetes|Diabetes Mellitus, Type 1",11/17/2015,NVO
NCT00620282,The Effect of Liraglutide on Endothelial Function in Subjects With Type 2 Diabetes Mellitus,"Diabetes|Diabetes Mellitus, Type 2",6/15/2011,NVO
NCT01234649,Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM),Gestational Diabetes Mellitus|Type 2 Diabetes Mellitus|Metabolic Syndrome|Impaired Glucose Tolerance|Disorder of Glucose Regulation,7/26/2019,NVO
NCT01999322,A Trial Evaluating Compatibility and Safety of FIAsp and Insulin Aspart With an External Continuous Subcutaneous Insulin Infusion System in Adult Subjects With Type 1 Diabetes,"Diabetes|Diabetes Mellitus, Type 1",10/31/2017,NVO
NCT01253811,Safety and Efficacy of Monthly Replacement Therapy With Recombinant Factor XIII (rFXIII) in Paediatric Subjects With Congenital Factor XIII A-subunit Deficiency,Congenital Bleeding Disorder|Congenital FXIII Deficiency,6/24/2016,NVO
NCT02964247,LIRA-ADD2SGLT2i - Liraglutide Versus Placebo as add-on to SGLT2 Inhibitors.,"Diabetes|Diabetes Mellitus, Type 2",7/10/2019,NVO
NCT02906917,A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment Intensification,"Diabetes|Diabetes Mellitus, Type 2",9/28/2018,NVO
NCT02825251,Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 Diabetes,"Diabetes|Diabetes Mellitus, Type 1",7/24/2018,NVO
NCT02773368,A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes Mellitus,"Diabetes|Diabetes Mellitus, Type 2",10/23/2018,NVO
NCT02670915,Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes,"Diabetes|Diabetes Mellitus, Type 1",4/4/2019,NVO
NCT02648204,Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.,"Diabetes|Diabetes Mellitus, Type 2",5/8/2018,NVO
NCT02500706,Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes,"Diabetes|Diabetes Mellitus, Type 1",8/10/2018,NVO
NCT02420262,A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus,"Diabetes|Diabetes Mellitus, Type 2",12/7/2017,NVO
NCT02305381,Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes,"Diabetes|Diabetes Mellitus, Type 2",2/16/2018,NVO
NCT02298192,A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms,"Diabetes|Diabetes Mellitus, Type 2",5/23/2017,NVO
NCT02128932,Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes,"Diabetes|Diabetes Mellitus, Type 2",3/8/2018,NVO
NCT02098395,The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes,"Diabetes|Diabetes Mellitus, Type 1",6/3/2016,NVO
NCT02054897,Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Subjects With Type 2 Diabetes,"Diabetes|Diabetes Mellitus, Type 2",1/23/2018,NVO
NCT02034513,"A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 Diabetes","Diabetes|Diabetes Mellitus, Type 1",5/15/2017,NVO
NCT02030600,"A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes","Diabetes|Diabetes Mellitus, Type 2",1/30/2017,NVO
NCT01959529,A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events,"Diabetes|Diabetes Mellitus, Type 2",11/17/2017,NVO
NCT01952145,A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus,"Diabetes|Diabetes Mellitus, Type 2",1/20/2017,NVO
NCT02100475,"A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification","Diabetes|Diabetes Mellitus, Type 2",1/20/2017,NVO
NCT01885208,Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes,"Diabetes|Diabetes Mellitus, Type 2",3/30/2018,NVO
NCT01850615,"Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes","Diabetes|Diabetes Mellitus, Type 2",1/17/2018,NVO
NCT01849289,A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes,"Diabetes|Diabetes Mellitus, Type 2",1/14/2016,NVO
NCT01836523,The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes,"Diabetes|Diabetes Mellitus, Type 1",3/6/2017,NVO
NCT01835431,A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus,"Diabetes|Diabetes Mellitus, Type 1",11/17/2015,NVO
NCT01831765,Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes,"Diabetes|Diabetes Mellitus, Type 1",1/23/2018,NVO
NCT01819129,Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes,"Diabetes|Diabetes Mellitus, Type 2",12/5/2017,NVO
NCT01814137,A Randomised Trial Comparing Efficacy and Safety After Intensification With Either Insulin Aspart Once Daily as add-on or Changing to Basal Bolus Treatment With Insulin Degludec and Insulin Aspart in Subjects With Type 2 Diabetes Previously Treated With Insulin Degludec/Insulin Aspart Twice Daily,"Diabetes|Diabetes Mellitus, Type 2",11/13/2015,NVO
NCT01720446,Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes,"Diabetes|Diabetes Mellitus, Type 2",3/15/2018,NVO
NCT01713530,A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin,"Diabetes|Diabetes Mellitus, Type 2",11/17/2015,NVO
NCT01680341,Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine,"Diabetes|Diabetes Mellitus, Type 2",11/17/2015,NVO
NCT01676116,The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy,"Diabetes|Diabetes Mellitus, Type 2",7/9/2018,NVO
NCT01664247,The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification,"Diabetes|Diabetes Mellitus, Type 2",4/20/2016,NVO
NCT01620489,Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment,"Diabetes|Diabetes Mellitus, Type 2",10/30/2014,NVO
NCT01618162,The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy,"Diabetes|Diabetes Mellitus, Type 2",2/17/2017,NVO
NCT01617434,The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes,"Diabetes|Diabetes Mellitus, Type 2",10/28/2014,NVO
NCT01570751,"A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin","Diabetes|Diabetes Mellitus, Type 2",11/18/2015,NVO
NCT01557166,Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea,Metabolism and Nutrition Disorder|Obesity|Obstructive Sleep Apnoea,2/9/2015,NVO
NCT01541215,"Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes","Diabetes|Diabetes Mellitus, Type 2",12/11/2018,NVO
NCT01513473,A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus,"Diabetes|Diabetes Mellitus, Type 1",1/12/2016,NVO
NCT01493778,Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A,Congenital Bleeding Disorder|Haemophilia A,10/30/2018,NVO
NCT01395810,Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773,Congenital Bleeding Disorder|Haemophilia B,5/9/2018,NVO
NCT01392573,A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 Diabetes,"Diabetes|Diabetes Mellitus, Type 2",1/20/2017,NVO
NCT01392547,Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and Inhibitors,Congenital Bleeding Disorder|Haemophilia A With Inhibitors|Haemophilia B With Inhibitors,12/6/2013,NVO
NCT01388361,Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin,"Diabetes|Diabetes Mellitus, Type 2",11/26/2015,NVO
NCT01365507,Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing Regimens,"Diabetes|Diabetes Mellitus, Type 2",11/20/2015,NVO
NCT01364428,Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes Mellitus,"Diabetes|Diabetes Mellitus, Type 2",11/18/2015,NVO
NCT01336023,"Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes","Diabetes|Diabetes Mellitus, Type 2",6/2/2017,NVO
NCT01333111,Safety and Efficacy of NNC-0156-0000-0009 in Haemophilia B Patients,Congenital Bleeding Disorder|Haemophilia B,7/28/2017,NVO
NCT01326026,Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes Mellitus,"Diabetes|Diabetes Mellitus, Type 2",11/17/2015,NVO
NCT01386528,Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B,Congenital Bleeding Disorder|Haemophilia B,7/24/2017,NVO
NCT01272232,Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes,Metabolism and Nutrition Disorder|Obesity,2/9/2015,NVO
NCT01272219,Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes,Metabolism and Nutrition Disorder|Obesity,2/9/2015,NVO
NCT01179048,Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results,"Diabetes|Diabetes Mellitus, Type 2",3/1/2017,NVO
NCT01138501,Safety and Efficacy of Turoctocog Alfa in Previously Treated Male Children With Haemophilia A,Congenital Bleeding Disorder|Haemophilia A,6/11/2014,NVO
NCT01135992,Switching From Insulin Glargine to Insulin Degludec in Subjects With Type 2 Diabetes Mellitus (BEGIN™),"Diabetes|Diabetes Mellitus, Type 2",1/22/2016,NVO
NCT01079234,Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes,"Diabetes|Diabetes Mellitus, Type 1",12/31/2015,NVO
NCT01076647,Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes,"Diabetes|Diabetes Mellitus, Type 2",11/10/2015,NVO
NCT01068678,Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes,"Diabetes|Diabetes Mellitus, Type 2",12/28/2015,NVO
NCT01068665,Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes,"Diabetes|Diabetes Mellitus, Type 2",11/13/2015,NVO
NCT01046110,Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With Insulin,"Diabetes|Diabetes Mellitus, Type 2",11/18/2015,NVO
NCT01045707,"Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 Diabetes","Diabetes|Diabetes Mellitus, Type 2",11/20/2015,NVO
NCT01045447,"Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 Diabetes","Diabetes|Diabetes Mellitus, Type 2",11/18/2015,NVO
NCT00984126,"Safety and Efficacy of Turoctocog Alfa (N8) in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543, NN7008-3545, NN7008-3600, NN7008-3893 and NN7008-4015",Congenital Bleeding Disorder|Haemophilia A,7/27/2017,NVO
NCT00982644,Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes,"Diabetes|Diabetes Mellitus, Type 2",11/13/2015,NVO
NCT00982228,Comparison of NN1250 Plus Insulin Aspart With Insulin Glargine Plus Insulin Aspart in Type 1 Diabetes,"Diabetes|Diabetes Mellitus, Type 1",12/29/2015,NVO
NCT00978627,Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes,"Diabetes|Diabetes Mellitus, Type 1",11/20/2015,NVO
NCT00978380,Safety of Monthly Recombinant Factor XIII Replacement Therapy in Subjects With Congenital Factor XIII Deficiency: An Extension to Trial F13CD-1725,Congenital Bleeding Disorder|Congenital FXIII Deficiency,12/13/2016,NVO
NCT00972283,Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 Diabetes,"Diabetes|Diabetes Mellitus, Type 2",11/13/2015,NVO
NCT00856986,The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes,"Diabetes|Diabetes Mellitus, Type 2",5/13/2011,NVO
NCT00840086,Safety and Efficacy of Turoctocog Alfa in Haemophilia A Subjects,Congenital Bleeding Disorder|Haemophilia A,9/4/2014,NVO
NCT00789191,Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 Diabetes,"Diabetes|Diabetes Mellitus, Type 2",12/10/2010,NVO
NCT00781937,Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance,Metabolism and Nutrition Disorder|Obesity,11/28/2011,NVO
NCT00773279,"Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics","Diabetes|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2|Delivery Systems",3/27/2017,NVO
NCT00713648,Evaluation of Recombinant Factor XIII for Prevention of Bleeding in Patients With FXIII Inherited Deficiency,Congenital Bleeding Disorder|Congenital FXIII Deficiency,7/14/2014,NVO
NCT00700817,"The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus","Diabetes|Diabetes Mellitus, Type 2",8/4/2010,NVO
NCT00518882,Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes,"Diabetes|Diabetes Mellitus, Type 2",3/23/2010,NVO
NCT01230021,Safety of a Single Intravenous Dose of Recombinant Factor XIII in Children With Congenital FXIII A-subunit Deficiency,Congenital Bleeding Disorder|Congenital FXIII Deficiency,6/12/2014,NVO
NCT00561470,Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen,Colorectal Neoplasms|Neoplasm Metastasis,9/28/2012,
NCT00806546,An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months,Migraine Disorders,3/20/2013,
NCT00792103,An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months,Migraine Disorders,5/7/2013,
NCT00724815,The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine,Migraine Disorders,5/7/2013,
NCT00578812,PCM Cervical Disc System,Radiculopathy|Myelopathy,2/12/2013,NUVA
NCT00798967,Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) Subjects,Short Bowel Syndrome,2/1/2012,
NCT00300755,Study Evaluating Pantoprazole in Children With Gastroesophageal Reflux Disease (GERD),Gastroesophageal Reflux,5/19/2010,
NCT00259012,Study Evaluating Pantoprazole Sodium Enteric-Coated Spheroid Suspension In Infants With Presumed GERD,Gastroesophageal Reflux,5/7/2010,
NCT00930644,Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS),Short Bowel Syndrome,12/24/2014,
NCT01341912,Study to Investigate the Long-term Efficacy and Safety of Human-cl rhFVIII in Previously Treated Patients (PTPs),Severe Hemophilia A,2/3/2014,
NCT01012323,"A Study of NewGam, Human Immunoglobulin 10%, in Patients With Primary Immunodeficiency Diseases",Primary Immunodeficiency Diseases,3/16/2017,
NCT01313507,High Infusion Rate Study of Immunoglobulin Intravenous (Human) 10% (NewGam),Primary Immunodeficiency Disease,3/29/2017,
NCT01365546,Wilate in Subjects With Von Willebrand Disease Who Undergo Surgery,Prevent Bleeding in Major Surgery,3/9/2015,
NCT02267226,Efficacy and Safety Study of Octafibrin for On-demand Treatment of Acute Bleeding and to Prevent Bleeding During and After Surgery,Congenital Fibrinogen Deficiency,2/20/2019,
NCT02089113,Second Phase 3 Study Evaluating Safety and Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery,Post Ocular Surgical Inflammation and Pain,3/30/2016,OCUL
NCT01579565,"Safety, Efficacy and Pharmacokinetics of OMS302 in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification",Intraocular Lens Replacement,8/22/2014,OMER
NCT01454063,Safety and Efficacy of OMS302 in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification,Intraocular Lens Replacement,8/21/2014,OMER
NCT00769314,Phase 3 Clinical Study for the Treatment of Cold Sore,Herpes Labialis,12/21/2012,
NCT00390780,Efficacy and Safety Study of Miconazole Lauriad to Treat Oropharyngeal Candidiasis in HIV Patients,HIV Infections,8/29/2013,
NCT01704079,Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency,"Chronic Kidney Disease|Hyperparathyroidism, Secondary|Vitamin D Deficiency",8/17/2016,
NCT01651000,Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency,"Chronic Kidney Disease|Hyperparathyroidism, Secondary|Vitamin D Deficiency",8/17/2016,
NCT01219855,Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT),Chronic Kidney Disease|Secondary Hyperparathyroidism|Vitamin D Insufficiency,8/25/2016,
NCT00468728,PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD),Clostridium Infections|Diarrhea,7/29/2011,
NCT01623323,Study Evaluating the Safety of Intranasal Administration of 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects With Chronic Sinusitis With or Without Nasal Polyps,Chronic Sinusitis With or Without Nasal Polyps,3/1/2016,
NCT01623310,12-Month OL Intranasal Fluticasone Propionate BID Using OptiNose Device,Nasal Polyps,1/24/2018,
NCT01622569,"Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi Directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Extension Phase to Assess Safety",Bilateral Nasal Polyposis,12/5/2018,
NCT01624662,"Efficacy and Safety Study of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Using a Novel Bi-directional Device",Bilateral Nasal Polyposis,12/5/2018,
NCT01462812,Safety & Efficacy of a Single Dose of Sumatriptan Powder Delivered Intranasally With the Bi-directional Device in Adults With Acute Migraine,Migraine Headache,5/6/2015,
NCT00662532,Antibiotic Study for Dental Implants,Periodontitis,5/27/2010,
NCT01764386,Method-of-Use Study Assessing the Effect of Naltrexone Sustained Release (SR)/ Bupropion SR on Body Weight and Cardiovascular Risk Factors in Overweight and Obese Subjects,Obesity|Overweight,11/26/2015,
NCT00567255,A Safety and Efficacy Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects,Obesity|Overweight,11/21/2014,
NCT00532779,A Study of the Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects,Obesity|Overweight,11/21/2014,
NCT00474630,A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes,"Obesity|Overweight|Diabetes Mellitus, Type 2",11/21/2014,
NCT00456521,A Safety and Efficacy Study of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects Participating in an Intensive Behavior Modification Program,Obesity|Overweight,11/21/2014,
NCT01908842,Efficacy of BNX Sublingual Tablets Versus BNX Sublingual Film for Treatment of Opioid-Dependent Adults,"Opioid Dependence, on Agonist Therapy",5/22/2015,
NCT01848054,Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence,Opioid-Related Disorders|Opiate Dependence,6/24/2015,
NCT00587834,Safety and Efficacy of Gintuit(TM)for Oral Soft Tissue Regeneration,Gingival Recession,11/8/2012,
NCT00909870,Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers,Venous Leg Ulcer,2/4/2013,
NCT00830947,Effect of Cyclic Loading (Vibration) on Orthodontic Tooth Movement,Malocclusion,12/23/2013,
NCT01949155,OTO-201 for the Treatment of Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement,Otitis Media With Effusion,11/11/2016,OTIC
NCT01949142,OTO-201 for the Treatment of Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement,Otitis Media With Effusion,6/15/2016,OTIC
NCT00365859,Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD),Autistic Disorder|Behavioral Symptoms,1/25/2010,
NCT00337571,Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD),Behavioral Symptoms|Autistic Disorder,7/23/2009,
NCT00332241,Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD),Autistic Disorder,7/23/2009,
NCT00105196,A Study of Aripiprazole in Patients With Major Depressive Disorder,Major Depressive Disorder,5/18/2009,
NCT00162942,Study for the Treatment of Crohn's Disease With Adacolumn,Crohn's Disease,4/7/2009,
NCT02194933,Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Schizophrenia With Impulsivity,Schizophrenia With Impulsivity,9/11/2018,
NCT02013622,Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia,Schizophrenia,3/29/2016,
NCT02013609,"Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment",MDD,3/29/2016,
NCT02013531,Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms,Major Depressive Disorder|Anxiety,3/29/2016,
NCT02012218,Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy,Major Depressive Disorder (MDD),10/8/2015,
NCT00550459,Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients,Hyponatremia,4/28/2011,
NCT00428948,Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD),"Polycystic Kidney Disease, Autosomal Dominant",7/2/2017,
NCT01668797,"Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia",Acute Schizophrenia,1/13/2017,
NCT02160145,Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease,Chronic Kidney Disease|Autosomal Dominant Polycystic Kidney Disease,8/8/2018,
NCT01727726,"A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial","Depressive Disorder|Depression|Depressive Disorder, Major|Mood Disorders|Mental Disorders",6/8/2018,
NCT01727713,Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder,Tourette's Disorder|Tic Disorder,10/16/2015,
NCT01727700,Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder,Tourette's Disorder|Tic Disorder,2/13/2015,
NCT01432444,Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole,Schizophrenia,3/27/2015,
NCT01397786,Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia,Schizophrenia,3/27/2017,
NCT01396421,Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia,Acute Schizophrenia,10/29/2015,
NCT01393613,Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia,Acute Schizophrenia,11/26/2015,
NCT01360866,Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial),"Depressive Disorder|Depression|Depressive Disorder, Major|Mood Disorders|Mental Disorders",9/17/2018,
NCT01360645,Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial),"Depressive Disorder|Depression|Depressive Disorder, Major|Mood Disorders|Mental Disorders",11/26/2015,
NCT01360632,Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial),"Depressive Disorder|Depression|Depressive Disorder, Major|Mood Disorders|Mental Disorders",1/1/2016,
NCT01149655,Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia,Schizophrenia,4/2/2015,
NCT00706654,Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia,Schizophrenia,8/14/2013,
NCT00705783,Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia,Schizophrenia,7/19/2013,
NCT00110461,Aripiprazole in Children and Adolescents With Bipolar I Disorder,Bipolar Disorder,5/21/2012,
NCT00102518,"Aripiprazole Open-Label, Safety and Tolerability Study",Schizophrenia|Bipolar Disorder,8/31/2012,
NCT00102063,Aripiprazole in Adolescents With Schizophrenia,Schizophrenia,8/1/2012,
NCT00890682,Study of Postoperative Analgesia in Bunionectomy,Bunion|Hallux Valgus,8/5/2013,PCRX
NCT00745290,A Phase 3 Study to Evaluate the Safety and Efficacy of SKY0402 in Subjects Undergoing Total Knee Arthroplasty,Postoperative Pain,8/6/2013,PCRX
NCT00744848,Study to Evaluate Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy,Hemorrhoids,8/6/2013,PCRX
NCT02532647,Safety and Efficacy of Remimazolam in ASA III and IV Patients Undergoing Colonoscopy,Colonoscopy,1/23/2019,
NCT02296892,A Phase III Study of Remimazolam in Patients Undergoing Bronchoscopy,Bronchoscopy,3/12/2019,
NCT02290873,A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients,Colonoscopy,11/9/2018,
NCT00545753,Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice,Pediculosis,10/11/2012,
NCT00545168,Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice,Pediculus Capitis Infestation,10/11/2012,
NCT02877927,Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI,Bacterial Infections|Skin Structures and Soft Tissue Infections,11/30/2018,PRTK
NCT02531438,Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13),Bacterial Pneumonia|Community-Acquired Infections,11/29/2018,PRTK
NCT02378480,Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23),Bacterial Infections|Skin Structures and Soft Tissue Infections,3/21/2019,PRTK
NCT00772603,Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures,"Epilepsies, Partial",2/11/2014,
NCT00935649,PinPointe FootLaser for the Treatment of Onychomycosis,Infected Toenails|Onychomycosis,4/9/2013,
NCT02454959,Crossover Study to Assess the Efficacy of PT003 With and Without a Valved Holding Chamber in Subjects With Moderate to Severe COPD,COPD,4/19/2017,
NCT02343458,"Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD",Chronic Obstructive Pulmonary Disease,2/20/2019,
NCT02268396,Glycopyrronium and Formoterol Fumarate (GFF) Metered Dose Inhaler (MDI) Dose Indicator Study in Adults With Moderate to Very Severe COPD,COPD,12/23/2016,
NCT01970878,"Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® (PINNACLE 3)",Chronic Obstructive Pulmonary Disease (COPD),2/6/2017,
NCT01854658,"Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2)",Chronic Obstructive Pulmonary Disease (COPD),3/28/2017,
NCT01854645,"Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD); (PINNACLE 1)",Chronic Obstructive Pulmonary Disease,3/28/2017,
NCT00942604,A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations,Actinic Keratoses,3/19/2012,
NCT00916006,"A Multi-center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)",Actinic Keratosis,3/21/2012,
NCT00915551,"A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)",Actinic Keratosis,3/16/2012,
NCT00742391,A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations,Actinic Keratoses,3/21/2012,
NCT01444092,Safety Study of Entocort for Children With Crohn's Disease,Crohn's Disease,8/11/2016,PRGO
NCT01453946,Safety and Maintenance Study of Entocort for Children With Crohn's Disease,Crohn's Disease,6/19/2015,PRGO
NCT02912650,A Safety And Efficacy Study of Ibuprofen 250 mg / Acetaminophen 500 mg In The Treatment Of Post-Surgical Dental Pain,Post-surgical Pain Following Extraction of Molar Teeth,8/30/2017,PFE
NCT02863575,A Dental Pain Study Comparing The Analgesic Efficacy Of Ibuprofen/Caffeine,Pain,4/8/2019,PFE
NCT02837952,A Study of Ibuprofen (IBU) 250mg/APAP 500mg In The Treatment Of Post-Surgical Dental Pain,Pain,3/5/2018,PFE
NCT02761980,A Study of Ibuprofen 250 mg / Acetaminophen 500 mg Comparing The Antipyretic Effects in Healthy Male Volunteers,Fever,12/7/2018,PFE
NCT02118792,"Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis","Dermatitis, Atopic",3/6/2017,PFE
NCT02118766,"Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis","Dermatitis, Atopic",3/6/2017,PFE
NCT01362491,Ibuprofen Sodium Tension Headache Study,Pain,7/30/2014,PFE
NCT01216163,Study Evaluating A Novel Ibuprofen Formulation In The Treatment Of Dental Pain,Pain,8/20/2012,PFE
NCT00402987,Testing The Effectiveness Of Celecoxib In Patients With Painful Sore Throat,Pharyngitis,3/12/2009,PFE
NCT01266161,Multiple Dose Dental Pain Study Of Ibuprofen Extended Release,Pain,8/15/2018,PFE
NCT01008605,Caverject User Study,Erectile Dysfunction,3/28/2012,PFE
NCT00904670,Quillivant Oral Suspension (Quillivant XR) in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD),Attention Deficit Hyperactivity Disorder,6/26/2014,PFE
NCT01391858,Postoperative Pain and Morphine Consumption After Mastectomy - Lyrica,Post-operative Pain,6/11/2014,PFE
NCT00561431,High Dose CVVHDF Compared to Standard Dose CVVHDF,Acute Renal Failure,3/12/2010,PFE
NCT01564784,A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia,Acute Lymphoblastic Leukemia,1/17/2018,PFE
NCT00863798,Study Evaluating Desvenlafaxine Succinate Sustained Release In Adults With Major Depressive Disorder,Major Depressive Disorder,5/6/2011,PFE
NCT00574873,Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML,Chronic Myeloid Leukemia,11/5/2012,PFE
NCT00098293,"Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/Lamivudine",HIV-1,10/5/2012,PFE
NCT02697773,Efficacy and Safety of a Subcutaneous Tanezumab Titration Dosing Regimen in Subjects With Moderate to Severe Osteoarthritis of the Hip or Knee,"Osteoarthritis, Knee|Osteoarthritis, Hip",4/23/2019,PFE
NCT02480153,A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).,Rheumatoid Arthritis,9/26/2017,PFE
NCT02458287,"Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Subjects With Hyperlipidemia Or Dyslipidemia",Hyperlipidemia,12/19/2017,PFE
NCT02364999,A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC,Non-Small Cell Lung Cancer,6/27/2018,PFE
NCT02294019,Actual Use Trial of Ibuprofen 400 mg,Patient Compliance,5/30/2016,PFE
NCT02222493,A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).,Rheumatoid Arthritis,9/11/2017,PFE
NCT02213263,"A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06)",Follicular Lymphoma,10/30/2018,PFE
NCT02135029,Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins,Hyperlipidemia,12/14/2017,PFE
NCT02100514,Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events,Hyperlipidemia,7/21/2017,PFE
NCT01994889,Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy,Transthyretin (TTR) Amyloid Cardiomyopathy,4/3/2019,PFE
NCT01968980,A 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial Hypercholesterolemia,Heterozygous Familial Hypercholesterolemia,5/19/2017,PFE
NCT01968967,Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events,Hyperlipidemia,7/24/2017,PFE
NCT01968954,Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events,Hyperlipidemia,5/17/2017,PFE
NCT01964326,Actual Use Trial of Atorvastatin Calcium 10 mg,Hypercholesterolemia,1/27/2016,PFE
NCT01945034,5% Topical Ibuprofen (IBU) for Ankle Sprain,Ankle Injuries,5/26/2016,PFE
NCT01882439,Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors,Psoriatic Arthritis,9/15/2017,PFE
NCT01877668,Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study,Psoriatic Arthritis,7/6/2017,PFE
NCT01830855,"A Trial to Assess the Lot Consistency, Safety, Tolerability and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Subjects Aged ≥10 to <19 Years",Meningococcal Vaccine,6/14/2016,PFE
NCT01789606,Self-Selection and Actual Use Trial of Ibuprofen 600 mg Immediate Release/Extended Caplet,Analgesia,8/28/2017,PFE
NCT01701362,Placebo-controlled Safety and Efficacy Study of Pregabalin in Subjects With Post-traumatic Peripheral Neuropathic Pain,Neuropathic Pain,6/7/2017,PFE
NCT01654250,NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD),Attention Deficit Hyperactivity Disorder,2/3/2016,PFE
NCT01628120,"A Phase 3, Long-Term Safety Study of Subcutaneous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME -Anemia Management With Epoetin",Chronic Renal Failure Requiring Hemodialysis,7/19/2018,PFE
NCT01628107,"A Phase 3, Long-Term Safety Study of Intravenous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin",Chronic Renal Failure Requiring Hemodialysis,7/19/2018,PFE
NCT01571362,A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain,Chronic Pain|Low Back Pain|Analgesia,4/4/2017,PFE
NCT01474772,Efficacy and Safety Study of Pregabalin in the Treatment of Pain on Walking in Patients With Diabetic Peripheral Neuropathy (DPN),Diabetic Peripheral Neuropathy,11/18/2014,PFE
NCT01465763,"A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis",Ulcerative Colitis,6/7/2016,PFE
NCT01458951,"A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis",Ulcerative Colitis,6/1/2016,PFE
NCT01458574,"A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis",Ulcerative Colitis,5/18/2017,PFE
NCT01455415,Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain,Painful Diabetic Peripheral Neuropathy,4/23/2015,PFE
NCT01432236,A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression,Fibromyalgia,10/22/2014,PFE
NCT01428583,Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain,Chronic Noncancer Pain,11/21/2016,PFE
NCT01389596,A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years,"Epilepsy, Partial Seizures",3/21/2017,PFE
NCT01372150,A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD,Major Depressive Disorder,11/20/2015,PFE
NCT01371734,A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD,Major Depressive Disorder,3/20/2017,PFE
NCT01371721,"A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD",Major Depressive Disorder,2/8/2017,PFE
NCT01371708,"A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD",Major Depressive Disorder,12/8/2016,PFE
NCT01360554,ARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer,Non-Small Cell Lung Cancer,5/24/2017,PFE
NCT01352845,"A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.",Healthy,2/23/2016,PFE
NCT01352793,A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years,"Meningitis, Meningococcal",3/11/2015,PFE
NCT01309737,"A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis",Psoriasis,9/19/2014,PFE
NCT01302119,Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the Toenail,Onychomycosis of Toenails,8/15/2014,PFE
NCT02072824,"A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures.",Partial Onset Seizures,10/9/2018,PFE
NCT01276639,"A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis",Psoriasis,9/19/2014,PFE
NCT01271933,Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients,Fibromyalgia,9/14/2018,PFE
NCT01270971,Efficacy and Safety Evaluation of AN2690 Topical Solution to Treat Onychomycosis of the Toenail,Onychomycosis of Toenails,8/15/2014,PFE
NCT01270828,Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia,Post Herpetic Neuralgia,1/13/2016,PFE
NCT01262677,Once-A-Day Pregabalin For Partial Seizures,"Partial Seizures|Epilepsies, Partial",6/5/2018,PFE
NCT01186744,"A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis",Psoriasis,6/4/2014,PFE
NCT01154140,A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung,Non Squamous Lung Cancer,1/5/2015,PFE
NCT01057693,Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy,"Diabetic Neuropathy, Painful",2/22/2013,PFE
NCT01039688,"Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTX","Arthritis, Rheumatoid",4/6/2018,PFE
NCT01025336,Study Evaluating Persistence Of Antibody Response Elicited By 13vPnC In Healthy Adults Previously Vaccinated,Healthy,6/20/2012,PFE
NCT00991276,Polysomnography Study Of Pregabalin And Pramipexole Versus Placebo In Patients With Restless Legs Syndrome And Associated Sleep Disturbance,Restless Legs Syndrome,10/8/2012,PFE
NCT00965484,Genotropin Study Assessing Use of Injection Pen,Growth Hormone Deficiency|Idiopathic Short Stature,12/23/2010,PFE
NCT00980655,Study to Evaluate 13 Valent Pneumococcal Conjugate Vaccine (13vPnC) Vaccine Followed by 23-valent Pneumococcal Polysaccharide Vaccine (23vPS) Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients,"Vaccines, Pneumococcal Conjugate Vaccine",4/21/2014,PFE
NCT00963235,Safety & Immunogenicity of 13vPnC in HIV-Infected Subjects Aged 18 or Older Who Were Previously Immunized With 23vPS,HIV Infections|Pneumococcal Infections,6/10/2013,PFE
NCT00960440,"Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors","Arthritis, Rheumatoid",1/10/2013,PFE
NCT00932893,"An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene","Carcinoma, Non-Small-Cell Lung",6/6/2013,PFE
NCT00887224,Relapse Prevention Study Of Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder,Major Depressive Disorder,6/27/2012,PFE
NCT00883740,Effects Of Pregabalin (Lyrica) On Sleep Maintenance In Subjects With Fibromyalgia,Fibromyalgia|Sleep Disorders,8/10/2011,PFE
NCT00856544,"A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis Medications","Arthritis, Rheumatoid",1/10/2013,PFE
NCT00853385,"A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis",Rheumatoid Arthritis,1/9/2013,PFE
NCT00847613,"A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate","Arthritis, Rheumatoid",1/9/2013,PFE
NCT00814307,"A Phase 3 Study Comparing 2 Doses of CP-690,550 vs. Placebo for Treatment of Rheumatoid Arthritis","Arthritis, Rheumatoid",1/11/2013,PFE
NCT00808132,Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis,Menopause|Osteoporosis,12/20/2013,PFE
NCT00806026,Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients,Idiopathic Restless Legs Syndrome,9/27/2012,PFE
NCT00798707,Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive Disorder,Major Depressive Disorder,6/6/2011,PFE
NCT00827606,Atorvastatin Three Year Pediatric Study,Familial Hypercholesterolemia,6/2/2015,PFE
NCT00761631,Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Healthy Children Aged 15 Months to 17 Years,Healthy Subjects,8/10/2011,PFE
NCT00761267,"Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive Candidiasis",Candidemia,9/14/2018,PFE
NCT00743652,Study Evaluating the Impact of the 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Alaskan Native Children.,Pneumococcal Disease|13-valent Pneumococcal Vaccine,2/10/2012,PFE
NCT00683800,Study Evaluating The Safety And Efficacy Of Desvenlafaxine Succinate For Vasomotor Symptoms In Menopausal Women,Vasomotor Symptoms,8/17/2011,PFE
NCT00678392,Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer,Kidney Neoplasms,3/27/2012,PFE
NCT00662558,A Six Week Study Of The Pain Relieving Effects Of Celecoxib 200 Mg Twice Daily Compared To Tramadol 50 Mg Four Times Daily In Patients With Chronic Low Back Pain,Low Back Pain,11/23/2009,PFE
NCT00631371,Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects,Renal Cell Carcinoma,6/4/2013,PFE
NCT00644969,Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder,Smoking Cessation,4/15/2011,PFE
NCT00611026,Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine Extended Release(ER)in Patients With Overactive Bladder.,Overactive Bladder,1/12/2011,PFE
NCT00716859,"A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma.",Glaucoma,12/2/2010,PFE
NCT00596466,Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures,Epilepsy,9/11/2012,PFE
NCT00551135,Surgical Pain After Inguinal Hernia Repair (SPAIHR),"Pain, Postoperative|Hernia, Inguinal",7/15/2010,PFE
NCT00549549,Celebrex In Acute Gouty Arthritis Study,"Arthritis, Gouty",2/24/2011,PFE
NCT00546637,"Fesoterodine ""add-on"" Male Overactive Bladder Study",Overactive Bladder Syndrome,11/22/2010,PFE
NCT00536484,Fesoterodine Flexible Dose Study,Overactive Bladder,9/11/2009,PFE
NCT00531479,Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis,Aspergillosis,4/30/2012,PFE
NCT00521586,Study Evaluating 13 Valent Pneumococcal Conjugate Vaccine With Trivalent Inactivated Influenza Vaccine,Influenza,4/9/2015,PFE
NCT00500266,Study Evaluating Safety of 13-Valent Pneumococcal Conjugate Vaccine in Healthy Elderly Subjects,Pneumococcal Infections,9/16/2011,PFE
NCT00483548,Adjunctive Ziprasidone in the Treatment of Bipolar I Depression,"Bipolar Disorder|Depression, Bipolar",2/23/2010,PFE
NCT00474786,Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line Sunitinib,Renal Cell Carcinoma,3/7/2013,PFE
NCT00471146,Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.,"Carcinoma, Pancreatic Ductal",7/16/2012,PFE
NCT00468845,Study Of The Efficacy And Safety Of Pregabalin Compared To Placebo For Treatment Of Post-Surgical Pain From Hysterectomy,"Pain, Postoperative",5/26/2011,PFE
NCT00543439,"Study Evaluating Prophylaxis Treatment & Characterizing Efficacy, Safety, & PK Of B-Domain Deleted Recombinant FVIII",Hemophilia A,1/11/2019,PFE
NCT00457392,A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone,"Carcinoma, Non-Small Cell Lung",8/2/2011,PFE
NCT00448916,Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures,"Epilepsies, Partial",12/2/2014,PFE
NCT00444925,Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB),Overactive Bladder,9/3/2009,PFE
NCT00442546,Efficacy And Safety Of Pregabalin For Pain Following Total Knee Replacement,Osteoarthritis|Postoperative Pain,8/18/2010,PFE
NCT00435409,A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer,Breast Neoplasms,1/13/2011,PFE
NCT00427895,Study Comparing a 13-valent Pneumococcal Conjugate Vaccine With 23-valent Pneumococcal Polysaccharide Vaccine in Adults,Pneumococcal Infections,9/5/2012,PFE
NCT00425100,A Clinical Trial To Assess Fesoterodine On Treatment Satisfaction And Symptom Improvement In Overactive Bladder Patients,Overactive Bladder,2/10/2009,PFE
NCT00420992,"A Study of Embeda (Kadian NT, ALO-01) in Subjects With Pain Due to Osteoarthritis of the Hip or Knee",Osteoarthritis|Chronic Pain,10/30/2009,PFE
NCT00415597,"Study of Embeda (Kadian NT, ALO-01) in Subjects With Chronic Moderate to Severe Nonmalignant Pain",Pain,10/29/2009,PFE
NCT00413699,"Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis","Arthritis, Rheumatoid",3/27/2018,PFE
NCT00413010,Pregabalin in the Treatment of Patients With Generalized Anxiety Disorder (GAD).,Generalized Anxiety Disorder,12/2/2009,PFE
NCT00407745,A 17-Week Trial To Assess Pregabalin For The Treatment Of Nerve Pain Due To Spinal Cord Injury,Neuralgia|Spinal Cord Injuries,12/8/2011,PFE
NCT00401245,The Effect Of Dose Titration And Dose Tapering On The Tolerability Of DVS SR In Women With Vasomotor Symptoms,Vasomotor Symptoms,10/12/2011,PFE
NCT00396097,"Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature",Idiopathic Short Stature,11/13/2013,PFE
NCT02187744,A Study Of PF-05280014 Or Trastuzumab Plus Taxotere® And Carboplatin In HER2 Positive Breast Cancer In The Neoadjuvant Setting (REFLECTIONS B327-04),Early Breast Cancer,4/7/2017,PFE
NCT00384033,Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive Disorder,"Depressive Disorder, Major",3/15/2012,PFE
NCT00375674,A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer,Kidney Neoplasms,8/18/2017,PFE
NCT00373958,Study Comparing 13-valent Pneumococcal Conjugate Vaccine With 7-valent Pneumococcal Conjugate Vaccine,"Vaccines, Pneumococcal",2/21/2013,PFE
NCT00373256,A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer,Breast Neoplasms,10/8/2010,PFE
NCT00393939,Study Of Sunitinib In Combination With Docetaxel Vs Docetaxel In Patients With Advanced Breast Cancer,Breast Neoplasms,2/28/2011,PFE
NCT00348374,Exubera vs Lispro in a Lantus-based Regimen for Improved Glycemic Control in Type 2 Diabetes,Diabetes Mellitus,3/16/2010,PFE
NCT00918580,Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Children With Sickle Cell Disease,Pneumococcal Conjugate Vaccine,4/21/2014,PFE
NCT00319501,Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures.,"Seizures|Epilepsies, Partial|Epilepsy, Complex Partial|Epilepsy, Generalized|Epilepsy",8/16/2016,PFE
NCT00312494,3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects,Bipolar Disorder,1/22/2010,PFE
NCT00285012,Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).,Smoking Cessation,12/3/2009,PFE
NCT00282464,A Six-Week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression.,Bipolar Disorder,6/2/2009,PFE
NCT00280566,Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed),Bipolar Mania|Bipolar Disorder,12/14/2009,PFE
NCT00265330,Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed),Bipolar Disorder,4/3/2009,PFE
NCT00264875,Open Label Safety And Efficacy Study Of Pregabalin In Subjects With Nerve Pain Asociated With Human Immunodeficiency Virus (HIV) Neuropathy,Peripheral Neuropathy|HIV Infections,3/23/2009,PFE
NCT00257166,Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed),Bipolar Disorder,7/19/2013,PFE
NCT00232180,A Comparison Of Outcomes In Patients In New York Heart Association (NYHA) Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure Medicines,Heart Failure,6/27/2011,PFE
NCT00232141,Study of Pregabalin Versus Placebo in the Treatment of Nerve Pain Associated With HIV Neuropathy,HIV Infections|Peripheral Neuropathy,8/11/2009,PFE
NCT00242710,Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women,Endometrial Hyperplasia|Osteoporosis,12/20/2013,PFE
NCT00205777,Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women,Osteoporosis,4/10/2013,PFE
NCT00159861,The Efficacy and Safety of Sildenafil Citrate Used in Combination With Intravenous Epoprostenol in PAH,Pulmonary Hypertension,1/12/2011,PFE
NCT00159874,A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children,Pulmonary Arterial Hypertension,8/11/2014,PFE
NCT00141271,A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression,Bipolar Disorder,3/24/2009,PFE
NCT00139659,A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With Asthma,Asthma|Diabetes Mellitus,5/12/2010,PFE
NCT00159913,"A Randomized, Double-Blind, Placebo-Controlled Study of Sildenafil in Children With Pulmonary Arterial Hypertension.","Pulmonary Arterial Hypertension, Children",7/21/2009,PFE
NCT00117598,Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL),Lymphoma,3/6/2012,PFE
NCT00101686,Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.,Colorectal Neoplasms,11/26/2009,PFE
NCT00083889,SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma,"Carcinoma, Renal Cell",12/10/2009,PFE
NCT00075218,A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST),Gastrointestinal Stromal Tumor,9/28/2009,PFE
NCT00065468,Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma,"Carcinoma, Renal Cell|Kidney Neoplasms",10/25/2012,PFE
NCT00364182,Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia B,Hemophilia B,8/23/2011,PFE
NCT00036270,Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane,Breast Neoplasms,12/4/2009,PFE
NCT00712348,Switchover Trial From Imiglucerase to Plant Cell Expressed Recombinant Human Glucocerebrosidase,Gaucher Disease,6/5/2014,PFE
NCT00376168,A Phase III Trial to Assess the Safety and Efficacy of Plant Cell Expressed GCD in Patients With Gaucher Disease,Gaucher Disease,7/26/2012,PFE
NCT00282984,Efficacy and Safety of Varenicline in Smokers With Cardiovascular Disease Who Wish to Quit Smoking,Smoking Cessation,4/29/2009,PFE
NCT00098748,"Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced NonCCR5-Tropic HIV-1 Infected Subjects",HIV Infections,10/21/2010,PFE
NCT00098722,"Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects",HIV Infections,5/16/2012,PFE
NCT00098306,"Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects",HIV Infections,4/27/2012,PFE
NCT00705939,Plant Cell Expressed Recombinant Human Glucocerebrosidase Extension Trial,Gaucher Disease,7/15/2014,PFE
NCT00605280,"A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension.",Macular Edema Associated With Diabetes Mellitus,3/30/2011,PFE
NCT00409175,Safety and Efficacy Study of Fx-1006A in Patients With Familial Amyloidosis,Familial Amyloid Polyneuropathy,12/17/2012,PFE
NCT00669331,Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis,Bronchiectasis,4/29/2016,
NCT01188564,"Efficacy, Safety and Immunogenicity Study of Recombinant Human C1 Inhibitor for the Treatment of Acute HAE Attacks",Hereditary Angioedema,8/7/2015,
NCT00233402,Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy,Bladder Cancer,10/11/2013,
NCT01056341,Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy,Infantile Hemangioma,6/24/2014,
NCT00556478,"Efficacy, Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment Premature Ejaculation",Premature Ejaculation,9/26/2016,
NCT01515657,Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated and Immediate Release Aspirin in Diabetic Patients,"Diabetes Mellitus, Type 2",9/4/2015,PLXP
NCT02008942,Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated Aspirin in Diabetic Patients,"Diabetes Mellitus, Type 2",9/4/2015,PLXP
NCT00069784,The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention),"Diabetes Mellitus, Non-Insulin-Dependent",1/25/2013,
NCT02220725,A Study in Older Subject to Evaluate the Safety and Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Rivaroxaban,Bleeding,9/25/2018,PTLA
NCT02207725,A Study in Older Subjects to Evaluate the Safety and Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Apixaban,Bleeding,9/27/2018,PTLA
NCT01583218,Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study),Venous Thromboembolism (VTE),9/20/2017,PTLA
NCT00995410,Study to Evaluate the Long-Term Safety of PA32540 in Subjects Who Are at Risk for Developing Aspirin-Associated Gastric Ulcers,Aspirin-Associated Gastric Ulcers,2/17/2016,
NCT00961350,A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers,Gastric Ulcer,1/21/2016,
NCT00960869,Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers,Gastric Ulcer,2/17/2016,
NCT00665431,Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis,Osteoarthritis,12/6/2011,
NCT00664560,Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis,Osteoarthritis,2/27/2012,
NCT00527904,"A 12-month, Phase 3, Open-label, Multi-center Study to Evaluate the Long-term Safety of PN400 (VIMOVO)",Gastric Ulcer,8/20/2010,
NCT00527787,Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxen,Gastric Ulcer,12/28/2010,
NCT00817206,Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily,Renal Failure,9/10/2015,
NCT02452190,Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood Eosinophils,Asthma,2/6/2019,
NCT01919801,Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Induced Angioedema,Angiotensin Converting Enzyme Inhibitor Induced Angioedema,10/10/2016,
NCT00552344,A Study to Evaluate Safety of Long Term Therapy of Certolizumab Pegol Patients With Crohn's Disease,Crohn Disease,1/21/2016,
NCT02635204,A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis,Psoriasis,4/13/2018,
NCT02445807,A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis,Chronic Stable Plaque Psoriasis,4/13/2018,
NCT01967069,A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis,Psoriasis,3/13/2017,
NCT01947491,"A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis",Psoriasis,10/6/2016,
NCT01959945,"Safety, Reactogenicity and Immunogenicity of Flublok Quadrivalent (Recombinant Influenza Vaccine,Seasonal Formulation)",Influenza,8/2/2016,
NCT00539864,"Safety and Reactogenicity of FluBlok and Comparison of Immunogenicity, Efficacy and Effectiveness Against TIV",Influenza,7/27/2011,
NCT02285998,Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age,Influenza,10/4/2016,
NCT01825200,"Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age",Influenza,2/18/2015,
NCT02110901,A Study of PRT-201 Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-1),Chronic Kidney Disease,7/9/2019,PRTO
NCT01999777,Study to Evaluate the Safety and Efficacy of USL261 in Patients With Increased Bouts of Seizure Activity in the EMU,Epilepsy,11/27/2018,
NCT01452529,Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain,Chronic Low Back Pain,12/4/2014,
NCT01400139,Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period.,Chronic Nonmalignant and Nonneuropathic Pain,12/4/2014,
NCT01369615,Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001,Pain,1/15/2015,
NCT01358526,Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain,Low Back Pain,9/3/2014,
NCT01324570,"Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children",Pain,7/6/2017,
NCT01192295,Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids,Pain,2/6/2015,
NCT01151098,Safety of Buprenorphine Transdermal Systems in Subjects With Chronic Nonmalignant Pain - a 28-week Extension Study,Chronic Nonmalignant Pain,9/23/2010,
NCT01141283,Safety of BTDS in Subjects With Osteoarthritic (OA) Pain of Hip or Knee: A 6-Month Open-label Extension Phase,Osteoarthritis,9/21/2010,
NCT00531427,Buprenorphine Transdermal System (BTDS) in Subjects w/Mod-sev Osteoarthritis (OA) Chronic Pain of Knee,Chronic Pain|Osteoarthritis of the Knee,9/21/2010,
NCT00490919,Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Chronic Low Back Pain,Low Back Pain,9/9/2010,
NCT00315445,The Safety and Efficacy of the Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Back Pain.,Back Pain,8/10/2011,
NCT00313846,Safety and Efficacy of Buprenorphine Transdermal System in Subjects With Moderate to Severe Osteoarthritis of Hip or Knee,Osteoarthritis,9/28/2010,
NCT00312572,Safety and Efficacy of Dose Conversion From Vicodin® to Buprenorphine Transdermal System (Butrans™) in Subjects With OA Pain,Osteoarthritis,9/23/2010,
NCT03172481,PRC-063 Classroom Study in Children (6-12 Years of Age) With ADHD,ADHD,6/4/2019,
NCT02139124,The Efficacy and Safety of PRC-063 in Adult ADHD Patients,ADHD,5/7/2019,
NCT00400179,A Safety and Efficacy Study in Patients With Gastric Cancer,Gastric Cancer,4/23/2012,
NCT01343004,Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women,Osteoporosis|Postmenopausal Osteoporosis,3/1/2017,RDUS
NCT01986361,Placebo-Controlled Onset-of-Action Study of Flurbiprofen Utilizing the Double-Stopwatch Method,Acute Pharyngitis|Sore Throat,8/24/2017,
NCT01049334,A Study of Flurbiprofen 8.75 mg Lozenge in Patient With Pharyngitis,Pharyngitis,9/21/2017,
NCT01048866,A Study of Flurbiprofen 8.75 mg Lozenge in Patients With Pharyngitis,Pharyngitis,9/21/2017,
NCT01537081,Safety and Efficacy of Mucinex and IR Guaifenesin the Treatment of Symptoms of Acute Upper Respiratory Tract Infections,Acute Upper Respiratory Tract Infection,9/12/2013,
NCT02678286,Evaluation of N1539 Following Abdominoplasty Surgery,"Pain, Post-operative",2/14/2018,REPH
NCT02675907,Evaluation of N1539 Following Bunionectomy Surgery,"Pain, Post-operative",9/29/2017,REPH
NCT02246439,BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis,Gastroenteritis|Gastritis,2/20/2019,RDHL
NCT01980095,ERADICATE Hp - Treating Helicobacter Pylori With RHB-105,Dyspepsia|Helicobacter Pylori Infection,1/10/2017,RDHL
NCT03054428,"Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis","Moderate-to-Severe Atopic Dermatitis|Dermatitis, Dermatitis Atopic|Eczema, Skin Diseases, Skin|Diseases Genetic, Genetic|Diseases Inborn, Skin|Disease, Eczematous Skin|Hypersensitivity, Immediate|Hypersensitivity, Immune System Diseases|Dermatitis, Atopic",7/23/2019,REGN
NCT02912468,A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal Polyps,Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP),7/25/2019,REGN
NCT02585778,Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin),Hypercholesterolaemia,5/17/2018,REGN
NCT02528214,Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma,Asthma,10/23/2018,REGN
NCT02414854,Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest),Asthma,10/23/2018,REGN
NCT02277769,Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis,"Dermatitis, Atopic",10/16/2017,REGN
NCT02277743,Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis,"Dermatitis, Atopic",11/21/2017,REGN
NCT02260986,Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis,Atopic Dermatitis,10/17/2017,REGN
NCT02121210,To Evaluate the Immunogenicity and Safety of Sarilumab Administered as Monotherapy in Patients With Rheumatoid Arthritis (RA),Rheumatoid Arthritis,6/20/2017,REGN
NCT02057250,To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis,RA,6/20/2017,REGN
NCT02023879,Phase III Study To Evaluate Alirocumab in Patients With Hypercholesterolemia Not Treated With a Statin (ODYSSEY CHOICE II),Hypercholesterolemia,3/15/2017,REGN
NCT01954394,Open Label Study of Long Term Safety Evaluation of Alirocumab,Hypercholesterolemia,7/24/2018,REGN
NCT01926782,Study to Evaluate the Efficacy and Safety of an Every Four Weeks Treatment Regimen of Alirocumab (REGN727/ SAR236553) in Patients With Primary Hypercholesterolemia (ODYSSEY CHOICE 1),Hypercholesterolemia,3/21/2017,REGN
NCT01768572,To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN),Rheumatoid Arthritis,6/26/2017,REGN
NCT01730053,Study of Alirocumab (REGN727/SAR236553) added-on to Rosuvastatin Versus Other Lipid Modifying Treatments (LMT) (ODYSSEY OPTIONS II),Hypercholesterolemia,10/28/2015,REGN
NCT01730040,Study of the Efficacy and Safety of Alirocumab (REGN727/SAR236553) in Combination With Other Lipid-modifying Treatment (LMT) (ODYSSEY OPTIONS I),Hypercholesterolemia,8/31/2015,REGN
NCT01709578,To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET),Rheumatoid Arthritis,8/8/2017,REGN
NCT01709513,"Study of Alirocumab (REGN727/SAR236553) in Patients With Primary Hypercholesterolemia and Moderate, High, or Very High Cardiovascular (CV) Risk, Who Are Intolerant to Statins (ODYSSEY ALTERNATIVE)",Hypercholesterolemia,8/28/2015,REGN
NCT01663402,ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab,Atherosclerotic Cardiovascular Disease,3/18/2019,REGN
NCT01644188,Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe on Top of Statin in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY COMBO II),Hypercholesterolemia,11/6/2015,REGN
NCT01644175,Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia (ODYSSEY COMBO I),Hypercholesterolemia,11/6/2015,REGN
NCT01623115,Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy,Hypercholesterolemia,11/4/2015,REGN
NCT01617655,Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia (ODYSSEY HIGH FH),Hypercholesterolaemia,11/6/2015,REGN
NCT01571284,Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen,Colorectal Cancer Metastatic,2/27/2018,REGN
NCT01507831,Long-term Safety and Tolerability of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY Long Term),Hypercholesterolemia,12/22/2015,REGN
NCT01644474,Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe in Patients With Hypercholesterolemia,Hypercholesterolemia,11/6/2015,REGN
NCT02325791,Study to Evaluate the Efficacy and Safety of Suptavumab (REGN2222) for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants,Respiratory Syncytial Virus Infections,11/6/2018,REGN
NCT00856206,Review of Safety Using Rilonacept in Preventing Gout Exacerbations (RE-SURGE),Gout,4/28/2017,REGN
NCT00855920,Study Utilizing Rilonacept in Gout Exacerbations,Acute Gout Flare,4/28/2017,REGN
NCT00829829,PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1,Intercritical Gout,4/28/2017,REGN
NCT00288704,Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS),"Familial Cold Autoinflammatory Syndrome (FCAS)|Familial Cold Urticaria|Muckle-Wells Syndrome (MWS)|Genetic Diseases, Inborn",11/13/2009,REGN
NCT01061736,Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients,Rheumatoid Arthritis,6/28/2017,REGN
NCT00532155,A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer,Carcinoma|Non Small Cell Lung,1/1/2013,REGN
NCT00519285,Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer,Prostatic Neoplasms|Neoplasm Metastasis,10/10/2013,REGN
NCT00327444,Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites,Ovarian Neoplasms|Ascites,1/1/2013,REGN
NCT01810939,"A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL)",Chronic Kidney Disease (CKD)|Hyperkalemia (HK),12/15/2015,
NCT01739595,Phase III Study to Evaluate Morning Testosterone Normalization in Overweight Men With Secondary Hypogonadism,Secondary Hypogonadism,5/27/2015,
NCT01534208,Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism,Secondary Hypogonadism,7/24/2014,
NCT01532414,Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary Hypogonadism,Secondary Hypogonadism,5/27/2015,
NCT02683772,Astral VAPS AutoEPAP Clinical Trial,Upper Airway Obstruction|Respiratory Insufficiency|Respiratory Failure,7/26/2019,RMD
NCT01115582,Efficacy of To Be Marketed (TBM) Cholic Acid Capsules Used to Treat Children With Inborn Errors of Bile Acid Synthesis,Inborn Errors of Bile Acid Synthesis,12/9/2016,RTRX
NCT02059135,"Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia",Preeclampsia,8/9/2017,
NCT00110513,Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery,Antithrombin III Deficiency,5/11/2012,
NCT00056550,Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations.,"Antithrombin Deficiency, Congenital",10/16/2012,
NCT01844830,"Comparison of Intranasal Kovacaine Mist, and Placebo for Anesthetizing Maxillary Teeth in Pediatric Patients",Anesthesia,8/30/2017,
NCT01745380,"Comparison of Intranasal Kovacaine Mist, and Placebo for Anesthetizing Maxillary Teeth in Adults",Anesthesia,1/31/2017,
NCT01710787,"Comparison of Intranasal Kovacaine Mist, Tetracaine Alone, and Placebo for Anesthetizing Maxillary Teeth in Adults",Anesthesia,8/30/2017,
NCT02076399,A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP),Immune Thrombocytopenic Purpura,1/11/2019,RIGL
NCT02076412,A Efficacy and Safety Study of Fostamatinib in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP),Immune Thrombocytopenic Purpura,1/25/2019,RIGL
NCT00955747,Naturlose (D-Tagatose) Efficacy Evaluation Trial,Type 2 Diabetes,11/19/2014,
NCT01503021,Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in CKD Patients Receiving Chronic Hemodialysis,End Stage Renal Disease|Chronic Kidney Disease,4/21/2015,RMTI
NCT01322347,Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients (CRUISE 2),Renal Failure Chronic Requiring Hemodialysis,4/24/2015,RMTI
NCT01320202,Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients,Renal Failure Chronic Requiring Hemodialysis,4/28/2015,RMTI
NCT01227421,Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza,Influenza,1/8/2014,
NCT00082433,Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer,Cancer|Breast Cancer,8/17/2009,
NCT00080301,Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer,Breast Cancer|Metastases,8/17/2009,
NCT00255970,Regenafil Versus Demineralized Freeze Dried Bone Allograft (DFDBA) for Periodontal Defects,Periodontal Diseases,8/5/2011,RTIX
NCT00821873,Evaluation of the CR Plug for Repair of Defects Created at the Harvest Site From an Autograft in the Knee.,Knee Injury,11/6/2013,RTIX
NCT00324896,"Treatment of Insomnia in Patients With Parkinson's Disease: A Multi-site, Placebo-controlled Study of Eszopiclone",Parkinson's Disease|Insomnia,5/31/2013,
NCT02942017,A Study to Evaluate Safety and Efficacy of SAGE-547 in Participants With Moderate Postpartum Depression (547-PPD-202C),Postpartum Depression,6/13/2019,SAGE
NCT02942004,A Study to Evaluate Efficacy and Safety of SAGE-547 in Participants With Severe Postpartum Depression (547-PPD-202B),Postpartum Depression,6/13/2019,SAGE
NCT02477618,A Study With SAGE-547 for Super-Refractory Status Epilepticus,Super-Refractory Status Epilepticus,5/2/2019,SAGE
NCT01516736,Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim,Chemotherapy-induced Neutropenia|Breast Cancer,6/28/2017,
NCT02638259,Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis,Rheumatoid Arthritis,2/23/2018,
NCT01693029,Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa,Anemia|Chronic Kidney Disease (CKD),5/12/2017,
NCT00619957,Efficacy and Safety of Risedronate Therapy Administered 35 mg Once A Week in Men With Osteoporosis,Other Osteoporosis,10/28/2011,GCVRZ
NCT00885105,Evaluation of Responses to Fluzone® in Infants ≥ 6 Months of Age Who Did or Did Not Receive Fluzone® at 2 Months of Age,Influenza,1/1/2010,GCVRZ
NCT00247273,A Study of Monthly Risedronate for Osteoporosis,Postmenopausal Osteoporosis,6/21/2011,GCVRZ
NCT02787551,"Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period",Type 2 Diabetes Mellitus,6/12/2019,GCVRZ
NCT02735044,Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes Mellitus,Type 1 Diabetes Mellitus,6/19/2019,GCVRZ
NCT02320721,Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications,Type 2 Diabetes Mellitus,7/11/2017,GCVRZ
NCT02294474,Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin Glargine,Type 2 Diabetes Mellitus,1/18/2018,GCVRZ
NCT02273180,Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine,Type 1 Diabetes Mellitus,1/18/2018,GCVRZ
NCT02058160,Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes,Type 2 Diabetes,2/10/2017,GCVRZ
NCT02058147,Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM,Type 2 Diabetes,2/10/2017,GCVRZ
NCT01798706,Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients,Type 2 Diabetes,10/14/2016,GCVRZ
NCT01768559,Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic Patients,Type 2 Diabetes,1/4/2017,GCVRZ
NCT01712984,Study of Intradermal Quadrivalent Influenza Vaccine in Adults Aged 18 Through 64 Years,Influenza,2/10/2014,GCVRZ
NCT01683266,Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus,Type 1 Diabetes Mellitus,4/23/2015,GCVRZ
NCT01676220,Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy,Type 2 Diabetes Mellitus,4/23/2015,GCVRZ
NCT01517412,Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin,Type 2 Diabetes Mellitus,10/14/2016,GCVRZ
NCT01499095,Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy,Type 2 Diabetes Mellitus,4/23/2015,GCVRZ
NCT01499082,Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin,Type 2 Diabetes Mellitus,4/23/2015,GCVRZ
NCT01346293,Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age,Tetanus|Diphtheria|Pertussis|Measles|Polio,5/29/2015,GCVRZ
NCT01308580,Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer,Prostate Cancer,10/11/2016,GCVRZ
NCT01308567,Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer,Prostate Cancer,3/3/2017,GCVRZ
NCT01240746,Study of Quadrivalent Influenza Vaccine Among Children,Influenza,1/14/2014,GCVRZ
NCT01218646,Study of Quadrivalent Influenza Vaccine Among Adults,Influenza,9/12/2013,GCVRZ
NCT01147250,Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide),Acute Coronary Syndrome,10/14/2016,GCVRZ
NCT00976937,24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 Years,Type 2 Diabetes Mellitus,10/11/2016,GCVRZ
NCT00975286,24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine,Type 2 Diabetes Mellitus,10/11/2016,GCVRZ
NCT00993473,6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes,Type 1 Diabetes Mellitus,6/22/2012,GCVRZ
NCT00772928,Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™,Diphtheria|Tetanus|Haemophilus Infection|Pertussis|Polio,2/12/2010,GCVRZ
NCT00772109,Study of Fluzone Vaccine Administered by Intradermal Route in Comparison With Standard Fluzone® in Adults,Orthomyxoviridae Infection|Influenza|Myxovirus Infection,8/10/2011,GCVRZ
NCT00763815,"GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone",Diabetes Mellitus Type 2,10/11/2016,GCVRZ
NCT00751881,An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis,Multiple Sclerosis,6/26/2013,GCVRZ
NCT00622700,Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis,Multiple Sclerosis,12/19/2014,GCVRZ
NCT00483574,Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers,Meningococcal Meningitis|Measles|Mumps|Rubella|Varicella,7/6/2011,GCVRZ
NCT00467519,Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age,Tetanus|Diphtheria|Pertussis,12/3/2010,GCVRZ
NCT00422292,Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers,Meningococcal Meningitis|Measles|Mumps|Rubella|Varicella,6/2/2011,GCVRZ
NCT00391053,"Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly",Orthomyxoviridae Infection|Influenza|Myxovirus Infection,4/30/2010,GCVRZ
NCT00384397,"A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers",Meningococcal Meningitis|Measles|Mumps|Rubella|Varicella,6/2/2011,GCVRZ
NCT00314132,Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis.,Encephalitis|Japanese Encephalitis,12/5/2012,GCVRZ
NCT00258895,Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL®,Diphtheria|Tetanus|Pertussis,9/28/2009,GCVRZ
NCT00255047,Safety and Immune Response of Different Pediatric Combination Vaccines.,Diphtheria|Polio|Pertussis,11/10/2010,GCVRZ
NCT00230178,Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome,Tumor Lysis Syndrome|Cancer|Hyperuricemia,12/31/2009,GCVRZ
NCT00314145,A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX,Japanese Encephalitis,12/5/2012,GCVRZ
NCT00803049,Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple Sclerosis,Multiple Sclerosis,1/30/2017,GCVRZ
NCT00132301,Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma,Prostate Cancer,6/25/2018,GCVRZ
NCT00851903,Evaluation of Insulin Glargine in Combination With Sitagliptin in Type 2 Diabetes Patients: EASIE Extension Trial,"Diabetes Mellitus, Type 2",10/4/2012,GCVRZ
NCT00763451,"GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin","Diabetes Mellitus, Type 2",12/14/2016,GCVRZ
NCT00715624,"GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin","Diabetes Mellitus, Type 2",10/11/2016,GCVRZ
NCT00713830,"GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Sulfonylurea","Diabetes Mellitus, Type 2",12/14/2016,GCVRZ
NCT00712673,"GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin","Diabetes Mellitus, Type 2",12/15/2016,GCVRZ
NCT00707031,"GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin","Diabetes Mellitus, Type 2",10/11/2016,GCVRZ
NCT00688701,GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy,"Diabetes Mellitus, Type 2",12/12/2016,GCVRZ
NCT00549939,Alfuzosin Treatment in Children and Adolescents With Neurogenic Urinary Bladder Dysfunction,Neurogenic Urinary Bladder,2/8/2011,GCVRZ
NCT00489736,Efficacy & Safety of Dronedarone Versus Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation,Atrial Fibrillation,11/9/2009,GCVRZ
NCT00417079,XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer,Neoplasms|Prostatic Neoplasms,12/23/2010,GCVRZ
NCT00283062,Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy,Prostatic Neoplasms,1/23/2012,GCVRZ
NCT00174785,A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation,Atrial Fibrillation|Atrial Flutter,12/23/2009,GCVRZ
NCT00134563,Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis,Multiple Sclerosis,11/6/2012,GCVRZ
NCT01358266,Study Assessing Double-masked Uveitis Treatment,"Uveitis; Posterior, Disorder",7/16/2019,
NCT00697073,Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients,Friedreich's Ataxia,8/4/2011,
NCT00537680,"Study to Assess the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia",Friedreich's Ataxia,12/29/2011,
NCT01027884,Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD),"Muscular Dystrophy, Duchenne|Ambulatory Care",10/19/2015,
NCT00536744,Effectiveness of dermaPACE™ Device and Standard Treatment Compared to Standard Treatment Alone for Diabetic Foot Ulcers,Diabetic Foot Ulcers,4/14/2014,
NCT00675103,Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients,Chronic Gout Refractory to Conventional Therapy,6/28/2011,
NCT01356498,Open-Label Extension Study for Patients Who Completed a Phase 3 Double-blind Study of PEG-uricase for Symptomatic Gout,Gout,12/2/2011,
NCT00325195,Safety and Efficacy Study of PEG-uricase in the Treatment of Hyperuricemic Patients With Symptomatic Gout,Gout,2/25/2011,
NCT00475852,A Study Testing the Effectiveness of Nesiritide in Patients With Acute Decompensated Heart Failure,Heart Decompensation,5/10/2012,
NCT00450112,Gel-200 Extension and Open-Label Study in Osteoarthritis of the Knee,Osteoarthritis of the Knee,8/22/2011,
NCT00449696,Gel-200 Versus Placebo in Osteoarthritis of the Knee,Osteoarthritis of the Knee,9/15/2011,
NCT02914275,A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age.,"Influenza, Human",1/23/2019,
NCT02545543,A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 5 Through 17 Years of Age,"Influenza, Human",4/18/2017,
NCT02214225,A Study to Evaluate the Immunogenicity and Safety of bioCSL Quadrivalent Influenza Vaccine (QIV) in Adults Aged 18 Years and Above.,"Influenza, Human",2/23/2016,
NCT00959049,A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine in a Pediatric Population,Influenza,7/29/2011,
NCT03331042,SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.,Transient Insomnia,6/5/2019,
NCT01993940,Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation,Opioid-induced Constipation,5/30/2017,
NCT01965652,Long Term Safety of Naldemedine,Opioid-induced Constipation,5/30/2017,
NCT01965158,Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation,Opioid-induced Constipation,5/30/2017,
NCT00723190,"Open-Label, Chronic Exposure, Safety Study of CLONICEL (Clonidine HCl Sustained Release) in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)",Attention Deficit Hyperactivity Disorder,2/27/2012,
NCT00491894,Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions,Cerebral Palsy|Neurological Conditions|Mental Retardation|Sialorrhea,7/9/2012,
NCT00262080,Efficacy and Safety Study of DX-88 to Treat Acute Attacks of Hereditary Angioedema (HAE),Hereditary Angioedema (HAE),5/11/2010,SHPGF
NCT00097695,Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema,Angioedema,12/24/2013,SHPGF
NCT00506285,Methylphenidate Transdermal System (MTS) in the Treatment of Adult ADHD,Attention Deficit Hyperactivity Disorder,1/16/2015,SHPGF
NCT01560403,"A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021",Short Bowel Syndrome,12/25/2014,SHPGF
NCT00697515,Safety and Efficacy Workplace Environment Study of Lisdexamfetamine Dimesylate (LDX) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD),ADHD,2/1/2010,SHPGF
NCT02682381,Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition,Short Bowel Syndrome,10/16/2018,SHPGF
NCT02604407,Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD),Attention Deficit Hyperactivity Disorder (ADHD),6/14/2017,SHPGF
NCT02584959,Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema,Hereditary Angioedema (HAE),11/28/2018,SHPGF
NCT02466425,Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD),Attention Deficit Hyperactivity Disorder (ADHD),3/20/2017,SHPGF
NCT02284516,A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3),Dry Eye Disease,3/15/2017,SHPGF
NCT02009163,Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder,Binge Eating Disorder,4/1/2016,SHPGF
NCT01952080,"A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome",Short Bowel Syndrome,9/14/2015,SHPGF
NCT01743729,A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye,Dry Eye Disease,2/24/2017,SHPGF
NCT01718509,SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder,Binge Eating Disorder,8/21/2014,SHPGF
NCT01718483,SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder,Binge Eating Disorder,7/21/2014,SHPGF
NCT01657019,Open Label Extension in Adults With Binge Eating Disorder (BED),Binge Eating Disorder,12/15/2015,SHPGF
NCT01636206,Safety Study of Lifitegrast to Treat Dry Eye,Dry Eye Disease,10/3/2016,SHPGF
NCT01436162,Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder,Major Depressive Disorder,11/7/2014,SHPGF
NCT01436149,Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder,Major Depressive Disorder,11/19/2014,SHPGF
NCT01421498,Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE) (OPUS-1),Keratoconjunctivitis Sicca|Dry Eye Disease,2/24/2017,SHPGF
NCT01386658,"A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema",Hereditary Angioedema (HAE),3/25/2019,SHPGF
NCT01268098,Study of Safety and Efficacy of a rhPTH[1-84] of Fixed Doses of 25 and 50 mcg in Adults With Hypoparathyroidism (RELAY),Hypoparathyroidism,3/6/2015,SHPGF
NCT01244490,Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD),Attention Deficit Hyperactivity Disorder,7/14/2014,SHPGF
NCT01106430,Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate,Attention-Deficit/Hyperactivity Disorder,6/24/2013,SHPGF
NCT01081145,Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD),Attention-deficit/Hyperactivity Disorder,6/9/2014,SHPGF
NCT01081132,Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl,Attention-Deficit/Hyperactivity Disorder,5/23/2014,SHPGF
NCT01005888,C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks,Hereditary Angioedema,6/3/2010,SHPGF
NCT00997984,Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study),Attention-Deficit/Hyperactivity Disorder,10/26/2011,SHPGF
NCT00912093,A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3),Hereditary Angioedema,8/6/2014,SHPGF
NCT00764868,Vyvanse Adolescent Open-Label Safety and Efficacy Extension Study,ADHD,3/28/2011,SHPGF
NCT00735371,Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD),Attention Deficit Hyperactivity Disorder (ADHD),2/23/2010,SHPGF
NCT00734578,Efficacy and Safety of SPD503 in Combination With Psychostimulants,ADHD,11/23/2010,SHPGF
NCT00732615,Use of NPSP558 in the Treatment of Hypoparathyroidism,Hypoparathyroidism,3/6/2015,SHPGF
NCT00635427,An Open-Label Extension Study of GA-GCB ERT in Patients With Type 1 Gaucher Disease,"Gaucher Disease, Type 1",1/28/2014,SHPGF
NCT00545740,Prevention of Recurrence of Diverticulitis,Diverticulitis,1/25/2013,SHPGF
NCT00545103,Prevention of Recurrence of Diverticulitis,Diverticulitis,12/19/2012,SHPGF
NCT00497796,Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients,Cytomegalovirus Infections,6/4/2015,SHPGF
NCT00500149,A Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD),ADHD,6/5/2009,SHPGF
NCT00462709,Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks,Hereditary Angioedema,5/3/2010,SHPGF
NCT00457015,Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE),Hereditary Angioedema (HAE),5/4/2010,SHPGF
NCT00456508,Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE),Hereditary Angioedema (HAE),12/28/2012,SHPGF
NCT00441545,Head to Head Study Against Sevelamer Hydrochloride,"Chronic Kidney Disease, Stage 5",8/13/2009,SHPGF
NCT00438815,Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks,Hereditary Angioedema,6/9/2010,SHPGF
NCT00411645,Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients,Cytomegalovirus Infections,6/3/2015,SHPGF
NCT00367835,SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms,ADHD,11/26/2009,SHPGF
NCT00289211,C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks,Hereditary Angioedema,6/2/2010,SHPGF
NCT00151892,Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis,Ulcerative Colitis,9/21/2010,SHPGF
NCT00172185,Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458),Short Bowel Syndrome,4/23/2013,SHPGF
NCT00081458,Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome,Short Bowel Syndrome,7/15/2013,SHPGF
NCT00864851,Safety and Efficacy Study of Several Replagal Dosing Regimens on Cardiac Function in Adults With Fabry Disease,Fabry Disease,6/6/2014,SHPGF
NCT00784654,"Double-blind, Placebo-controlled, Randomised Withdrawal, Extension, Safety and Efficacy Study of LDX in Children and Adolescents Aged 6-17",ADHD,10/2/2012,SHPGF
NCT02052141,Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary Angioedema,Hereditary Angioedema (HAE),8/28/2018,SHPGF
NCT01124643,Extension Study of TKT028 Evaluating Safety and Clinical Outcomes of Replagal® in Adult Patients With Fabry Disease,Fabry Disease,8/22/2014,SHPGF
NCT00630747,Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Idursulfase,Hunter Syndrome|Mucopolysaccharidosis II (MPS II),3/17/2014,SHPGF
NCT00478647,Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase,Gaucher Disease,9/2/2010,SHPGF
NCT00069641,Iduronate-2-sulfatase Enzyme Replacement Therapy in Mucopolysaccharidosis II (MPS II),Mucopolysaccharidosis II,5/13/2015,SHPGF
NCT02055118,Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment,Hunter Syndrome,12/13/2018,SHPGF
NCT00553631,Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) ERT Compared With Imiglucerase in Type I Gaucher Disease,"Gaucher Disease, Type 1",1/4/2011,SHPGF
NCT01685567,Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure,Carotid Artery Disease,3/6/2017,SILK
NCT00430092,Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002b),Inflammation,7/2/2009,
NCT00429923,Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002a),Inflammation,7/2/2009,
NCT00345969,Exercise and Testosterone Therapy in Elderly Men With Physical Frailty,Physical Frailty|Hip Fracture|Elective Hip Replacement|Hypogonadism,2/21/2018,
NCT00775528,Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis,Cystic Fibrosis|Pancreatic Exocrine Insufficiency,10/1/2010,
NCT00690820,Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency (PEI) Due to Cystic Fibrosis (CF),Cystic Fibrosis|Pancreatic Exocrine Insufficiency,3/10/2010,
NCT00510484,Study Investigating a Delayed-Release Pancrelipase in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis,Cystic Fibrosis,7/20/2009,
NCT00414908,A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy,Chronic Pancreatitis|Pancreatectomy|Pancreatic Exocrine Insufficiency,9/16/2009,
NCT01243450,"Bioequivalence Study of Generic Tretinoin 0.04% Microsphere Gel, 0.04% Retin-A Micro® and Placebo",Acne,11/18/2014,
NCT01135069,"Bioequivalence Study of Generic Tretinoin 0.1% Microsphere Gel, 0.1% Retin-A Micro® and Placebo",Acne,10/16/2014,
NCT01330628,Randomized Study of Laser and Balloon Angioplasty Versus Balloon Angioplasty to Treat Peripheral In-stent Restenosis,Peripheral Arterial Disease,6/15/2016,
NCT00598806,Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612),Bladder Cancer,8/15/2017,SPPI
NCT00461591,Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611),Bladder Cancer,8/15/2017,SPPI
NCT00996372,Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women,"Sexual Dysfunctions, Psychological",6/12/2014,
NCT00996164,Fixed 100 mg Every Evening of Flibanserin vs Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder,"Sexual Dysfunctions, Psychological",5/19/2014,
NCT00360555,Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder,"Sexual Dysfunctions, Psychological",6/27/2016,
NCT00360529,24-week Placebo-controlled Trial of Flibanserin Once Daily in Premenopausal Women With Hypoactive Sexual Desire Disorder,"Sexual Dysfunctions, Psychological",6/27/2016,
NCT00360243,6-mo. Min Eff Dose of Flibanserin: 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA,"Sexual Dysfunctions, Psychological",6/27/2016,
NCT00955825,Study of Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Adult Patients With Allergic Grass Pollen Rhinoconjunctivitis,Allergic Rhinitis Due to Grass Pollens,5/19/2016,
NCT02237950,Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV),Bacterial Vaginosis,7/9/2019,
NCT01656772,Vdrive Evaluation of Remote Steering and Testing in Lasso Electrophysiology Procedures Study,Atrial Fibrillation,6/4/2015,
NCT00597428,Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone,Opioid-Induced Bowel Dysfunction,12/7/2015,
NCT00595946,Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone,Opioid-Induced Bowel Dysfunction,2/3/2016,
NCT00947661,Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular Hypertension,Open Angle Glaucoma|Ocular Hypertension,5/30/2016,
NCT00945958,Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular Hypertension,Open Angle Glaucoma|Ocular Hypertension,5/5/2016,
NCT01797185,Safety Study of SPARC1104,Spasticity,3/12/2019,
NCT01457352,Efficacy and Safety of SPARC0921 in Subjects With Spasticity,Spasticity,6/18/2019,
NCT02688556,Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca,Keratoconjunctivitis Sicca,4/8/2019,
NCT02254265,Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca,Keratoconjunctivitis Sicca|Dry Eye Disease,12/14/2018,
NCT01191801,Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory AML,Acute Myeloid Leukemia,5/9/2017,SNSS
NCT00790023,Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis,Seasonal Allergic Rhinitis,6/8/2012,
NCT01287364,Evaluation of a Novel Questionnaire to Assess Patient Satisfaction With and Preference of Intranasal Corticosteroids for the Treatment of Allergic Rhinitis,Perennial Allergic Rhinitis,10/31/2012,
NCT01033825,Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis,Perennial Allergic Rhinitis,7/19/2012,
NCT02046369,Lurasidone Pediatric Bipolar Study,Bipolar I Depression,12/20/2017,
NCT01911442,Lurasidone Pediatric Autism Study,Autism,2/25/2016,
NCT01911429,Pediatric Schizophrenia Efficacy and Safety Study,Schizophrenia,3/22/2017,
NCT01821378,Lurasidone Low-Dose - High-Dose Study Study,Schizophrenia,1/8/2016,
NCT01575561,"This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296",Bipolar I Disorder,8/22/2016,
NCT01566162,"A Twelve Week, Open Label Extension Study in Patients With Schizophrenia",Schizophrenia,11/20/2014,
NCT01458275,A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR),Seasonal Allergic Rhinitis,5/15/2014,
NCT01451541,A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).,Perennial Allergic Rhinitis|PAR,5/6/2014,
NCT01435928,PEARL Schizophrenia Maintenance,Schizophrenia,9/25/2014,
NCT01423253,Major Depressive Disorder With Mixed Features - Extension,Major Depressive Disorder,10/14/2015,
NCT01421134,Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose,Major Depressive Disorder With Mixed Features,10/9/2015,
NCT01401465,"Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spray",Perennial Allergic Rhinitis,4/30/2013,
NCT01358357,Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex,Bipolar I Disorder,7/26/2016,
NCT01284517,Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression,Bipolar Depression,10/14/2013,
NCT01378429,Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis,Perennial Allergic Rhinitis|PAR,5/26/2014,
NCT01143090,A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder,Schizophrenia|Schizoaffective Disorder,12/17/2012,
NCT01143077,A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents,Schizophrenia|Schizoaffective Disorder,8/16/2012,
NCT01091662,Safety & Efficacy of Eslicarbazepine Monotherapy in Sub.w/Partial Epilepsy Not Well Controlled by Current Antiepileptic,Epilepsy,12/21/2015,
NCT01067105,A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older,Perennial Allergic Rhinitis,6/11/2012,
NCT00953147,A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older,Allergic Rhinitis|Perennial Allergic Rhinitis,6/7/2012,
NCT00910247,Eslicarbazepine Acetate Monotherapy Long Term Study,Epilepsy,7/17/2018,
NCT00909779,Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects,Chronic Obstructive Pulmonary Disease,11/11/2013,
NCT01010971,Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older,Seasonal Allergic Rhinitis,6/8/2012,
NCT00868959,Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression,Bipolar Depression,4/1/2014,
NCT00868699,Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy),Bipolar Depression,7/2/2013,
NCT00868452,Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on),Bipolar Depression,4/2/2013,
NCT00866775,Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs,Epilepsy With Simple or Complex Partial Onset Seizures,2/4/2016,
NCT00857220,Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia,Insomnia|Attention Deficit Hyperactivity Disorder,7/22/2013,
NCT00856973,Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia,Insomnia|Attention Deficit Hyperactivity Disorder,4/10/2013,
NCT00809757,"A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma",Asthma,7/28/2014,
NCT00790192,Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.,Schizophrenia,10/6/2011,
NCT00789698,Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia,Chronic Schizophrenia,8/21/2012,
NCT00641745,Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia,Schizophrenia|Schizoaffective Disorder,10/6/2011,
NCT00615433,Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia,Schizophrenia,2/14/2011,
NCT00549718,Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia,Schizophrenia,12/14/2010,
NCT00250679,Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease,Chronic Obstructive Pulmonary Disease|Bronchitis|Emphysema,2/19/2009,
NCT02347774,Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4),COPD|Chronic Obstructive Pulmonary Disease,3/13/2018,
NCT02347761,Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD,COPD,3/22/2018,
NCT02276222,A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD,Chronic Obstructive Pulmonary Disease (COPD),3/13/2018,
NCT00529555,Periocline as an Adjunct to Scaling and Root Planing for Adult Periodontitis,Adult Periodontitis,5/9/2014,
NCT00908349,Safety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial Epilepsy,Partial Epilepsy,5/31/2017,SUPN
NCT01556997,Perindopril Amlodipine for the Treatment of Hypertension,Essential Hypertension,8/25/2015,
NCT01982240,12-Week Study of Plecanatide for CIC (The CIC3 Study),Chronic Idiopathic Constipation,3/21/2019,
NCT01489254,Efficacy and Safety of GTR in Comparison to Copaxone®,Multiple Sclerosis,10/31/2016,
NCT01607957,Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies,Colorectal Cancer,5/21/2019,
NCT01048242,Treatment of Insomnia in Elderly Sleep Apnea Patients With Ramelteon (TAK 375),Insomnia|Obstructive Sleep Apnea,5/3/2017,TAK
NCT02425111,Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease,Crohn's Disease,9/14/2018,TAK
NCT02139046,Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout,Gout,11/3/2016,TAK
NCT01456195,Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes,"Diabetes Mellitus, Type 2",4/5/2016,TAK
NCT01364649,Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual Dysfunction,Treatment Outcome,10/9/2014,TAK
NCT01192022,TachoSil® Versus Surgicel® Original for the Secondary Treatment of Local Bleeding in Adult and Pediatric Patients Undergoing Hepatic Resection Surgery,Hemorrhage,11/25/2015,TAK
NCT01179516,Safety and Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder,"Depressive Disorder, Major",12/18/2013,TAK
NCT01163266,Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder,"Depressive Disorder, Major",12/18/2013,TAK
NCT01153009,Safety and Efficacy of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder,"Depressive Disorder, Major",12/18/2013,TAK
NCT01101035,Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES),Cardiovascular Disease,6/14/2018,TAK
NCT01033071,Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.,Essential Hypertension,2/7/2012,TAK
NCT01023581,Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 Diabetes,"Diabetes Mellitus, Type 2",3/26/2013,TAK
NCT00968708,Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome,"Diabetes Mellitus, Type 2|Acute Coronary Syndrome",4/15/2014,TAK
NCT00856284,Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes Mellitus,Type 2 Diabetes Mellitus,12/3/2013,TAK
NCT00847808,Efficacy of Dexlansoprazole MR on Heartburn Control in Participants Previously Receiving Twice Daily Proton Pump Inhibitor Therapy,Gastroesophageal Reflux,4/29/2011,TAK
NCT00847626,Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe Hypertension,Hypertension,2/7/2012,TAK
NCT00846365,Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension,Essential Hypertension,3/13/2012,TAK
NCT00818883,Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe Hypertension,Essential Hypertension,2/7/2012,TAK
NCT00790933,An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's Disease,Ulcerative Colitis|Crohn's Disease,3/12/2019,TAK
NCT00727857,Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus.,Diabetes Mellitus,3/9/2010,TAK
NCT00707993,Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics,Diabetes Mellitus,5/24/2013,TAK
NCT00696436,An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.,Hypertension,4/19/2011,TAK
NCT00696384,A Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension,Hypertension,1/4/2012,TAK
NCT00696241,Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential Hypertension,Hypertension,4/19/2011,TAK
NCT00695955,One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension,Hypertension,4/19/2011,TAK
NCT00627016,A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn,Gastroesophageal Reflux,5/6/2010,TAK
NCT00591773,Efficacy and Safety of Azilsartan Medoxomil Co-Administered With Chlorthalidone in Participants With Essential Hypertension,Hypertension,4/19/2011,TAK
NCT00591578,Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential Hypertension,Hypertension,4/19/2011,TAK
NCT00591266,"Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential Hypertension",Hypertension,4/19/2011,TAK
NCT00591253,Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential Hypertension,Hypertension,4/19/2011,TAK
NCT00506883,MPC-004 for the Treatment of an Acute Gout Flare,Gout,9/22/2009,TAK
NCT00432276,Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus,Diabetes Mellitus,4/4/2013,TAK
NCT00430248,Efficacy and Safety of Oral Febuxostat in Participants With Gout,Gout,7/16/2009,TAK
NCT00395512,Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes Mellitus,Diabetes Mellitus,3/27/2013,TAK
NCT00328627,Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.,Type 2 Diabetes Mellitus,4/4/2013,TAK
NCT00321984,Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Gastroesophageal Reflux Disease,Gastroesophageal Reflux Disease,3/23/2009,TAK
NCT00321737,Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive Esophagitis,"Esophagitis, Reflux|Esophagitis, Peptic",8/28/2009,TAK
NCT00306384,Long-term Safety of Alogliptin in Patients With Type 2 Diabetes Mellitus,Diabetes Mellitus,3/22/2013,TAK
NCT00286494,Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus,Diabetes Mellitus,9/27/2011,TAK
NCT00286468,Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus.,Diabetes Mellitus,8/25/2011,TAK
NCT00286455,Efficacy and Safety of Alogliptin in Subjects With Type 2 Diabetes,Diabetes Mellitus,8/29/2011,TAK
NCT00286442,Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes Mellitus,Diabetes Mellitus,8/25/2011,TAK
NCT00286429,Efficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes.,Diabetes Mellitus,8/12/2011,TAK
NCT00255190,Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn,Gastroesophageal Reflux Disease,8/12/2009,TAK
NCT00255164,Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive Esophagitis,"Esophagitis, Reflux|Esophagitis, Peptic",8/28/2009,TAK
NCT00255151,Comparison of Dexlansoprazole MR to Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive Esophagitis,"Esophagitis, Reflux|Esophagitis, Peptic",8/28/2009,TAK
NCT00251758,Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Heartburn,Gastroesophageal Reflux Disease,3/23/2009,TAK
NCT00251745,Efficacy and Safety of Dexlansoprazole Modified Release Formulation to Treat Heartburn,Gastroesophageal Reflux Disease,3/23/2009,TAK
NCT00251719,Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis,"Esophagitis, Reflux|Esophagitis, Peptic",3/23/2009,TAK
NCT00251693,Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis,"Esophagitis, Reflux|Esophagitis, Peptic",3/23/2009,TAK
NCT00225277,Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes Mellitus,Diabetes Mellitus,6/10/2009,TAK
NCT01156597,Effects of Pioglitazone on High-density Lipoprotein (HDL) Function in Persons With Diabetes,Type 2 Diabetes Mellitus,11/11/2014,TAK
NCT01469819,Lubiprostone Effect on Gastrointestinal Tract Transit Times Measured by Smartpill in Patients With Chronic Constipation,Chronic Idiopathic Constipation,8/1/2016,TAK
NCT00220961,Actos Now for Prevention of Diabetes (ACT NOW),Impaired Glucose Tolerance|Type 2 Diabetes,8/11/2016,TAK
NCT00335283,Efficacy of Lansoprazole in Chronic Post Nasal Drip,Larynx Disease,8/21/2012,
NCT02933866,Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis,Scalp Psoriasis,12/6/2018,TARO
NCT02618759,Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Mild to Moderate Plaque Psoriasis,Plaque Psoriasis,12/10/2018,TARO
NCT02595073,Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone (DSXS) With Atopic Dermatitis,Atopic Dermatitis,12/7/2018,TARO
NCT01206660,Effects of Desoximetasone Spray 0.25% in Patients With Moderate to Severe Plaque Psoriasis,Psoriasis,7/3/2014,TARO
NCT00927472,"Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice",Pediculosis,8/4/2014,TARO
NCT00752973,Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice,Pediculosis,4/3/2014,TARO
NCT00963508,"Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice",Pediculosis,6/13/2014,TARO
NCT00959764,A Study Comparing Oral Calcitonin to Nasal Spray Calcitonin in Postmenopausal Osteoporotic Women,"Osteoporosis, Postmenopausal",11/19/2013,
NCT01202747,Evaluation of Screening Methods for Treatment of Meibomian Gland Dysfunction,Chalazion|Dry Eye Syndromes,12/6/2011,
NCT02025621,Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass,Coronary Artery Bypass Grafting|Mitral Valve Surgery|Low Cardiac Output Syndrome,5/22/2018,TENX
NCT00759681,"ArterX Surgical Sealant, A Randomized Prospective Multicenter Trial",Vascular Disease,1/31/2013,
NCT01741701,A Pilot Study of Oxaloacetate in Subjects With Treated PD,Parkinson's Disease,3/17/2016,
NCT01500226,Ph 3 Safety/Efficacy Study of Rolapitant for Prevention of CINV in Subjects Receiving Moderately Emetogenic Chemotherapy,Chemotherapy-induced Nausea and Vomiting,11/4/2015,
NCT01500213,Ph3 Safety/Efficacy Study of Rolapitant for the Prevention of CINV in Subjects Receiving Highly Emetogenic Chemotherapy,Chemotherapy-induced Nausea and Vomiting,11/4/2015,
NCT01499849,Ph3 Safety/Efficacy Study of Rolapitant for the Prevention of CINV in Subjects Receiving Highly Emetogenic Chemotherapy,Chemotherapy-induced Nausea and Vomiting,11/4/2015,
NCT02784704,Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections,Complicated Intra-abdominal Infections|Complicated Appendicitis,2/18/2019,TTPH
NCT01844856,Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections,Complicated Intra-abdominal Infections,3/21/2016,TTPH
NCT01978938,Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections,cUTI,12/11/2018,TTPH
NCT01133626,Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Allergic Rhinitis (PAR),Perennial Allergic Rhinitis,7/4/2012,TEVA
NCT01024608,Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR),Seasonal Allergic Rhinitis|Hay Fever,5/23/2012,TEVA
NCT00544882,A Study to Evaluate Hormone Patterns and Ovarian Follicular Activity With DR-1021,Healthy,6/10/2014,TEVA
NCT02969408,A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Asthma,Asthma,5/3/2019,TEVA
NCT02629861,Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine,Migraine,11/8/2018,TEVA
NCT02621931,Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine,Migraine,12/6/2018,TEVA
NCT02513160,Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma,Persistent Asthma,9/11/2017,TEVA
NCT02501629,An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils,Asthma|Elevated Blood Eosinophils|Oral Corticosteroid Dependence,9/13/2018,TEVA
NCT02175771,Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma,Persistent Asthma,4/14/2017,TEVA
NCT02141854,Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma,Asthma,4/12/2017,TEVA
NCT02139644,Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma,Asthma,4/12/2017,TEVA
NCT02126839,A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric Asthmatics,Asthma,2/5/2016,TEVA
NCT02040779,A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma,Persistent Asthma,12/11/2017,TEVA
NCT02040766,A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma,Asthma,2/12/2018,TEVA
NCT02031640,A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma,Asthma,1/5/2018,TEVA
NCT01922739,"Open-Label, Extension Study to Evaluate the Safety of Hydrocodone Bitartrate Extended-Release Tablets",Low Back Pain,6/2/2017,TEVA
NCT01789970,Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain,Low Back Pain,4/5/2017,TEVA
NCT01747629,Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State Pharmacokinetics,Asthma,5/21/2015,TEVA
NCT01707992,"The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)",Multiple Sclerosis,3/13/2019,TEVA
NCT01508936,Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma,Eosinophilic Asthma,6/27/2016,TEVA
NCT01424813,A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma,Asthma,5/20/2015,TEVA
NCT01307319,Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies,Seasonal Allergic Rhinitis|SAR,2/20/2015,TEVA
NCT01287039,A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma,Eosinophilic Asthma,6/27/2016,TEVA
NCT01285323,A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma,Eosinophilic Asthma,6/27/2016,TEVA
NCT01270464,A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma,Eosinophilic Asthma,6/6/2016,TEVA
NCT01240863,Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) for Relief of Moderate to Severe Pain in Patients With Osteoarthritis or Low Back Pain Who Require Opioid Treatment for an Extended Period of Time,Chronic Pain,6/5/2017,TEVA
NCT01223365,Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) in Patients Who Require Opioid Treatment for an Extended Period of Time,Chronic Pain,4/5/2017,TEVA
NCT01178125,A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy,Contraception|Female Contraception,12/11/2013,TEVA
NCT01134705,Study in Adult and Adolescent Subjects With PAR (Perennial Allergic Rhinitis),"Rhinitis, Allergic, Perennial",5/23/2012,TEVA
NCT00988247,Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 Mcg in Allergic Rhinitis,"Rhinitis, Allergic, Perennial",5/23/2012,TEVA
NCT00877006,Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study,Non-Hodgkin's Lymphoma|Mantle Cell Lymphoma,4/28/2014,TEVA
NCT00577655,Albuterol HFA MDI in Pediatric Participants With Asthma,Asthma,12/3/2009,TEVA
NCT01791972,Efficacy of Albuterol SPIROMAX® in Adult and Adolescent Patients With Exercise-Induced Bronchoconstriction (EIB),Exercise-Induced Bronchoconstriction (EIB),5/19/2015,TEVA
NCT01697956,Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR),Allergic Rhinitis,10/8/2015,TEVA
NCT01874145,Safety and Tolerability of Glatiramer Acetate,Relapsing-Remitting Multiple Sclerosis,1/14/2016,TEVA
NCT01857323,Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI),Asthma|Chronic Obstructive Pulmonary Disease (COPD),6/8/2015,TEVA
NCT01795859,First Time Use of SD-809 in Huntington Disease,Chorea,8/11/2017,TEVA
NCT01783548,Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR),Allergic Rhinitis,10/12/2015,TEVA
NCT01698320,Safety Study of Albuterol Spiromax® in Subjects With Asthma,Asthma,8/19/2015,TEVA
NCT01067521,"A Study in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) to Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) Injection 40 mg Administered Three Times a Week Compared to Placebo",Relapsing Remitting Multiple Sclerosis,10/9/2018,TEVA
NCT00996580,A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy,Pregnancy Prevention,6/14/2013,TEVA
NCT03091673,Glucose Response of G-Pen (Glucagon Injection) in Pediatric T1D Patients,"Diabetes Mellitus, Type 1",11/16/2018,
NCT01156571,A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention (PCI) (CHAMPION PHOENIX),Atherosclerosis|Percutaneous Coronary Intervention|Acute Coronary Syndrome,6/18/2013,MDCO
NCT00803634,Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure (PRONTO),Hypertension|Heart Failure,8/19/2014,MDCO
NCT00666328,Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage (ACCELERATE),Hypertension|Hemorrhage,4/8/2013,MDCO
NCT02742441,A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 310),Plaque Psoriasis,11/14/2018,
NCT02367911,A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis,Plaque Psoriasis,9/27/2018,
NCT02368210,A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 306),Plaque Psoriasis,11/26/2018,
NCT01882647,A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305),Plaque Psoriasis,2/13/2017,
NCT01871402,A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304),Plaque Psoriasis,4/11/2016,
NCT02253173,Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women,Vulvovaginal Atrophy|Menopause|Dyspareunia|Painful Intercourse,5/25/2017,TXMD
NCT01942668,A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms,Menopause,5/6/2019,TXMD
NCT00608023,TH9507 Extension Study in Patients With HIV- Associated Lipodystrophy,Lipodystrophy|HIV Infections,1/15/2014,
NCT03095456,Revefenacin Peak Inspiratory Flow Rate (PIFR) Study in COPD,"Chronic Obstructive Pulmonary Disease, COPD|Low Peak Inspiratory Flow Rate (PIFR)",12/31/2018,TBPH
NCT02518139,A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD),Chronic Obstructive Pulmonary Disease (COPD),12/31/2018,TBPH
NCT02512510,Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD),Chronic Obstructive Pulmonary Disease (COPD),12/31/2018,TBPH
NCT02459080,Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD),Chronic Obstructive Pulmonary Disease (COPD),12/31/2018,TBPH
NCT01746979,Clinical Trial Testing TH-302 in Combination With Gemcitabine in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma,Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma,12/2/2017,
NCT01429441,Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole,Vitreomacular Adhesion Including Macular Hole,1/11/2016,
NCT00798317,Trial of Microplasmin Intravitreal Injection for Non-Surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-007) Trial.,Vitreomacular Adhesion,1/30/2013,
NCT00781859,Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-006) Trial.,Vitreomacular Adhesion,1/28/2013,
NCT00703118,"A Safety and Effectiveness Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment","Hepatitis C, Chronic",8/11/2011,JNJ
NCT00758043,A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response,Hepatitis C,7/21/2011,JNJ
NCT00627926,A Phase 3 Study of Telaprevir in Combination With Pegasys® and Copegus® in Treatment-Naive Subjects With Genotype 1 Hepatitis C Virus (HCV),Hepatitis C,7/21/2011,JNJ
NCT00543725,TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors,HIV Infections|HIV-1,7/12/2011,JNJ
NCT00540449,TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.,HIV Infections|HIV-1|Human Immunodeficiency Virus Type 1,7/11/2011,JNJ
NCT00524368,A Study to Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN),Human Immunodeficiency Virus - Type 1,9/22/2010,JNJ
NCT00359021,An Open-label Trial With TMC125 in Patients Who Have Virologically Failed in a DUET Trial (TMC125-C206 or TMC125-C216).,HIV-1,3/7/2013,JNJ
NCT00460746,Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects.,HIV,11/10/2009,JNJ
NCT00381303,"GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men.",HIV|Infectious,10/19/2010,JNJ
NCT02015234,12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients,Primary Fibromyalgia,7/7/2017,TNXP
NCT01903265,BEdtime Sublingual TNX-102 SL as Fibromyalgia Intervention Therapy (BESTFIT),Primary Fibromyalgia,12/23/2016,TNXP
NCT01066585,A Safety and Efficacy Study Comparing 0.5% Ivermectin Cream to a Vehicle Control in Subjects With Head Lice Infestation,Head Lice,4/4/2012,
NCT01068158,A Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects,Head Lice,4/4/2012,
NCT01390038,Simpliciti IDE Trial; Replacing the Humeral Head in Total Shoulder Arthroplasty,"Primary Generalized (Osteo)Arthritis|Post-traumatic Arthrosis of Other Joints, Upper Arm",4/14/2016,
NCT00466193,A Study of Zolpidem Tartrate Sublingual Tablet in Adult Patients With Insomnia,Insomnia,1/20/2012,
NCT03088267,Dyanavel® XR Extended-Release Oral Suspension in the Treatment of Children With ADHD: A Laboratory School Study,Attention Deficit Hyperactivity Disorder,7/9/2019,
NCT01421511,TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections,Skin and Subcutaneous Tissue Bacterial Infections,9/8/2014,
NCT01170221,TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.,Skin and Subcutaneous Tissue Bacterial Infections,9/3/2014,
NCT02346240,Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO),Psoriasis|Plaque Psoriasis,7/18/2018,
NCT02326272,A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO),Psoriasis|Plaque Psoriasis,8/13/2018,
NCT02326298,An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO),Psoriasis|Plaque Psoriasis,8/13/2018,
NCT01537042,A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis,Restless Legs Syndrome|End-Stage Renal Disease,11/3/2014,
NCT01087788,Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis,"Arthritis, Psoriatic",2/25/2014,
NCT01087762,Certolizumab Pegol in Subjects With Active Axial Spondyloarthritis,Spondyloarthropathies,12/25/2013,
NCT00655551,Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures,Partial Epilepsies|Partial Onset Seizures,10/20/2010,
NCT00655486,Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures,Partial Epilepsies|Partial Onset Seizures,7/15/2011,
NCT00522275,Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures,Partial Epilepsies,11/22/2010,
NCT00520741,Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures,Epilepsy,4/23/2014,
NCT01921205,Study to Investigate Lacosamide as Add-on Therapy in Subjects ≥4 Years to <17 Years of Age With Partial Onset Seizures,Epilepsy,3/19/2018,
NCT01569464,Rotigotine Effect on All-day Functioning and Quality of Life in Subjects With Moderate to Severe Restless Legs Syndrome (RLS),Restless Legs Syndrome,8/26/2014,
NCT01521923,"A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis",Rheumatoid Arthritis,1/10/2017,
NCT01519791,"A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis",Rheumatoid Arthritis,9/22/2015,
NCT01484977,eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam,Epilepsy,11/26/2014,
NCT01728077,"Evaluation of Long-term Safety, and Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects With Epilepsy",Epilepsy,8/2/2017,
NCT01408576,Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosus,Systemic Lupus Erythematosus,10/3/2018,
NCT01405508,Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy,Epilepsy,4/13/2016,
NCT01653262,Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV),Epilepsy,8/15/2016,
NCT01262365,Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus,Systemic Lupus Erythematosus,6/29/2018,
NCT01261793,Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE),Systemic Lupus Erythematosus,6/29/2018,
NCT01261325,Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures,Epilepsy,8/15/2016,
NCT00761774,"An Open-label, Multinational, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam",Epilepsy,4/23/2018,
NCT00753454,Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA),Rheumatoid Arthritis,6/14/2012,
NCT00717236,Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis,Rheumatoid Arthritis,5/6/2011,
NCT00628108,Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months,Allergic Rhinitis|Chronic Urticaria,10/14/2009,
NCT00619801,Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin,Allergic Rhinitis|Chronic Urticaria,9/4/2009,
NCT00594386,An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advance-Stage Parkinson's Disease,Parkinson's Disease,12/18/2009,
NCT00594165,An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease.,Early-Stage Parkinson's Disease,2/25/2010,
NCT00552058,Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease,Crohn Disease,12/30/2010,
NCT00530855,Trial to Assess Long-term Lacosamide (LCM) Monotherapy Use and Safety of LCM Monotherapy and Adjunctive Therapy for Partial-onset Seizures,Epilepsy,6/3/2015,
NCT00522379,Trial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal Patch,Parkinson's Disease,12/10/2012,
NCT00505687,An Open-Label Extension Trial to Assess the Safety and Tolerability of Long Term Treatment of Rotigotine in Subjects With Idiopathic Parkinson's Disease,Idiopathic Parkinson's Disease,1/12/2010,
NCT00464269,"Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures",Epilepsy,4/13/2016,
NCT00419393,Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures,Epilepsy,7/13/2011,
NCT00419094,Conversion to Monotherapy Study With Keppra XR for Partial Seizures,Epilepsy,12/20/2010,
NCT00474058,Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine,Parkinson's Disease,4/12/2010,
NCT00356408,"Examining the Long Term Safety, Efficacy, and Corticosteroid-sparing Effect of Certolizumab Pegol in Crohn's Disease",Crohn's Disease,5/25/2011,
NCT00333788,Follow-up to Welcome Study C87042 [NCT00308581] Examining Certolizumab Pegol (CDP870) in Subjects With Crohn's Disease,Crohn's Disease,7/12/2011,
NCT00308581,Certolizumab in Crohn's Disease Patients With Loss of Response or Intolerance to Infliximab,Crohn's Disease,11/17/2009,
NCT00175877,A Study of the Safety and Effectiveness of Lyophilized Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis,Rheumatoid Arthritis,3/8/2013,
NCT00160706,A follow-on Safety Study in Subjects With Crohn's Disease Who Have Previously Been Withdrawn From the Double-blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] Due to an Exacerbation of Crohn's Disease,Crohn's Disease,7/4/2013,
NCT00160693,Open Label Long-Term Safety Study of Certolizumab Pegol (CZP) for Patients With Rheumatoid Arthritis,Rheumatoid Arthritis,7/9/2012,
NCT00160524,A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425],Crohn's Disease,10/10/2013,
NCT00152516,"Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures","Epilepsy, Partial",1/13/2010,
NCT00160641,A Study of the Safety and Effectiveness of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis,Rheumatoid Arthritis,3/7/2013,
NCT00150800,"This Trial, Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy, Who May Have Benefited From Brivaracetam as Adjunctive Treatment, the Opportunity to Receive Open Label Brivaracetam Treatment",Epilepsy,12/5/2018,
NCT00368251,Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease (ULD) in Adolescents and Adults,Unverricht-Lundborg Disease,4/13/2016,
NCT00235443,A Follow-On Trial to Assess the Long Term Safety and Efficacy of SPM 927 in Painful Distal Diabetic Neuropathy,Diabetic Neuropathy,10/5/2009,
NCT02230566,A Phase 3 Study of UX003 Recombinant Human Betaglucuronidase (rhGUS) Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis Type 7 (MPS 7),MPS 7|Sly Syndrome|Mucopolysaccharidosis|MPS VII,2/16/2018,RARE
NCT02377921,"Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sialic Acid in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)","Hereditary Inclusion Body Myopathy|Distal Myopathy With Rimmed Vacuoles|Distal Myopathy, Nonaka Type|GNE Myopathy",7/9/2018,RARE
NCT01934582,A Pharmacokinetic Substudy of the TDE-PH-304 Protocol,Pulmonary Arterial Hypertension,10/27/2016,
NCT00887978,Efficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial Hypertension,Pulmonary Hypertension,1/15/2013,
NCT00325442,FREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor for the Treatment of Pulmonary Arterial Hypertension (PAH),Pulmonary Hypertension,6/10/2013,
NCT00325403,FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH),Pulmonary Hypertension,3/18/2013,
NCT00147199,Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH),Pulmonary Hypertension,8/12/2013,
NCT00189202,"Efficacy of Sirolimus-Based, Steroid Avoidance Immunosuppression African Americans",End Stage Renal Disease|Kidney Transplantation,4/5/2017,
NCT01191086,Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures,Epilepsy,2/23/2015,
NCT01142193,Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures,Epilepsy,5/7/2014,
NCT01246479,"Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study",Japanese Encephalitis,4/29/2015,
NCT01047839,"Immunogenicity and Safety of the Japanese Encephalitis Vaccine IC51 (IXIARO®, JESPECT®) in a Pediatric Population in Non-endemic Countries",Encephalitis,12/19/2014,
NCT01430754,Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder,Non-24-Hour Sleep-Wake Disorder,10/10/2014,VNDA
NCT01163032,Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder,Non-24-Hour Sleep-Wake Disorder,10/16/2014,VNDA
NCT00548340,VEC-162 Study in Adult Patients With Primary Insomnia,Primary Insomnia,10/15/2014,VNDA
NCT00291187,VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia,Insomnia,10/15/2014,VNDA
NCT01428661,Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder,Major Depressive Disorder,6/19/2015,VNDA
NCT02339246,Pharmacokinetic Comparison Of All FK-506 Formulations,Renal Failure,1/18/2016,
NCT01962922,Crossover Study to Compare PK of Once Daily LCP-Tacro Tablets to Generic Tacrolimus Capsules Twice Daily.,Renal Failure,8/15/2016,
NCT01438710,Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO),Renal Failure|Tremors,5/8/2015,
NCT01187953,"Double-Blind,Double-Dummy,Efficacy/Safety,LCP-Tacro™ Vs Prograf®,Prevention Rejection,De Novo Adult Kidney Tx",Renal Failure,5/29/2015,
NCT02390219,Study to Evaluate Lumacaftor and Ivacaftor Combination Therapy in Subjects 12 Years and Older With Advanced Lung Disease,Cystic Fibrosis|Advanced Lung Disease,11/1/2017,VRTX
NCT02797132,"Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Subjects Aged 2 Through 5 Years With Cystic Fibrosis, Homozygous for F508del",Cystic Fibrosis,10/30/2018,VRTX
NCT02516410,"A Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-CFTR Mutation",Cystic Fibrosis,6/12/2018,VRTX
NCT02514473,"A Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination With Ivacaftor in Subjects With CF, Homozygous for the F508del-CFTR Mutation",Cystic Fibrosis,10/23/2017,VRTX
NCT02412111,"A Phase 3 Study of Tezacaftor (VX-661) in Combination With Ivacaftor (VX-770) in Subjects Aged 12 Years and Older With Cystic Fibrosis (CF), Who Have One F508del-CFTR Mutation and a Second Mutation That Has Been Demonstrated to be Clinically Responsive to Ivacaftor",Cystic Fibrosis,1/8/2019,VRTX
NCT02392234,"A Phase 3 Study to Evaluate the Efficacy and Safety of Ivacaftor and VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutation",Cystic Fibrosis,6/12/2018,VRTX
NCT02347657,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor",Cystic Fibrosis,6/12/2018,VRTX
NCT01931839,A Phase 3 Rollover Study of Lumacaftor in Combination With Ivacaftor in Subjects 12 Years and Older With Cystic Fibrosis,"Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation",5/12/2017,VRTX
NCT01897233,"Study of Lumacaftor in Combination With Ivacaftor in Subjects 6 Through 11 Years of Age With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation",Cystic Fibrosis,12/5/2016,VRTX
NCT01807949,A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation,"Cystic Fibrosis, Homozygous for the F508del CFTR Mutation",9/1/2015,VRTX
NCT01807923,A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation,"Cystic Fibrosis, Homozygous for the F508del CFTR Mutation",8/31/2015,VRTX
NCT00426660,Expanded Access Program for Maraviroc At Multiple Centers,HIV Infections,10/17/2011,
NCT00889252,"Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers",Allergic Conjunctivitis,11/23/2010,
NCT00889330,Safety and Efficacy Study of a Eye Drop for Eye Allergy,Allergic Conjunctivitis,12/8/2011,
NCT00569777,"Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers",Allergic Conjunctivitis,11/23/2010,
NCT01471041,Safety and Efficacy Study of the Venous Window Needle Guide to Access Arteriovenous (AV)Fistulae,End Stage Renal Disease|AV Fistula|Kidney Failure,6/3/2016,
NCT01471028,Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure,Acute Alcoholic Hepatitis,2/15/2019,
NCT00895011,Research Evaluating an Investigational Medication for Erectile Dysfunction - Post-Prostatectomy,Erectile Dysfunction,6/28/2012,VVUS
NCT00853606,Long-Term Safety and Efficacy Study of Avanafil in Men With Erectile Dysfunction,Erectile Dysfunction,6/28/2012,VVUS
NCT00809471,Research Evaluating an Investigational Medication for Erectile Dysfunction - Diabetic ED (REVIVE-D),Erectile Dysfunction,6/28/2012,VVUS
NCT00790751,Research Evaluating an Investigational Medication for Erectile Dysfunction - General ED,Erectile Dysfunction,6/28/2012,VVUS
NCT00594100,GORE Embolic Protection With Reverse Flow,Carotid Artery Stenosis,5/5/2009,
NCT00737672,GORE VIABAHN Endoprosthesis Versus Percutaneous Transluminal Angioplasty (PTA) to Revise AV Grafts in Hemodialysis,Renal Failure|Hemodialysis,10/21/2014,
NCT01113931,Treatment of Chlamydia Infection Comparing WC2031 Tablets With Vibramycin,Urogential Chlamydia Trachomatis Infection,1/27/2012,
NCT01070979,Hormone Replacement Therapy for Use in Postmenopausal Women for Relief of Hot Flushes and Urogenital Symptoms.,Hormone Replacement Therapy,4/8/2011,
NCT01037244,Treatment of Erectile Dysfunction I,Erectile Dysfunction,12/22/2011,
NCT01037218,Treatment of Erectile Dysfunction II,Erectile Dysfunction,12/22/2011,
NCT00932321,Study of Safety and Efficacy of an Oral Contraceptive,Prevention of Pregnancy,3/22/2011,
NCT00713310,Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis,Ulcerative Colitis,4/4/2012,
NCT00577473,Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I),Ulcerative Colitis,6/22/2011,
NCT00541658,A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis,Postmenopausal Osteoporosis,6/21/2011,
NCT00505778,A Comparison of Once a Day Dose Compared to 2 Doses/Day,Ulcerative Colitis,5/12/2011,
NCT00477633,Study of Safety and Efficacy of an Oral Contraceptive,Contraception,1/24/2011,
NCT00467259,Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women,Hypoactive Sexual Desire Disorder,12/15/2011,
NCT00391807,Study of Safety and Efficacy of an Oral Contraceptive,Contraception,12/22/2010,
NCT00073021,Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis,Ulcerative Colitis,7/28/2011,
NCT00106028,Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children,Osteogenesis Imperfecta,6/28/2010,
NCT00350636,A Comparison of a New Drug to Treat Overactive Bladder vs. Placebo,Overactive Bladder,5/10/2010,
NCT00224133,The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months,Benign Prostatic Hyperplasia,4/27/2010,
NCT00224120,A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo,Benign Prostatic Hyperplasia,12/3/2009,
NCT00224107,A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo,Benign Prostatic Hyperplasia (BPH),12/3/2009,
NCT00223977,2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.,Iron Deficiency Anemia,9/28/2009,
NCT02110147,Open-Label Study of Uridine Triacetate in Pediatric Patients With Hereditary Orotic Aciduria,Hereditary Orotic Aciduria,6/28/2017,
NCT00606632,Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody,Renal Cell Carcinoma|Kidney Cancer,4/14/2014,
NCT00087022,Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer,Kidney Cancer,9/12/2018,
NCT00574548,"Study Evaluating the Safety, Tolerability and Immunogenicity of 13vPnC as a 2-Dose Regimen or With 23vPS",Pneumococcal Vaccines,5/9/2011,PFE
NCT00868296,Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD),Gastroesophageal Reflux,1/7/2010,PFE
NCT00546572,"Study Evaluating The Safety, Tolerability And Immunogenicity Of A 13-Valent Pneumococcal Conjugate Vaccine (13vPnC)",Pneumococcal Infections,5/30/2011,PFE
NCT00444457,Study Evaluating 13-valent Pneumococcal Conjugate Vaccine In Healthy Infants,"Vaccines, Pneumococcal",7/14/2010,PFE
NCT00406640,Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal Women,"Depression|Depressive Disorder|Depressive Disorder, Major",6/29/2010,PFE
NCT00369343,Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal Women,"Depression|Depressive Disorder|Depressive Disorder, Major",5/7/2012,PFE
NCT00366249,Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.,Bacterial Infections|Diabetic Foot|Osteomyelitis,8/21/2009,PFE
NCT00365300,Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Gastroesophageal Reflux Disease (GERD),Gastroesophageal Reflux,1/7/2010,PFE
NCT00362609,Study Evaluating Pantoprazole in Neonates and Preterm Infants With GERD,Gastroesophageal Reflux,5/14/2010,PFE
NCT00141817,Study Evaluating Pantoprazole in Children With GERD,Gastroesophageal Reflux,12/28/2011,PFE
NCT00243659,"Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery",Hemophilia A,7/20/2009,PFE
NCT00375934,Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery,"Pain, Postoperative",6/22/2010,
NCT00366444,Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery,"Pain, Postoperative",4/13/2011,
NCT00748098,Polysomnography Study of GSK1838262 Extended Release Tablets Versus Placebo in RLS and Associated Sleep Disturbance,Restless Legs Syndrome|Restless Legs Syndrome (RLS),5/18/2011,
NCT02656069,Safety and Efficacy of G-Pen Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics,"Hypoglycemia|Diabetes Mellitus, Type 1",9/28/2018,XERS
NCT00758758,Performance of the Hedrocel(R) Cervical Fusion Device,Symptomatic Cervical Disc Disease,8/12/2013,ZBH
NCT01115569,Long-Term Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Pain,Chronic Pain,4/25/2014,ZGNX
NCT01081912,Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain,Back Pain Lower Back Chronic,4/21/2014,ZGNX
NCT02745392,Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine,Acute Migraine,2/14/2018,ZSAN
NCT02163499,Open-label Safety and Efficacy of Sodium Zirconium Cyclosilicate for up to 12 Months,Hyperkalemia,6/27/2018,
NCT02107092,Open-label Safety & Efficacy of ZS (Sodium Zirconium Cyclosilicate)10g qd to Extend Study ZS-004 in Hyperkalemia.,Hyperkalemia,8/15/2018,
NCT02088073,Safety & Efficacy of Zirconium Silicate Dosed for 28 Days in Hyperkalemia.,Hyperkalemia,12/7/2018,
NCT01737697,Safety & Efficacy of Zirconium Silicate in Mild to Moderate Hyperkalemia,Hyperkalemia,10/12/2018,
NCT00491608,Immunogenicity and Safety Study of Topical Recombinant Thrombin in Surgical Hemostasis,Spinal Surgery|Vascular Surgery,1/12/2012,
NCT03128307,OTC Mouthpiece for Snoring,Snoring,12/14/2017,
